<SEC-DOCUMENT>0001437749-16-032927.txt : 20160527
<SEC-HEADER>0001437749-16-032927.hdr.sgml : 20160527
<ACCEPTANCE-DATETIME>20160527125308
ACCESSION NUMBER:		0001437749-16-032927
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160721
FILED AS OF DATE:		20160527
DATE AS OF CHANGE:		20160527

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Diffusion Pharmaceuticals Inc.
		CENTRAL INDEX KEY:			0001053691
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				300645032
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24477
		FILM NUMBER:		161681251

	BUSINESS ADDRESS:	
		STREET 1:		2020 AVON COURT
		STREET 2:		SUITE 4
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902
		BUSINESS PHONE:		(434) 220-0718

	MAIL ADDRESS:	
		STREET 1:		2020 AVON COURT
		STREET 2:		SUITE 4
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RestorGenex Corp
		DATE OF NAME CHANGE:	20140307

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stratus Media Group, Inc
		DATE OF NAME CHANGE:	20080722

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FERIS INTERNATIONAL, INC.
		DATE OF NAME CHANGE:	20080228
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>dffn20160526_pre14a.htm
<DESCRIPTION>FORM PRE 14A
<TEXT>
<HTML><HEAD><TITLE>dffn20160526_pre14a.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA1 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2958 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>UNITED STATES</B></FONT></P>
<P id=PARA2959 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P id=PARA2960 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Washington, D.C. 20549</B></FONT></P>
<P id=PARA2961 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA2962 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SCHEDULE 14A</B></FONT></P>
<P id=PARA2963 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2964 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proxy Statement Pursuant to Section 14(a) of<BR>the Securities Exchange Act of 1934 (Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;)</FONT></P>
<P id=PARA2957 style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<TABLE id=TBL85  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA10 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Filed by the Registrant&nbsp;&nbsp;&#9746;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA11 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA12 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Filed by a Party other than the Registrant&nbsp;&nbsp;&#9744;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA13 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA14 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Check the appropriate box:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA15 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9746;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA16 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Preliminary Proxy Statement</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA17 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA18 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA19 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA20 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Definitive Proxy Statement</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA21 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA22 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Definitive Additional Materials</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA23 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA24 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Soliciting Material under &#167;240.14a-12</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA25 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid" colSpan=4>
<P id=PARA26 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Diffusion Pharmaceuticals Inc.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA27 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Name of Registrant as Specified In Its Charter)</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA28 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid" colSpan=4>
<P id=PARA29 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Not Applicable</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA30 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA31 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 100%; VERTICAL-ALIGN: top" colSpan=4>
<P id=PARA32 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Payment of Filing Fee (Check the appropriate box):</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA33 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9746;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA34 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">No fee required.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA35 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA36 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA37 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(1)</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top">
<P id=PARA38 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Title of each class of securities to which transaction applies:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA39 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA40 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA41 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA42 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(2)</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top">
<P id=PARA43 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate number of securities to which transaction applies:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA44 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA45 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA46 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA47 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(3)</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top">
<P id=PARA48 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA49 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA50 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA51 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA52 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(4)</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top">
<P id=PARA53 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proposed maximum aggregate value of transaction:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA54 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA55 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA56 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA57 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(5)</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top">
<P id=PARA58 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total fee paid:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA59 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA60 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA61 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA62 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA63 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fee paid previously with preliminary materials.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA64 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT></P></TD>
<TD style="WIDTH: 94.9%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA65 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.3%; VERTICAL-ALIGN: top">
<P id=PARA66 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(1)</FONT></P></TD>
<TD style="WIDTH: 90.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA67 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Amount Previously Paid:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA68 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.3%; VERTICAL-ALIGN: top">
<P id=PARA69 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.6%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid" colSpan=2>
<P id=PARA70 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.3%; VERTICAL-ALIGN: top">
<P id=PARA71 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(2)</FONT></P></TD>
<TD style="WIDTH: 90.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA72 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Form, Schedule or Registration Statement No.:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA73 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.3%; VERTICAL-ALIGN: top">
<P id=PARA74 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.6%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid" colSpan=2>
<P id=PARA75 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.3%; VERTICAL-ALIGN: top">
<P id=PARA76 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(3)</FONT></P></TD>
<TD style="WIDTH: 90.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA77 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Filing Party:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA78 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.3%; VERTICAL-ALIGN: top">
<P id=PARA79 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.6%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid" colSpan=2>
<P id=PARA80 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 4.3%; VERTICAL-ALIGN: top">
<P id=PARA81 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(4)</FONT></P></TD>
<TD style="WIDTH: 90.6%; VERTICAL-ALIGN: top" colSpan=2>
<P id=PARA82 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Date Filed:</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">
<P id=PARA83 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 4.3%; VERTICAL-ALIGN: top">
<P id=PARA84 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 90.6%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid" colSpan=2>&nbsp; </TD></TR></TABLE>
<P id=PARA86 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK87  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR87  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM87  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR87  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA87.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 100%">
<P id=PARA2461 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt">&nbsp;<IMG src="a1.jpg" width=450 height=147></P></TD></TR></TABLE>
<P id=PARA89 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><FONT style="FONT-SIZE: 10pt; FONT-STYLE: normal; BACKGROUND-COLOR: yellow"></FONT></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA91 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Diffusion Pharmaceuticals Inc.</B></FONT></P>
<P id=PARA92 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>2020 Avon Court, Suite 4</B></FONT></P>
<P id=PARA93 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Charlottesville,&nbsp;Virginia 22902</B></FONT></P>
<P id=PARA94 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA95 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">June __, 2016</FONT></P>
<P id=PARA96 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA97 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dear Fellow Stockholders:</FONT></P>
<P id=PARA98 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA99 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We are pleased to invite you to join us for the Diffusion Pharmaceuticals Inc. Annual Meeting of Stockholders to be held on Thursday, July 21, 2016, at 9:00 a.m., Eastern Time, in the Preston Room at the Omni Charlottesville Hotel located at 212 Ridge McIntire Road, Charlottesville,&nbsp;Virginia 22903. Details about the meeting, nominees for election to the Board of Directors and other matters to be acted on at the meeting are presented in the Notice of Annual Meeting of Stockholders and proxy statement that follow.</FONT></P>
<P id=PARA100 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA101 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">It is important that your shares be represented at the meeting, regardless of the number of shares you hold.&nbsp; Accordingly, please exercise your right to vote by completing, signing, dating and returning your proxy card, or by using Internet or telephone voting as described in the accompanying proxy statement, or by following the instructions for voting on the Notice Regarding the Availability of Proxy Materials you received for the meeting.</FONT></P>
<P id=PARA102 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA103 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On behalf of the Board of Directors and management of Diffusion, it is my pleasure to express our appreciation for your support.</FONT></P>
<P id=PARA104 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA105 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Sincerely,</FONT></P>
<P id=PARA106 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA107 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA108 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA109 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David G. Kalergis</FONT></P>
<P id=PARA110 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Chairman and Chief Executive Officer</I></FONT></P>
<P id=PARA111 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA112 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Your vote is important. Please exercise your right to vote as soon as possible by completing, signing, dating and returning your proxy card, or by using Internet or telephone voting as described in the accompanying proxy statement. By doing so, you may save us the expense of additional solicitation.</B></FONT></P>
<P id=PARA113 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA114 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>You can help us make a difference by eliminating paper proxy mailings. With your consent, we will provide all future proxy materials electronically. Instructions for consenting to electronic delivery can be found on your proxy card or at </B><U><B>www.proxyvote.com</B></U><B>. Your consent to receive stockholder materials electronically will remain in effect until canceled.</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA117.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK117  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR117  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM117  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR117  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA117.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 100%">
<P id=PARA2462 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt">&nbsp;<IMG src="a1.jpg" width=450 height=147></P></TD></TR></TABLE>
<P id=PARA118 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA121 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS<BR>TO BE HELD ON THURSDAY, JULY 21, 2016</B></FONT></P>
<P id=PARA122 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA123 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To the Stockholders of Diffusion Pharmaceuticals Inc.:</FONT></P>
<P id=PARA124 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA125 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Annual Meeting of Stockholders of Diffusion Pharmaceuticals Inc., a Delaware corporation, will be held on Thursday, July 21, 2016 at 9:00&nbsp;a.m., Eastern Time, in the Preston Room at the Omni Charlottesville Hotel located at 212 Ridge McIntire Road, Charlottesville,&nbsp;Virginia 22903 for the following purposes:</FONT></P>
<P id=PARA126 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB128  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA129 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">1.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA130 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To elect five persons to serve as directors until our next annual meeting of stockholders or until their respective successors are elected and qualified.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA134 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA135 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To ratify the selection of KPMG LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2016.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA139 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA140 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To approve, on an advisory basis, the compensation of our named executive officers during the year ended December 31, 2015, as disclosed in the accompanying proxy statement.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA144 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">4.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA145 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To approve an amendment to our Certificate of Incorporation, as amended, to effect a reverse stock split of the shares of our common stock, par value $0.001 per share, at a ratio of not less than 1-to-2 and not greater than 1-to-20, with the exact ratio and effective time of the reverse stock split to be determined by our Board of Directors, if at all.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA149 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">5.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA150 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To approve an amendment to the Diffusion Pharmaceuticals Inc. 2015 Equity Incentive Plan to increase the number of shares of our common stock available for issuance thereunder by (i) 2,500,000 shares immediately and (ii) 4.0% of the total shares of the Company&#8217;s common stock outstanding as of December 31 on each subsequent January 1 through the term of the plan.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA154 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA155 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To approve an adjournment of the meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal No.&nbsp;4.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA159 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA160 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To transact such other business as may properly come before the meeting or any adjournment of the meeting.</FONT></P></TD></TR></TABLE>
<P id=PARA131 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P id=PARA162 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Only stockholders of record at the close of business on May 24, 2016 will be entitled to notice of, and to vote at, the meeting and any adjournments thereof. A stockholder list will be available at Diffusion&#8217;s corporate offices beginning 10 days prior to the date of the meeting during normal business hours for examination by any stockholder registered on Diffusion&#8217;s stock ledger as of the record date for any purpose germane to the meeting.</FONT></P>
<P id=PARA163 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL171  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA164 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">By Order of the Board of Directors,</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA165 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA166 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA167 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Ben L. Shealy</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA168 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">June __, 2016</FONT></P></TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA169 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Senior Vice President &#8211; Finance &amp; Treasurer</I></FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA170 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Charlottesville, Virginia</FONT></P></TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD></TR></TABLE>
<P id=PARA172 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK2965  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2965  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2965  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2965  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2965.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>TABLE OF CONTENTS</B></FONT></P>
<P id=PARA173 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<HR style="BORDER-TOP: medium none; HEIGHT: 1px; BORDER-RIGHT: medium none; WIDTH: 18%; BORDER-BOTTOM: medium none; COLOR: #000000;  BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000" align="center">

<P id=PARA3305 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"></P>
<TABLE id=S1  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD width=36>&nbsp;</TD>
<TD width=1082>&nbsp;</TD>
<TD width=51>&nbsp;</TD></TR>
<TR>
<TD width=36>
<P id=PARA2966 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD width=1082>
<P id=PARA2967 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD width=51>
<P id=PARA2968 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt"><U>Page</U></P></TD></TR>
<TR>
<TD width=36>
<P id=PARA2969 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD width=1082>
<P id=PARA2970 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD width=51>
<P id=PARA2971 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=1118 colSpan=2>
<P id=PARA2972 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA2974 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;1</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA2975 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA2976 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">When and Where Will the Annual Meeting Be Held?</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA2977 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;1</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA2978 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA2979 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">What are the Purposes of the Annual Meeting?</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA2980 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;1</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA2981 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA2982 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Who is Entitled to Vote at the Annual Meeting?</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA2983 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;2</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA2984 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA2985 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">How Do I Vote My Shares?</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA2986 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;2</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA2987 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA2988 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">How Will My Shares Be Voted?</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA2989 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;3</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA2990 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA2991 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">How Does the Board of Directors Recommend that I Vote?</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA2992 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;3</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA2993 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA2994 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">How Can I Revoke or Change My Vote?</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA2995 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;4</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA2996 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA2997 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">How Many Shares Must Be Present to Hold the Annual Meeting?</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA2998 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;4</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA2999 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3000 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">What Vote is Required for Each Proposal?</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3001 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;4</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3002 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3003 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Who Will Count the Votes?</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3004 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;5</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3005 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3006 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Who Do I Contact if I Have Questions Regarding the Annual Meeting?</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3007 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;5</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3008 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3009 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Are There Any Matters to be Voted on at the Annual Meeting that are not Included in this Proxy Statement?</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3010 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;5</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3011 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3012 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">How Will Business Be Conducted at the Annual Meeting?</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3013 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;6</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3014 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3015 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3016 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" colSpan=2>
<P id=PARA3017 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3019 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;7</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>&nbsp;</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" colSpan=2><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">RECENT CHANGE OF CONTROL&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">OF REGISTRANT</FONT></TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>7</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>&nbsp;</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" colSpan=2>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>9</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3020 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3021 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Section&nbsp;16(a)&nbsp;Beneficial Ownership Reporting Compliance</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3022 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;11</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3023 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3024 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3025 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>
<P id=PARA3026 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">PROPOSAL NO. 1 &#8212; ELECTION OF DIRECTORS</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3028 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;12</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3029 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3030 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Number of Directors</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3031 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;12</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3032 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3033 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Nominees for Director</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3034 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;12</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3035 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3036 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Information About Current Directors and Board Nominees</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3037 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;12</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3038 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3039 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Additional Information About Current Directors and Board Nominees</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3040 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;12</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3041 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3042 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Board Recommendation</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3043 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;14</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3044 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3045 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3046 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" colSpan=2>
<P id=PARA3047 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">PROPOSAL NO. 2 &#8212; RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3049 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;15</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3050 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3051 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Change and Selection of Independent Registered Public Accounting Firm</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3052 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;15</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3053 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3054 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Ratification of Independent Registered Public Accounting Firm</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3055 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;15</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3056 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3057 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Independent Auditor&#8217;s Fees</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3058 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;16</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3059 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3060 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Pre-Approval Policies and Procedures</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3061 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;16</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3062 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3063 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Board Recommendation</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3064 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;16</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3065 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3066 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3067 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>
<P id=PARA3068 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">PROPOSAL NO. 3 &#8212; ADVISORY VOTE ON EXECUTIVE COMPENSATION</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3070 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;17</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3071 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3072 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Introduction</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3073 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;17</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3074 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3075 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Reasons Why You Should Vote FOR Our Say-on-Pay Vote</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3076 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;17</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3077 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3078 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Proposed Resolution</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3079 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;18</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>
<P id=PARA3080 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>
<P id=PARA3081 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Board Recommendation</P></TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>
<P id=PARA3082 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt">&nbsp;18</P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>
<P id=PARA3083 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>
<P id=PARA3084 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>
<P id=PARA3085 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>PROPOSAL NO. 4 &#8212; APPROVAL OF AN AMENDMENT TO DIFFUSION PHARMACEUTICALS INC.&#8217;S CERTIFICATE OF INCORPORATION TO EFFECT THE RESERVE STOCK SPLIT</TD>
<TD style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>19</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>General</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>19</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Reasons for the Reverse Stock Split</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>19</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Determination of Ratio</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>21</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Reverse Stock Split Amendment to the Charter</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>22</TD></TR></TABLE>
<P id=PARA3391 style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;<FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3392  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3392  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3392  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">i</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3392  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3392.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE id=S1  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Principal Effects of the Reverse Stock Split</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>22</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Effect on Authorized but Unissued Shares</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>23</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Procedure for Effecting Reverse Stock Split and Exchange of Stock Certificates</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>23</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Fractional Shares</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>23</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Risks Associated with the Reverse Stock Split</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>23</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Book-Entry Shares</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>24</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Certificated Shares</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>24</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Principal Effects of Reverse Stock Split on Outstanding Options, Outstanding Convertible Debt, </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants, and Option Plan</FONT></TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>25</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Accounting Matters</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>25</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Effect on Par Value</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>25</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>No Going Private Transaction</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>25</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Potential Anti-Takeover Effect</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>25</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>No Dissenters&#8217; Appraisal Rights</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>26</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Material United States Federal Income Tax Consequences of the Reverse Stock Split</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>26</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Interests of Directors and Executive Officers</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>26</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Reservation of Right to Abandon Reverse Stock Split</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>27</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Vote Required</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>27</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Board Recommendation</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>27</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=51>&nbsp;</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" colSpan=2>PROPOSAL NO. 5 &#8212; APPROVAL OF AN AMENDMENT TO THE DIFFUSION PHARMACEUTICALS INC. 2015 EQUITY INCENTIVE PLAN</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>28</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Introduction</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>28</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Share Reserve</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>28</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Summary of the 2015 Plan</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>29</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Material U.S. Federal Income Tax Consequences</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>35</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>New Plan Benefits</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>37</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Equity Compensation Plan Information as of December 31, 2015</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>37</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Board Recommendation</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>37</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>&nbsp;</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>PROPOSAL NO. 6 &#8212; ADJOURNMENT OF ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES IN FAVOR OF PROPOSAL NO. 4</TD>
<TD style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>38</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Adjournment to Solicit Additional Proxies</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>38</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Board Recommendation</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>38</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=51>&nbsp;</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>CORPORATE GOVERNANCE</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>39</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Introduction</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>39</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Corporate Governance Guidelines</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>39</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Director Independence</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>39</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Board Leadership Structure</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>40</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Executive Sessions</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>40</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Board Meetings and Attendance</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>40</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Board Committees</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>40</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Audit Committee</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>40</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Compensation Committee</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>41</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Nominating and Corporate Governance Committee</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>43</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Audit Committee Report</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>46</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Complaint Procedures</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>46</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Policy Regarding Director Attendance at Annual Meetings of Stockholders</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>46</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Process Regarding Stockholder Communications with Board of Directors</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>47</TD></TR></TABLE>
<P id=PARA3441 style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;<FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3443  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3443  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3443  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">ii</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3443  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3443.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>DIRECTOR COMPENSATION</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>48</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Overview of Director Compensation Program</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>48</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Cash Compensation</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>48</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Long-Term Equity-Based Incentive Compensation</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>48</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Indemnification Agreements</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>49</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Summary Director Compensation Table for Fiscal 2015</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>49</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>&nbsp;</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>&nbsp;</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" colSpan=2>EXECUTIVE COMPENSATION</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>50</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Merger with Diffusion Pharmaceuticals LLC</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>50</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Summary Compensation Table for Fiscal 2015</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>50</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Employment and Other Agreements</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>50</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Indemnification Agreements</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>51</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Outstanding Equity Awards at Fiscal Year End</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>52</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Post-Termination Severance and Change in Control Arrangements</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>52</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Change of Control</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>53</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>&nbsp;</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>&nbsp;</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>RELATED PERSON RELATIONSHIPS AND TRANSACTIONS</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>54</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Overview</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>54</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Convertible Notes</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>54</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Merger with Diffusion LLC</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>55</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Jones Consulting Agreement</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>55</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>&nbsp;</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>&nbsp;</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" colSpan=2>OTHER MATTERS</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>56</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Stockholder Proposals for 2016 Annual Meeting</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>56</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Director Nominations for 2017 Annual Meeting</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>56</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Annual Report</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>57</TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #cceeff" width=1082>Householding of Annual Meeting Materials</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=51>57</TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="BACKGROUND-COLOR: #ffffff" width=36>&nbsp;</TD>
<TD style="BACKGROUND-COLOR: #ffffff" width=1082>Cost and Method of Solicitation</TD>
<TD style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width=51>57</TD></TR></TABLE>
<P id=PARA3450 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 27pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA398 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>As used in this proxy statement, references to &#8220;Diffusion,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar references refer to Diffusion Pharmaceuticals Inc. (formerly known as RestorGenex Corporation) and our consolidated subsidiaries, and the term &#8220;common stock&#8221; refers to our common stock, par value $0.001 per share. </I></FONT></P>
<P id=PARA3473.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3473  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3473  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3473  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">iii</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3473  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3473.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 100%">
<P id=PARA3474 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt">&nbsp;<IMG src="a1.jpg" width=450 height=147></P></TD></TR></TABLE>
<P id=PARA400 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P id=PARA403 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>2020 Avon Court, Suite 4</B></FONT></P>
<P id=PARA404 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Charlottesville, Virginia 22902</B></FONT></P>
<P id=PARA405 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<HR style="BORDER-TOP: medium none; HEIGHT: 1px; BORDER-RIGHT: medium none; WIDTH: 18%; BORDER-BOTTOM: medium none; COLOR: #000000;  BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000" align="center">

<P id=PARA407 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA408 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>PROXY STATEMENT FOR<BR>ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>
<P id=PARA409 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA410 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>TO BE HELD ON THURSDAY, JULY 21, 2016</B></FONT></P>
<P id=PARA411 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<HR style="BORDER-TOP: medium none; HEIGHT: 1px; BORDER-RIGHT: medium none; WIDTH: 18%; BORDER-BOTTOM: medium none; COLOR: #000000;  BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000" align="center">

<P id=PARA413 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA414 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board of Directors of Diffusion Pharmaceuticals Inc. is using this proxy statement to solicit your proxy for use at the Diffusion Pharmaceuticals Inc. 2016 Annual Meeting of Stockholders to be held at 9:00 a.m., Eastern Time, on Thursday, July 21, 2016. The Board of Directors expects to make available electronically or to send to our stockholders the Notice of Annual Meeting of Stockholders, this proxy statement and a form of proxy on or about June __, 2016.</FONT></P>
<P id=PARA415 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA416 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Important Notice Regarding the Availability of Proxy Materials for the</B></FONT></P>
<P id=PARA417 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Stockholder Meeting to Be Held on Thursday, July 21, 2016</B></FONT></P>
<P id=PARA418 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA419 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Our proxy statement and annual report to stockholders, which includes our annual report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2015, are available at www.proxyvote.com.</B></FONT></P>
<P id=PARA420 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA421 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</B></FONT></P>
<P id=PARA422 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA423 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>When and Where Will the Annual Meeting Be Held?</B></FONT></P>
<P id=PARA424 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA425 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Annual Meeting of Stockholders of Diffusion Pharmaceuticals Inc. will be held on Thursday, July 21, 2016, at 9:00 a.m., Eastern Time, in the Preston Room at the Charlottesville Omni Hotel located at 212 Ridge McIntire Road, Charlottesville, Virginia 22903.</FONT></P>
<P id=PARA426 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA427 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>What are the Purposes of the Annual Meeting?</B></FONT></P>
<P id=PARA428 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA429 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The purposes of the Annual Meeting are to vote on the following items:</FONT></P>
<P id=PARA430 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB432  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA433 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">1.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA434 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To elect five persons to serve as directors until our next annual meeting of stockholders or until their respective successors are elected and qualified.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA438 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA439 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To ratify the selection of KPMG LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2016.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA443 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA444 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement.</FONT></P></TD></TR></TABLE>
<P id=PARA435 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3475  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3475  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3475  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">1</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3475  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3475.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE id=MTAB447  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA448 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">4.<U></U><U></U></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA449 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To approve an amendment (the &#8220;<U>Charter Amendment</U>&#8221;) to our Certificate of Incorporation, as amended, to effect a reverse stock split of the shares of our common stock, par value $0.001 per share, at a ratio of not less than 1-to-2 and not greater than 1-to-20, with the exact ratio and effective time of the reverse stock split to be determined by our Board of Directors, if at all (the &#8220;<U>Reverse Stock Split</U>&#8221;).</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA453 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">5.<U></U><U></U></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA454 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To approve an amendment (the &#8220;<U>2015 Plan Amendment</U>&#8221;) to the Diffusion Pharmaceuticals Inc. 2015 Equity Incentive Plan (the &#8220;<U>2015 Plan</U>&#8221;) to increase the number of shares of our common stock available for issuance thereunder by (i) 2,500,000 shares immediately and (ii) 4.0% of the total shares of the Company&#8217;s common stock outstanding as of December 31 on each subsequent January 1 through the term of the 2015 Plan.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA458 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA459 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To approve an adjournment of the meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal No.&nbsp;4.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA463 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA464 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To transact such other business as may properly come before the meeting or any adjournment of the meeting.</FONT></P></TD></TR></TABLE>
<P id=PARA450 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P id=PARA466 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Who is Entitled to Vote at the Annual Meeting?</B></FONT></P>
<P id=PARA467 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA468 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stockholders of record at the close of business on May 24, 2016 will be entitled to notice of and to vote at the meeting or any adjournment of the Annual Meeting. As of that date, there were 102,429,200 shares of our common stock outstanding. Each share of our common stock is entitled to one vote on each matter to be voted on at the Annual Meeting. Stockholders are not entitled to cumulate voting rights.</FONT></P>
<P id=PARA469 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA470 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>How Do I Vote My Shares?</B></FONT></P>
<P id=PARA471 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA472 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Your vote is important. Whether you hold shares directly as a stockholder of record or beneficially in &#8220;street name&#8221; (through a broker, bank or other nominee), you may vote your shares without attending the Annual Meeting. You may vote by granting a proxy or, for shares held in street name, by submitting voting instructions to your broker or nominee.</FONT></P>
<P id=PARA473 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA474 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If you are a stockholder whose shares are registered in your name, you may vote your shares in person at the meeting or by one of the three following methods:</FONT></P>
<P id=PARA475 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB477  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA478 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA479 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Vote by Internet</B>, by going to the web address http://www.proxyvote.com and following the instructions for Internet voting shown on your proxy card.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA483 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA484 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Vote by Telephone</B>, by dialing 1-800-690-6903 and following the instructions for telephone voting shown on your proxy card.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA488 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA489 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Vote by Proxy Card</B>, by completing, signing, dating and mailing the enclosed proxy card in the envelope provided.&nbsp; If you vote by Internet or telephone, please do not mail your proxy card.</FONT></P></TD></TR></TABLE>
<P id=PARA480 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA491 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If your shares are held in street name, you may receive a separate voting instruction form or you may need to contact your broker, bank or other nominee to determine whether you will be able to vote electronically using the Internet or telephone.</FONT></P>
<P id=PARA492 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA493 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The deadline for voting by telephone or by using the Internet is 11:59&nbsp;p.m., Eastern Time, on July 20, 2016.&nbsp; Please see your proxy card or the information your bank, broker or other holder of record provided to you for more information on your options for voting.</FONT></P>
<P id=PARA3476.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3476  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3476  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3476  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">2</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3476  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3476.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA495 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>How Will My Shares Be Voted?</B></FONT></P>
<P id=PARA496 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA497 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If you return your signed proxy card or use Internet or telephone voting before the Annual Meeting, the named proxies will vote your shares as you direct.</FONT></P>
<P id=PARA498 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA499 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For Proposal No.&nbsp;1&#8212;Election of Directors, you may:</FONT></P>
<P id=PARA500 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB502  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA503 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA504 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vote <B>FOR</B> all five of the nominees for director;</FONT></P></TD></TR></TABLE>
<P id=PARA505 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB507  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA508 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA509 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>WITHHOLD</B> your vote from all five of the nominees for director; or</FONT></P></TD></TR></TABLE>
<P id=PARA510 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB512  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA513 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA514 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>WITHHOLD</B> your vote from one or more of the five nominees for director that you designate.</FONT></P></TD></TR></TABLE>
<P id=PARA515 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA516 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For Proposal No.&nbsp;2&#8212;Ratification of Selection of Independent Registered Public Accounting Firm, Proposal No.&nbsp;3&#8212; Advisory Vote on Executive Compensation, Proposal No.&nbsp;4&#8212;Approval of an Amendment to Diffusion&#8217;s Certificate of Incorporation, as amended, to Effect the Reverse Stock Split, Proposal No.&nbsp;5&#8212; Approval of an Amendment to the Diffusion 2015 Equity Incentive Plan and Proposal No.&nbsp;6&#8212;Adjournment of Annual Meeting, if Necessary, to Solicit Additional Proxies if There are Insufficient Votes in Favor of Proposal No.&nbsp;4, you may:</FONT></P>
<P id=PARA517 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB519  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA520 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA521 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vote <B>FOR</B> the proposal;</FONT></P></TD></TR></TABLE>
<P id=PARA522 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB524  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA525 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA526 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vote <B>AGAINST</B> the proposal; or</FONT></P></TD></TR></TABLE>
<P id=PARA527 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB529  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA530 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA531 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>ABSTAIN</B> from voting on the proposal.</FONT></P></TD></TR></TABLE>
<P id=PARA532 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA533 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If you send in your proxy card or use Internet or telephone voting, but you do not specify how you want to vote your shares, the proxies will vote your shares:</FONT></P>
<P id=PARA534 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB536  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA537 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA538 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> all five of the nominees for director in Proposal No.&nbsp;1&#8212; Election of Directors;</FONT></P></TD></TR></TABLE>
<P id=PARA539 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB541  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA542 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA543 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;2&#8212;Ratification of Selection of Independent Registered Public Accounting Firm;</FONT></P></TD></TR></TABLE>
<P id=PARA544 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB546  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA547 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA548 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;3&#8212; Advisory Vote on Executive Compensation;</FONT></P></TD></TR></TABLE>
<P id=PARA549 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB551  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA552 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA553 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;4&#8212;Approval of an Amendment to Diffusion&#8217;s Certificate of Incorporation, as amended, to Effect the Reverse Stock Split;</FONT></P></TD></TR></TABLE>
<P id=PARA554 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB556  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA557 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA558 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;5&#8212; Approval of an Amendment to the Diffusion 2015 Equity Incentive Plan; and</FONT></P></TD></TR></TABLE>
<P id=PARA559 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB561  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA562 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA563 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;6&#8212;Adjournment of Annual Meeting, if Necessary, to Solicit Additional Proxies if There are Insufficient Votes in Favor of Proposal No.&nbsp;4.</FONT></P></TD></TR></TABLE>
<P id=PARA564 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA565 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>How Does the Board of Directors Recommend that I Vote?</B></FONT></P>
<P id=PARA566 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA567 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board of Directors recommends that you vote:</FONT></P>
<P id=PARA568 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB570  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA571 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA572 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> all five of the nominees for director in Proposal No.&nbsp;1&#8212;Election of Directors;</FONT></P></TD></TR></TABLE>
<P id=PARA573 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB575  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA576 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA577 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;2&#8212;Ratification of Selection of Independent Registered Public Accounting Firm;</FONT></P></TD></TR></TABLE>
<P id=PARA578 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB580  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA581 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA582 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;3&#8212; Advisory Vote on Executive Compensation;</FONT></P></TD></TR></TABLE>
<P id=PARA583 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB585  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA586 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA587 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;4&#8212;Approval of an Amendment to Diffusion&#8217;s Certificate of Incorporation, as amended, to Effect the Reverse Stock Split;</FONT></P></TD></TR></TABLE>
<P id=PARA588 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3477  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3477  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3477  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">3</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3477  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3477.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE id=MTAB590  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA591 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA592 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;5&#8212; Approval of an Amendment to the Diffusion 2015 Equity Incentive Plan; and</FONT></P></TD></TR></TABLE>
<P id=PARA593 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB595  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA596 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA597 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FOR</B> Proposal No.&nbsp;6&#8212;Adjournment of Annual Meeting, if Necessary, to Solicit Additional Proxies if There are Insufficient Votes in Favor of Proposal No.&nbsp;4.</FONT></P></TD></TR></TABLE>
<P id=PARA598 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA599 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>How Can I Revoke or Change My Vote?</B></FONT></P>
<P id=PARA600 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA601 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If you are a stockholder whose shares are registered in your name, you may revoke your proxy at any time before it is voted by one of the following methods:</FONT></P>
<P id=PARA602 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB604  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA605 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA606 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Submitting another proper proxy with a more recent date than that of the proxy first given by following the Internet or telephone voting instructions or completing, signing, dating and returning a proxy card to us;</FONT></P></TD></TR></TABLE>
<P id=PARA607 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB609  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA610 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA611 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Sending written notice of revocation to our Corporate Secretary; or</FONT></P></TD></TR></TABLE>
<P id=PARA612 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB614  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA615 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA616 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Attending the Annual Meeting and voting by ballot.</FONT></P></TD></TR></TABLE>
<P id=PARA617 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA618 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If you hold your shares through a broker, bank or other nominee, you may revoke your proxy by following instructions your broker, bank or other nominee provides.</FONT></P>
<P id=PARA619 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA620 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>How Many Shares Must Be Present to Hold the Annual Meeting?</B></FONT></P>
<P id=PARA621 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA622 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The presence at the Annual Meeting, in person or by proxy, of the holders of a majority (51,214,601 shares) of the outstanding shares of our common stock as of the record date will constitute a quorum for the transaction of business at the Annual Meeting. In general, shares of our common stock represented by a properly signed and returned proxy card will be counted as shares present and entitled to vote at the Annual Meeting for purposes of determining a quorum. Shares represented by proxies marked &#8220;Abstain&#8221; and &#8220;broker non-votes&#8221; are counted in determining whether a quorum is present. A &#8220;broker non-vote&#8221; is a proxy returned by a broker on behalf of its beneficial owner customer that is not voted on a particular matter because voting instructions have not been received by the broker from the customer, and the broker does not have discretionary authority to vote on behalf of such customer on such matter. If there is not a quorum, a majority of the shares of our common stock present at the Annual Meeting may adjourn the Annual Meeting to a later date.</FONT></P>
<P id=PARA623 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA624 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>What Vote is Required for Each Proposal?</B></FONT></P>
<P id=PARA625 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA626 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Assuming a quorum is represented at the Annual Meeting, either in person or by proxy, the following vote is required for each of the following matters:</FONT></P>
<P id=PARA627 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB629  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA630 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA631 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proposal No.&nbsp;1&#8212;Election of Directors requires the affirmative vote of a plurality of the votes cast at the election.</FONT></P></TD></TR></TABLE>
<P id=PARA632 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB634  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA635 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA636 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proposal No.&nbsp;2&#8212;Ratification of Selection of Independent Registered Public Accounting Firm requires &#8220;For&#8221; votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter. If you &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote.</FONT></P></TD></TR></TABLE>
<P id=PARA637 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB639  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA640 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA641 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proposal No.&nbsp;3&#8212; Advisory Vote on Executive Compensation requires &#8220;For&#8221; votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter. If you &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote.</FONT></P></TD></TR></TABLE>
<P id=PARA642 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB644  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA645 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA646 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proposal No.&nbsp;4&#8212;Approval of an Amendment to Diffusion&#8217;s Certificate of Incorporation, as amended, to Effect the Reverse Stock Split requires &#8220;For&#8221; votes from the holders of a majority of shares outstanding and entitled to vote on the matter. If you &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote.</FONT></P></TD></TR></TABLE>
<P id=PARA647 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3478  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3478  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3478  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">4</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3478  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3478.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE id=MTAB649  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA650 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA651 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proposal No.&nbsp;5&#8212; Approval of an Amendment to the Diffusion 2015 Equity Incentive Plan requires &#8220;For&#8221; votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter. If you &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote.</FONT></P></TD></TR></TABLE>
<P id=PARA652 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB654  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA655 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA656 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proposal No.&nbsp;6&#8212;Adjournment of Annual Meeting, if Necessary, to Solicit Additional Proxies if There are Insufficient Votes in Favor of Proposal No.&nbsp;4 requires &#8220;For&#8221; votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter. If you &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote.</FONT></P></TD></TR></TABLE>
<P id=PARA657 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA658 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If your shares are held in &#8220;street name&#8221; and you do not indicate how you wish to vote, your broker is permitted to exercise its discretion to vote your shares on certain &#8220;routine&#8221; matters. The only routine matter to be submitted to our stockholders at the Annual Meeting is Proposal No.&nbsp;2&#8212;Ratification of Selection of Independent Registered Public Accounting Firm. None of our other proposals are routine matters. Accordingly, if you do not direct your broker how to vote for a director in Proposal No.&nbsp;1 or how to vote for Proposal No.&nbsp;3, Proposal No.&nbsp;4, Proposal No.&nbsp;5 or Proposal No.&nbsp;6, your broker may not exercise discretion and may not vote your shares on that proposal.</FONT></P>
<P id=PARA659 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA660 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For purposes of Proposal No.&nbsp;1, Proposal No. 2, Proposal No.&nbsp;3, Proposal No.&nbsp;5 and Proposal No.&nbsp;6, broker non-votes are not considered to be &#8220;votes cast&#8221; at the meeting.&nbsp; As such, a broker non-vote will not be counted as a vote &#8220;For&#8221; or &#8220;Withheld&#8221; with respect to a director in Proposal No.&nbsp;1, or a vote &#8220;For&#8221; or &#8220;Against&#8221; Proposal No. 2, Proposal No.&nbsp;3, Proposal No.&nbsp;5 or Proposal No.&nbsp;6, will have no effect on the outcome of the vote on any such proposal. A broker non-vote with respect to Proposal No.&nbsp;4, however, will be counted as a vote &#8220;Against&#8221; Proposal No.&nbsp;4. Proxies marked &#8220;Abstain&#8221; will be counted in determining the total number of &#8220;votes cast&#8221; on each of the proposals and will have the effect of a vote &#8220;Against&#8221; a proposal.</FONT></P>
<P id=PARA661 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA662 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Who Will Count the Votes?</B></FONT></P>
<P id=PARA663 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA664 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We currently expect that Broadridge Financial Solutions,&nbsp;Inc. will tabulate the votes and our Corporate Secretary will be our inspector of elections for the Annual Meeting.</FONT></P>
<P id=PARA665 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA666 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Who Do I Contact if I Have Questions Regarding the Annual Meeting?</B></FONT></P>
<P id=PARA667 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA668 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If you have questions about the Annual Meeting or would like additional copies of this Proxy Statement, you should contact our Senior Vice President &#8211; Finance &amp; Treasurer, Ben Shealy, at 2020 Avon Court, Suite 4, Charlottesville, Virginia 22902.</FONT></P>
<P id=PARA669 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA670 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Are There Any Matters to be Voted on at the Annual Meeting that are not Included in this Proxy Statement?</B></FONT></P>
<P id=PARA671 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA672 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We currently are not aware of any business to be acted upon at the Annual Meeting other than that described in this proxy statement. If, however, other matters properly are brought before the Annual Meeting, or any adjournment or postponement of the Annual Meeting, your proxy includes discretionary authority on the part of the individuals appointed to vote your shares or act on those matters according to their best judgment, including to adjourn the Annual Meeting if a quorum is not present.</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA674.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK674  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR674  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM674  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">5</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR674  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA674.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA675 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>How Will Business Be Conducted at the Annual Meeting?</B></FONT></P>
<P id=PARA676 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA677 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The presiding officer at the Annual Meeting will determine how business at the meeting will be conducted.&nbsp; Only nominations and other proposals brought before the Annual Meeting in accordance with the advance notice and information requirements of our Amended and Restated Bylaws will be considered, and no such nominations or other proposals were received. In order for a stockholder proposal to have been included in our proxy statement for the Annual Meeting, our Corporate Secretary must have received such proposal a reasonable period of time before we began to print and send our proxy materials.&nbsp; Under our Amended and Restated Bylaws, complete and timely written notice of a proposed nominee for election to the Board of Directors at the Annual Meeting or a proposal for any other business to be brought before the Annual Meeting must have been received by our Corporate Secretary not later than January 25, 2016 and not earlier than December 26, 2015, and must have contained the specific information required by our Amended and Restated Bylaws.</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA679.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK679  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR679  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM679  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">6</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR679  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA679.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA680 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>
<P id=PARA681 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA682 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">This proxy statement contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and are subject to the safe harbor created by those sections. We have identified some of these forward-looking statements with words like &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;might,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;anticipate,&#8221; &#8220;estimate&#8221; and &#8220;continue&#8221;, the negative of these words, other words and terms of similar meaning and the use of future dates. Forward-looking statements involve risks and uncertainties. These uncertainties include factors that affect all businesses as well as matters specific to us.&nbsp; Forward-looking statements by their nature address matters that are, to different degrees, uncertain.&nbsp; Uncertainties and risks may cause our actual results to be materially different than those expressed in or implied by our forward-looking statements. For us, particular uncertainties and risks include, among others, our history of operating losses and negative cash flow, uncertainties regarding clinical testing, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent annual report on Form&nbsp;10-K. All forward-looking statements in this proxy statement speak only as of the date of this proxy statement and are based on our current beliefs and expectations. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as otherwise required by law.</FONT></P>
<P id=PARA683 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA684 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>RECENT CHANGE OF CONTROL</B>&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>OF REGISTRANT</B></FONT></P>
<P id=PARA685 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA686 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of December 31, 2015, we operated as RestorGenex Corporation, (&#8220;RestorGenex&#8221;). On January 8, 2016, RestorGenex completed the merger (the &#8220;Merger&#8221;) of its wholly owned subsidiary, Arco Merger Sub, LLC (&#8220;Merger Sub&#8221;), with and into Diffusion Pharmaceuticals LLC, a Virginia limited liability company (&#8220;Diffusion LLC&#8221;), in accordance with the terms of the Agreement and Plan of Merger, dated as of December 15, 2015, among the Company, Merger Sub and Diffusion LLC (the &#8220;Merger Agreement&#8221;). As a result of the Merger, Diffusion LLC, the surviving company in the Merger, became our wholly owned subsidiary.</FONT></P>
<P id=PARA687 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA688 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At the effective time of the Merger (the &#8220;Effective Time&#8221;), each outstanding unit of membership interest of Diffusion LLC (the &#8220;Diffusion Units&#8221;) was converted into the right to receive 3.652658 shares of our common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), as determined pursuant to the Merger Agreement (the &#8220;Exchange Ratio&#8221;). Also at the Effective Time, the rights of the holders of each outstanding convertible promissory note convertible into Diffusion Units (the &#8220;Diffusion Convertible Notes&#8221;) to convert such Diffusion Convertible Notes into Diffusion Units was converted into the right to convert such securities into a number of shares of Common Stock equal to the number of Diffusion Units such Diffusion Convertible Note would be convertible into pursuant to its terms multiplied by the Exchange Ratio. In addition, at the Effective Time and as a result of the Merger, all outstanding options to purchase Diffusion Units were converted into and became options to purchase common stock on terms substantially identical to those in effect prior to the Effective Time, except for adjustments to the underlying number of shares and the exercise price based on the Exchange Ratio. No fractional shares of common stock were issued in connection with the Merger, and holders of Diffusion Units received cash in lieu thereof.&nbsp;</FONT></P>
<P id=PARA689 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA690 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;In connection with the Merger, we issued to the holders of outstanding Diffusion Units an aggregate of approximately 81.6 million shares of common stock. In addition, and taking into account the adjustments to the number of shares and exercise price as a result of the Merger, we assumed Diffusion Unit Options exercisable for 14,952,156 shares of common stock with a weighted average exercise price of $0.40 per share. As a result of the Merger, the former equity holders of Diffusion LLC owned approximately 84.1% of the common stock of the combined company, and the stockholders of RestorGenex immediately prior to the Merger owned approximately 15.9% of the common stock of the combined company, in each case, immediately following the Effective Time on a fully-diluted basis (subject to certain exceptions and adjustments) and calculated in accordance with the terms of the Merger Agreement.&nbsp; </FONT></P>
<P id=PARA691 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA692 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Following the completion of the Merger, we filed a Certificate of Amendment to our Certificate of Incorporation (the &#8220;Charter&#8221;) with the Secretary of State of the State of Delaware which amended the Charter to effect a change of our corporate name from &#8220;RestorGenex Corporation&#8221; to &#8220;Diffusion Pharmaceuticals Inc.&#8221; On January 25, 2016, our Common Stock began trading on the OTCQX marketplace of the OTC Market Groups (the &#8220;OTCQX&#8221;) under the symbol &#8220;DFFN.&#8221;</FONT></P>
<P id=PARA3479.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3479  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3479  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3479  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">7</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3479  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3479.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA694 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In connection with the completion of the Merger and in accordance with the terms of the Merger Agreement, our pre-Merger board of directors accepted the resignations from the board and each of its committees of the following directors of the Company, constituting all of the directors of the Company prior to the Merger, with such resignations effective immediately prior to the Effective Time:&nbsp; Sol J. Barer, Ph.D., Isaac Blech, Rex Bright, Stephen M. Simes and Nelson K. Stacks. The Board of Directors also accepted the resignations of the following executive officers of the Company, constituting all of the executive officers of the Company prior to the Merger, with such resignations effective immediately prior to the Effective Time:&nbsp; Stephen M. Simes as Chief Executive Officer, Phillip B. Donenberg as Chief Financial Officer and Secretary, and Mark A. Weinberg, M.D. as Senior Vice President, Clinical Development. </FONT></P>
<P id=PARA695 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA696 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Also in connection with the completion of the Merger and in accordance with the terms of the Merger Agreement, the outgoing directors, prior to their resignation and in accordance with the Company&#8217;s bylaws, fixed the number of directors at six, and appointed the following six individuals, constituting all of the directors of Diffusion prior to the Merger, to serve as directors of the Company, effective at the Effective Time and until the Company&#8217;s next annual meeting of stockholders, and until their respective successors are elected and qualified or until their earlier resignation or removal:&nbsp; David G. Kalergis, John L. Gainer, Thomas Byrne, Robert Adams, Mark T. Giles and Alan Levin. David G. Kalergis was appointed Chairman of the Board. </FONT></P>
<P id=PARA697 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA698 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Following the completion of the Merger, the newly constituted Board of Directors also appointed the following individuals to serve as executive officers of the Company until their successors have been duly elected and qualified or until their earlier resignation or removal: David G. Kalergis as Chief Executive Officer, John L. Gainer Ph.D. as Chief Scientific Officer, David R. Jones M.D. as Chief Medical Officer and Ben L. Shealy as Senior Vice President &#8211; Finance, Treasurer and Secretary.</FONT></P>
<P id=PARA699 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA700 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As reported in our Current Report on Form 8-K filed on April 1, 2016, Thomas Byrne resigned as a member of our board of directors (the &#8220;Board&#8221;) and was appointed our General Counsel, in each case, effective April 1, 2016.</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA703.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK703  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR703  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM703  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">8</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR703  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA703.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA704 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></FONT></P>
<P id=PARA705 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA706 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Based on information available to us and filings with the SEC, the following table sets forth certain information regarding the beneficial ownership (as defined by Rule 13d-3 under the Securities Exchange Act of 1934) of our outstanding common stock as of May 24, 2016 for (i) each person who beneficially owns 5% or more of the shares of common stock then outstanding; (ii) each of our current directors and nominees; (iii) each of our current named executive officers (as defined in Item&nbsp;402(a)(3) of Regulation S-K under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) as of December 31, 2015; and (iv) all of our current directors and executive officers as a group. </FONT></P>
<P id=PARA707 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA708 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Beneficial ownership and percentage ownership are determined in accordance with the rules of the SEC and include voting or investment power with respect to shares of stock. This information does not necessarily indicate beneficial ownership for any other purpose. Under these rules, shares of common stock issuable under stock options or warrants that are exercisable within 60 days of May 24, 2016 are deemed outstanding for the purpose of computing the percentage ownership of the person holding the options or warrants, but are not deemed outstanding for the purpose of computing the percentage ownership of any other person. Ownership is based upon information provided by each respective director and officer, Forms&nbsp;4, Schedules 13D and 13G and other public documents filed with the SEC for some of the stockholders.</FONT></P>
<P id=PARA709 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA710 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unless otherwise indicated and subject to applicable community property laws, to our knowledge, each stockholder named in the following table possesses sole voting and investment power over their shares of common stock, except for those jointly owned with that person&#8217;s spouse. Unless otherwise indicated below, the address of each person listed on the table is c/o Diffusion Pharmaceuticals Inc. 2020 Avon Court, Suite 4, Charlottesville Virginia 22902.</FONT></P>
<P id=PARA711 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL836  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL836.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL836.finRow.1.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL836.finRow.1.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=6>
<P id=PARA714 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Shares Beneficially Owned</B></FONT></P></TD>
<TD id=TBL836.finRow.1.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL836.finRow.2>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA716 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Name and Address of Beneficial Owner</B></FONT></P></TD>
<TD id=TBL836.finRow.2.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL836.finRow.2.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA718 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Number</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(1)</B></FONT></P></TD>
<TD id=TBL836.finRow.2.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL836.finRow.2.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL836.finRow.2.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA721 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Percent of<BR>Class</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(2)</B></FONT></P></TD>
<TD id=TBL836.finRow.2.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL836.finRow.3 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA723 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Greater than 5% Holders</I></B></FONT></P></TD>
<TD id=TBL836.finRow.3.lead.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.3.symb.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.3.amt.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.3.trail.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.3.lead.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.3.symb.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.3.amt.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.3.trail.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD></TR>
<TR id=TBL836.finRow.4 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<P id=PARA726 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Richard Baxter Gilliam (3)</FONT></P></TD>
<TD id=TBL836.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">14,248,350</TD>
<TD id=TBL836.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.4.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.4.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.4.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">13.9</TD>
<TD id=TBL836.finRow.4.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>
<P id=PARA734 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.5 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA735 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">PANDA Holdings, LLC (4)</FONT></P></TD>
<TD id=TBL836.finRow.5.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.5.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.5.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6,296,346</TD>
<TD id=TBL836.finRow.5.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.5.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.5.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.5.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6.1</TD>
<TD id=TBL836.finRow.5.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>
<P id=PARA738 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.6 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<P id=PARA739 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Michael S. &amp; Ellen A. Geismar</FONT></P></TD>
<TD id=TBL836.finRow.6.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.6.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.6.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5,524,137</TD>
<TD id=TBL836.finRow.6.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.6.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.6.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.6.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.4</TD>
<TD id=TBL836.finRow.6.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>
<P id=PARA742 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.7 style="BACKGROUND-COLOR: #cceeff">
<TD style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.7.lead.B2 style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.7.symb.B2 style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.7.amt.B2 style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.7.trail.B2 style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.7.lead.B3 style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.7.symb.B3 style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.7.amt.B3 style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.7.trail.B3 style="BACKGROUND-COLOR: #cceeff">&nbsp;</TD></TR>
<TR id=TBL836.finRow.8 style="BACKGROUND-COLOR: #ffffff">
<TD style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; MARGIN-TOP: 0px; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt">
<P id=PARA743 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Current Directors and Executive Officers as of December 31, 2015:</I></B></FONT></P></TD>
<TD id=TBL836.finRow.8.lead.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.8.symb.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.8.amt.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.8.trail.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.8.lead.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.8.symb.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.8.amt.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.8.trail.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"><I><B>&nbsp;</B></I></TD></TR>
<TR id=TBL836.finRow.9 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA746 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David G. Kalergis (5) </FONT></P></TD>
<TD id=TBL836.finRow.9.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.9.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.9.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,418,881</TD>
<TD id=TBL836.finRow.9.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.9.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.9.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.9.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.3</TD>
<TD id=TBL836.finRow.9.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>
<P id=PARA754 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.10 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA755 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">John L. Gainer, Ph.D. (6)</FONT></P></TD>
<TD id=TBL836.finRow.10.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.10.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.10.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,765,985</TD>
<TD id=TBL836.finRow.10.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.10.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.10.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.10.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4.6</TD>
<TD id=TBL836.finRow.10.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>
<P id=PARA763 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.11 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA764 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David R. Jones, M.D. (7)</FONT></P></TD>
<TD id=TBL836.finRow.11.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.11.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.11.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,734,039</TD>
<TD id=TBL836.finRow.11.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.11.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.11.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.11.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.7</TD>
<TD id=TBL836.finRow.11.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>
<P id=PARA772 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.12 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA773 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Ben Shealy (8)</FONT></P></TD>
<TD id=TBL836.finRow.12.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.12.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.12.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">820,229</TD>
<TD id=TBL836.finRow.12.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.12.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.12.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.12.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.8</TD>
<TD id=TBL836.finRow.12.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>
<P id=PARA781 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.13 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA782 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Thomas Byrne (9)</FONT></P></TD>
<TD id=TBL836.finRow.13.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.13.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.13.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,336,797</TD>
<TD id=TBL836.finRow.13.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.13.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.13.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.13.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.3</TD>
<TD id=TBL836.finRow.13.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>%</TD></TR>
<TR id=TBL836.finRow.14 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA791 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark T. Giles (10)</FONT></P></TD>
<TD id=TBL836.finRow.14.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.14.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.14.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">6,875,321</TD>
<TD id=TBL836.finRow.14.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.14.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.14.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.14.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">6.7</TD>
<TD id=TBL836.finRow.14.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>
<P id=PARA799 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.15 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA800 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Alan Levin (11)</FONT></P></TD>
<TD id=TBL836.finRow.15.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.15.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.15.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">428,919</TD>
<TD id=TBL836.finRow.15.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.15.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.15.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.15.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.4</TD>
<TD id=TBL836.finRow.15.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>
<P id=PARA806 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.16 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA807 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Robert Adams (12)</FONT></P></TD>
<TD id=TBL836.finRow.16.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.16.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.16.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,162,047</TD>
<TD id=TBL836.finRow.16.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.16.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.16.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.16.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.1</TD>
<TD id=TBL836.finRow.16.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>
<P id=PARA813 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.17 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA814 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Named Executive Officers as of December 31, 2015:</I></B></FONT></P></TD>
<TD id=TBL836.finRow.17.lead.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.17.symb.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.17.amt.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.17.trail.B2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.17.lead.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.17.symb.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.17.amt.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD>
<TD id=TBL836.finRow.17.trail.B3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I><B>&nbsp;</B></I></TD></TR>
<TR id=TBL836.finRow.18 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA815 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stephen M. Simes (13)</FONT></P></TD>
<TD id=TBL836.finRow.18.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.18.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.18.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,042,975</TD>
<TD id=TBL836.finRow.18.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.18.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.18.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.18.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.0</TD>
<TD id=TBL836.finRow.18.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>
<P id=PARA818 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.19 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA819 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Phillip B. Donenberg (14)</FONT></P></TD>
<TD id=TBL836.finRow.19.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.19.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.19.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">521,475</TD>
<TD id=TBL836.finRow.19.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.19.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.19.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.19.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.5</TD>
<TD id=TBL836.finRow.19.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>
<P id=PARA822 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.20 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA823 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark A. Weinberg, M.D. (15)</FONT></P></TD>
<TD id=TBL836.finRow.20.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.20.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.20.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">521,475</TD>
<TD id=TBL836.finRow.20.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.20.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.20.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL836.finRow.20.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.5</TD>
<TD id=TBL836.finRow.20.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>
<P id=PARA826 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR>
<TR id=TBL836.finRow.21 style="BACKGROUND-COLOR: #cceeff">
<TD style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; MARGIN-TOP: 0px; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt">
<P id=PARA827 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All current directors and executive officers as a group (eight persons) (16)</FONT></P></TD>
<TD id=TBL836.finRow.21.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.21.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.21.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">20,542,218</TD>
<TD id=TBL836.finRow.21.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL836.finRow.21.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.21.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL836.finRow.21.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">18.8</TD>
<TD id=TBL836.finRow.21.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>
<P id=PARA835 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</FONT></P></TD></TR></TABLE>
<P id=PARA837 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">________________________</FONT></P>
<TABLE id=MTAB841  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">*</TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA838 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Indicates less than 1%.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA842 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(1)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA843 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Represents shares of common stock and shares of restricted stock held as of May 24, 2016 plus shares of common stock that may be acquired upon exercise of options, warrants and other rights exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA844 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3480  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3480  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3480  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">9</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3480  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3480.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE id=MTAB846  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA847 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(2)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA848 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Based on 102,429,200 shares of the registrant&#8217;s common stock that were issued and outstanding as of May 24, 2016. The percentage ownership and voting power for each person (or all directors and executive officers as a group) is calculated by assuming the exercise or conversion of all options, warrants and convertible securities exercisable or convertible within 60 days of May 24, 2016 held by such person and the non-exercise and non-conversion of all outstanding warrants, options and convertible securities held by all other persons (including our other directors and executive officers).</FONT></P></TD></TR></TABLE>
<P id=PARA849 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB851  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA852 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(3)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA853 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Based solely on the Form 3 filed with the Securities and Exchange Commission by Mr. Gilliam on February 19, 2016. Consists of (a) 12,687,975 shares held by Mr. Gilliam directly and (b) 1,560,375 shares held by Westwood Tall Oaks LLC. Mr. Gilliam is a manager of Westwood Tall Oaks LLC.</FONT></P></TD></TR></TABLE>
<P id=PARA854 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB856  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA857 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(4)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA858 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark T. Giles, one of our directors, is the managing member of PANDA Holdings, LLC and may be deemed to be the beneficial owner of such securities. Mr. Giles disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.</FONT></P></TD></TR></TABLE>
<P id=PARA859 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB861  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA862 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(5)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA863 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Consists of (a) 686,699 shares held directly by Mr. Kalergis directly, (b) 73,878 shares held by Mr. Kalergis&#8217; wife, (c)&nbsp;382,517 shares held jointly with Mr. Kalergis&#8217; wife, and (d) 1,275,787 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016. Mr. Kalergis disclaims beneficial ownership of the shares held by his daughter.</FONT></P></TD></TR></TABLE>
<P id=PARA864 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB866  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA867 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(6)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA868 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Consists of (a) 3,725,711 shares held by the John L. Gainer Declaration of Trust dated February 19, 2008 and (b) 1,040,274 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016. Dr. Gainer is a trustee of the revocable trust, and, as such, may be deemed to share beneficial ownership of such shares. Dr. Gainer expressly disclaims beneficial ownership of any such shares except to the extent of his pecuniary interest therein.</FONT></P></TD></TR></TABLE>
<P id=PARA869 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB871  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA872 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(7)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA873 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Consists of (a) 382,557 shares held directly by Dr. Jones and (b) 1,351,482 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA874 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB876  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA877 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(8)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA878 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Consists of shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA879 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB881  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA882 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(9)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA883 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Consists of (a) 1,391,867 shares held by Mr. Byrne directly and (b) 944,930 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016. </FONT></P></TD></TR></TABLE>
<P id=PARA884 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB886  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA887 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(10)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA888 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Consists of (a) 44,069 shares held for the benefit of Mr. Giles in his individual retirement account, (b) 6,296,346 shares held by PANDA Holdings LLC and (c) 534,906 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016. Mr. Giles is the managing member of PANDA Holdings LLC and may be deemed to be the beneficial owner of such securities. Mr. Giles disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.</FONT></P></TD></TR></TABLE>
<P id=PARA889 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB891  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA892 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(11)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA893 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Consists of (a) 63,939 shares held by Mr. Levin directly, (b) 184,093 restricted shares held by Mr. Levin directly and (c) 180,887 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA894 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB896  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA897 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(12)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA898 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Consists of (a) 255,868 shares held directly by Mr. Adams directly, (b) 94,636 shares held jointly with Mr. Adams&#8217; wife, (c) 188,973 shares held for the benefit of Mr. Adams in his 401(k) retirement account and (d) 622,570 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA899 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB901  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA902 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(13)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA903 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective immediately prior to the Merger on January 8, 2016, Mr. Simes resigned as our Chief Executive Officer. Consists of 1,042,975 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA904 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB906  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA907 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(14)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA908 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective immediately prior to the Merger on January 8, 2016, Mr. Donenberg resigned as our Chief Financial Officer. Consists of 521,475 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA909 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB911  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA912 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(15)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA913 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective immediately prior to the Merger on January 8, 2016, Dr. Weinberg resigned as our Senior Vice President, Clinical Development. Consists of 521,475 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA914 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB916  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA917 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(16)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA918 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Includes 6,771,065 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 24, 2016.</FONT></P></TD></TR></TABLE>
<P id=PARA920 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3565  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3565  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3565  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">10&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3565  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3565.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Section&nbsp;16(a)&nbsp;Beneficial Ownership Reporting Compliance</B></FONT></P>
<P id=PARA921 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA922 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Section&nbsp;16(a)&nbsp;of the Securities Exchange Act of 1934, as amended, requires our directors and executive officers and all persons who beneficially own more than 10 percent of the outstanding shares of our common stock to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock.&nbsp; Directors, executive officers and greater than 10 percent beneficial owners also are required to furnish us with copies of all Section&nbsp;16(a)&nbsp;forms they file. To our knowledge, based on a review of the copies of such reports and amendments to such reports furnished to us with respect to the year ended December&nbsp;31, 2015, and based on written representations by our directors and executive officers, all required Section&nbsp;16 reports under the Exchange Act, for our directors, executive officers and beneficial owners of greater than 10 percent of our common stock were filed on a timely basis during the year ended December&nbsp;31, 2015, except that on September 21, 2015 Dr. Isaac Blech, our former director, filed a late Form 4 reporting a transaction that occurred on January 7, 2014.</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA925.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK925  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR925  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM925  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">11</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR925  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA925.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA926 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>PROPOSAL NO. 1 &#8212; ELECTION OF DIRECTORS</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA928 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA929 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA930 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Number of Directors</B></FONT></P>
<P id=PARA931 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA932 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our Amended and Restated Bylaws provide that the Board of Directors will consist of at least one member, or such other number as may be determined by the Board of Directors or our stockholders. The Board of Directors has fixed the number of directors at five.</FONT></P>
<P id=PARA933 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA934 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Nominees for Director</B></FONT></P>
<P id=PARA935 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA936 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board of Directors has nominated the following five individuals to serve as our directors until the next annual meeting of our stockholders or until their successors are elected and qualified. All of the nominees named below are current members of the Board of Directors.</FONT></P>
<P id=PARA937 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB939  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA940 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA941 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David G. Kalergis</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA944 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA945 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">John L. Gainer, Ph.D.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">&#9679;</TD>
<TD style="VERTICAL-ALIGN: top">Robert Adams</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">&#9679;</TD>
<TD style="VERTICAL-ALIGN: top">Mark T. Giles</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA956 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA957 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Alan Levin</FONT></P></TD></TR></TABLE>
<P id=PARA958 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA959 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Proxies only can be voted for the number of persons named as nominees in this proxy statement, which is five.</FONT></P>
<P id=PARA960 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA961 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If prior to the Annual Meeting, the Board of Directors should learn that any nominee will be unable to serve for any reason, the proxies that otherwise would have been voted for this nominee will be voted for a substitute nominee as selected by the Board of Directors. Alternatively, the proxies, at the discretion of the Board of Directors, may be voted for that fewer number of nominees as results from the inability of any nominee to serve. The Board of Directors has no reason to believe that any of the nominees will be unable to serve.</FONT></P>
<P id=PARA962 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA963 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Information About Current Directors and Board Nominees</B></FONT></P>
<P id=PARA964 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA965 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below sets forth, as of May 24, 2016, certain information that has been furnished to us by each current director and each individual who has been nominated by the Board of Directors to serve as a director of our company.</FONT></P>
<P id=PARA966 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL997  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 68%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA967 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Name</B></FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD style="WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA969 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Age</B></FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD style="WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA971 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Director Since</B></FONT></P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="WIDTH: 68%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA972 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David G. Kalergis</FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="WIDTH: 12%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA974 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">67</FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="WIDTH: 16%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA976 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</FONT></P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="WIDTH: 68%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA977 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">John L. Gainer, Ph.D.</FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD style="WIDTH: 12%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA979 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">77</FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD style="WIDTH: 16%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA981 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</FONT></P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="WIDTH: 68%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA982 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Robert Adams<SUP style="vertical-align: baseline; position: relative; bottom:.33em;">(1)</SUP></FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="WIDTH: 12%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA984 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">66</FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="WIDTH: 16%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA986 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</FONT></P></TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="WIDTH: 68%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA987 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark T. Giles<SUP style="vertical-align: baseline; position: relative; bottom:.33em;">(1)</SUP></FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD style="WIDTH: 12%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA989 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">61</FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD style="WIDTH: 16%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA991 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</FONT></P></TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="WIDTH: 68%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA992 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Alan Levin<SUP style="vertical-align: baseline; position: relative; bottom:.33em;">(1)</SUP>&nbsp;</FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="WIDTH: 12%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA994 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">54</FONT></P></TD>
<TD style="WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="WIDTH: 16%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA996 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</FONT></P></TD></TR></TABLE>
<P id=PARA998 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">________________________</FONT></P>
<TABLE id=MTAB1000  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA1001 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(1)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1002 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Current member of the Audit, Compensation and Nominating and Corporate Governance Committee.</FONT></P></TD></TR></TABLE>
<P id=PARA1003 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1004 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Additional Information About Current Directors and Board Nominees</B></FONT></P>
<P id=PARA1005 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1006 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The paragraphs below provide information about each current director and nominee for director, including all positions he or she holds, his or her principal occupation and business experience for the past five years, and the names of other publicly-held companies of which he or she currently serves as a director or served as a director during the past five years. We believe that all of our director nominees display personal and professional integrity; satisfactory levels of education and/or business experience; broad-based business acumen; an appropriate level of understanding of our business and its industry and other industries relevant to our business; the ability and willingness to devote adequate time to the work of the Board of Directors and its committees; a fit of skills and personality with those of our other directors that helps build a board of directors that is effective, collegial and responsive to the needs of our company; strategic thinking and a willingness to share ideas; a diversity of experiences, expertise and background; and the ability to represent the interests of all of our stockholders. The information presented below regarding each director and nominee for director also sets forth specific experience, qualifications, attributes and skills that led the Board of Directors to the conclusion that he or she should serve as a director in light of our business and structure.</FONT></P>
<P id=PARA3482.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3482  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3482  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3482  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">12</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3482  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3482.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1008 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>David G. Kalergis</I></B>&nbsp;&#8211;Mr. Kalergis has served as our Chairman of the Board and Chief Executive Officer since the completion of the Merger in January 2016. Mr. Kalergis, along with Dr. Gainer, is a co-founder of Diffusion LLC and has served as a director of Diffusion LLC since its inception in 2001 and as its Chief Executive Officer since 2004. Prior to joining Diffusion LLC, Mr. Kalergis held positions with the University of Virginia, as the general counsel and director of business development for Pharmaceutical Research Associates, Inc., a pharmaceutical contract research organization, as an intelligence analyst for the U.S. Government and with the law firm Dewey, Ballantine, Bushby, Palmer &amp; Wood, practicing in the areas of corporate finance, public offerings and mergers and acquisitions. In addition, from July 1998 until May 2012, Mr. Kalergis served on the board of directors and audit committee of Virginia National Bank. Mr. Kalergis received a B.A. in psychology, as well as an M.B.A. and J.D., from the University of Virginia, and is a graduate of the Harvard Business School&#8217;s Leadership and Strategy in the Pharmaceutical and Biotechnology Industry program.</FONT></P>
<P id=PARA1009 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1010 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board believes Mr. Kalergis&#8217; perspective and experience as the Chief Executive Officer and a director of Diffusion LLC, as well as his depth of operating and senior management experience in our industry and educational background, provide him with the qualifications to serve as a director.</FONT></P>
<P id=PARA1011 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1012 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>John L. Gainer, Ph.D.</I></B>&nbsp;&#8211; Dr. Gainer has served as a director and as our Chief Scientific Officer since the completion of the Merger in January 2016. Dr. Gainer, along with Mr. Kalergis, is a co-founder of Diffusion LLC and has served as one of its directors and as its Chief Scientific Officer since its inception in 2001. From 1966 until his retirement in 2005, Dr. Gainer was a professor of chemical engineering at the University of Virginia. During his career, Dr. Gainer authored more than 100 scientific journal articles, including more than 30 published in medical journals, and spent two sabbaticals investigating drug actions and related research at Karolinska Institute in Stockholm and the laboratory of a major pharmaceutical company. He has been a member of the International Society for Oxygen Transport in Tissues since its inception in 1973. Dr. Gainer received a BSChE from West Virginia University, a MS in chemical engineering from the Massachusetts Institute of Technology, and a Ph.D. in chemical engineering from the University of Delaware.</FONT></P>
<P id=PARA1013 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1014 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board believes Dr. Gainer&#8217;s perspective and experience as a director and officer of Diffusion LLC, as well as the depth and breadth of his scientific knowledge, provide him with the qualifications to serve as a director.</FONT></P>
<P id=PARA1015 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1016 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Robert Adams</I></B>&nbsp;&#8211; Mr. Adams has served as a director since the completion of the Merger in January 2016 and as a director of Diffusion LLC since 2002. Prior to his retirement in 2015, Mr. Adams was a partner in the intellectual property law firm of Nixon &amp; Vanderhye P.C, where he had practiced for over 25 years, focusing on patent litigation and international patent licensing and negotiations. During that time period, Mr. Adams was lead litigation counsel in more than 50 major intellectual property lawsuits, where he directly handled, for example, all intellectual property valuations and settlements on behalf of his U.S. and foreign clients. Moreover, Mr. Adams served as the head negotiator for a well-known Japanese consumer products company for 15 years in various complicated licensing situations. Those negotiations typically involved the cross-licensing of up to hundreds of U.S. and foreign patent rights. His lead licensing activities on behalf of that client included, among other things, multi-year negotiations with Texas Instruments, Advanced Micro Devices and Freescale. Mr. Adams received a B.A. from the University of Maryland and a J.D. from George Washington University (with honors), and is a member of the Virginia State Bar.</FONT></P>
<P id=PARA1017 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1018 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board believes Mr. Adams&#8217; perspective and experience as a director of Diffusion LLC, as well as the depth and breadth of his intellectual property experience, provide him with the qualifications to serve as a director.</FONT></P>
<P id=PARA3483.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3483  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3483  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3483  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">13</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3483  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3483.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1020 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Mark T. Giles</I></B>&nbsp;&#8211; Mr. Giles has served as a director since the completion of the Merger in January 2016 and as a director of Diffusion LLC since 2008.&nbsp; Since July 2007, Mr. Giles has been the sole managing member of Panda Holdings, LLC, which engages in the investment and management of private capital. Prior to joining Panda Holdings, Mr. Giles served as the Chief Executive Officer of Virginia National Bank from July 1998 until June 2007 and thereafter continued to serve as the non-executive Chairman until December 2011. Prior to joining Virginia National Bank, Mr. Giles also served as the president of two publicly traded bank holding companies and subsidiary banks in Texas and practiced law with the banking group of a Houston law firm.&nbsp; He chairs the boards of Relay Foods, Inc. and Expedition Trust Company. He also serves on the boards of The Paramount Theater Foundation, The Paramount Theater Operating Company and the Computers4Kids Program.&nbsp; Mr. Giles received a B.S. from the McIntire School of Commerce at the University of Virginia and a J.D. from the University of Virginia School of Law.</FONT></P>
<P id=PARA1021 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1022 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board believes Mr. Giles&#8217; perspective and experience as a director of Diffusion LLC, as well as the depth and breadth of his business and legal experience, provide him with the qualifications to serve as a director.</FONT></P>
<P id=PARA1023 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1024 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Alan Levin</I></B>&nbsp;&#8211; Mr. Levin has served as a director since the completion of the Merger in January 2016 and as a director of Diffusion LLC since June 2015. &nbsp;He&nbsp;previously served as Executive Vice President and Chief Financial Officer of Endo Health Solutions Inc. (&#8220;Endo&#8221;), a global specialty healthcare company, from June 2009 until his retirement in September 2013. Prior to joining Endo, Mr. Levin worked with Texas Pacific Group, a leading private equity firm, and one of their start-up investments. Before that, he was Senior Vice President &amp; Chief Financial Officer of Pfizer, Inc. where he worked for 20 years in a variety of executive positions of increasing responsibility, including Treasurer and Senior Vice President of Finance &amp; Strategic Management for the company&#8217;s research and development organization. Mr. Levin received a bachelor&#8217;s degree from Princeton University and a master&#8217;s degree from New York University&#8217;s Stern School of Business. Mr. Levin is a certified public accountant.&nbsp; He is a member of the Board of Directors of Aceto Corp, a NASDAQ-traded company specialized in generics and pharmaceutical intermediate products. &nbsp;He is also a member of the Advisory Board of Auven Therapeutics, a private equity fund; and the Critical Path Institute,&nbsp;a nonprofit collaboration between the Food and Drug Administration and&nbsp;pharmaceutical industry participants focused on streamlining and accelerating the development and regulatory pathways for innovative medicines.</FONT></P>
<P id=PARA1025 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1026 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board believes&nbsp;that the combination of Mr. Levin&#8217;s perspective and experience as a director of Diffusion LLC; his experience in financial reporting, treasury and corporate finance (including his prior positions as chief financial officer of Endo and Pfizer, Inc.); and his executive-level experience in the pharmaceutical industry all provide him with the qualifications and skills to serve as a director.</FONT></P>
<P id=PARA1027 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1028 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Recommendation</B></FONT></P>
<P id=PARA1029 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1030 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>The Board of Directors recommends a vote FOR the election of all five of the nominees for director named in this proxy statement.</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1032.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK1032  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR1032  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM1032  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">14</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR1032  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA1032.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1033 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>PROPOSAL NO. 2 &#8212; RATIFICATION OF SELECTION OF INDEPENDENT <BR>REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1035 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA1036 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1037 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Change and Selection of Independent Registered Public Accounting Firm</B></FONT></P>
<P id=PARA1038 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1039 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On January 8, 2016, after the completion of the Merger, the Audit Committee of the Board (i) approved the dismissal of Deloitte&nbsp;&amp; Touche LLP (&#8220;Deloitte&#8221;) as the Company&#8217;s independent registered public accounting firm effective as of the date of Deloitte&#8217;s completion of the audit services for the year ended December 31, 2015 and the filing of the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2015 and (ii) appointed KPMG LLP (&#8220;KPMG&#8221;) as the Company&#8217;s independent registered public accounting firm for the year ending December 31, 2016. On March 25, 2016, the Company filed its annual report on Form&nbsp;10-K for the year ended December 31, 2015.</FONT></P>
<P id=PARA1040 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1041 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deloitte was initially engaged by the Company on November 20, 2014 and served as the Company&#8217;s independent registered public accounting firm for the years ended December 31, 2015 and December 31, 2014. Deloitte&#8217;s reports on the Company&#8217;s consolidated financial statements for the fiscal years ended December&nbsp;31, 2015 and December 31, 2014 did not contain an adverse opinion or disclaimer of opinion, nor was either report qualified or modified as to uncertainty, audit scope or accounting principles, except that Deloitte&#8217;s report on the Company&#8217;s consolidated financial statements for the year ended December 31, 2015 includes explanatory paragraphs relating to the ability of the Company to continue as a going concern and the acquisition via the Merger of Diffusion LLC in January 2016.</FONT></P>
<P id=PARA1042 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1043 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the fiscal years ended December 31, 2015 and December&nbsp;31, 2014 and the subsequent interim period, there were no: (i)&nbsp;disagreements with Deloitte on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure which, if not resolved to the satisfaction of Deloitte, would have caused Deloitte to make reference to the matter in their report, or (ii)&nbsp;reportable events as defined in Item 304(a)(1)(v)&nbsp;of Regulation S-K.</FONT></P>
<P id=PARA1044 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1045 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the fiscal years ended December&nbsp;31, 2015 and December 31, 2014 and the subsequent interim period prior to the Company&#8217;s engagement of KPMG, neither the Company nor anyone acting on its behalf consulted KPMG regarding either: (i)&nbsp;the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company&#8217;s consolidated financial statements, and either a written report was provided to the Company or oral advice was provided that KPMG concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii)&nbsp;any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv)&nbsp;of Regulation S-K) or a reportable event (as described in Item 304(a)(1)(v)&nbsp;of Regulation S-K).</FONT></P>
<P id=PARA1046 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1047 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Ratification of Independent Registered Public Accounting Firm</B></FONT></P>
<P id=PARA1048 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1049 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of KPMG as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of KPMG to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee, in its discretion, may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in our best interests and the best interests of our stockholders.</FONT></P>
<P id=PARA1050 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1051 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Representatives of KPMG will be present at the Annual Meeting to respond to appropriate questions.&nbsp; They also will have an opportunity to make a statement if they wish to do so.</FONT></P>
<P id=PARA3484.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3484  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3484  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3484  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">15</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3484  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3484.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1053 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Independent Auditor&#8217;s Fees</B></FONT></P>
<P id=PARA1054 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1055 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As we did not engage KPMG as our independent registered public accounting firm until after the completion of the Merger in January 2016, KPMG did not bill us for professional services during the years ended December 31, 2015 or 2014.</FONT></P>
<P id=PARA1056 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1057 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below presents fees billed to us for professional services rendered by Deloitte, our former independent registered public accounting firm, for the years ended December&nbsp;31, 2015 and December&nbsp;31, 2014.</FONT></P>
<P id=PARA1058 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL1071  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL1071.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1071.finRow.1.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1071.finRow.1.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=6>
<P id=PARA1059 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Aggregate Amount Billed<BR>by Deloitte</B></FONT></P></TD>
<TD id=TBL1071.finRow.1.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL1071.finRow.2>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1071.finRow.2.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1071.finRow.2.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1060 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>2015</B></FONT></P></TD>
<TD id=TBL1071.finRow.2.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL1071.finRow.2.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1071.finRow.2.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1061 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>2014</B></FONT></P></TD>
<TD id=TBL1071.finRow.2.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL1071.finRow.3 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA1062 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Audit Fees<SUP style="vertical-align: baseline; position: relative; bottom:.33em;">(1)</SUP></FONT></P></TD>
<TD id=TBL1071.finRow.3.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1071.finRow.3.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1071.finRow.3.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">223,000</TD>
<TD id=TBL1071.finRow.3.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1071.finRow.3.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1071.finRow.3.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1071.finRow.3.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">205,000</TD>
<TD id=TBL1071.finRow.3.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1071.finRow.4 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA1065 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Audit-Related Fees </FONT></P></TD>
<TD id=TBL1071.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1071.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1071.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</TD>
<TD id=TBL1071.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL1071.finRow.4.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1071.finRow.4.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1071.finRow.4.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</TD>
<TD id=TBL1071.finRow.4.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1071.finRow.5 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA1068 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All Other Fees</FONT></P></TD>
<TD id=TBL1071.finRow.5.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1071.finRow.5.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1071.finRow.5.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL1071.finRow.5.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1071.finRow.5.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1071.finRow.5.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1071.finRow.5.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL1071.finRow.5.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR></TABLE>
<P id=PARA1072 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">________________________</FONT></P>
<TABLE id=MTAB1074  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA1075 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(1)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1076 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Audit fees for 2015 consisted of fees payable to Deloitte for the audit of our annual financial statements and the review of our quarterly financial information for the year ended December 31, 2015. Audit fees for 2014 consisted of fees payable to Deloitte for the audit of our annual financial statements for the year ended December&nbsp;31, 2014.</FONT></P></TD></TR></TABLE>
<P id=PARA1077 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1078 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Pre-Approval Policies and Procedures</B></FONT></P>
<P id=PARA1079 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1080 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Audit Committee has adopted procedures pursuant to which all audit, audit-related and tax services and all permissible non-audit services provided by our independent registered public accounting firm must be pre-approved by the Audit Committee. All services rendered by Deloitte, our former independent registered public accounting firm, during 2015 were permissible under applicable laws and regulations and were approved in advance by the former Audit Committee in accordance with the rules&nbsp;adopted by the SEC in order to implement requirements of the Sarbanes-Oxley Act of 2002, other than de minimis non-audit services allowed under applicable law.</FONT></P>
<P id=PARA1081 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1082 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Recommendation</B></FONT></P>
<P id=PARA1083 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1084 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>The Board of Directors unanimously recommends a vote FOR ratification of the selection of KPMG LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2016.</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1086.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK1086  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR1086  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM1086  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">16</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR1086  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA1086.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1087 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>PROPOSAL NO. 3 &#8212; ADVISORY VOTE ON EXECUTIVE COMPENSATION</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1089 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA1090 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1091 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Introduction</B></FONT></P>
<P id=PARA1092 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1093 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board of Directors is providing our stockholders with an advisory vote on executive compensation pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, and Section&nbsp;14A of the Securities Exchange Act of 1934, as amended.&nbsp; This advisory vote, commonly known as a &#8220;say-on-pay&#8221; vote, is a non-binding vote on the compensation paid to our named executive officers as described in this proxy statement under the heading &#8220;<I>Executive Compensation</I>&#8221;, including the Summary Compensation Table and the other related tables and narrative disclosure. As the Merger was not completed until January 8, 2016, the discussion under the heading &#8220;<I>Executive Compensation</I>&#8221; relates to our named executive officers during the year ended December 31, 2015 and prior to the completion of the Merger. The Board is currently considering what changes, if any, will be made to the Company&#8217;s compensation policies for the year ending December 31, 2016.</FONT></P>
<P id=PARA1094 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1095 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Reasons Why You Should Vote FOR Our Say-on-Pay Vote</B></FONT></P>
<P id=PARA1096 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1097 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our executive compensation program during the year ended December 31, 2015 was generally designed to:</FONT></P>
<P id=PARA1098 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1100  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1101 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1102 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Attract and retain executives important to the success of our company and the creation of value for our stockholders;</FONT></P></TD></TR></TABLE>
<P id=PARA1103 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1105  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1106 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1107 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Motivate our executives to achieve company and individual performance objectives and create stockholder value; and</FONT></P></TD></TR></TABLE>
<P id=PARA1108 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1110  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1111 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1112 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reward our executives for the achievement of company and individual performance objectives, the creation of stockholder value in the short and long term and their contributions, in general, to the success of our company.</FONT></P></TD></TR></TABLE>
<P id=PARA1113 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1114 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Please read the &#8220;<I>Executive Compensation</I>&#8221; section of this proxy statement.&nbsp; That section of this proxy statement, which includes compensation tables and related narrative discussion, describes in detail the compensation programs and policies for our named executive officers and the executive compensation decisions made by the Compensation Committee and Board of Directors in 2015.</FONT></P>
<P id=PARA1115 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1116 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Important considerations include:</FONT></P>
<P id=PARA1117 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1119  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1120 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1121 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During 2014 and 2015, we engaged an independent consulting firm, Radford, to assist us in designing our executive compensation program.</FONT></P></TD></TR></TABLE>
<P id=PARA1122 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1124  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1125 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><SUP style="vertical-align: baseline; position: relative; bottom:.33em;"></SUP></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1126 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We closely monitored the compensation policies and practices of other life-sciences companies with market capitalizations, revenues and organizational sizes similar to ours, with the objective of providing our executives total cash compensation and total direct compensation at the 50<SUP style="vertical-align: baseline; position: relative; bottom:.33em;">th </SUP>percentile of companies in our peer group, which we believe is fair to our executives and our stockholders.</FONT></P></TD></TR></TABLE>
<P id=PARA1127 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1129  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1130 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1131 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To motivate our executives and align their interests with those of our stockholders, we provided our executives stock options, which vest over a period of three years, linking our executives&#8217; long-term compensation with the long-term price performance of our common stock, and providing a substantial retention incentive.</FONT></P></TD></TR></TABLE>
<P id=PARA1132 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1134  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1135 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1136 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All incentive compensation awards, including annual and long-term equity and incentive awards, were subject to a &#8220;clawback&#8221; or &#8220;forfeiture&#8221; mechanism.</FONT></P></TD></TR></TABLE>
<P id=PARA1137 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1139  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1140 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1141 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We provided our executives with only modest change in control and severance benefits, most of which are triggered only upon a termination event.</FONT></P></TD></TR></TABLE>
<P id=PARA1142 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3485  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3485  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3485  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">17</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3485  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3485.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE id=MTAB1144  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1145 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1146 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We did not provide tax &#8220;gross-up&#8221; payments.</FONT></P></TD></TR></TABLE>
<P id=PARA1147 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1149  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1150 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1151 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We did not provide our executives substantial perquisites, supplemental retirement benefits, pension arrangements, post-retirement health coverage, nonqualified defined contribution or other deferred compensation.</FONT></P></TD></TR></TABLE>
<P id=PARA1152 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1154  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1155 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1156 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our insider trading policy prohibits executive officers from engaging in hedging or monetization transactions, holding Diffusion securities in a margin account and engaging in significant pledging transactions.</FONT></P></TD></TR></TABLE>
<P id=PARA1157 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1159  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1160 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1161 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We had (and have) an independent Compensation Committee that makes executive compensation decisions.</FONT></P></TD></TR></TABLE>
<P id=PARA1162 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1163 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We are requesting stockholder approval of the compensation of our named executive officers as disclosed in this proxy statement. This &#8220;say-on-pay&#8221; vote gives our stockholders the opportunity to express their views on our executive compensation. The vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement.</FONT></P>
<P id=PARA1164 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1165 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Proposed Resolution</B></FONT></P>
<P id=PARA1166 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1167 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accordingly, the Board of Directors unanimously recommends that our stockholders vote in favor of the say-on-pay vote as set forth in the following resolution at the Annual Meeting:</FONT></P>
<P id=PARA1168 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1169 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">RESOLVED, that the stockholders of Diffusion Pharmaceuticals Inc. approve, on an advisory basis, the compensation paid to the named executive officers during the year ended December 31, 2015, as described in this proxy statement pursuant to the compensation disclosure rules&nbsp;of the Securities and Exchange Commission, including the &#8220;<I>Executive Compensation</I>&#8221; section, the Summary Compensation Table, and the other related tables and narrative disclosure.</FONT></P>
<P id=PARA1170 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1171 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As this is an advisory vote, the outcome of the vote is not binding on us with respect to future executive compensation decisions, including those relating to our named executive officers, or otherwise.&nbsp; The Compensation Committee and Board of Directors will take into account the outcome of the vote when considering future executive compensation decisions.</FONT></P>
<P id=PARA1172 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1173 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Recommendation</B></FONT></P>
<P id=PARA1174 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1175 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>The Board of Directors unanimously recommends a vote FOR approval, on an advisory basis, of the compensation paid to our named executive officers, as described in this proxy statement.</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1177.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK1177  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR1177  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM1177  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">18</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR1177  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA1177.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1178 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>PROPOSAL NO. 4 &#8212; APPROVAL OF AN AMENDMENT TO DIFFUSION <BR>PHARMACEUTICALS INC.&#8217;S CERTIFICATE OF INCORPORATION TO EFFECT <BR>THE RESERVE STOCK SPLIT</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1180 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA1181 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1182 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>General&nbsp;</B></FONT></P>
<P id=PARA1183 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1184 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board has unanimously approved, and recommended that our stockholders approve, an amendment to our Charter (the &#8220;Certificate of Amendment&#8221;), to effect the Reverse Stock Split at a ratio of not less than 1-to-2 and not greater than 1-to-20, with the final decision of whether to proceed with the Reverse Stock Split, the effective time of the Reverse Stock Split, and the exact ratio of the Reverse Stock Split to be determined by the Board, in its discretion. If the stockholders approve the Reverse Stock Split, and the Board decides to implement it, the Reverse Stock Split will become effective as of 12:01 a.m., Eastern Time on a date to be determined by the Board that will be specified in the Certificate of Amendment. If the Board does not decide to implement the Reverse Stock Split within twelve months from the date of the Annual Meeting, the authority granted in this proposal to implement the Reverse Stock Split will terminate.</FONT></P>
<P id=PARA1185 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1186 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Reverse Stock Split will be realized simultaneously for all outstanding common stock. The Reverse Stock Split will affect all holders of common stock uniformly and each stockholder will hold the same percentage of common stock outstanding immediately following the Reverse Stock Split as that stockholder held immediately prior to the Reverse Stock Split, except for immaterial adjustments that may result from the treatment of fractional shares as described below. The Reverse Stock Split will not change the par value of our common stock and will not reduce the number of authorized shares of common stock. </FONT></P>
<P id=PARA1187 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1188 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Reasons for the Reverse Stock Split&nbsp;</B></FONT></P>
<P id=PARA1189 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1190 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our Board believes that a Reverse Stock Split is desirable for a number of reasons. First, the Board believes that a Reverse Stock Split could improve the marketability and liquidity of our common stock. Second, the Board believes that a Reverse Stock Split may facilitate the listing of our common stock on a stock exchange such as the NASDAQ. Third, our Board believes that a reverse split would assist in providing us with flexibility and as many alternatives as possible to obtain financings that we are seeking to accomplish.</FONT></P>
<P id=PARA1191 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1192 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Marketability&nbsp;</I></FONT></P>
<P id=PARA1193 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1194 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our Board believes that the increased market price of our common stock expected as a result of implementing a Reverse Stock Split could improve the marketability and liquidity of our stock and could encourage interest and trading in our stock. Theoretically, the number of shares outstanding and the per share price should not, by themselves, affect the marketability of our common stock, the type of investor who acquires them, or our reputation in the financial community. However, in practice, we believe this is not necessarily the case, as we believe that many investors view low-priced stocks as speculative and generally avoid the purchase of such securities. Our Board believes that there is a reluctance of many brokerage firms to recommend low-priced stocks to their retail clients (whether due to internal restrictions and/or limitations or otherwise). Further, we believe that certain brokerage house policies and practices tend to discourage individual brokers who administer brokerage accounts within those firms from encouraging their clients to transact trades in low-priced stocks. In addition, institutional investors, pursuant to internal policies, often are restricted and/or limited from investing in companies whose stocks trade at low prices.&nbsp;&nbsp;Stockbrokers are also subject to certain restrictions on their ability to recommend lower priced stocks to their retail clients trading because of what we believe to be a general presumption in the industry that such securities are highly speculative. In addition, the structure of trading commissions tends to have an adverse impact upon purchasers of low-priced stocks because the brokerage commission on a sale of such securities generally represents a higher percentage of the purchase/sales price than the commission on a relatively higher-priced issue. We believe that the Reverse Stock Split will make our common stock a more attractive and cost effective investment for many investors, which we in turn believe would enhance the liquidity of the holders of our common stock.</FONT></P>
<P id=PARA3486.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3486  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3486  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3486  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">19</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3486  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3486.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1196 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Reverse Stock Split is intended, in part, to result in a price level for our common stock that will increase investor interest and possibly eliminate, or at the least reduce, the resistance of brokerage firms. On June __, 2016, the closing bid price for our common stock, as reported on the OTC Bulletin Board, was $______ per share. No assurances can be given that the market price for our common stock will increase in the same proportion as the Reverse Stock Split or, if increased, that such price will be maintained. In addition, no assurances can be given that the Reverse Stock Split will increase the price of our common stock to a sufficiently high enough level that is attractive to brokerage houses and retail and institutional investors.</FONT></P>
<P id=PARA1197 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1198 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Further, our Board believes that a higher stock price could help us establish business development relationships with other companies. Theoretically, decreasing the number of shares of common stock outstanding should not, by itself, affect our reputation in our business community. In practice, however, we believe that potential business development partners may be less confident in the prospects of a company with a low stock price, and are less likely to enter into business relationships with a company with a low stock price. If the Reverse Stock Split successfully increases the per share price of our common stock, we believe this may increase our ability to attract business development partners. </FONT></P>
<P id=PARA1199 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1200 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Stock Exchange Requirements</I></FONT></P>
<P id=PARA1201 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1202 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our common stock is currently quoted on the OTCQX under the symbol &#8220;DFFN&#8221;. Prior to January 25, 2016, our common stock was quoted under the symbol &#8220;RESX.&#8221; It has never been listed on any national securities exchange. As noted above, on June __, 2016, the closing bid price for our common stock, as reported on the OTC Bulletin Board, was $______ per share. We believe that we meet all of the initial listing requirements to be listed on the NASDAQ other than the minimum per share market price of our common stock.</FONT></P>
<P id=PARA1203 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1204 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We believe that the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">will enhance our ability to obtain an initial listing on the NASDAQ Stock Market. The NASDAQ requires, among other items, an initial bid price of least $4.00 per share or if certain financial and governance standards are achieved, a closing price on the OTC Markets QB (or higher) tier of $3.00 (or $2.00 depending on the applicable listing standard) for five consecutive days and following initial listing, maintenance of a continued price of at least $1.00 per share. Reducing the number of outstanding shares of our common stock should, absent other&nbsp;factors, increase the per share market price of our common stock, although we cannot provide any assurance that our minimum bid price would remain following the Reverse Stock Split over the minimum bid price requirement of any such stock exchange.</FONT></P>
<P id=PARA1205 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1206 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reducing the number of outstanding shares of our common stock should, absent other factors, increase the per share market price of our common stock, although we cannot provide any assurance that we will be able to meet or maintain a bid price over the minimum initial listing bid price requirement of the NASDAQ or other national stock exchange or any other exchange. Although our Board has determined that it is in the Company&#8217;s and our stockholders&#8217; best interests to position our common stock for potential listing on the NASDAQ or other national stock exchange, the board may ultimately determine to not pursue any listing. There can be no assurance that any such application will result in the listing of our common stock on any exchange.</FONT></P>
<P id=PARA1207 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1208 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The NASDAQ also requires that an applicant have at least three market makers and comply with certain corporate governance requirements, including having at least three Audit Committee members (each of whom must be independent), at least two Compensation Committee members (each of whom must be independent) and a Board with a majority of independent members. In addition, director nominees must be selected, or recommended to the Board for selection, either by independent directors constituting a majority of the Board in a vote in which only independent directors participate or by a Nominating Committee comprised solely of independent directors. We believe that we currently satisfy all of the Board and Committee composition and independence requirements for listing on the NASDAQ. </FONT></P>
<P id=PARA1209 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1210 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Further, no assurance can be given that, even if we satisfy the above listing requirements, we will apply to have our common stock listed on the NASDAQ or another national securities exchange, or that, if we do so apply, our application will be approved, or that, if our common stock is listed on the NASDAQ or another national securities exchange, we will be able to satisfy the maintenance requirements for continued listing.</FONT></P>
<P id=PARA3487.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3487  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3487  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3487  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">20</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3487  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3487.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1212 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Financing Flexibility</I></FONT></P>
<P id=PARA1213 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1214 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition, the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">will provide us with the ability to support our present capital needs and future anticipated growth. The Reverse Stock Split alone would have no effect on our authorized capital stock, and the total number of authorized shares would remain the same as before the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split. This would have the effect of increasing the number of shares of common stock available for issuance, which the Board feels it is important to provide us with flexibility and as many alternatives as possible to obtain financing. We have historically met our capital needs primarily through the sale of our debt and equity securities. The availability of additional shares of common stock would provide us with the flexibility to consider and respond to future business opportunities and needs as they arise, including public or private financings, subscription rights offerings, mergers, acquisitions, stock dividends, stock splits and the granting of equity incentive awards. The additional available shares would be available for issuance from time to time at the discretion of the Board when opportunities arise, without further stockholder action or the related delays and expenses, except as may be required for a particular transaction by law, the rules of any exchange on which our securities may then be listed, or other agreements or restrictions. There are no preemptive rights relating to the common stock. As such, any issuance of additional shares of our common stock would increase the number of outstanding shares of our common stock and (unless such issuance was pro-rata among existing stockholders) the percentage ownership of existing stockholders would be diluted accordingly. At this time, we do not have any plans, arrangements or understandings, whether written or oral, to issue any of the additional shares that will be made available if the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">is approved and the Board implements the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split.</FONT></P>
<P id=PARA1215 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1216 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reducing the number of outstanding shares of our common stock through the Reverse Stock Split is intended, absent other factors, to increase the per share market price of our common stock. However, other factors, such as events relating to our financial results, general market conditions and the market perception of our Company, may adversely affect the market price of our common stock. As a result, there can be no assurance that the Reverse Stock Split, if completed, will result in the intended benefits described above, that the market price of our common stock will increase following the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">or that the market price of our common stock will not decrease in the future. Additionally, we cannot assure you that the market price per share of our common stock after a Reverse Stock Split will increase in proportion to the reduction in the number of shares of our common stock outstanding before the Reverse Stock Split. Accordingly, the total market capitalization of our common stock after the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">may be lower than the total market capitalization before the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split.</FONT></P>
<P id=PARA1217 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1218 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Determination of Ratio</B></FONT></P>
<P id=PARA1219 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1220 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The ratio of the&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reverse Stock Split, if approved and implemented, will be a ratio of not less than 1-to-2 and not more than 1-to-20, as determined by our Board in its sole discretion. The Board believes that stockholder adoption of a range of Reverse Stock Split ratios (as opposed to adoption of a single Reverse Stock Split ratio or a set of fixed ratios) provides maximum flexibility to achieve the purposes of a Reverse Stock Split and, therefore, is in the best interests of the Company. In determining a ratio following the receipt of stockholder adoption, the Board (or any authorized committee of the Board) may consider, among other things, factors such as:</FONT></P>
<P id=PARA1221 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1223  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1224 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1225 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the historical trading price and trading volume of our common stock;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">&#9679;</TD>
<TD style="VERTICAL-ALIGN: top">the number of shares of our common stock outstanding;</TD></TR></TABLE>
<P id=PARA1226 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1228  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1229 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1230 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the then-prevailing trading price and trading volume of our common stock and the anticipated impact of the Reverse Stock Split on the trading market for our common stock;</FONT></P></TD></TR></TABLE>
<P id=PARA1231 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1233  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1234 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1235 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">our ability to have our shares of common stock listed on a stock exchange such as the NASDAQ or another national securities exchange;</FONT></P></TD></TR></TABLE>
<P id=PARA1236 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1238  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1239 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1240 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the anticipated impact of the Reverse Stock Split on our ability to raise additional financing;</FONT></P></TD></TR></TABLE>
<P id=PARA1241 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1243  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1244 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1245 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the anticipated impact of a particular ratio on our ability to reduce administrative and transactional costs; and</FONT></P></TD></TR></TABLE>
<P id=PARA1246 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1248  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1249 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1250 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">prevailing general market and economic conditions.</FONT></P></TD></TR></TABLE>
<P id=PARA1251 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3488  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3488  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3488  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">21</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3488  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3488.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1252 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board (or any authorized committee of the Board) reserves the right to elect to abandon the Reverse Stock Split, notwithstanding stockholder adoption thereof, if it determines, in its sole discretion, that the Reverse Stock Split is no longer in the best interests of the Company and its stockholders. The Reverse Stock Split, if authorized pursuant to this resolution and if deemed by the Board to be in the best interests of the Company and its stockholders, will be effected, if at all, at a time that is not later than twelve months from the date of the Special Meeting.</FONT></P>
<P id=PARA1253 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1254 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Reverse Stock Split Amendment to the Charter&nbsp;</B></FONT></P>
<P id=PARA1255 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1256 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If the Reverse Stock Split is approved, the following paragraph shall be added at the end of subsection A&nbsp;of ARTICLE IV of the Charter: </FONT></P>
<P id=PARA1257 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1258 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;Effective upon the effective time of this Certificate of Amendment of the Certificate of Incorporation with the Secretary of State of the State of Delaware (the &#8220;<U>Effective Time</U>&#8221;), each ___ shares of Common Stock issued and outstanding immediately prior to the Effective Time shall, automatically and without the necessity of any further action, be changed, reclassified and combined into one (1)&nbsp;share of Common Stock (the &#8220;<U>Reverse Stock Split</U>&#8221;). No fractional shares shall be issued in connection with the Reverse Stock Split. Stockholders who otherwise would be entitled to receive fractional shares of Common Stock shall have rounded up to one additional whole share. Each certificate that immediately prior to the Effective Time represented shares of Common Stock (&#8220;<U>Old Certificates</U>&#8221;), shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the elimination of fractional shares as described above.&#8221;</FONT></P>
<P id=PARA1259 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1260 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Certificate of Amendment attached hereto as <U>Appendix A</U> reflects the changes that will be implemented to our Charter if the Reverse Stock Split is approved. </FONT></P>
<P id=PARA1261 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1262 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Principal Effects of the Reverse Stock Split&nbsp;</B></FONT></P>
<P id=PARA1263 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1264 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If the stockholders approve the proposal to authorize the Board to implement the Reverse Stock Split and the Board implements the Reverse Stock Split, we will amend the existing provision of Article IV of our Charter in the manner set forth above. </FONT></P>
<P id=PARA1265 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1266 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">By approving this amendment, stockholders will approve the combination of any number of shares of common stock between and including 2&nbsp;and 20, with the exact number to be determined by the Board, into one (1)&nbsp;share. The Certificate of Amendment to be filed with the Secretary of State of the State of Delaware will include only that number determined by the Board to be in the best interests of the Company and its stockholders. In accordance with these resolutions, the Board will not implement any amendment providing for a different split ratio. </FONT></P>
<P id=PARA1267 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1268 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As explained above, the Reverse Stock Split will be effected simultaneously for all issued and outstanding shares of common stock and the exchange ratio will be the same for all issued and outstanding shares of common stock. The Reverse Stock Split will affect all of our stockholders uniformly and will not affect any stockholder&#8217;s percentage ownership interests in the Company, except to the extent that the Reverse Stock Split results in any of our stockholders having his or her shares rounded up to a whole share in lieu of owning a fractional share, as described in the section titled &#8220;<B>Fractional Shares</B>,&#8221; below. </FONT></P>
<P id=PARA1269 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1270 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Reverse Stock Split will not change the terms of our common stock. After the Reverse Stock Split, the shares of our common stock will have the same voting rights and rights to dividends and distributions and will be identical in all other respects to our common stock now authorized. Common stock issued pursuant to the Reverse Stock Split will remain fully paid and non-assessable. The Reverse Stock Split will not affect the Company&#8217;s continuing obligations under the periodic reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Following the Reverse Stock Split, unless we simultaneously list our common stock on the NASDAQ or other national stock exchange, bid and ask prices for our common stock will continue to be quoted on the OTCQX under the symbol &#8220;DFFN,&#8221; although the OTCQX will add the letter &#8220;D&#8221; to the end of the trading symbol for a period of 20 trading days after the effective time to indicate that a reverse stock split has occurred.</FONT></P>
<P id=PARA3489.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3489  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3489  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3489  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">22</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3489  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3489.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1272 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The shares that are authorized but unissued after the Reverse Stock Split will be available for issuance, and, if we issue these shares, the ownership interest of holders of our common stock may be diluted. We may issue such shares to raise capital and/or as consideration in acquiring other businesses or establishing strategic relationships with other companies. Such acquisitions or strategic relationships may be effected using shares of common stock or other securities convertible into common stock and/or by using capital that may need to be raised by selling such securities. We do not have any agreement, arrangement or understanding at this time with respect to any specific transaction or acquisition for which the newly unissued authorized shares would be issued. </FONT></P>
<P id=PARA1273 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1274 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Effect on Authorized but Unissued Shares</B></FONT></P>
<P id=PARA1275 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1276 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Reverse Stock Split will have the effect of significantly increasing the number of authorized but unissued shares of common stock available for issuance. The number of shares of common stock that we are authorized to issue will not be decreased and will remain at 1,000,000,000. Because the number of outstanding shares will be reduced as a result of the Reverse Stock Split, the number of shares available for future issuance by us will be increased. As of May 24, 2016 we have 897,570,800 authorized and unissued shares, of which 24,746,891 are currently reserved for issuance. Upon completion of the Reverse Stock Split we expect to have significantly more authorized and unissued shares.</FONT></P>
<P id=PARA1277 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1278 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Procedure for Effecting Reverse Stock Split and Exchange of Stock Certificates&nbsp;</B></FONT></P>
<P id=PARA1279 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1280 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If the Reverse Stock Split is approved by the Company&#8217;s stockholders, and if at such time the Board still believes that the Reverse Stock Split is in the best interests of the Company and its stockholders, the Board will determine the ratio of the Reverse Stock Split to be implemented. The Reverse Stock Split will become effective as of 12:01&nbsp;a.m., Eastern Time on the date specified in the Certificate of Amendment as filed with the office of the Secretary of State of the State of Delaware (the &#8220;effective time&#8221;). The Board will determine the exact timing of the filing of the Certificate of Amendment based on its evaluation as to when the filing would be the most advantageous to the Company and its stockholders. If the Board does not decide to implement the Reverse Stock Split within twelve months from the date of the Special Meeting, the authority granted in this proposal to implement the Reverse Stock Split will terminate. </FONT></P>
<P id=PARA1281 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1282 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Except as described below under the section titled &#8220;<B>Fractional Shares</B>,&#8221; at the effective time, each number of issued and outstanding pre-reverse split shares that the Board has determined will be combined into one post-reverse split share, will, automatically and without any further action on the part of our stockholders, be combined into and become one share of common stock, and each certificate which, immediately prior to the effective time represented pre-reverse stock split shares, will be deemed for all corporate purposes to evidence ownership of post-reverse split shares. </FONT></P>
<P id=PARA1283 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1284 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Fractional Shares&nbsp;</B></FONT></P>
<P id=PARA1285 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1286 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">No fractional shares will be issued in connection with the Reverse Stock Split. Instead, stockholders who otherwise would be entitled to receive&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">fractional shares because they hold a number of shares not evenly divisible by the split ratio will automatically be entitled to receive an additional share of common stock. In other words, any fractional share will be rounded up to the nearest whole number. Stockholders of record at the effective time of the Reverse Stock Split who otherwise would be entitled to receive fractional shares because they hold a number of pre-split shares not evenly divisible by the number of pre-split shares for which each post-split share is to be exchanged, will, in lieu of a fractional share, be entitled, upon surrender to the exchange agent of certificate(s) representing such pre-split shares, to entitled to receive an additional share of common stock. In other words, any fractional share will be rounded up to the nearest whole number.</FONT></P>
<P id=PARA3490.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3490  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3490  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3490  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">23</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3490  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3490.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1288 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Risks Associated with the Reverse Stock Split&nbsp;</B></FONT></P>
<P id=PARA1289 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1290 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We cannot predict whether the Reverse Stock Split will increase the market price for our common stock. The history of similar stock split combinations for companies in like circumstances is varied, and the market price of our common stock will also be based on our performance and other factors, some of which are unrelated to the number of shares outstanding. Further, there are a number of risks associated with the Reverse Stock Split, including: </FONT></P>
<P id=PARA1291 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1293  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1294 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1295 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The market price per share of our shares of common stock post-Reverse Stock Split may not ever exceed or remain in excess of the minimum bid price per share as required by the NASDAQ, or the Company may fail to meet the other requirements for initial or continued listing on the NASDAQ.</FONT></P></TD></TR></TABLE>
<P id=PARA1296 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1298  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1299 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1300 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Although the Board believes that a higher stock price may help generate the interest of new investors, the Reverse Stock Split may not result in a per-share price that will successfully attract certain types of investors and such resulting share price may not satisfy the investing guidelines of institutional investors or investment funds. Further, other factors, such as our financial results, market conditions and the market perception of our business, may adversely affect the interest of new investors in the shares of our common stock. As a result, the trading liquidity of the shares of our common stock may not improve as a result of the Reverse Stock Split and there can be no assurance that the Reverse Stock Split, if completed, will result in the intended benefits described above.\</FONT></P></TD></TR></TABLE>
<P id=PARA1301 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1303  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1304 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1305 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Reverse Stock Split could be viewed negatively by the market, and other factors, such as those described above, may adversely affect the market price of the shares of our common stock. Consequently, the market price per post-Reverse Stock Split shares may not increase in proportion to the reduction of the number of shares of our common stock outstanding before the implementation of the Reverse Stock Split. Accordingly, the total market capitalization of our shares of common stock after the Reverse Stock Split may be lower than the total market capitalization before the Reverse Stock Split. Any reduction in total market capitalization as the result of the Reverse Stock Split may make it more difficult for us to meet the NASDAQ Listing Rule regarding minimum value of listed securities, which could prevent our shares from listing, or continuing to be listed on the NASDAQ.</FONT></P></TD></TR></TABLE>
<P id=PARA1306 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1308  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1309 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1310 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Reverse Stock Split may result in some stockholders owning &#8220;odd lots&#8221; of less than 100 shares of common stock. Odd lot shares may be more difficult to sell, and brokerage commissions and other costs of transactions in odd lots are generally somewhat higher than the costs of transactions in &#8220;round lots&#8221; of even multiples of 100 shares.</FONT></P></TD></TR></TABLE>
<P id=PARA1311 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1312 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Book-Entry Shares&nbsp;</B></FONT></P>
<P id=PARA1313 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1314 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If the Reverse Stock Split is effected, stockholders who hold uncertificated shares (i.e., shares held in book-entry form and not represented by a physical stock certificate), either as direct or beneficial owners, will have their holdings electronically adjusted automatically by our transfer agent (and, for beneficial owners, by their brokers or banks that hold in &#8220;street name&#8221; for their benefit, as the case may be) to give effect to the Reverse Stock Split. Stockholders who hold uncertificated shares as direct owners will be sent a statement of holding from our transfer agent that indicates the number of post-reverse stock split shares of our common stock owned in book-entry form. </FONT></P>
<P id=PARA1315 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1316 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Certificated Shares&nbsp;</B></FONT></P>
<P id=PARA1317 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1318 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As soon as practicable after the effective time of the Reverse Stock Split, stockholders will be notified that the Reverse Stock Split has been effected. We expect that our transfer agent will act as exchange agent for purposes of implementing the exchange of stock certificates. Holders of pre-split shares will be asked to surrender to the exchange agent certificates representing pre-split shares in exchange for certificates representing post-split shares in accordance with the procedures to be set forth in a letter of transmittal to be sent by us or our exchange agent. No new certificates will be issued to a stockholder until such stockholder has surrendered such stockholder&#8217;s outstanding certificate(s) together with the properly completed and executed letter of transmittal to the exchange agent. Any pre-split shares submitted for transfer, whether pursuant to a sale or other disposition, or otherwise, will automatically be exchanged for post-split shares. </FONT></P>
<P id=PARA1319 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1320 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>STOCKHOLDERS SHOULD NOT DESTROY ANY STOCK CERTIFICATE(S) AND SHOULD NOT SUBMIT ANY CERTIFICATE(S) UNTIL REQUESTED TO DO SO. </B></FONT></P>
<P id=PARA3491.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3491  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3491  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3491  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">24</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3491  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3491.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1322 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Principal Effects of Reverse Stock Split on Outstanding Options, Outstanding Convertible Debt, </B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Warrants, and Option Plan </B></FONT></P>
<P id=PARA1323 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1324 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of the May 24, 2016, there were outstanding stock options to purchase an aggregate of 17,879,116 shares of our common stock with a weighted average exercise price of $0.86 per share and warrants to purchase an aggregate of 4,768,175 shares of common stock with a weighted average exercise price of $7.83 per share. In addition, as of the May 24, 2016 we had $550,000 in convertible debt outstanding entitling the holders thereof to acquire shares of our common stock</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">. When the Reverse Stock Split becomes effective, the number of shares of common stock covered by such rights will be reduced to between and including one-twentieth and one-half of the number currently covered (rounded up to the nearest whole number), and the exercise or conversion price per share will be increased by between and including two and 20 times the current exercise or conversion price (rounded down to the nearest $0.01), resulting in the same aggregate price being required to be paid therefor upon exercise or conversion thereof as was required immediately preceding the Reverse Stock Split. </FONT></P>
<P id=PARA1325 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1326 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition, the number of shares of common stock and number of shares of common stock subject to stock options or similar rights authorized under the Company&#8217;s equity incentive plan will automatically be proportionately adjusted for the Reverse Stock Split ratio, such that fewer shares will be subject to such plans. Further, the per share exercise price under such plans will automatically be proportionately adjusted for the Reverse Stock Split.</FONT></P>
<P id=PARA1327 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1328 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Accounting Matters&nbsp;</B></FONT></P>
<P id=PARA1329 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1330 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Reverse Stock Split will not affect the common stock capital account on our balance sheet. However, because the par value of our common stock will remain unchanged at the effective time of the split, the components that make up the common stock capital account will change by offsetting amounts. Depending on the size of the Reverse Stock Split the Board decides to implement, the stated capital component will be reduced proportionately based upon the Reverse Stock Split and the additional paid-in capital component will be increased with the amount by which the stated capital is reduced. Immediately after the Reverse Stock Split, the per share net income or loss and net book value of our common stock will be increased because there will be fewer shares of common stock outstanding. All historic share and per share amounts in our financial statements and related footnotes will be adjusted accordingly for the Reverse Stock Split. </FONT></P>
<P id=PARA1331 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1332 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Effect on Par Value&nbsp;</B></FONT></P>
<P id=PARA1333 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1334 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The proposed amendment to our Charter will not affect the par value of our common stock, which will remain at $0.001 per share. </FONT></P>
<P id=PARA1335 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1336 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>No Going Private Transaction&nbsp;</B></FONT></P>
<P id=PARA1337 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1338 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Notwithstanding the decrease in the number of outstanding shares following the proposed Reverse Stock Split, our Board does not intend for this transaction to be the first step in a &#8220;going private transaction&#8221; within the meaning of Rule 13e-3 of the Exchange Act. </FONT></P>
<P id=PARA1339 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1340 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Potential Anti-Takeover Effect&nbsp;</B></FONT></P>
<P id=PARA1341 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1342 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Although the increased proportion of unissued authorized shares to issued shares could, under certain circumstances, have an anti-takeover effect (for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of the Board or contemplating a tender offer or other transaction for the combination of the Company with another company), the Reverse Stock Split proposal is not being proposed in response to any effort of which we are aware to accumulate shares of our common stock or obtain control of the Company, nor is it part of a plan by management to recommend a series of similar amendments to the Board and stockholders. Other than the Reverse Stock Split proposal, the Board does not currently contemplate recommending the adoption of any other actions that could be construed to affect the ability of third parties to take over or change control of the Company. </FONT></P>
<P id=PARA3492.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3492  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3492  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3492  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">25</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3492  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3492.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1344 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>No Dissenters&#8217; Appraisal Rights </B></FONT></P>
<P id=PARA1345 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1346 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Under the Delaware General Corporation Law, our Charter or bylaws, the Company&#8217;s stockholders are not entitled to dissenters&#8217; appraisal rights with respect to the Reverse Stock Split, and we will not independently provide stockholders with any such right. </FONT></P>
<P id=PARA1347 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1348 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Material United States Federal Income Tax Consequences of the Reverse Stock Split&nbsp;</B></FONT></P>
<P id=PARA1349 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1350 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following is not intended as tax or legal advice. Each holder should seek advice based on his, her or its particular circumstances from an independent tax advisor. </FONT></P>
<P id=PARA1351 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1352 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following is a summary of certain United States federal income tax consequences of the Reverse Stock Split generally applicable to beneficial holders of shares of our common stock. This summary addresses only such stockholders who hold their pre-split shares as capital assets and will hold the post-split shares as capital assets. This discussion does not address all United States federal income tax considerations that may be relevant to particular stockholders in light of their individual circumstances or to stockholders that are subject to special rules, such as financial institutions, trusts, estates, entities treated as partnerships for U.S. federal income tax purposes, tax-exempt organizations, regulated investment companies, REITs, insurance companies, dealers in securities, and foreign stockholders. The following summary is based upon the provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), applicable Treasury Regulations thereunder, judicial decisions and Internal Revenue Service (&#8220;IRS&#8221;) rulings, as of the date hereof, all of which are subject to change, possibly on a retroactive basis. Tax consequences under state, local, foreign, and other laws are not addressed herein. Each stockholder should consult their tax advisor as to the particular facts and circumstances which may be unique to such stockholder and also as to any estate, gift, state, local or foreign tax considerations arising out of the Reverse Stock Split. </FONT></P>
<P id=PARA1353 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1354 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Exchange Pursuant to Reverse Stock Split </I></FONT></P>
<P id=PARA1355 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1356 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Reverse Stock Split is intended to qualify as a tax-free recapitalization under the Code. Assuming the Reverse Stock Split so qualifies, then generally, for U.S. federal income tax purposes, no gain or loss will be recognized by the Company in connection with the Reverse Stock Split, and no gain or loss will be recognized by the stockholders that exchange their pre-split shares for post-split shares. The post-split shares in the hands of a stockholder following the Reverse Stock Split will generally have an aggregate tax basis equal to the aggregate tax basis of the pre-split shares held by that stockholder immediately prior to the Reverse Stock Split, and a stockholder&#8217;s holding period for its post-split shares generally will be the same as its holding period for the pre-split shares. </FONT></P>
<P id=PARA1357 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1358 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Whole Shares in Lieu of Fractional Shares</I></FONT></P>
<P id=PARA1359 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1360 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A stockholder who receives a whole share of common stock in lieu of a fractional share generally may recognize gain in an amount not to exceed the excess of the fair market value of such whole share over the fair market value of the fractional share to which the stockholder was otherwise entitled. Any such recognition of gain may affect the holding period and adjusted tax basis of the stockholder&#8217;s whole share received in lieu of a fractional share. Stockholders should consult with their own tax advisors regarding the U.S. federal income tax consequences to them of the Reverse Stock Split. Backup withholding may apply to a stockholder who receives a whole share of common stock in lieu of a fractional share unless the stockholder provides the exchange agent with appropriate documentation establishing that backup withholding is not required.</FONT></P>
<P id=PARA1361 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1362 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Interests of Directors and Executive Officers&nbsp;</B></FONT></P>
<P id=PARA1363 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1364 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this proposal except to the extent of their ownership of shares of our common stock. </FONT></P>
<P id=PARA3493.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3493  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3493  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3493  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">26</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3493  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3493.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1366 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Reservation of Right to Abandon Reverse Stock Split&nbsp;</B></FONT></P>
<P id=PARA1367 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1368 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We reserve the right to not file the Certificate of Amendment and to abandon the Reverse Stock Split without further action by our stockholders at any time before the effectiveness of the filing with the Secretary of the State of Delaware of the Certificate of Amendment, even if the authority to effect these amendments is approved by our stockholders at the annual meeting. By voting in favor of a reverse stock split, you are expressly also authorizing the Board to delay, not proceed with, and abandon, these proposed amendments if it should so decide, in its sole discretion, that such action is in the best interests of our stockholders. </FONT></P>
<P id=PARA1369 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1370 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Vote Required&nbsp;</B></FONT></P>
<P id=PARA1371 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1372 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The affirmative vote of the holders of a majority of the outstanding shares of our common stock entitled to vote on the matter either in person or by proxy is required to approve the Certificate of Amendment to our Charter to effect the Reverse Stock Split of our common stock. Abstentions and broker non-votes, if any, will thus count as votes AGAINST the Reverse Stock Split. </FONT></P>
<P id=PARA1373 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1374 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the proxy card or, if no direction is made, then FOR the Reverse Stock Split. </FONT></P>
<P id=PARA1375 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1376 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Recommendation</B></FONT></P>
<P id=PARA1377 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1378 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>The Board of Directors unanimously recommends that stockholders vote &#8220;FOR&#8221; the Amendment to the Charter to effect the Reverse Stock Split.</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA1381.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK1381  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR1381  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM1381  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">27</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR1381  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA1381.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1382 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>PROPOSAL NO. 5 &#8212; APPROVAL OF AN AMENDMENT TO THE DIFFUSION <BR>PHARMACEUTICALS INC. 2015 EQUITY INCENTIVE PLAN</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1384 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA1385 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1386 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Introduction</B></FONT></P>
<P id=PARA1387 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1388 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board unanimously approved, and recommends that our stockholders approve, an amendment to the Diffusion Pharmaceuticals Inc. 2015 Equity Incentive Plan (the &#8220;2015 Plan&#8221;) to increase the number of shares available for grant under the 2015 Plan by (i) 2,500,000 shares immediately and (ii) 4.0% of the total shares of the Company&#8217;s common stock outstanding as of December 31 on each subsequent January 1 through the term of the 2015 Plan. A copy of the amendment is attached to this Proxy Statement as Appendix&nbsp;B. This amendment will become effective only upon its approval by our stockholders.</FONT></P>
<P id=PARA1389 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1390 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The purpose of the 2015 Plan is to advance the interests of our company and stockholders by enabling us to attract and retain qualified individuals to perform services for us, by providing incentive compensation for such individuals that is linked to the growth and profitability of our company and increases in stockholder value, and aligning the interests of such individuals with the interests of our stockholders through opportunities for equity participation in our company. The 2015 Plan was first adopted by our Board of Directors on March 10, 2015 and was subsequently approved by our stockholders. The maximum number of shares that may be issued under the plan is 2,500,000, not including any shares subject to options or other equity awards assumed in connection with certain fundamental transactions, including the Merger.</FONT></P>
<P id=PARA1391 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1392 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Since the adoption of the 2015 Plan, we have granted equity incentive awards to participants in the 2015 Plan. As of May 24, 2016 we had 400,400 total shares of our common stock underlying awards outstanding under the 2015 Plan (including awards assumed in connection the Merger) with 2,099,600 shares remaining for future grants under the 2015 Plan. As of May 24, 2016 we had outstanding under all of our equity and equity-based plans&nbsp;17,879,116 stock options (including options outstanding under the 2015 Plan and options not granted pursuant to any plan, prior to our adoption of the 2015 Plan in June 2015), with a weighted average exercise price of $0.86 and a weighted average remaining term of 7.9&nbsp;years. Of those stock options, 12,266,807 are currently vested.</FONT></P>
<P id=PARA1393 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1394 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board has concluded that it is in our best interests, and in the best interests of our stockholders, to increase the number of shares available for grant under the 2015 Plan by (i) 2,500,000 shares immediately and (ii)&nbsp;4.0% of the total shares of the Company&#8217;s common stock outstanding as of December 31 on each subsequent January 1 through the term of the 2015 Plan. In making this recommendation, the Board considered various aspects of the 2015 Plan, including the number of shares subject to outstanding awards, the number of shares that remain available for future awards under the 2015 Plan, our historical pattern of and future expectations for granting equity awards, the cost of issuing additional shares, the impact of share dilution on existing shareholders, and the central role of equity compensation in our compensation programs. The Board believes that the proposed increase in the number of shares is necessary for retaining the flexibility to grant equity-based compensation at levels that optimal for motivating and rewarding our employee&#39;s for their contributions to our success and the growth in the value of our common stock.</FONT></P>
<P id=PARA1395 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1396 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following summary of the 2015 Plan sets for the principal features of the 2015 Plan, as amended. This summary is entirely qualified by reference to the 2015 Plan, a copy of which is attached to this Proxy Statement as Appendix&nbsp;C. In the event of any contradiction or inconsistency between the summary and the terms of the 2015 Plan, the terms of the 2015 Plan will control.</FONT></P>
<P id=PARA1397 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1398 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Share Reserve</B></FONT></P>
<P id=PARA1399 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1400 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We initially reserved an aggregate of 2,500,000 shares of our common stock for issuance pursuant to awards granted under the 2015 Plan, and in connection with the Merger we assumed 6,650 stock options that are also subject to the 2015 Plan. As of May 24, 2016 there were 2,099,600 shares available for future awards under the 2015 Plan, and, if our stockholders approve the proposed amendment, there will be 4,599,600 shares available for future awards under the 2015 Plan, subject to the annual increases provided for in the Amendment.</FONT></P>
<P id=PARA3494.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3494  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3494  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3494  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">28</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3494  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3494.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1402 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Summary of the 2015 Plan</B></FONT></P>
<P id=PARA1403 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1404 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Purpose</I>. The purpose of the 2015 Plan is to advance the interests of our company and stockholders by enabling us to attract and retain qualified individuals to perform services for us, by providing incentive compensation for such individuals that is linked to the growth and profitability of our company and increases in stockholder value, and aligning the interests of such individuals with the interests of our stockholders through opportunities for equity participation in our company. Providing stock incentive awards under the plan will be an important element in our overall success. In general, the Board of Directors believes that equity-based incentives align the interests of our management and employees with those of our stockholders. In addition, providing incentive awards under the plan is an important strategy for attracting and retaining the type of high-quality executives, employees and advisors the Board of Directors believes is necessary for the achievement of our goals.&nbsp; Given the intense competition for such personnel, the Board of Directors believes that its ability to offer competitive compensation packages, including those with equity-based incentive components, such as stock options, is particularly important in attracting and retaining qualified candidates.</FONT></P>
<P id=PARA1405 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1406 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Eligibility</I>. All employees (including officers and directors who also are employees), non-employee directors, consultants, advisors and independent contractors of Diffusion, or any subsidiary, will be eligible to receive incentive awards under the plan.</FONT></P>
<P id=PARA1407 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1408 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Shares Available for Issuance</I>. The maximum number of shares of our common stock available for issuance under the 2015 Plan, if the amendment is approved by our stockholders, will be 5,000,000, which amount will be subject to annual increases of up to 4.0% of our outstanding stock as of each December 31, beginning December 31, 2016. The number of shares available for issuance under the plan is subject to increase to the extent that we issue shares or incentive awards under the plan in connection with certain merger and acquisition transactions, or assume any plan in a merger or acquisition transaction.&nbsp; However, any available shares in an assumed plan may only be utilized to the extent permitted under applicable exchange or market on which our common stock may be traded or quoted.</FONT></P>
<P id=PARA1409 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1410 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Share Counting.</I><I>&nbsp;</I></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;Shares of our common stock that are issued under the plan or that potentially are issuable pursuant to outstanding incentive awards reduce the number of shares remaining available. All shares so subtracted from the amount available under the plan with respect to an incentive award that lapses, expires, is forfeited or for any reason is terminated, unexercised or unvested and any shares of our common stock that are subject to an incentive award that is settled or paid in cash or any other form other than shares of our common stock will automatically again become available for issuance under the plan. However, any shares not issued due to the exercise of an option by a &#8220;net exercise&#8221; or the tender or attestation as to ownership of previously acquired shares (as described below), as well as shares covered by a stock appreciation right, to the extent exercised, and shares withheld by us to satisfy any tax withholding obligations will not again become available for issuance under the plan. Any shares of our common stock repurchased by us on the open market using the proceeds from the exercise of an award under the plan will not increase the number of shares available for future grants of awards under the plan. Any shares of our common stock that are subject to an incentive award under the plan that terminates by expiration, forfeiture, cancellation, or otherwise without the issuance of shares or are settled in cash in lieu of shares, or are exchanged to the extent permitted under the plan, prior to the issuance of shares, will be available again for grant under the plan. The shares of our common stock available for issuance under the plan may be authorized and unissued shares or treasury shares.</FONT></P>
<P id=PARA1411 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1412 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Grant Limits</I>. If the amendment is approved by our stockholders, under the terms of the 2015 Plan no more than 2,500,000 shares of our common stock may be issued pursuant to the exercise of incentive stock options and no more than 1,000,000 shares of our common stock may be issued or issuable in connection with restricted stock grants, restricted stock unit awards, performance awards and stock bonuses, or &#8220;full value&#8221; awards.</FONT></P>
<P id=PARA1413 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1414 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All of the share limitations in the plan may be adjusted to reflect changes in our corporate structure or shares, as described below. In addition, the limits on the number of shares that may be issued as incentive stock options will not apply to certain incentive awards granted upon our assumption or substitution of like awards in any merger or acquisition.</FONT></P>
<P id=PARA3495.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3495  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3495  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3495  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">29</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3495  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3495.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1416 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Adjustments</I>. In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, divestiture or extraordinary dividend (including a spin-off) or any other similar change in our corporate structure or shares, we must adjust:</FONT></P>
<P id=PARA1417 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1419  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1420 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1421 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the number and kind of securities available for issuance under the plan; and</FONT></P></TD></TR></TABLE>
<P id=PARA1422 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1424  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1425 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1426 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">in order to prevent dilution or enlargement of the rights of participants, the number, kind and, where applicable, the exercise price of securities subject to outstanding incentive awards.</FONT></P></TD></TR></TABLE>
<P id=PARA1427 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1428 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Administration</I>. The plan will be administered by the Board of Directors or by a committee of the Board.&nbsp; Any such committee will consist of at least two members of the Board, all of whom are &#8220;non-employee directors&#8221; within the meaning of Rule&nbsp;16b-3 under the Exchange Act, and who are &#8220;independent directors&#8221; within the meaning of the rules of any applicable exchange or market on which our common stock may be traded or quoted).&nbsp; We expect the Compensation Committee of the Board of Directors to administer the plan. The Board of Directors or the committee administering the plan is referred to as the &#8220;committee.&#8221; The committee may delegate its duties, power and authority under the plan to any of our officers to the extent consistent with applicable corporate law, except with respect to participants subject to Section&nbsp;16 of the Exchange Act.</FONT></P>
<P id=PARA1429 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1430 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The committee has the authority to determine all provisions of incentive awards consistent with terms of the plan, including, the eligible recipients who will be granted one or more incentive awards under the plan, the nature and extent of the incentive awards to be made to each participant, the time or times when incentive awards will be granted, the duration of each incentive award, and the restrictions and other conditions to which the payment or vesting of incentive awards may be subject. The committee has the authority to pay the economic value of any incentive award in the form of cash, our common stock or any combination of both, and may amend or modify the terms of outstanding incentive awards (except for any prohibited &#8220;re-pricing&#8221; of options, discussed below) so long as the amended or modified terms are permitted under the plan and any adversely affected participant has consented to the amendment or modification.</FONT></P>
<P id=PARA1431 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1432 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The committee, in its sole discretion, may amend the terms of the plan or incentive awards with respect to participants resident outside of the United States or employed by a non-U.S. subsidiary in order to comply with local legal requirements, to otherwise protect our or subsidiary&#8217;s interests, or to meet objectives of the plan, and may, where appropriate, establish one or more sub-plans for the purposes of qualifying for preferred tax treatment under foreign tax laws. This authority does not, however, permit the committee to take any action:</FONT></P>
<P id=PARA1433 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1435  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1436 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1437 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">to reserve shares or grant incentive awards in excess of the limitations provided in the plan;</FONT></P></TD></TR></TABLE>
<P id=PARA1438 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1440  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1441 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1442 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">to effect any re-pricing of options, as discussed below;</FONT></P></TD></TR></TABLE>
<P id=PARA1443 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1445  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1446 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1447 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">to grant options or stock appreciation rights having an exercise price less than 100 percent of the &#8220;fair market value&#8221; (as defined below) of one share of our common stock on the date of grant; or</FONT></P></TD></TR></TABLE>
<P id=PARA1448 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1450  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1451 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1452 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">for which stockholder approval would then be required pursuant to Section&nbsp;422 of the Code or applicable exchange or market on which our common stock may be traded or quoted).</FONT></P></TD></TR></TABLE>
<P id=PARA1453 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1454 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Except in connection with certain specified changes in our corporate structure or shares, the committee may not, without prior approval of our stockholders, seek to effect any re-pricing of any previously granted, &#8220;underwater&#8221; option or stock appreciation right by:</FONT></P>
<P id=PARA1455 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1457  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1458 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1459 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">amending or modifying the terms of the underwater option or stock appreciation right to lower the exercise price;</FONT></P></TD></TR></TABLE>
<P id=PARA1460 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1462  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1463 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1464 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">canceling the underwater option or stock appreciation right in exchange for cash, replacement options or stock appreciation rights having a lower exercise price or other incentive awards; or</FONT></P></TD></TR></TABLE>
<P id=PARA1465 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1467  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1468 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1469 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">repurchasing the underwater options and stock appreciation rights and granting new incentive awards under the plan.</FONT></P></TD></TR></TABLE>
<P id=PARA1470 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3496  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3496  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3496  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">30</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3496  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3496.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1471 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For purposes of the plan, an option or stock appreciation right is deemed to be &#8220;underwater&#8221; at any time when the fair market value of our common stock is less than the exercise price.</FONT></P>
<P id=PARA1472 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1473 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Types of Awards</I>. Stock options (including both incentive stock options and non-statutory stock options), stock appreciation rights or SARs, restricted stock, restricted stock units or RSUs, performance awards or units, stock bonuses and other stock-based awards may be granted under the 2015 Plan. Incentive awards may be granted either alone or in addition to or in tandem with any other type of incentive award.</FONT></P>
<P id=PARA1474 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1475 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Options</I>. Stock options entitle the holder to purchase a specified number of shares of our common stock at a specified price, which is called the exercise price, subject to the terms and conditions of the award agreement. The 2015 Plan permits the grant of both incentive stock options and non-statutory stock options. Each stock option granted under the plan must be evidenced by an award agreement or statement that specifies the exercise price, the term, the number of shares underlying the stock option, the vesting and any other conditions. The exercise price to be paid by a participant at the time an option is exercised may not be less than 100 percent of the fair market value of one share of our common stock on the date of grant (or 110 percent of the fair market value of one share of our common stock on the date of grant of an incentive stock option if the participant owns, directly or indirectly, more than 10 percent of the total combined voting power of all classes of stock of Diffusion or any parent or subsidiary). However, in the event options are granted as a result of our assumption or substitution of options in a merger or acquisition, the exercise price will be the price determined by the committee pursuant to the conversion terms applicable to the transaction. The term &#8220;fair market value&#8221; under the plan means as of any date the closing sale price of our common stock as of such date at the end of the regular trading session, as reported by any national securities exchange on which our common stock is then listed (or, if no shares were traded on such date, as of the next preceding date on which there was such a trade), or if our common stock is not so listed, admitted to unlisted trading privileges, or reported on any national securities exchange, the closing sale price as of such date at the end of the regular trading session, as reported by the OTCQX marketplace of the OTC Markets Group or other comparable service (or, if no shares were traded or quoted on such date, as of the next preceding date on which there was such a trade or quote). Our common stock is currently listed for quotation on the OTCQX marketplace of the OTC Markets Group, under the symbol &#8220;DFFN.&#8221; On June __, 2016, the last reported sale price per share of our common stock was $_____ per share.</FONT></P>
<P id=PARA1476 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1477 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The total purchase price of the shares to be purchased upon exercise of an option will be paid (1)&nbsp;in cash, (2)&nbsp;by using a broker-assisted cashless exercise procedure pursuant to which the optionee, upon exercise of an option, irrevocably instructs a broker or dealer to sell a sufficient number of shares of our common stock or loan a sufficient amount of money to pay all or a portion of the exercise price of the option and/or any related withholding tax obligations and remit such sums to us and directs us to deliver stock certificates to be issued upon such exercise directly to such broker or dealer; or (3)&nbsp;by using a cashless exercise procedure pursuant to which the optionee surrenders to us shares of our common stock either underlying the option or that are otherwise held by the optionee. In the case of a &#8220;net exercise&#8221; of an option, we will not require a payment of the exercise price of the option from the participant but will reduce the number of shares of our common stock issued upon the exercise by the largest number of whole shares having a fair market value that does not exceed the aggregate exercise price for the shares exercised. Any shares of our common stock tendered or covered by an attestation will be valued at their fair market value on the exercise date.</FONT></P>
<P id=PARA1478 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1479 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options may be exercised in whole or in installments, as determined by the committee, and the committee may impose conditions or restrictions to the exercisability of an option, including that the participant remain continuously employed by us for a certain period or that the participant or us (or any subsidiary, division or other subunit of our company) satisfy certain specified performance objectives. An option may not become exercisable, nor remain exercisable after 10 years from its date of grant (five years from its date of grant in the case of an incentive stock option if the participant owns, directly or indirectly, more than 10 percent of the total combined voting power of all classes of stock of our company or any parent or subsidiary).</FONT></P>
<P id=PARA3497.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3497  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3497  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3497  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">31</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3497  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3497.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1481 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Stock Appreciation Rights</I>. A stock appreciation right is the right to receive a payment from us, in the form of shares of our common stock, cash or a combination of both, equal to the difference between the fair market value of one or more shares of our common stock and a specified exercise price of such shares.&nbsp; Stock appreciation rights will be subject to such terms and conditions, if any, consistent with the other provisions of the plan, as may be determined by the committee. The committee will have the sole discretion to determine the form in which payment of the economic value of stock appreciation rights will be made to a participant (i.e., cash, our common stock or any combination thereof) or to consent to or disapprove the election by a participant of the form of such payment.</FONT></P>
<P id=PARA1482 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1483 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The exercise price of a stock appreciation right will be determined by the committee, in its discretion, at the date of grant but may not be less than 100 percent of the fair market value of one share of our common stock on the date of grant, except as provided below in connection with certain &#8220;tandem&#8221; grants (as further defined below). However, in the event that stock appreciation rights are granted as a result of our assumption or substitution of stock appreciation rights in a merger or acquisition, the exercise price will be the price determined by the committee pursuant to the conversion terms applicable to the transaction. A stock appreciation right will become exercisable at such time and in such installments as may be determined by the committee in its sole discretion at the time of grant; provided, however, that no stock appreciation right may be exercisable after 10 years from its date of grant.</FONT></P>
<P id=PARA1484 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1485 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Restricted Stock Awards and Restricted Stock Units</I>. A restricted stock award or a restricted stock unit award is an award of our common stock that vests at such times and in such installments as may be determined by the committee and, until it vests, is subject to restrictions on transferability and/or the possibility of forfeiture. The committee may impose such restrictions or conditions to the vesting of restricted stock awards and restricted stock units as it deems appropriate, including that the participant remain continuously employed by us for a certain period or that the participant or us (or any subsidiary, division or other subunit of our company) satisfy specified performance objectives. To enforce the restrictions, the committee may place a legend on the stock certificates referring to such restrictions and may take other steps to enforce the restrictions.</FONT></P>
<P id=PARA1486 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1487 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unless the committee determines otherwise, any dividends (other than regular quarterly cash dividends) or distributions paid with respect to shares of our common stock subject to the unvested portion of a restricted stock award will be subject to the same restrictions as the shares to which such dividends or distributions relate. Additionally, unless the plan provides otherwise, a participant will have all voting, liquidation and other rights with respect to shares of our common stock issued to the participant as a restricted stock award upon the participant becoming the holder of record of such shares as if the participant were a holder of record of shares of our unrestricted common stock.</FONT></P>
<P id=PARA1488 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1489 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Performance Awards or Units</I>. A participant may be granted one or more performance awards or units under the plan, and such performance awards or units will be subject to such terms and conditions, if any, consistent with the other provisions of the plan, as may be determined by the committee in its sole discretion, including, but not limited to, the achievement of one or more specified performance objectives.</FONT></P>
<P id=PARA1490 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1491 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Stock Bonuses</I>. A participant may be granted one or more stock bonuses under the plan, and such stock bonuses will be subject to such terms and conditions, if any, consistent with the other provisions of the plan, as may be determined by the committee in its sole discretion, including, but not limited to, the achievement of one or more specified performance objectives.</FONT></P>
<P id=PARA1492 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1493 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Other Stock-Based Awards.</I><I> </I></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Subject to such terms and conditions, consistent with the other provisions of the plan, the committee may grant other stock-based awards not otherwise described by the terms of the plan (including the grant or offer for sale of unrestricted shares of common stock) in such amounts and subject to such terms and conditions as the committee will determine. Such incentive awards may involve the transfer of actual shares of common stock to participants or payment in cash or otherwise of amounts based on the value of shares of common stock, and may include incentive awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States<I>.</I></FONT></P>
<P id=PARA1494 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1495 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Change in Control</I>. In the event a &#8220;change in control&#8221; of our company occurs, then, unless otherwise provided at the time of the grant of the incentive award: (a)&nbsp; all options and stock appreciation rights will become immediately exercisable in full and will remain exercisable in accordance with their terms; (b)&nbsp;all restrictions and vesting requirements applicable to any incentive award based solely on the continued service of the participant will terminate; and (c)&nbsp;all incentive awards the vesting or payment of which are based on specified performance objectives will vest as though such performance objectives were fully achieved at target and will become immediately payable; provided, however, that no incentive award that provides for a deferral of compensation within the meaning of Section&nbsp;409A of the Code will be cashed out upon the occurrence of a change in control unless the event or circumstances constituting the change in control also constitute a &#8220;change in the ownership&#8221; of the company, a &#8220;change in the effective control&#8221; of the company or a &#8220;change in the ownership of a substantial portion of the assets&#8221; of the company, in each case as determined under Section&nbsp;409A of the Code. The treatment of any other incentive awards in the event of a change in control will be as determined by the committee in connection with the grant thereof, as reflected in the applicable incentive award agreement.</FONT></P>
<P id=PARA3498.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3498  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3498  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3498  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">32</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3498  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3498.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1497 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Alternative Treatment of Incentive Awards in Connection with a Change in Control.</I><I> </I></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In connection with a change in control, the committee in its sole discretion, either in an incentive award agreement at the time of grant of an incentive award or at any time after the grant of such an incentive award, may determine that any or all outstanding incentive awards granted under the plan, whether or not exercisable or vested, as the case may be, will be canceled and terminated and that in connection with such cancellation and termination the holder of such incentive award will receive for each share of common stock subject to such incentive award a cash payment (or the delivery of shares of stock, other securities or a combination of cash, stock and securities with a fair market value (as determined by the committee in good faith) equivalent to such cash payment) equal to the difference, if any, between the consideration received by stockholders of the company in respect of a share of common stock in connection with such change in control and the purchase price per share, if any, under the incentive award, multiplied by the number of shares of common stock subject to such incentive award (or in which such incentive award is denominated); provided that if such product is zero ($0) or less or to the extent that the incentive award is not then exercisable, the incentive award may be canceled and terminated without payment therefor; provided, however, that no incentive award that provides for a deferral of compensation within the meaning of Section&nbsp;409A of the Code will be cashed out upon the occurrence of a change in control unless payment was specified in the incentive award agreement at the time of grant and the event or circumstances constituting the change in control also constitute a &#8220;change in the ownership&#8221; of our company, a &#8220;change in the effective control&#8221; of our company or a &#8220;change in the ownership of a substantial portion of the assets&#8221; of our company, in each case as determined under Section&nbsp;409A of the Code.</FONT></P>
<P id=PARA1498 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1499 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For purposes of the plan, a &#8220;change in control&#8221; of our company occurs upon any one or more of the following, subject to certain exceptions: (i)&nbsp;the accumulation (if over time, in any consecutive 12 month period), whether directly, indirectly, beneficially or of record, by any individual, entity or group of 50.1 percent or more of the shares of our outstanding common stock, whether by merger, consolidation, sale or other transfer of shares of our common stock (other than a merger or consolidation where our stockholders prior to the merger or consolidation are the holders of a majority of the voting securities of the entity that survives such merger or consolidation), (ii)&nbsp;a sale of all or substantially all of our assets or (iii)&nbsp;during any period of 12 consecutive months, the individuals who, at the beginning of such period, constitute the Board of Directors, and any new director whose election by the Board of Directors or nomination for election by our stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the 12-month period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board of Directors.</FONT></P>
<P id=PARA1500 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1501 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Effect of Termination of Employment or Other Services</I>. If a participant ceases to be employed by, or perform other services for, us, all incentive awards held by the participant will be treated as set forth below unless provided otherwise in the agreement evidencing the incentive award or modified by the committee in its discretion as set forth below. Upon termination due to death, disability or retirement, all outstanding, exercisable options and stock appreciation rights then held by the participant will remain exercisable for a period of one year thereafter (but in no event after the expiration date of any such option or stock appreciation rights), all unvested restricted stock awards, all outstanding stock unit awards or restricted stock units, performance awards or units and stock bonuses then held by the participant will be terminated and forfeited; provided, however, that with respect to any such incentive awards the vesting of which is based on the achievement of specified performance objectives, if a participant&#8217;s employment or other service with the company or any subsidiary, as the case may be, is terminated by reason of death or disability prior to the end of the performance period of such incentive award, but after the conclusion of a portion of the performance period (but in no event less than one year), the committee may, in its sole discretion, cause shares of common stock to be delivered or payment made with respect to the participant&#8217;s incentive award, but only if otherwise earned for the entire performance period and only with respect to the portion of the applicable performance period completed at the date of such event, with proration based on full fiscal years only and no shares to be delivered for partial fiscal years.</FONT></P>
<P id=PARA3499.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3499  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3499  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3499  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">33</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3499  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3499.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1503 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Upon termination for a reason, other than death, disability or retirement, which is not also for &#8220;cause&#8221; (as defined in the plan), all outstanding options and stock appreciation rights then held by the participant will, to the extent exercisable as of such termination, remain exercisable in full for a period of three months after such termination (but in no event after the expiration date of any such option or stock appreciation right). Also, upon such termination all options and stock appreciation rights that are not exercisable; all unvested restricted stock awards; and all outstanding stock unit awards or restricted stock units, performance awards, stock bonuses and other stock-based awards then held by the participant will be terminated and forfeited.</FONT></P>
<P id=PARA1504 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1505 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If a participant is determined by the committee, acting in its sole discretion, to have committed any action which would constitute &#8220;cause&#8221; or &#8220;adverse action&#8221; (both as defined in the plan), regardless of whether such action or the committee&#8217;s determination occurs before or after the termination of the participant&#8217;s employment with us or any subsidiary, all rights of the participant under the plan and any award agreements evidencing an incentive award then held by the participant shall terminate and be forfeited without notice of any kind. Additionally, the committee acting in its sole discretion will have the authority to rescind the exercise, vesting, settlement or issuance of, or payment in respect of, any incentive awards of the participant that were exercised, vested, settled or issued, or as to which such payment was made, and to require the participant to pay to us, within 10 days of receipt from us of notice of such rescission, any amount received or the amount of any gain realized as a result of such rescinded exercise, vesting, settlement, issuance or payment (including any dividends paid or other distributions made with respect to any shares of common stock subject to any incentive award). We may defer the exercise of any option or stock appreciation right for a period of up to six months after receipt of the participant&#8217;s written notice of exercise or the issuance of share certificates upon the vesting of any incentive award for a period of up to six months after the date of such vesting in order for the committee to make any determination as to the existence of cause or an adverse action.</FONT></P>
<P id=PARA1506 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1507 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The committee at any time (including on or after the date of grant or following termination), in connection with a participant&#8217;s termination, may cause options or stock appreciation rights held by the participant to terminate, become or continue to become exercisable and/or remain exercisable, and restricted stock awards, restricted stock units, performance awards, stock bonuses or other stock-based awards then held by such participant to terminate, vest, settle or become free of restrictions and conditions to payment, as the case may be.</FONT></P>
<P id=PARA1508 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1509 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Dividend Equivalent Rights</I>. Any participant selected by the committee may be granted dividend equivalents based on the dividends declared on shares of our common stock that are subject to any incentive award, to be credited as of dividend payment dates, during the period between the grant date of the incentive award and the date the incentive award is exercised, vests, is settled or expires, as determined by the committee.&nbsp; Such dividend equivalents will be converted to cash or additional shares of common stock by such formula and at such time and subject to such limitations as may be determined by the committee. However, the committee may not grant dividend equivalents based on the dividends declared on shares of our common stock that are subject to an option or stock appreciation right and no dividend or dividend equivalents will be paid out with respect to any unvested incentive awards, the vesting of which is based on the achievement of performance objectives.</FONT></P>
<P id=PARA1510 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1511 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Term; Termination; Amendments</I>. Unless terminated earlier, the plan will terminate at midnight on the day before the 10th anniversary of its approval by our stockholders.&nbsp; Incentive awards outstanding at the time the plan is terminated may continue to be exercised, earned or become free of restriction, according to their terms. The Board of Directors may suspend or terminate the plan or any portion of the plan at any time. In addition to the committee&#8217;s authority to amend the plan with respect to participants resident outside of the United States or employed by a non-U.S. subsidiary, the Board of Directors may amend the plan from time to time in order that incentive awards under the plan will conform to any change in applicable laws or regulations or in any other respect that the Board of Directors may deem to be in our best interests; provided, however, that no amendments to the plan will be effective without stockholder approval, if it is required under Section&nbsp;422 of the Internal Revenue Code or the rules of any applicable exchange or market on which our common stock may be traded or quoted), or if the amendment seeks to increase the number of shares reserved for issuance under the plan (other than as a result of a permitted adjustment upon certain corporate events, such as stock splits) or to modify the prohibitions on underwater option re-pricing discussed above. Termination, suspension or amendment of the plan will not adversely affect any outstanding incentive award without the consent of the affected participant, except for adjustments in the event of changes in our capitalization or a &#8220;change in control&#8221; of our company.</FONT></P>
<P id=PARA3500.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3500  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3500  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3500  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">34</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3500  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3500.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1513 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Transferability</I>. In general, no right or interest in any incentive award may be assigned or transferred by a participant, except by will or the laws of descent and distribution, or subjected to any lien or otherwise encumbered. However, a participant is entitled to designate a beneficiary to receive an incentive award on such participant&#8217;s death, and in the event of such participant&#8217;s death, payment of any amounts due under the plan, will be made to, and exercise of any options or stock appreciation rights may be made by, such beneficiary. Additionally, upon a participant&#8217;s request, the committee may permit a participant to transfer all or a portion of a non-statutory option, other than for value, to certain of the participant&#8217;s family members or related family trusts, foundations or partnerships. Permitted transferees of non-statutory options will remain subject to all the terms and conditions of the incentive award applicable to the participant.</FONT></P>
<P id=PARA1514 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1515 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Material U.S. Federal Income Tax Consequences</B></FONT></P>
<P id=PARA1516 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1517 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>The discussion below is a summary of the U.S. federal income tax consequences that may result in connection with participant&#8217;s participation in the plan and is based on current statutes, regulations and interpretations, all of which are subject to change, possibly with retroactive effect. The description does not include foreign, state or local income tax consequences. In addition, the description is not intended to address specific tax consequences applicable to an insider (directors, executive officers or greater than 10 percent stockholders of our company).</I></FONT></P>
<P id=PARA1518 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1519 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Incentive Stock Options</I>. In general, an eligible employee will not recognize federal taxable income upon the grant or the exercise of an incentive stock option, and we will not be entitled to an income tax deduction upon the grant or the exercise of an incentive stock option. For purposes of the alternative minimum tax, however, the eligible employee will be required to treat an amount equal to the difference between the fair market value of the common stock on the date of exercise over the exercise price as an item of adjustment in computing the eligible employee&#8217;s alternative minimum taxable income. If the eligible employee does not dispose of the common stock received pursuant to the exercise of the incentive stock option within two years after the date of the grant of the incentive stock option or within one year after the date of exercise of the incentive stock option, a subsequent disposition of the common stock generally will result in long-term capital gain or loss to such individual with respect to the difference between the amount realized on the disposition and the exercise price of the option. We will not be entitled to any income tax deduction as a result of such disposition.</FONT></P>
<P id=PARA1520 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1521 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If the eligible employee disposes of the common stock acquired upon exercise of the incentive stock option within two years after the date of the grant of the incentive stock option or within one year after the date of exercise of the incentive stock options, then in the year of such disposition, the eligible employee generally will recognize ordinary income, and we will be entitled to an income tax deduction in an amount equal to the lesser of: (1)&nbsp;the excess of the fair market value of the common stock on the date of exercise over the exercise price; or (2)&nbsp;the amount realized upon disposition over the exercise price. Any gain in excess of such amount recognized by the eligible employee as ordinary income will be taxed to the eligible employee as short-term or long-term capital gain (depending on the period of time the eligible employee held the common stock).</FONT></P>
<P id=PARA1522 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1523 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Non-Statutory Stock Options</I>. An eligible employee, non-employee director or consultant will not recognize any federal taxable income upon the grant of a non-statutory stock option, and we will not be entitled to an income tax deduction at the time of such grant. Upon the exercise of a non-statutory stock option, the eligible employee, non-employee director or consultant generally will recognize ordinary income and we will be entitled to take an income tax deduction in an amount equal to the excess of the fair market value of the common stock on the date of exercise over the exercise price. Upon a subsequent sale of the common stock by the eligible employee, non-employee director or consultant, he or she will recognize short-term or long-term capital gain or loss (depending on the period of time the eligible employee held the common stock).</FONT></P>
<P id=PARA1524 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1525 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Stock Appreciation Rights</I>. An eligible employee, non-employee director or consultant will not recognize any federal taxable income upon the grant of a stock appreciation right, and we will not be entitled to an income tax deduction at the time of such grant. An eligible employee, non-employee director or consultant will recognize ordinary income for federal income tax purposes upon the exercise of a stock appreciation right under the plan for cash, common stock or a combination of cash and common stock, and the amount of income that the eligible employee, non-employee director or consultant will recognize will depend on the amount of cash, if any, and the fair market value of the common stock, if any, that he or she receives as a result of such exercise. We generally will be entitled to a federal income tax deduction in an amount equal to the ordinary income recognized by the eligible employee, non-employee director or consultant in the same taxable year in which the eligible employee, non-employee director or consultant recognizes such income.</FONT></P>
<P id=PARA3501.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3501  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3501  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3501  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">35</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3501  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3501.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1527 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Restricted Stock Awards</I>. An eligible employee, non-employee director or consultant is not subject to any federal income tax when an award of restricted stock is made, nor are we entitled to an income tax deduction at such time, unless the restrictions on the common stock do not present a &#8220;substantial risk of forfeiture&#8221; or the stock is &#8220;transferable,&#8221; each within the meaning of Section&nbsp;83 of the Internal Revenue Code. Common stock that is subject to a substantial risk of forfeiture within the meaning of Section&nbsp;83 of the Internal Revenue Code is transferable within the meaning of that section if the transferee would not be subject to such risk of forfeiture after such transfer. In the year that the restricted stock is either no longer subject to a substantial risk of forfeiture or is transferable, the eligible employee, non-employee director or consultant will recognize ordinary income in an amount equal to the excess, if any, of the fair market value of the shares of common stock transferred to the eligible employee, non-employee director or consultant, generally determined on the date the restricted stock is no longer subject to a substantial risk of forfeiture, or is transferable, whichever comes first, over the amount, if any, paid for such shares.</FONT></P>
<P id=PARA1528 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1529 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Restricted Stock Unit Awards, Performance Awards and Stock Bonuses</I>. Neither the participant nor our company incurs any federal income tax consequences as a result of the grant of a restricted stock unit award, performance award or stock bonus. Upon payment of a restricted stock unit award, performance award or stock bonus in cash, the participant will include the amount paid as ordinary income in the year the payment was received; if payment is made in stock, the participant will include as ordinary income in the year of receipt an amount equal to the fair market value of the shares received.&nbsp; In each case, we will receive a corresponding tax deduction (provided that the award is not otherwise subject to the limitations of Section&nbsp;162(m)&nbsp;of the Internal Revenue Code), when the amount is included by the participant as ordinary income, or reported as taxable income of the participant by us, pursuant to applicable information reporting requirements. At the time of a subsequent sale or disposition of any shares of our common stock issued in connection with a restricted stock unit award, performance award or stock bonus, any gain or loss will be treated as long-term or short-term capital gain or loss, depending on the holding period from the date the shares were received.</FONT></P>
<P id=PARA1530 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1531 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Excise Tax on Parachute Payments</I>. Parachute payments are payments to employees or independent contractors who also are officers, stockholders or highly compensated individuals that are contingent upon a change in ownership or control of our company. In certain circumstances the grant, vesting, acceleration or exercise of options or other incentive awards could be treated as contingent on a change in ownership or control for purposes of determining the amount of a parachute payment. In general, the amount of a parachute payment would be the cash or the fair market value of the property received (or to be received) less the amount paid for such property. All or a portion of that parachute payment may be considered an excess parachute payment. If an individual were found to have received an excess parachute payment, he or she would be subject to a special 20 percent excise tax on the amount of the excess parachute payments, and we would not be allowed to claim any deduction with respect to such payments.</FONT></P>
<P id=PARA1532 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1533 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Under the terms of the plan, unless otherwise provided in a separate agreement between a participant and us, if, with respect to a participant, the acceleration of the vesting of an incentive award or the payment of cash in exchange for all or part of an award, together with any other payments that such participant has the right to receive from us, would constitute a &#8220;parachute payment,&#8221; then the payments to such participant will be reduced to the largest amount as will result in no portion of such payments being subject to the excise tax imposed by Section&nbsp;4999 of the Code.&nbsp; Such reduction, however, will only be made if the aggregate amount of the payments after such reduction exceeds the difference between the amount of such payments absent such reduction minus the aggregate amount of the excise tax imposed under Section&nbsp;4999 of the Code attributable to any such excess parachute payments. If such provisions are applicable and if an employee will be subject to a 20 percent excise tax on any &#8220;excess parachute payment&#8221; pursuant to Section&nbsp;4999 of the Code, we will be denied a deduction with respect to such excess parachute payment pursuant to Section&nbsp;280G of the Code.</FONT></P>
<P id=PARA3502.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3502  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3502  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3502  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">36</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3502  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3502.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1535 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Section&nbsp;409A.</I> If an incentive award constitutes deferred compensation under Section&nbsp;409A of the Code and the requirements of Section&nbsp;409A of the Code are not satisfied in form or operation, the incentive award will become taxable (or if later, when it vests), subject to ordinary income taxes, plus a 20 percent penalty tax, and plus an additional tax equal to interest on the tax that would have been paid if the award had been taxable when first earned and vested.</FONT></P>
<P id=PARA1536 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1537 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>New Plan Benefits</B></FONT></P>
<P id=PARA1538 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1539 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The benefits that will be awarded or paid under the 2015 Plan are not currently determinable. Awards granted under the 2015 Plan are within the discretion of the committee, and the committee has not determined future Awards or who might receive them.</FONT></P>
<P id=PARA1540 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1541 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Equity Compensation Plan Information as of December 31, 2015</B></FONT></P>
<P id=PARA1542 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL1584  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL1584.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 43%; VERTICAL-ALIGN: bottom">
<P id=PARA1543 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Plan Category</B></FONT></P></TD>
<TD id=TBL1584.finRow.1.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1584.finRow.1.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1545 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Number of</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Securities to be</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Issued upon Exercise</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>of Outstanding</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Options (a)</B></FONT></P></TD>
<TD id=TBL1584.finRow.1.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL1584.finRow.1.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1584.finRow.1.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1547 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Weighted Average</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Exercise Price of</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Outstanding</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Options (b)</B></FONT></P></TD>
<TD id=TBL1584.finRow.1.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL1584.finRow.1.lead.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1584.finRow.1.amt.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1549 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Number of Securities</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Remaining Available for</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Future Issuance under</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Equity Compensation</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Plans (Excluding</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Securities Reflected in</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Column (a))</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(c)</B></FONT></P></TD>
<TD id=TBL1584.finRow.1.trail.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL1584.finRow.2 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 43%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA1551 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Equity compensation plans approved by security holders</FONT></P></TD>
<TD id=TBL1584.finRow.2.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.2.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.2.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">400,400</TD>
<TD id=TBL1584.finRow.2.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1584.finRow.2.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.2.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1584.finRow.2.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.98</TD>
<TD id=TBL1584.finRow.2.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1584.finRow.2.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.2.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.2.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,099,600</TD>
<TD id=TBL1584.finRow.2.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1584.finRow.3 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 43%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<P id=PARA1562 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Equity compensation plans not approved by security holders</FONT></P></TD>
<TD id=TBL1584.finRow.3.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1584.finRow.3.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1584.finRow.3.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">17,478,716</TD>
<TD id=TBL1584.finRow.3.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL1584.finRow.3.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1584.finRow.3.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</TD>
<TD id=TBL1584.finRow.3.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.86</TD>
<TD id=TBL1584.finRow.3.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL1584.finRow.3.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1584.finRow.3.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL1584.finRow.3.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</TD>
<TD id=TBL1584.finRow.3.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1584.finRow.4 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 43%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA1573 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</FONT></P></TD>
<TD id=TBL1584.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">17,876,116</TD>
<TD id=TBL1584.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1584.finRow.4.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.4.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1584.finRow.4.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.86</TD>
<TD id=TBL1584.finRow.4.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1584.finRow.4.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.4.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1584.finRow.4.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,099,600</TD>
<TD id=TBL1584.finRow.4.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR></TABLE>
<P id=PARA1585 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1586 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Recommendation</B></FONT></P>
<P id=PARA1587 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1588 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>The Board of Directors unanimously recommends that stockholders vote &#8220;FOR&#8221; the Amendment to the 2015 Plan.</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1590.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK1590  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR1590  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM1590  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">37</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR1590  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA1590.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1591 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>PROPOSAL NO. 6 &#8212; ADJOURNMENT OF ANNUAL MEETING, IF NECESSARY, <BR></B>TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES <BR>IN FAVOR OF PROPOSAL NO. 4</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1593 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA1594 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1595 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Adjournment to Solicit Additional Proxies</B></FONT></P>
<P id=PARA1596 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1597 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If we fail to receive a sufficient number of votes to approve Proposal No.&nbsp;4&#8212; Approval of an Amendment to Diffusion&#8217;s Certificate of Incorporation, as amended, to Effect the Reverse Stock Split, we may propose to adjourn the Annual Meeting for a period of not more than 30 days, for the purpose of soliciting additional proxies to approve Proposal No.&nbsp;4. We currently do not intend to propose adjournment of the Annual Meeting if there are sufficient votes to approve Proposal No.&nbsp;4.</FONT></P>
<P id=PARA1598 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1599 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Recommendation</B></FONT></P>
<P id=PARA1600 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1601 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>The Board of Directors unanimously recommends that stockholders vote &#8220;FOR&#8221; Proposal No.&nbsp;6 to adjourn the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal No.&nbsp;4.</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1603.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK1603  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR1603  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM1603  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">38</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR1603  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA1603.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1604 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>CORPORATE GOVERNANCE</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1606 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA1607 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1608 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Introduction</B></FONT></P>
<P id=PARA1609 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1610 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our common stock is currently listed for quotation on the OTCQX marketplace of the OTC Markets Group under the symbol &#8220;DFFN.&#8221; The OTCQX does not require its listed companies to comply with certain corporate governance requirements. Therefore, the Board has adopted certain governance standards applicable under the Listing Rules of The NASDAQ Stock Market, including its standard of independence. This Amendment No. 1 includes descriptions of certain of these governance standards under the Listing Rules of The NASDAQ Stock Market for informational purposes.</FONT></P>
<P id=PARA1611 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1612 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As noted above, the Merger was completed on January 8, 2016 and, at the effective time, the directors and executive officers of the Company resigned and were replaced by the directors and executive officers of Diffusion LLC. For purposes of this Amendment No. 1, we refer to the pre-Merger Board and its Committees as the &#8220;RestorGenex Board of Directors&#8221; or the &#8220;RestorGenex Board.&#8221;</FONT></P>
<P id=PARA1613 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1614 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Corporate Governance Guidelines</B></FONT></P>
<P id=PARA1615 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1616 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In March&nbsp;2015, the RestorGenex Board of Directors, upon recommendation of the RestorGenex Nominating and Corporate Governance Committee, adopted Corporate Governance Guidelines. A copy of these Corporate Governance Guidelines can be found on the Investor Relations&#8212;Corporate Governance section of our corporate website at <U>www.diffusionpharma.com</U>. Among the topics addressed in our Corporate Governance Guidelines are:</FONT></P>
<P id=PARA1617 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL1642  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 50.8%; VERTICAL-ALIGN: top">
<P id=PARA1618 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Board size, composition and qualifications;</FONT></P>
<P id=PARA1619 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Selection of directors;</FONT></P>
<P id=PARA1620 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Board leadership;</FONT></P>
<P id=PARA1621 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Board committees;</FONT></P>
<P id=PARA1622 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Board and committee meetings;</FONT></P>
<P id=PARA1623 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Executive sessions of outside directors;</FONT></P>
<P id=PARA1624 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Meeting attendance by directors and non-directors;</FONT></P>
<P id=PARA1625 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Appropriate information and access;</FONT></P>
<P id=PARA1626 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Ability to retain advisors;</FONT></P>
<P id=PARA1627 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Conflicts of interest and director independence;</FONT></P>
<P id=PARA1628 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Board interaction with corporate constituencies;</FONT></P>
<P id=PARA1629 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Stock ownership by directors and executive officers;</FONT></P>
<P id=PARA1630 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Retirement and term limits;</FONT></P></TD>
<TD style="WIDTH: 2.1%; VERTICAL-ALIGN: bottom">&nbsp; </TD>
<TD style="WIDTH: 47.1%; VERTICAL-ALIGN: top">
<P id=PARA1631 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Retirement and resignation policy;</FONT></P>
<P id=PARA1632 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Board compensation;</FONT></P>
<P id=PARA1633 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Loans to directors and executive officers;</FONT></P>
<P id=PARA1634 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Chief Executive Officer evaluation;</FONT></P>
<P id=PARA1635 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Board and committee evaluations;</FONT></P>
<P id=PARA1636 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Director continuing education;</FONT></P>
<P id=PARA1637 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Succession planning;</FONT></P>
<P id=PARA1638 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Related person transactions;</FONT></P>
<P id=PARA1639 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Communication with directors</FONT></P>
<P id=PARA1640 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Director attendance at annual meetings of stockholders; and</FONT></P>
<P id=PARA1641 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;Change of principal occupation and board memberships.</FONT></P></TD></TR></TABLE>
<P id=PARA1643 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1644 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Director Independence</B></FONT></P>
<P id=PARA1645 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1646 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board has determined that three of our five current directors &#8212; Robert Adams, Mark T. Giles and Alan Levin &#8212; are &#8220;independent directors&#8221; under the Listing Rules of The NASDAQ Stock Market, which the Board has adopted as its standard of independence. The Listing Rules of The NASDAQ Stock Market provide a non-exclusive list of persons who are not considered independent. For example, under these rules, a director who is, or during the past three years was, employed by Diffusion or by any parent or subsidiary of Diffusion, other than prior employment as an interim chairman or chief executive officer, would not be considered independent. No director qualifies as independent unless the Board affirmatively determines that the director does not have a material relationship with the listed company that would interfere with the exercise of independent judgment. In making an affirmative determination that a director is an &#8220;independent director,&#8221; the Board reviewed and discussed information provided by these individuals and by us with regard to each of their business and personal activities as they may relate to us and our management.</FONT></P>
<P id=PARA3503.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3503  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3503  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3503  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">39</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3503  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3503.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1648 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Leadership Structure</B></FONT></P>
<P id=PARA1649 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1650 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board believes that our stockholders are best served if the Board retains the flexibility to adapt its leadership structure to applicable facts and circumstances, which necessarily change over time. Accordingly, under our Corporate Governance Guidelines, the office of Chairman of the Board and Chief Executive Officer may or may not be held by one person. The Board believes it is best not to have a fixed policy on this issue and that it should be free to make this determination based on what it believes is best under the circumstances.</FONT></P>
<P id=PARA1651 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1652 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Currently, David G. Kalergis serves as both the Chairman of the Board and as our Chief Executive Officer. The Board believes that it is currently in the best interests of the Company&#39;s stockholders to combine these offices as it promotes information flow between management and the Board, effective decision making and an alignment of corporate strategy. However, the Board strongly endorses the concept of an independent director being in a position of leadership for the rest of the outside directors.&nbsp; Under our Corporate Governance Guidelines, if at any time the Chief Executive Officer and Chairman of the Board positions are held by the same person, the Board, upon recommendation of the Nominating and Corporate Governance Committee, will elect an independent director as a lead independent director. Mark T. Giles currently serves as our lead independent director.</FONT></P>
<P id=PARA1653 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1654 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Executive Sessions</B></FONT></P>
<P id=PARA1655 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1656 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At each regular meeting of the Board, our independent directors meet in executive session with no company management present during a portion of the meeting. Mr. Giles as our lead independent director presides over these executive sessions and serves as a liaison between the independent directors and our Chief Executive Officer.</FONT></P>
<P id=PARA1657 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1658 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Meetings and Attendance</B></FONT></P>
<P id=PARA1659 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1660 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The RestorGenex Board of Directors held 8 meetings during 2015. All of the directors on the RestorGenex Board during 2015 attended 75 percent or more of the aggregate meetings of the Board and all committees on which they served during 2015.</FONT></P>
<P id=PARA1661 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1662 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Board Committees</B></FONT></P>
<P id=PARA1663 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1664 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board has three standing committees:&nbsp; Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. Each of these committees has the composition and responsibilities described below. The Board from time to time may establish other committees to facilitate the management of our company and may change the composition and the responsibilities of our existing committees. Each of our three standing committees has a charter which can be found on the Investor Relations&#8212;Corporate Governance section of our corporate website at www.diffusionpharma.com. Messrs. Adams, Giles and Levin currently serve as the members of all three of our standing committees. Mr. Adams is the chairman of the Compensation Committee, Mr.&nbsp;Giles is the chairman of the Nominating and Corporate Governance Committee and Mr. Levin is the chairman of the Audit Committee.</FONT></P>
<P id=PARA1665 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1666 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Audit Committee</B></FONT></P>
<P id=PARA1667 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1668 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Responsibilities</I>.&nbsp; The primary responsibilities of the Audit Committee include:</FONT></P>
<P id=PARA1669 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1671  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1672 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1673 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">overseeing our accounting and financial reporting processes, systems of internal control over financial reporting and disclosure controls and procedures on behalf of the Board and reporting the results or findings of its oversight activities to the Board;</FONT></P></TD></TR></TABLE>
<P id=PARA1674 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1676  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1677 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1678 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">having sole authority to appoint, retain and oversee the work of our independent registered public accounting firm and establishing the compensation to be paid to the independent registered public accounting firm;</FONT></P></TD></TR></TABLE>
<P id=PARA1679 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3504  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3504  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3504  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">40</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3504  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3504.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE id=MTAB1681  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1682 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1683 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls and/or or auditing matters and for the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;</FONT></P></TD></TR></TABLE>
<P id=PARA1684 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1686  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1687 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1688 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">reviewing and pre-approving all audit services and permissible non-audit services to be performed for us by our independent registered public accounting firm as provided under the federal securities laws and rules&nbsp;and regulations of the SEC; and</FONT></P></TD></TR></TABLE>
<P id=PARA1689 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1691  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1692 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1693 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">overseeing our system to monitor and manage risk, and legal and ethical compliance programs, including the establishment and administration (including the grant of any waiver from) a written code of ethics applicable to each of our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions.</FONT></P></TD></TR></TABLE>
<P id=PARA1694 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1695 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Audit Committee has the authority to engage the services of outside experts and advisors as it deems necessary or appropriate to carry out its duties and responsibilities.</FONT></P>
<P id=PARA1696 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1697 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Composition and Audit Committee Financial Expert</I>. The current members of the Audit Committee are Messrs.&nbsp;Adams, Giles and Levin.&nbsp; Mr.&nbsp;Levin is the chair of the Audit Committee.</FONT></P>
<P id=PARA1698 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1699 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Each current member of the Audit Committee qualifies as &#8220;independent&#8221; for purposes of membership on audit committees under the Listing Rules&nbsp;of The NASDAQ Stock Market and the rules&nbsp;and regulations of the SEC and is &#8220;financially literate&#8221; under the Listing Rules&nbsp;of The NASDAQ Stock Market. In addition, the Board has determined that Mr.&nbsp;Levin qualifies as an &#8220;audit committee financial expert&#8221; as defined by the rules&nbsp;and regulations of the SEC and meets the qualifications of &#8220;financial sophistication&#8221; under the Listing Rules of The NASDAQ Stock Market as a result of his experience in senior financial positions.&nbsp; Stockholders should understand that these designations related to the Audit Committee members&#8217; experience and understanding with respect to certain accounting and auditing matters are disclosure requirements of the SEC and The NASDAQ Stock Market and do not impose upon any of them any duties, obligations or liabilities that are greater than those generally imposed on a member of the Audit Committee or of the Board.</FONT></P>
<P id=PARA1700 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1701 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Meetings</I>. The RestorGenex Audit Committee met 8 times during 2015.</FONT></P>
<P id=PARA1702 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1703 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Compensation Committee</B></FONT></P>
<P id=PARA1704 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1705 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Audit Committee has established procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls, or auditing matters, and the submission by our employees, on a confidential and anonymous basis, of concerns regarding questionable accounting or auditing matters. Our personnel with such concerns are encouraged to discuss their concerns with their supervisor first, who in turn will be responsible for informing our chief executive officer of any concerns raised. If an employee prefers not to discuss a particular matter with his or her own supervisor, the employee may instead discuss such matter with our chief executive officer. If an individual prefers not to discuss a matter with the chief executive officer or if the chief executive officer is unavailable and the matter is urgent, the individual is encouraged to contact the Chair of the Audit Committee, Alan Levin.</FONT></P>
<P id=PARA1706 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1707 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Compensation Committee</I></FONT></P>
<P id=PARA1708 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1709 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Responsibilities</I>. The primary responsibilities of the Compensation Committee include:</FONT></P>
<P id=PARA1710 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1712  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1713 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1714 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">determining the annual salaries, incentive compensation, long-term incentive compensation, special or supplemental benefits or perquisites and any and all other compensation applicable to our chief executive officer and other executive officers;</FONT></P></TD></TR></TABLE>
<P id=PARA1715 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1717  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1718 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1719 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">determining any revisions to corporate goals and objectives with respect to compensation for our chief executive officer and other executive officers and establishing and leading a process for the full Board to evaluate the performance of our chief executive officer and other executive officers in light of those goals and objectives;</FONT></P></TD></TR></TABLE>
<P id=PARA1720 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3505  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3505  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3505  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">41</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3505  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3505.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE id=MTAB1722  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1723 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1724 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">administering our equity-based compensation plans, including determining specific grants of options and other awards for executive officers and other employees under our equity-based compensation plans;</FONT></P></TD></TR></TABLE>
<P id=PARA1725 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1727  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1728 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1729 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">reviewing and discussing with our chief executive officer and reporting periodically to the Board plans for executive officer development and corporate succession plans for the chief executive officer and other key executive officers and employees; and</FONT></P></TD></TR></TABLE>
<P id=PARA1730 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1732  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1733 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1734 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">establishing and leading a process for determination of the compensation applicable to the non-employee directors on the Board.</FONT></P></TD></TR></TABLE>
<P id=PARA1735 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1736 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Compensation Committee has the authority to engage the services of outside experts and advisors as it deems necessary or appropriate to carry out its duties and responsibilities.</FONT></P>
<P id=PARA1737 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1738 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Composition</I>. The current members of the Compensation Committee are Messrs.&nbsp;Adams, Giles and Levin.&nbsp; Mr.&nbsp;Adams is the chair of the Compensation Committee. Each of the three current members of the Compensation Committee is an &#8220;independent director&#8221; under the Listing Rules&nbsp;of The NASDAQ Stock Market and a &#8220;non-employee director&#8221; within the meaning of Rule&nbsp;16b-3 under the Exchange Act.</FONT></P>
<P id=PARA1739 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1740 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Meetings</I>. The RestorGenex Compensation Committee met 3 times during 2015.</FONT></P>
<P id=PARA1741 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1742 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Processes and Procedures for Consideration and Determination of Executive Compensation</I>. As mentioned above, the Compensation Committee has authority to determine all compensation applicable to our executive officers. In setting executive compensation for our executive officers, the Compensation Committee considers, among other things, the following primary factors: each executive&#8217;s position within the company and the level of responsibility; the ability of the executive to affect key business initiatives; the executive&#8217;s individual experience and qualifications; compensation paid to executives of comparable positions by companies similar to our company; company and individual performance; the executive&#8217;s current and historical compensation levels; recommendations of our chief executive officer and input from the Compensation Committee&#8217;s independent consulting firm, Radford.</FONT></P>
<P id=PARA1743 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1744 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In making decisions regarding the form and amount of compensation to be paid to our executive officers (other than our chief executive officer), the Compensation Committee considers and gives weight to the recommendations of our chief executive officer recognizing that due to his reporting and otherwise close relationship with each executive, the chief executive officer often is in a better position than the Compensation Committee to evaluate the performance of each executive (other than himself). In making decisions regarding the form and amount of compensation to be paid to our chief executive officer, the Compensation Committee considers the recommendation of the chief executive officer with respect to his own compensation and the Compensation Committee&#8217;s own assessment of the chief executive officer&#8217;s annual performance and input from other Board members. The Compensation Committee meets in executive session regularly and makes all executive compensation decisions without the presence of the chief executive officer or any executive or employee of our company.</FONT></P>
<P id=PARA1745 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1746 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Compensation Committee has retained the services of Radford to provide advice with respect to executive compensation. Radford was engaged directly by the Compensation Committee and did not advise our management and only worked with management with the express permission of the Compensation Committee. Radford did not provide any services to our company other than those for which it was retained by the Compensation Committee. Radford&#8217;s engagement by the Compensation Committee includes reviewing and advising on all significant aspects of executive compensation. This includes base salaries, short-term cash incentives and long-term equity incentives for our executives, and cash compensation and long-term equity incentives for our non-employee directors. In so doing, at the request of the Compensation Committee, Radford recommended a peer group of companies, collected relevant market data from these companies to allow the Compensation Committee to compare elements of our executive compensation program to those of our peers and made other recommendations to the Compensation Committee regarding certain aspects of our executive compensation program. In making decisions regarding the form and amount of compensation to be paid to our executives, the Compensation Committee considers the information gathered by and recommendations of Radford.</FONT></P>
<P id=PARA3506.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3506  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3506  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3506  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">42</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3506  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3506.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1748 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Processes and Procedures for Consideration and Determination of Director Compensation</I>. The Board has delegated to the Compensation Committee the responsibility, among other things, to establish and lead a process for determination of compensation payable to our non-employee directors. The Compensation Committee makes recommendations regarding compensation payable to our non-employee directors to the entire Board, which then makes the final decisions.</FONT></P>
<P id=PARA1749 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1750 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In making decisions regarding compensation to be paid to our directors, the Board considers the recommendations of Radford, but also other factors, such as its own views as to the form and amount of compensation to be paid, the current and anticipated time demands placed on directors and other factors that may be relevant.</FONT></P>
<P id=PARA1751 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1752 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Nominating and Corporate Governance Committee</B></FONT></P>
<P id=PARA1753 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1754 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Responsibilities</I>. The primary responsibilities of the Nominating and Corporate Governance Committee are:</FONT></P>
<P id=PARA1755 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1757  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1758 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1759 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">identifying individuals qualified to become Board members;</FONT></P></TD></TR></TABLE>
<P id=PARA1760 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1762  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1763 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1764 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">recommending director nominees for each annual meeting of our stockholders and director nominees to fill any vacancies that may occur between meetings of stockholders;</FONT></P></TD></TR></TABLE>
<P id=PARA1765 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1767  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1768 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1769 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">being aware of best practices in corporate governance and developing and recommending to the Board a set of corporate governance standards to govern the Board, its committees, our company and our employees in the conduct of our business and affairs; and</FONT></P></TD></TR></TABLE>
<P id=PARA1770 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1772  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1773 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1774 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">developing and overseeing a Board and Board committee evaluation process.</FONT></P></TD></TR></TABLE>
<P id=PARA1775 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1776 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Nominating and Corporate Governance Committee has the authority to engage the services of outside experts and advisors as it deems necessary or appropriate to carry out its duties and responsibilities.</FONT></P>
<P id=PARA1777 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1778 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Composition</I>. The current members of the Nominating and Corporate Governance Committee are Messrs.&nbsp;Adams, Giles and Levin. Mr.&nbsp;Giles is the chair of the Nominating and Corporate Governance Committee. Each of the three current members of the Nominating and Corporate Governance Committee is an &#8220;independent director&#8221; within the meaning of the Listing Rules&nbsp;of The NASDAQ Stock Market.</FONT></P>
<P id=PARA1779 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1780 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Meetings</I>. The RestorGenex Nominating and Corporate Governance Committee met 2 times during 2015.</FONT></P>
<P id=PARA1781 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1782 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Director Nominations Process</I></B></FONT></P>
<P id=PARA1783 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1784 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In selecting nominees for the Board, the Nominating and Corporate Governance Committee first determines whether the incumbent directors are qualified to serve, and wish to continue to serve, on the Board. The Nominating and Corporate Governance Committee believes that our company and stockholders benefit from the continued service of qualified incumbent directors because those directors have familiarity with and insight into our company&#8217;s affairs that they have accumulated during their tenure with Diffusion. Appropriate continuity of Board membership also contributes to the Board&#8217;s ability to work as a collective body. Accordingly, it is the practice of the Nominating and Corporate Governance Committee, in general, to re-nominate an incumbent director at the upcoming annual meeting of stockholders if the director wishes to continue his or her service with the Board, the director continues to satisfy the Nominating and Corporate Governance Committee&#8217;s criteria for membership on the Board, the Nominating and Corporate Governance Committee believes the director continues to make important contributions to the Board, and there are no special, countervailing considerations against re-nomination of the director.</FONT></P>
<P id=PARA3507.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3507  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3507  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3507  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">43</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3507  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3507.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1786 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In identifying and evaluating new candidates for election to the Board, the Nominating and Corporate Governance Committee intends to first solicit recommendations for nominees from persons whom the Nominating and Corporate Governance Committee believes are likely to be familiar qualified candidates having the qualifications, skills and characteristics required for Board nominees from time to time.&nbsp; Such persons may include members of the Board and senior management of Diffusion. In addition, the Nominating and Corporate Governance Committee may engage a search firm to assist it in identifying qualified candidates.&nbsp; The Nominating and Corporate Governance Committee then intends to review and evaluate each candidate whom it believes merits serious consideration, taking into account available information concerning the candidate, any qualifications or criteria for Board membership established by the Nominating and Corporate Governance Committee, the existing composition of the Board and other factors that it deems relevant. In conducting its review and evaluation, the Nominating and Corporate Governance Committee may solicit the views of our management, other Board members and any other individuals it believes may have insight into a candidate. The Nominating and Corporate Governance Committee may designate one or more of its members and/or other Board members to interview any proposed candidate.</FONT></P>
<P id=PARA1787 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1788 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Nominating and Corporate Governance Committee will consider recommendations for the nomination of directors submitted by our stockholders. The Nominating and Corporate Governance Committee will evaluate candidates recommended by stockholders in the same manner as those recommended as stated above.</FONT></P>
<P id=PARA1789 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1790 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There are no formal requirements or minimum qualifications that a candidate must meet in order for the Nominating and Corporate Governance Committee to recommend the candidate to the Board. The Nominating and Corporate Governance Committee believes that each nominee should be evaluated based on his or her merits as an individual, taking into account the needs of the Company and the Board. However, in evaluating candidates, there are a number of criteria that the Nominating and Corporate Governance Committee generally views as relevant and is likely to consider. Some of these factors include:</FONT></P>
<P id=PARA1791 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1793  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1794 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1795 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">whether the candidate is an &#8220;independent director&#8221; under applicable independence tests under the federal securities laws and rules&nbsp;and regulations of the SEC;</FONT></P></TD></TR></TABLE>
<P id=PARA1796 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1798  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1799 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1800 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">whether the candidate is &#8220;financially sophisticated&#8221; and otherwise meets the requirements for serving as a member of an audit committee;</FONT></P></TD></TR></TABLE>
<P id=PARA1801 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1803  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1804 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1805 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">whether the candidate is an &#8220;audit committee financial expert&#8221; under the rules&nbsp;and regulations of the SEC;</FONT></P></TD></TR></TABLE>
<P id=PARA1806 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1808  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1809 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1810 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the needs of the Company with respect to the particular talents and experience of our directors;</FONT></P></TD></TR></TABLE>
<P id=PARA1811 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1813  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1814 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1815 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the personal and professional integrity and reputation of the candidate;</FONT></P></TD></TR></TABLE>
<P id=PARA1816 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1818  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1819 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1820 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the candidate&#8217;s level of education and business experience;</FONT></P></TD></TR></TABLE>
<P id=PARA1821 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1823  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1824 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1825 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the candidate&#8217;s business acumen;</FONT></P></TD></TR></TABLE>
<P id=PARA1826 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1828  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1829 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1830 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the candidate&#8217;s level of understanding of our business and industry and other industries relevant to our business;</FONT></P></TD></TR></TABLE>
<P id=PARA1831 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1833  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1834 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1835 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the candidate&#8217;s ability and willingness to devote adequate time to work of the Board and its committees;</FONT></P></TD></TR></TABLE>
<P id=PARA1836 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1838  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1839 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1840 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the fit of the candidate&#8217;s skills and personality with those of other directors and potential directors in building a board of directors that is effective, collegial and responsive to the needs of our company;</FONT></P></TD></TR></TABLE>
<P id=PARA1841 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1843  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1844 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1845 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">whether the candidate possesses strategic thinking and a willingness to share ideas;</FONT></P></TD></TR></TABLE>
<P id=PARA1846 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1848  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1849 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1850 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the candidate&#8217;s diversity of experiences, expertise and background; and</FONT></P></TD></TR></TABLE>
<P id=PARA1851 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1853  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1854 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1855 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the candidate&#8217;s ability to represent the interests of all stockholders and not a particular interest group.</FONT></P></TD></TR></TABLE>
<P id=PARA1856 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3508  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3508  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3508  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">44</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3508  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3508.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1857 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">While we do not have a stand-alone diversity policy, in considering whether to recommend any director nominee, including candidates recommended by stockholders, the Nominating and Corporate Governance Committee will consider the factors above, including the candidate&#8217;s diversity of experiences, expertise and background. The Nominating and Corporate Governance Committee seeks nominees with a broad diversity of experience, expertise and backgrounds. The Nominating and Corporate Governance Committee does not assign specific weights to particular criteria and no particular criterion is necessarily applicable to all prospective nominees. We believe that the backgrounds and qualifications of the directors, considered as a group, should provide a significant mix of experience, knowledge and abilities that will allow the Board to fulfill its responsibilities.</FONT></P>
<P id=PARA1858 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1859 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Board Oversight of Risk</I></B></FONT></P>
<P id=PARA1860 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1861 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Board as a whole has responsibility for risk oversight, with more in-depth reviews of certain areas of risk being conducted by the relevant Board committees that report on their deliberations to the full Board. The oversight responsibility of the Board and its committees is enabled by management reporting processes that are designed to provide information to the Board about the identification, assessment and management of critical risks and management&#8217;s risk mitigation strategies. The areas of risk that we focus on include regulatory, operational, financial (accounting, credit, liquidity and tax), legal, compensation, competitive, health, safety and environment, economic, political and reputational risks.</FONT></P>
<P id=PARA1862 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1863 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The standing committees of the Board oversee risks associated with their respective principal areas of focus. The Audit Committee&#8217;s role includes a particular focus on the qualitative aspects of financial reporting to stockholders, on our processes for the management of business and financial risk, our financial reporting obligations and for compliance with significant applicable legal, ethical and regulatory requirements. The Audit Committee, along with management, is also responsible for developing and participating in a process for review of important financial and operating topics that present potential significant risk to our company. The Compensation Committee is responsible for overseeing risks and exposures associated with our compensation programs and arrangements, including our executive and director compensation programs and arrangements, and management succession planning. The Nominating and Corporate Governance Committee oversees risks relating to our corporate governance matters and policies and director succession planning.</FONT></P>
<P id=PARA1864 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1865 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We recognize that a fundamental part of risk management is understanding not only the risks a company faces and what steps management is taking to manage those risks, but also understanding what level of risk is appropriate for our company. The involvement of the full Board in setting our business strategy is a key part of the Board&#8217;s assessment of management&#8217;s appetite for risk and also a determination of what constitutes an appropriate level of risk for our company.</FONT></P>
<P id=PARA1866 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1867 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We believe our current Board leadership structure is appropriate and helps ensure proper risk oversight for our company for a number of reasons, including: (1)&nbsp;general risk oversight by the full Board in connection with its role in reviewing our key long-term and short-term business strategies and monitoring on an on-going basis the implementation of our key business strategies; (2)&nbsp;more detailed oversight by our standing Board committees that are currently comprised of and chaired by our independent directors and (3)&nbsp;the focus of our Chairman of the Board on allocating appropriate Board agenda time for discussion regarding the implementation of our key business strategies and specifically risk management.</FONT></P>
<P id=PARA1868 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1869 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B><I>Code of Business Conduct and Ethics</I></B></FONT></P>
<P id=PARA1870 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1871 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our Code of Business Conduct and Ethics applies to all of our directors, executive officers, including our Chief Executive Officer and our Senior Vice President &#8211; Finance, Treasurer and Secretary, and other employees, and meets the requirements of the SEC. A copy of our Code of Business Conduct and Ethics will be available on the Investor Relations&#8212;Corporate Governance&#8212;Code of Business Conduct and Ethics section of our corporate website at <I>www.diffusionpharma.com</I>.</FONT></P>
<P id=PARA3509.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3509  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3509  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3509  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">45</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3509  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3509.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1873 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Audit Committee Report</B></FONT></P>
<P id=PARA1874 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1875 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">This report is furnished by the Audit Committee of the Board of Directors with respect to our financial statements for the year ended December&nbsp;31, 2015.</FONT></P>
<P id=PARA1876 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1877 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">One of the purposes of the Audit Committee is to oversee our accounting and financial reporting processes and the audit of our annual financial statements. Our management is responsible for the preparation and presentation of complete and accurate financial statements. Our independent registered public accounting firm is responsible for performing an independent audit of our financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States) and for issuing a report on their audit.</FONT></P>
<P id=PARA1878 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1879 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In performing its oversight role, the Audit Committee has reviewed and discussed our audited financial statements for the year ended December&nbsp;31, 2015 with our management.&nbsp; Management represented to the Audit Committee that our financial statements were prepared in accordance with generally accepted accounting principles. The Audit Committee has discussed with Deloitte, our independent registered public accounting firm for the year ended December 31, 2015, the matters required to be discussed under Public Company Accounting Oversight Board standards. The Audit Committee has received the written disclosures and the letter from our independent registered public accounting firm required by the applicable requirements of the Public Company Accounting Oversight Board regarding communications with audit committees concerning independence. The Audit Committee has discussed with Deloitte its independence and concluded that the independent registered public accounting firm is independent from our company and our management.</FONT></P>
<P id=PARA1880 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1881 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Based on the review and discussions of the Audit Committee described above, the Audit Committee recommended to the Board that our audited financial statements for the year ended December&nbsp;31, 2015 be included in our annual report on Form&nbsp;10-K for the year ended December&nbsp;31, 2015 for filing with the Securities and Exchange Commission.</FONT></P>
<P id=PARA1882 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1883 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">This report is dated as of March&nbsp;25, 2016.</FONT></P>
<P id=PARA1884 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1885 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 72pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Audit Committee</I></FONT></P>
<P id=PARA1886 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 72pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Alan Levin, Chair</FONT></P>
<P id=PARA1887 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 72pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Robert Adams</FONT></P>
<P id=PARA1888 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 72pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark T. Giles</FONT></P>
<P id=PARA1889 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1890 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Complaint Procedures</B></FONT></P>
<P id=PARA1891 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1892 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Audit Committee has established procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls, or auditing matters, and the submission by our employees, on a confidential and anonymous basis, of concerns regarding questionable accounting or auditing matters. Our personnel with such concerns are encouraged to discuss their concerns with their supervisor first, who in turn will be responsible for informing our chief executive officer of any concerns raised. If an employee prefers not to discuss a particular matter with his or her own supervisor, the employee may instead discuss such matter with our chief executive officer. If an individual prefers not to discuss a matter with the chief executive officer or if the chief executive officer is unavailable and the matter is urgent, the individual is encouraged to contact the Chair of the Audit Committee, Alan Levin.</FONT></P>
<P id=PARA1893 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1894 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Policy Regarding Director Attendance at Annual Meetings of Stockholders</B></FONT></P>
<P id=PARA1895 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1896 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">It is the policy of the Board that directors standing for re-election should attend our annual meeting of stockholders, if their schedules permit.</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1898.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK1898  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR1898  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM1898  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">46</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR1898  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA1898.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1899 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Process Regarding Stockholder Communications with Board of Directors</B></FONT></P>
<P id=PARA1900 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1901 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stockholders may communicate with the Board or any one particular director by sending correspondence, addressed to our Corporate Secretary, Diffusion Pharmaceuticals Inc., 2020 Avon Court, Suite 4, Charlottesville, Virginia 22902, with an instruction to forward the communication to the Board or one or more particular directors. Our Corporate Secretary will forward promptly all such stockholder communications to the Board of Directors or the one or more particular directors, with the exception of any advertisements, solicitations for periodical or other subscriptions and other similar communications.</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1903.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK1903  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR1903  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM1903  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">47</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR1903  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA1903.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA1904 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>DIRECTOR COMPENSATION</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1906 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA1907 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1908 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Overview of Director Compensation Program</B></FONT></P>
<P id=PARA1909 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1910 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As the Merger was not completed until January 8, 2016, the following discussion of director compensation relates to the RestorGenex Board during the year ended December 31, 2015. The Board is currently considering what changes, if any, will be made to the Company&#8217;s director compensation policies for the year ending December 31, 2016.</FONT></P>
<P id=PARA1911 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1912 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As described in more detail under the heading &#8220;<I>The Board, Its Committees and Corporate Governance</I><I>&#8212;Compensation Committee&#8212;Responsibilities</I>,&#8221; the Board has delegated to the Compensation Committee the responsibility, among other things, to establish and lead a process for the determination of compensation payable to our non-employee directors. The Compensation Committee makes recommendations regarding compensation payable to our non-employee directors to the entire Board, which then makes final decisions regarding such compensation.</FONT></P>
<P id=PARA1913 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1914 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The principal elements of our director compensation program for 2015 included:</FONT></P>
<P id=PARA1915 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1917  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1918 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1919 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">cash compensation in the form of annual cash retainers; and</FONT></P></TD></TR></TABLE>
<P id=PARA1920 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB1922  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA1923 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA1924 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">long-term equity-based incentive compensation, in the form of stock options.</FONT></P></TD></TR></TABLE>
<P id=PARA1925 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1926 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We do not compensate our employee directors separately for serving on the Board.</FONT></P>
<P id=PARA1927 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1928 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Cash Compensation</B></FONT></P>
<P id=PARA1929 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1930 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The cash compensation paid to the RestorGenex Board for 2015 consisted of the following described annual Board and Board committee cash retainers.</FONT></P>
<P id=PARA1931 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL1951  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL1951.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA1932 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Description</B></FONT></P></TD>
<TD id=TBL1951.finRow.1.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1951.finRow.1.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1933 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Annual<BR>Cash Retainer</B></FONT></P></TD>
<TD id=TBL1951.finRow.1.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL1951.finRow.2>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA1934 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Board Member (other than Chairman) </FONT></P></TD>
<TD id=TBL1951.finRow.2.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1951.finRow.2.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1951.finRow.2.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">35,000</TD>
<TD id=TBL1951.finRow.2.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1951.finRow.3>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
<P id=PARA1937 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Chairman of the Board </FONT></P></TD>
<TD id=TBL1951.finRow.3.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1951.finRow.3.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1951.finRow.3.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">50,000</TD>
<TD id=TBL1951.finRow.3.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD></TR>
<TR id=TBL1951.finRow.4>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA1939 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Audit Committee Chair </FONT></P></TD>
<TD id=TBL1951.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1951.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1951.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">15,000</TD>
<TD id=TBL1951.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1951.finRow.5>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
<P id=PARA1941 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Compensation Committee Chair </FONT></P></TD>
<TD id=TBL1951.finRow.5.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1951.finRow.5.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1951.finRow.5.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">10,000</TD>
<TD id=TBL1951.finRow.5.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD></TR>
<TR id=TBL1951.finRow.6>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA1943 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nominating and Corporate Governance Committee Chair </FONT></P></TD>
<TD id=TBL1951.finRow.6.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1951.finRow.6.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1951.finRow.6.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,500</TD>
<TD id=TBL1951.finRow.6.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1951.finRow.7>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
<P id=PARA1945 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Audit Committee Member (other than Chair) </FONT></P></TD>
<TD id=TBL1951.finRow.7.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1951.finRow.7.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1951.finRow.7.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">7,500</TD>
<TD id=TBL1951.finRow.7.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD></TR>
<TR id=TBL1951.finRow.8>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA1947 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Compensation Committee Member (other than Chair) </FONT></P></TD>
<TD id=TBL1951.finRow.8.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1951.finRow.8.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1951.finRow.8.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5,000</TD>
<TD id=TBL1951.finRow.8.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1951.finRow.9>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">
<P id=PARA1949 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nominating and Corporate Governance Committee Member (other than Chair) </FONT></P></TD>
<TD id=TBL1951.finRow.9.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1951.finRow.9.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1951.finRow.9.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">3,750</TD>
<TD id=TBL1951.finRow.9.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD></TR></TABLE>
<P id=PARA1952 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1953 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The annual cash retainers are paid on a quarterly basis in arrears at the end of each calendar quarter. For example, the retainers paid at the end of the first calendar quarter are for the period from January&nbsp;1 through March&nbsp;31.</FONT></P>
<P id=PARA1954 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1955 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Long-Term Equity-Based Incentive Compensation</B></FONT></P>
<P id=PARA1956 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1957 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition to cash compensation, our non-employee directors receive long-term equity-based incentive compensation in the form of options to purchase shares of our common stock. The options have a ten-year term and an exercise price equal to the fair market value of our common stock on the grant date. The options granted to our non-employee directors were originally scheduled to vest quarterly over three years. See note 1 to the Director Compensation Table under the heading &#8220;&#8212;<I>Summary Director Compensation Table for Fiscal 2015</I>&#8221; for a summary of all options granted to our non-employee directors during the year ended December&nbsp;31, 2015. See note 2 to the Director Compensation Table under the heading &#8220;&#8212;<I>Summary Director Compensation Table for Fiscal 2015</I>&#8221; for a summary of all options to purchase shares of our common stock held by our non-employee directors as of December&nbsp;31, 2015. The vesting of all options held by our directors as of immediately prior to the Effective Time vested in full upon the completion of the Merger.</FONT></P>
<P id=PARA3510.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3510  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3510  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3510  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">48</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3510  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3510.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1959 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Indemnification Agreements</B></FONT></P>
<P id=PARA1960 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1961 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We entered into agreements with all of the members of the RestorGenex Board, as well as our current directors, under which we are required to indemnify them against expenses, judgments, penalties, fines, settlements and other amounts actually and reasonably incurred, including expenses of a derivative action, in connection with an actual or threatened proceeding if any of them may be made a party because he or she is or was one of our directors. We will be obligated to pay these amounts only if the director acted in good faith and in a manner that he or she reasonably believed to be in or not opposed to our best interests.&nbsp; With respect to any criminal proceeding, we will be obligated to pay these amounts only if the director had no reasonable cause to believe his or her conduct was unlawful. The indemnification agreements also set forth procedures that will apply in the event of a claim for indemnification.</FONT></P>
<P id=PARA1962 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1963 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Summary Director Compensation Table for Fiscal 2015</B></FONT></P>
<P id=PARA1964 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1965 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below provides summary information concerning the compensation of each individual who served as a director of the Company during the year ended December&nbsp;31, 2015, other than Stephen M. Simes, our former Chief Executive Officer, Jerold Rubinstein, our former Chairman of the Board and Chief Executive Officer, David Sherris, Ph.D., our former Chief Scientific Officer, and Yael Schwartz, Ph.D., our former Executive Vice President of Preclinical Development.</FONT></P>
<P id=PARA1966 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1967 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>DIRECTOR COMPENSATION - 2015</B></FONT></P>
<P id=PARA1968 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL1998  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL1998.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA1969 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Name</B></FONT></P></TD>
<TD id=TBL1998.finRow.1.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1998.finRow.1.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1970 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Fees Earned or<BR>Paid in Cash ($)</B></FONT></P></TD>
<TD id=TBL1998.finRow.1.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL1998.finRow.1.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1998.finRow.1.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1971 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Option</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Awards ($)(1)(2)</B></FONT></P></TD>
<TD id=TBL1998.finRow.1.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL1998.finRow.1.lead.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1998.finRow.1.amt.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1972 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>All Other<BR>Compensation ($)(3)</B></FONT></P></TD>
<TD id=TBL1998.finRow.1.trail.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL1998.finRow.1.lead.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL1998.finRow.1.amt.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA1973 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Total ($)</B></FONT></P></TD>
<TD id=TBL1998.finRow.1.trail.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL1998.finRow.2>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA1974 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Sol J. Barer, Ph.D.</FONT></P></TD>
<TD id=TBL1998.finRow.2.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.2.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1998.finRow.2.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">58,750</TD>
<TD id=TBL1998.finRow.2.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.2.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.2.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1998.finRow.2.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL1998.finRow.2.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.2.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.2.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1998.finRow.2.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL1998.finRow.2.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.2.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.2.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL1998.finRow.2.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">58,750</TD>
<TD id=TBL1998.finRow.2.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1998.finRow.3>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: top">
<P id=PARA1983 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Isaac Blech </FONT></P></TD>
<TD id=TBL1998.finRow.3.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.3.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.3.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">55,000</TD>
<TD id=TBL1998.finRow.3.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.3.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.3.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.3.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">0</TD>
<TD id=TBL1998.finRow.3.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.3.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.3.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.3.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">0</TD>
<TD id=TBL1998.finRow.3.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.3.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.3.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.3.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">55,000</TD>
<TD id=TBL1998.finRow.3.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD></TR>
<TR id=TBL1998.finRow.4>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA1988 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Rex Bright </FONT></P></TD>
<TD id=TBL1998.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">56,563</TD>
<TD id=TBL1998.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.4.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.4.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.4.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL1998.finRow.4.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.4.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.4.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.4.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL1998.finRow.4.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.4.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.4.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL1998.finRow.4.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">56,563</TD>
<TD id=TBL1998.finRow.4.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL1998.finRow.5>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: top">
<P id=PARA1993 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nelson K. Stacks </FONT></P></TD>
<TD id=TBL1998.finRow.5.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.5.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.5.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">56,250</TD>
<TD id=TBL1998.finRow.5.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.5.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.5.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.5.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">0</TD>
<TD id=TBL1998.finRow.5.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.5.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.5.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.5.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">0</TD>
<TD id=TBL1998.finRow.5.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD>
<TD id=TBL1998.finRow.5.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.5.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD id=TBL1998.finRow.5.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt">56,250</TD>
<TD id=TBL1998.finRow.5.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" noWrap>&nbsp;</TD></TR></TABLE>
<P id=PARA1999 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">________________________</FONT></P>
<TABLE id=MTAB2001  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA2002 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(1)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2003 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There were no stock options awarded to our directors during 2015. </FONT></P></TD></TR></TABLE>
<P id=PARA2004 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB2006  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA2007 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(2)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2008 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below provides information regarding the aggregate number of options to purchase shares of common stock outstanding at December&nbsp;31, 2015 and held by each of the directors listed in the table. All stock options outstanding were subject to accelerated vesting and are fully exercisable pursuant to the Merger and the chart below reflects this:</FONT></P></TD></TR></TABLE>
<P id=PARA2009 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL2035  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 2.5%; MARGIN-RIGHT: 2.5%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 30%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid" width=293>
<P id=PARA2010 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Name</B></FONT></P></TD>
<TD id=TBL2035.finRow.1.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom" width=4><B>&nbsp;</B></TD>
<TD id=TBL2035.finRow.1.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width=141 colSpan=2>
<P id=PARA2011 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Aggregate Number</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>of Securities</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Underlying Options</B></FONT></P></TD>
<TD id=TBL2035.finRow.1.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px" width=4><B>&nbsp;</B></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width=182>
<P id=PARA2012 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Exercisable/</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Unexercisable</B></FONT></P></TD>
<TD id=TBL2035.finRow.1.lead.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom" width=4><B>&nbsp;</B></TD>
<TD id=TBL2035.finRow.1.amt.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width=171 colSpan=4>
<P id=PARA2013 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Range of</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Exercise</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Price(s)</B></FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width=4>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width=284 colSpan=3>
<P id=PARA2014 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Range of</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Expiration</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Date(s)</B></FONT></P></TD></TR>
<TR>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 30%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" width=293>
<P id=PARA2015 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Sol J. Barer, Ph.D.</FONT></P></TD>
<TD id=TBL2035.finRow.2.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.2.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.2.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=137>158,170</TD>
<TD id=TBL2035.finRow.2.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=4 noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=182>
<P id=PARA2017 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">81,992/76,178</FONT></P></TD>
<TD id=TBL2035.finRow.2.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.2.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=7>$</TD>
<TD id=TBL2035.finRow.2.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=67>3.00</TD>
<TD id=TBL2035.finRow.2.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=26>&#8211;</TD>
<TD id=TBL2035.finRow.2.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=71 noWrap>3.92</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=4>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=118>01/06/24</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=38>
<P id=PARA2019 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8211;</FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=128>07/23/24</TD></TR>
<TR>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 30%; VERTICAL-ALIGN: top" width=293>
<P id=PARA2020 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Isaac Blech </FONT></P></TD>
<TD id=TBL2035.finRow.3.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.3.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.3.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" width=137>104,890</TD>
<TD id=TBL2035.finRow.3.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" width=4 noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" width=182>
<P id=PARA2022 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">53,899/50,991</FONT></P></TD>
<TD id=TBL2035.finRow.3.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.3.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" width=7>&nbsp;</TD>
<TD id=TBL2035.finRow.3.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" width=67>&nbsp;3.00</TD>
<TD id=TBL2035.finRow.3.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width=26>&#8211;</TD>
<TD id=TBL2035.finRow.3.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" width=71 noWrap>3.92</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" width=4>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" width=118>01/06/24 </TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" width=38>
<P id=PARA2024 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8211;</FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" width=128>07/23/24</TD></TR>
<TR>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 30%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" width=293>
<P id=PARA2025 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Rex Bright </FONT></P></TD>
<TD id=TBL2035.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=137>78,815</TD>
<TD id=TBL2035.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=4 noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=182>
<P id=PARA2027 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">40,886/37,929</FONT></P></TD>
<TD id=TBL2035.finRow.4.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.4.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=7>&nbsp;</TD>
<TD id=TBL2035.finRow.4.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width=67>&nbsp;3.00</TD>
<TD id=TBL2035.finRow.4.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=26>&#8211;</TD>
<TD id=TBL2035.finRow.4.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=71 noWrap>3.92</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=4>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=118>01/06/24</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=38>
<P id=PARA2029 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8211;</FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width=128>07/23/24</TD></TR>
<TR>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 30%; VERTICAL-ALIGN: top" width=293>
<P id=PARA2030 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nelson K. Stacks </FONT></P></TD>
<TD id=TBL2035.finRow.5.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.5.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.5.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" width=137>78,815</TD>
<TD id=TBL2035.finRow.5.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" width=4 noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" width=182>
<P id=PARA2032 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">40,886/37,929</FONT></P></TD>
<TD id=TBL2035.finRow.5.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom" width=4>&nbsp;</TD>
<TD id=TBL2035.finRow.5.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" width=7>&nbsp;</TD>
<TD id=TBL2035.finRow.5.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" width=67>&nbsp;3.00</TD>
<TD id=TBL2035.finRow.5.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width=26>&#8211;</TD>
<TD id=TBL2035.finRow.5.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt" width=71 noWrap>3.92</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" width=4>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" width=118>02/04/24</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" width=38>
<P id=PARA2034 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8211;</FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" width=128>07/23/24</TD></TR></TABLE>
<P id=PARA2036 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB2038  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA2039 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(3)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2040 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We did not provide perquisites or other personal benefits to our directors during the year ended December 31, 2015.</FONT></P></TD></TR></TABLE>
<P id=PARA2041 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK2042  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2042  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2042  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">49</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2042  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2042.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA2043 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>EXECUTIVE COMPENSATION</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2045 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA2046 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2047 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Merger with Diffusion Pharmaceuticals LLC</B></FONT></P>
<P id=PARA2048 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2049 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As the Merger was not completed until January 8, 2016, the following discussion of executive compensation relates to our pre-Merger named executive officers during the year ended December 31, 2015, Stephen M. Simes, Philip B. Donenberg and Mark A. Weinberg, M.D., and the decisions and considerations of the RestorGenex Compensation Committee. Unless the context otherwise requires, all references in this &#8220;<I>Executive Compensation</I>&#8221; section refer to the RestorGenex Compensation Committee. Our current Board, including the Compensation Committee thereof, is currently considering what changes, if any, will be made to the Company&#8217;s executive compensation policies for the year ending December 31, 2016.</FONT></P>
<P id=PARA2050 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2051 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Summary Compensation Table for Fiscal 2015</B></FONT></P>
<P id=PARA2052 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2053 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below provides summary compensation information concerning all compensation awarded to, earned by or paid to the individuals that served as our principal executive officer during the year ended December&nbsp;31, 2015 and our two most highly compensated executive officers other than our principal executive officer during 2015.</FONT></P>
<P id=PARA2054 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2055 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SUMMARY COMPENSATION TABLE &#8212; 2015</B></FONT></P>
<P id=PARA2056 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL2136  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL2136.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 28%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA2057 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Name and Principal Position</B></FONT></P></TD>
<TD id=TBL2136.finRow.1.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2058 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Year</B></FONT></P></TD>
<TD id=TBL2136.finRow.1.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2059 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Salary</B></FONT></P></TD>
<TD id=TBL2136.finRow.1.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.lead.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.amt.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2060 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Bonus</B></FONT></P></TD>
<TD id=TBL2136.finRow.1.trail.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.lead.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.amt.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2061 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Option<BR>Awards</B></FONT></P></TD>
<TD id=TBL2136.finRow.1.trail.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.lead.D6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.amt.D6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2062 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>All Other</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Compensation(1)</B></FONT></P></TD>
<TD id=TBL2136.finRow.1.trail.D6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.lead.D7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2136.finRow.1.amt.D7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2063 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Total</B></FONT></P></TD>
<TD id=TBL2136.finRow.1.trail.D7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL2136.finRow.2>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA2064 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stephen M. Simes <BR></FONT></P></TD>
<TD id=TBL2136.finRow.2.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2015</TD>
<TD id=TBL2136.finRow.2.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL2136.finRow.2.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">425,000 </TD>
<TD id=TBL2136.finRow.2.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL2136.finRow.2.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0 </TD>
<TD id=TBL2136.finRow.2.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL2136.finRow.2.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0 </TD>
<TD id=TBL2136.finRow.2.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL2136.finRow.2.amt.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,571</TD>
<TD id=TBL2136.finRow.2.trail.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL2136.finRow.2.amt.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">433,571 </TD>
<TD id=TBL2136.finRow.2.trail.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2136.finRow.2>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I>Former Chief Executive Officer</I></TD>
<TD id=TBL2136.finRow.2.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2014</TD>
<TD id=TBL2136.finRow.2.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">349,808</TD>
<TD id=TBL2136.finRow.2.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">212,500</TD>
<TD id=TBL2136.finRow.2.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">489,647</TD>
<TD id=TBL2136.finRow.2.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.amt.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL2136.finRow.2.trail.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.2.lead.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.symb.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.2.amt.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,051,955</TD>
<TD id=TBL2136.finRow.2.trail.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2136.finRow.3>
<TD>&nbsp;</TD>
<TD id=TBL2136.finRow.3.lead.B2>&nbsp;</TD>
<TD id=TBL2136.finRow.3.symb.B2>&nbsp;</TD>
<TD id=TBL2136.finRow.3.amt.B2>&nbsp;</TD>
<TD id=TBL2136.finRow.3.trail.B2>&nbsp;</TD>
<TD id=TBL2136.finRow.3.lead.B3>&nbsp;</TD>
<TD id=TBL2136.finRow.3.symb.B3>&nbsp;</TD>
<TD id=TBL2136.finRow.3.amt.B3>&nbsp;</TD>
<TD id=TBL2136.finRow.3.trail.B3>&nbsp;</TD>
<TD id=TBL2136.finRow.3.lead.B4>&nbsp;</TD>
<TD id=TBL2136.finRow.3.symb.B4>&nbsp;</TD>
<TD id=TBL2136.finRow.3.amt.B4>&nbsp;</TD>
<TD id=TBL2136.finRow.3.trail.B4>&nbsp;</TD>
<TD id=TBL2136.finRow.3.lead.B5>&nbsp;</TD>
<TD id=TBL2136.finRow.3.symb.B5>&nbsp;</TD>
<TD id=TBL2136.finRow.3.amt.B5>&nbsp;</TD>
<TD id=TBL2136.finRow.3.trail.B5>&nbsp;</TD>
<TD id=TBL2136.finRow.3.lead.B6>&nbsp;</TD>
<TD id=TBL2136.finRow.3.symb.B6>&nbsp;</TD>
<TD id=TBL2136.finRow.3.amt.B6>&nbsp;</TD>
<TD id=TBL2136.finRow.3.trail.B6>&nbsp;</TD>
<TD id=TBL2136.finRow.3.lead.B7>&nbsp;</TD>
<TD id=TBL2136.finRow.3.symb.B7>&nbsp;</TD>
<TD id=TBL2136.finRow.3.amt.B7>&nbsp;</TD>
<TD id=TBL2136.finRow.3.trail.B7>&nbsp;</TD></TR>
<TR id=TBL2136.finRow.4>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA2096 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Phillip B. Donenberg <BR></FONT></P></TD>
<TD id=TBL2136.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2015 </TD>
<TD id=TBL2136.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">335,000 </TD>
<TD id=TBL2136.finRow.4.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0 </TD>
<TD id=TBL2136.finRow.4.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0 </TD>
<TD id=TBL2136.finRow.4.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6,732</TD>
<TD id=TBL2136.finRow.4.trail.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">341,732 </TD>
<TD id=TBL2136.finRow.4.trail.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2136.finRow.4>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I>Former Chief Financial Officer and Corporate Secretary</I></TD>
<TD id=TBL2136.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2014</TD>
<TD id=TBL2136.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">200,571</TD>
<TD id=TBL2136.finRow.4.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">87,100</TD>
<TD id=TBL2136.finRow.4.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">270,423</TD>
<TD id=TBL2136.finRow.4.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL2136.finRow.4.trail.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.4.lead.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.symb.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.4.amt.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">558,094</TD>
<TD id=TBL2136.finRow.4.trail.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2136.finRow.5>
<TD>&nbsp;</TD>
<TD id=TBL2136.finRow.5.lead.B2>&nbsp;</TD>
<TD id=TBL2136.finRow.5.symb.B2>&nbsp;</TD>
<TD id=TBL2136.finRow.5.amt.B2>&nbsp;</TD>
<TD id=TBL2136.finRow.5.trail.B2>&nbsp;</TD>
<TD id=TBL2136.finRow.5.lead.B3>&nbsp;</TD>
<TD id=TBL2136.finRow.5.symb.B3>&nbsp;</TD>
<TD id=TBL2136.finRow.5.amt.B3>&nbsp;</TD>
<TD id=TBL2136.finRow.5.trail.B3>&nbsp;</TD>
<TD id=TBL2136.finRow.5.lead.B4>&nbsp;</TD>
<TD id=TBL2136.finRow.5.symb.B4>&nbsp;</TD>
<TD id=TBL2136.finRow.5.amt.B4>&nbsp;</TD>
<TD id=TBL2136.finRow.5.trail.B4>&nbsp;</TD>
<TD id=TBL2136.finRow.5.lead.B5>&nbsp;</TD>
<TD id=TBL2136.finRow.5.symb.B5>&nbsp;</TD>
<TD id=TBL2136.finRow.5.amt.B5>&nbsp;</TD>
<TD id=TBL2136.finRow.5.trail.B5>&nbsp;</TD>
<TD id=TBL2136.finRow.5.lead.B6>&nbsp;</TD>
<TD id=TBL2136.finRow.5.symb.B6>&nbsp;</TD>
<TD id=TBL2136.finRow.5.amt.B6>&nbsp;</TD>
<TD id=TBL2136.finRow.5.trail.B6>&nbsp;</TD>
<TD id=TBL2136.finRow.5.lead.B7>&nbsp;</TD>
<TD id=TBL2136.finRow.5.symb.B7>&nbsp;</TD>
<TD id=TBL2136.finRow.5.amt.B7>&nbsp;</TD>
<TD id=TBL2136.finRow.5.trail.B7>&nbsp;</TD></TR>
<TR id=TBL2136.finRow.6>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA2123 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark A. Weinberg, M.D.<BR></FONT></P></TD>
<TD id=TBL2136.finRow.6.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2015</TD>
<TD id=TBL2136.finRow.6.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">357,000 </TD>
<TD id=TBL2136.finRow.6.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0 </TD>
<TD id=TBL2136.finRow.6.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0 </TD>
<TD id=TBL2136.finRow.6.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,787</TD>
<TD id=TBL2136.finRow.6.trail.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">358,787 </TD>
<TD id=TBL2136.finRow.6.trail.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2136.finRow.6>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"><I>Former Senior Vice President, Clinical Development</I></TD>
<TD id=TBL2136.finRow.6.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2014</TD>
<TD id=TBL2136.finRow.6.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">146,462</TD>
<TD id=TBL2136.finRow.6.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">74,435</TD>
<TD id=TBL2136.finRow.6.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">213,390</TD>
<TD id=TBL2136.finRow.6.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL2136.finRow.6.trail.6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2136.finRow.6.lead.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.symb.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2136.finRow.6.amt.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: top; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">434,287</TD>
<TD id=TBL2136.finRow.6.trail.7 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR></TABLE>
<P id=PARA2137 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">________________________</FONT></P>
<TABLE id=MTAB2139  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt; VERTICAL-ALIGN: top">
<P id=PARA2140 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(1)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2141 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All Other Compensation represents 401(k) Plan matching contributions by RestorGenex. We did not provide perquisites or other personal benefits other than a 401(k) matching contribution to our principal executive officers during the year ended December 31, 2015.</FONT></P></TD></TR></TABLE>
<P id=PARA2142 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2143 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Employment and Other Agreements</B></FONT></P>
<P id=PARA2144 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2145 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Stephen M. Simes, Chief Executive Officer.</I> On March&nbsp;5, 2014, we entered into an executive employment agreement with Stephen M. Simes pursuant to which he served as our Chief Executive Officer. The initial term of the agreement was three years, subject to extension as provided therein.&nbsp; Mr.&nbsp;Simes was entitled to an annual base salary of $425,000 with at least annual review and base salary increases as approved by the Board or Compensation Committee. Mr.&nbsp;Simes had the opportunity to earn a target annual bonus of 60 percent of base salary based upon achievement of performance objectives set by the Board or Compensation Committee after consultation with Mr.&nbsp;Simes, with the potential to earn a higher bonus for above target performance.&nbsp; Upon commencement of his employment, Mr.&nbsp;Simes received an initial grant of options to purchase 500,000 shares at an exercise price of $2.50 per share, which option vested quarterly. On July 24, 2014, Mr.&nbsp;Simes received a grant of options to purchase 542,975 shares at an exercise price of $3.92 per share, which option vested quarterly. The employment agreement contains certain severance and change of control provisions as described in more detail under the heading &#8220;&#8212;<I>Post-Termination Severance and Change in Control Arrangements</I>.&#8221; The employment agreement contained a clawback provision for certain performance-based compensation if a financial restatement occurs under certain circumstances. The employment agreement also contained customary confidentiality, assignment of inventions and non-solicitation provisions.</FONT></P>
<P id=PARA3511.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3511  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3511  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3511  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">50</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3511  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3511.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2147 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective immediately prior to the Merger on January 8, 2016, Mr. Simes resigned as our Chief Executive Officer.</FONT></P>
<P id=PARA2148 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2149 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Phillip B. Donenberg, Chief Financial Officer.</I> On May&nbsp;27, 2014, we entered into an executive employment agreement with Phillip B. Donenberg pursuant to which he served as our Chief Financial Officer. The initial term of the agreement was three years, subject to extension as provided therein. Mr.&nbsp;Donenberg was entitled to an annual base salary of $335,000 with at least annual review and base salary increases as approved by the Board or Compensation Committee. Mr.&nbsp;Donenberg had the opportunity to earn a target annual bonus of 45 percent of base salary based upon achievement of performance objectives set by the Board or Compensation Committee after consultation with Mr.&nbsp;Donenberg, with the potential to earn a higher bonus for above target performance. Upon commencement of his employment, Mr.&nbsp;Donenberg received an initial grant of options to purchase 250,000 shares at an exercise price of $4.00 per share, which option vested quarterly.&nbsp; On July 24, 2014, Mr.&nbsp;Donenberg received a grant of options to purchase 271,475 shares at an exercise price of $3.92 per share, which option vested quarterly. The employment agreement contains certain severance and change of control provisions as described in more detail under the heading &#8220;&#8212;<I>Post-Termination Severance and Change in Control Arrangements</I>.&#8221; The employment agreement contained a clawback provision for certain performance-based compensation if a financial restatement occurs under certain circumstances.&nbsp; The employment agreement also contained customary confidentiality, assignment of inventions and non-solicitation provisions.</FONT></P>
<P id=PARA2150 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2151 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective immediately prior to the Merger on January 8, 2016, Mr. Donenberg resigned as our Chief Financial Officer.</FONT></P>
<P id=PARA2152 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2153 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Mark A. Weinberg, M.D., Senior Vice President, Clinical Development.</I> On August&nbsp;4, 2014, we entered into an executive employment agreement with Mark A. Weinberg, M.D. pursuant to which he served as our Senior Vice President, Clinical Development.&nbsp; The initial term of the agreement was one year, subject to extension as provided therein. Dr.&nbsp;Weinberg was entitled to an annual base salary of $357,000 with at least annual review and base salary increases as approved by the Board or Compensation Committee. Dr.&nbsp;Weinberg had the opportunity to earn a target annual bonus of 50 percent of base salary based upon achievement of performance objectives set by the Board or Compensation Committee after consultation with Dr.&nbsp;Weinberg, with the potential to earn a higher bonus for above target performance. Upon commencement of his employment, Dr.&nbsp;Weinberg received a grant of options to purchase 521,475 shares at an exercise price of $3.90 per share, which option vested quarterly. The employment agreement contained certain severance and change of control provisions as described in more detail under the heading &#8220;&#8212;<I>Post-Termination Severance and Change in Control Arrangements</I>.&#8221; The employment agreement contained a clawback provision for certain performance-based compensation if a financial restatement occurs under certain circumstances.&nbsp; The employment agreement also contained customary confidentiality, assignment of inventions and non-solicitation provisions.</FONT></P>
<P id=PARA2154 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2155 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective immediately prior to the Merger on January 8, 2016, Dr. Weinberg resigned as our Senior Vice President, Clinical Development.</FONT></P>
<P id=PARA2156 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2157 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Indemnification Agreements</B></FONT></P>
<P id=PARA2158 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2159 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We entered into agreements with all of our former named executive officers named in this Amendment No. 1 under which we are required to indemnify them against expenses, judgments, penalties, fines, settlements and other amounts actually and reasonably incurred, including expenses of a derivative action, in connection with an actual or threatened proceeding if any of them may be made a party because he or she is or was one of our executive officers. We will be obligated to pay these amounts only if the executive officer acted in good faith and in a manner that he or she reasonably believed to be in or not opposed to our best interests.&nbsp; With respect to any criminal proceeding, we will be obligated to pay these amounts only if the executive officer had no reasonable cause to believe his or her conduct was unlawful. The indemnification agreements also set forth procedures that will apply in the event of a claim for indemnification.</FONT></P>
<P id=PARA3512.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3512  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3512  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3512  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">51</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3512  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3512.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P id=PARA2161 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Outstanding Equity Awards at Fiscal Year End</B></FONT></P>
<P id=PARA2162 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2163 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below provides information regarding unexercised stock option awards held by each of our named executive officers that remained outstanding at December&nbsp;31, 2015. We did not have any equity incentive plan awards or stock awards, each within the meaning of the SEC rules, outstanding at December&nbsp;31, 2015. </FONT></P>
<P id=PARA2164 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2165 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END - 2015</B></FONT></P>
<P id=PARA2166 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL2225  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL2225.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 26%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2225.finRow.1.lead.D6 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=12>
<P id=PARA2167 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Option Awards</B></FONT></P></TD></TR>
<TR id=TBL2225.finRow.2>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 26%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA2168 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Name</B></FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt">
<P id=PARA2169 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Grant<BR>Date</B></FONT></P></TD>
<TD id=TBL2225.finRow.2.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2225.finRow.2.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2170 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Number of Securities<BR>Underlying<BR>Unexercised Options (#)<BR>Vested</B></FONT></P></TD>
<TD id=TBL2225.finRow.2.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2225.finRow.2.lead.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2225.finRow.2.amt.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2171 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Number of Securities<BR>Underlying<BR>Unexercised Options (#)</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Unvested</B></FONT></P></TD>
<TD id=TBL2225.finRow.2.trail.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2225.finRow.2.lead.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom"><B>&nbsp;</B></TD>
<TD id=TBL2225.finRow.2.amt.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2172 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Option<BR>Exercise</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Price ($)</B></FONT></P></TD>
<TD id=TBL2225.finRow.2.trail.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt">
<P id=PARA2173 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Option<BR>Expiration<BR>Date</B></FONT></P></TD></TR>
<TR id=TBL2225.finRow.3>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 26%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA2174 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stephen M. Simes</FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
<P id=PARA2175 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">03/05/2014</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD id=TBL2225.finRow.3.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">333,333 </TD>
<TD id=TBL2225.finRow.3.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.3.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">166,667 </TD>
<TD id=TBL2225.finRow.3.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.3.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL2225.finRow.3.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.50 </TD>
<TD id=TBL2225.finRow.3.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
<P id=PARA2184 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">03/04/2024</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD></TR>
<TR id=TBL2225.finRow.3>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 26%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">07/24/2014</TD>
<TD id=TBL2225.finRow.3.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">271,488</TD>
<TD id=TBL2225.finRow.3.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.3.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">271,487</TD>
<TD id=TBL2225.finRow.3.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.3.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.3.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3.92</TD>
<TD id=TBL2225.finRow.3.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">07/23/2024</TD></TR>
<TR id=TBL2225.finRow.4>
<TD style="WIDTH: 26%">&nbsp;</TD>
<TD style="WIDTH: 1%">&nbsp;</TD>
<TD style="WIDTH: 12%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.lead.B3 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.symb.B3 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.amt.B3 style="WIDTH: 14%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.trail.B3 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.lead.B4 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.symb.B4 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.amt.B4 style="WIDTH: 14%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.trail.B4 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.lead.B5 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.symb.B5 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.amt.B5 style="WIDTH: 12%">&nbsp;</TD>
<TD id=TBL2225.finRow.4.trail.B5 style="WIDTH: 1%">&nbsp;</TD>
<TD style="WIDTH: 12%">&nbsp;</TD></TR>
<TR id=TBL2225.finRow.5>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 26%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA2197 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Phillip B. Donenberg </FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
<P id=PARA2198 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">05/27/2014</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD id=TBL2225.finRow.5.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">145,833 </TD>
<TD id=TBL2225.finRow.5.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.5.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">104,167 </TD>
<TD id=TBL2225.finRow.5.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.5.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4.00 </TD>
<TD id=TBL2225.finRow.5.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
<P id=PARA2206 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">05/26/2024</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD></TR>
<TR id=TBL2225.finRow.5>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 26%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">07/24/2014</TD>
<TD id=TBL2225.finRow.5.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">135,738</TD>
<TD id=TBL2225.finRow.5.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.5.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">135,737</TD>
<TD id=TBL2225.finRow.5.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.5.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.5.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3.92</TD>
<TD id=TBL2225.finRow.5.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">07/23/2024</TD></TR>
<TR id=TBL2225.finRow.6>
<TD style="WIDTH: 26%">&nbsp;</TD>
<TD style="WIDTH: 1%">&nbsp;</TD>
<TD style="WIDTH: 12%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.lead.B3 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.symb.B3 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.amt.B3 style="WIDTH: 14%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.trail.B3 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.lead.B4 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.symb.B4 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.amt.B4 style="WIDTH: 14%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.trail.B4 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.lead.B5 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.symb.B5 style="WIDTH: 1%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.amt.B5 style="WIDTH: 12%">&nbsp;</TD>
<TD id=TBL2225.finRow.6.trail.B5 style="WIDTH: 1%">&nbsp;</TD>
<TD style="WIDTH: 12%">&nbsp;</TD></TR>
<TR id=TBL2225.finRow.7>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 26%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA2219 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark A. Weinberg, M.D.</FONT></P></TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
<P id=PARA2220 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">08/04/2014</FONT></P></TD>
<TD id=TBL2225.finRow.7.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.7.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.7.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">260,738</TD>
<TD id=TBL2225.finRow.7.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.7.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.7.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.7.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">260,737</TD>
<TD id=TBL2225.finRow.7.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2225.finRow.7.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.7.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2225.finRow.7.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3.90</TD>
<TD id=TBL2225.finRow.7.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">
<P id=PARA2224 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #cceeff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">08/03/2024</FONT></P></TD></TR></TABLE>
<P id=PARA2226 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">________________________</FONT></P>
<P id=PARA2227 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In connection with the change of control that took place upon the completion of the Merger, all of the awards set forth in the table above vested in full.</FONT></P>
<P id=PARA2228 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2229 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Post-Termination Severance and Change in Control Arrangements</B></FONT></P>
<P id=PARA2230 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2231 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As described under the heading &#8220;&#8212;<I>Employment and Other Agreements</I>,&#8221; we entered into employment agreements with our former executive officers that provided for certain severance and change of control benefits.&nbsp; Under these agreements, if an executive&#8217;s employment was terminated by us other than for &#8220;cause,&#8221; or by the executive for &#8220;good reason,&#8221; in addition to any accrued but unpaid salary and benefits through the date of termination, the executive would be entitled to a severance cash payment from us in an amount equal to the number of months of base salary set forth in the table below, and in the case of certain executives, a pro rata portion of the executive&#8217;s target annual bonus.&nbsp; In addition, the executives will be entitled to reimbursements for COBRA (Consolidated Omnibus Budget Reconciliation Act of 1985, as amended) continuation coverage for up to the number of months set forth in the table below:</FONT></P>
<P id=PARA2232 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL2249  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 37.5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA2233 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Name</B></FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA2234 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Number&nbsp;of&nbsp;Months&nbsp;Base<BR>Salary&nbsp;as&nbsp;Severance</B></FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA2235 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Pro&nbsp;Rata&nbsp;Portion&nbsp;of<BR>Target&nbsp;Annual&nbsp;Bonus?</B></FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA2236 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Maximum&nbsp;Number&nbsp;of<BR>Months&nbsp;COBRA<BR>Reimbursement</B></FONT></P></TD>
<TD style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp; </TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="WIDTH: 37.5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA2237 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 10pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stephen M. Simes</FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA2238 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">12</FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA2239 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Yes</FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA2240 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">12</FONT></P></TD>
<TD style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp; </TD></TR>
<TR style="BACKGROUND-COLOR: #ffffff">
<TD style="WIDTH: 37.5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA2241 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 10pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Phillip B. Donenberg </FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<P id=PARA2242 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">12</FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<P id=PARA2243 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Yes</FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<P id=PARA2244 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">12</FONT></P></TD>
<TD style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp; </TD></TR>
<TR style="BACKGROUND-COLOR: #cceeff">
<TD style="WIDTH: 37.5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<P id=PARA2245 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 10pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark A. Weinberg, M.D. </FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA2246 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">12</FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA2247 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">No</FONT></P></TD>
<TD style="WIDTH: 2.5%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp; </TD>
<TD style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<P id=PARA2248 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">12</FONT></P></TD>
<TD style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp; </TD></TR></TABLE>
<P id=PARA2250 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2251 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The receipt of severance benefits is dependent upon the executive executing and delivering a release of claims to us.</FONT></P>
<P id=PARA2252 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2253 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Under the employment agreements, &#8220;cause&#8221; was generally defined as (i)&nbsp;the executive&#8217;s failure to substantially perform the fundamental duties and responsibilities associated with executive&#8217;s position, including executive&#8217;s failure or refusal to carry out reasonable instructions; (ii)&nbsp;the executive&#8217;s material breach of any material written company policy; (iii)&nbsp;the executive&#8217;s gross misconduct in the performance of his or her duties for the company; (iv)&nbsp;the executive&#8217;s material breach of the terms of his or her employment agreement; (v)&nbsp;the executive&#8217;s conviction of any fraudulent or felony criminal offense or any other criminal offense which reflects adversely on the us or reflects conduct or character that the Board reasonably concludes is inconsistent with continued employment; or (vi)&nbsp;the executive&#8217;s conviction of any criminal conduct that is a &#8220;statutory disqualifying event&#8221; (as defined under federal securities laws, rules&nbsp;and regulations).&nbsp; &#8220;Good reason&#8221; generally means any of the following actions taken by us or a successor corporation or entity without the executive&#8217;s consent: (i)&nbsp;material reduction of the executive&#8217;s base compensation; (ii)&nbsp;material reduction in the executive&#8217;s title, authority, duties or responsibilities; (iii)&nbsp;failure or refusal of a successor to our company to materially assume our obligations under the employment agreement in the event of a change in control; (iv)&nbsp;relocation of the executive&#8217;s job site that results in an increase in the executive&#8217;s one-way driving distance by more than 50 miles from the executive&#8217;s then-current principal residence; or (v)&nbsp;any other material breach by us of the employment agreement.</FONT></P>
<P id=PARA3513.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3513  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3513  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3513  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">52</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3513  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3513.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2255 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Change of Control</B></FONT></P>
<P id=PARA2256 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2257 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition, under the terms of the stock option agreements with our executives, if a change in control occurred, options held by our executives will become immediately vested and exercisable immediately prior to (but conditioned upon completion of) the change in control and remain exercisable through their expiration date.&nbsp; Alternatively, the Board could cash out the options.</FONT></P>
<P id=PARA2258 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2259 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition, under the terms of their employment agreements, if Mr.&nbsp;Simes, Mr.&nbsp;Donenberg or Dr.&nbsp;Weinberg terminated his employment for good reason or is involuntarily terminated other than for cause within 12 months of a change in control or prior to a change in control if the termination of his employment was either a condition of the change in control at the request or insistence of a person related to the change in control, then such executive would receive a higher severance payment than outside the context of a change in control. For Mr.&nbsp;Simes and Mr.&nbsp;Donenberg, the severance payment would equal 24 months of base salary plus two times the pro rata portion of the executive&#8217;s target annual bonus.&nbsp; For Dr.&nbsp;Weinberg, the severance payment would equal 18 months of base salary.</FONT></P>
<P id=PARA2260 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2261 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For purposes of the stock option agreements and employment agreements, a &#8220;change in control&#8221; means the occurrence of any one or more of the following, subject to certain exceptions: (i)&nbsp;the accumulation (if over time, in any consecutive 12 month period), whether directly, indirectly, beneficially or of record, by any individual, entity or group of 50.1 percent or more of the shares of our outstanding common stock, whether by merger, consolidation, sale or other transfer of shares of our common stock (other than a merger or consolidation where our stockholders prior to the merger or consolidation are the holders of a majority of the voting securities of the entity that survives such merger or consolidation), (ii)&nbsp;a sale of all or substantially all of our assets or (iii)&nbsp;during any period of 12 consecutive months, the individuals who, at the beginning of such period, constitute the Board, and any new director whose election by the Board or nomination for election by our stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the 12-month period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board.</FONT></P>
<P id=PARA2262 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2263 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The completion of the Merger constituted a change of control of the Company and, in connection with the completion of the Merger and their resignation in connection therewith, Mr.&nbsp;Simes, Mr.&nbsp;Donenberg and Dr.&nbsp;Weinberg received the severance benefits described above due to them in connection with a change of control pursuant to their respective employment agreements, and their respective outstanding equity awards vested in full as described above.</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2265.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK2265  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2265  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2265  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">53</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2265  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2265.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA2266 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>RELATED PERSON RELATIONSHIPS AND TRANSACTIONS</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2268 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA2269 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2270 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Overview</B></FONT></P>
<P id=PARA2271 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2272 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following is a summary of certain transactions that have occurred since January 1, 2014 to which we were or are a participant, including any transaction in which:</FONT></P>
<P id=PARA2273 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB2275  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA2276 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2277 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the amounts involved exceeded one percent of the average of our total assets; and</FONT></P></TD></TR></TABLE>
<P id=PARA2278 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB2280  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA2281 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2282 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">a related person (including any current director, executive officer, holder of more than five percent of our outstanding shares of common stock or any member of their immediate family) had or will have a direct or indirect material interest, other than compensation arrangements.</FONT></P></TD></TR></TABLE>
<P id=PARA2283 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2284 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Convertible Notes</B></FONT></P>
<P id=PARA2285 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2286 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During 2014 and 2015, certain of our current directors, executive officers and five-percent stockholders purchased Diffusion Convertible Notes on the terms offered to other investors in the principal amounts set forth opposite their name below. In addition, prior to the completion of the Merger, in December 2015, the directors, executive officers and five-percent stockholders converted their Diffusion Convertible Notes into the number of Diffusion Units set forth below.</FONT></P>
<P id=PARA2287 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL2324  style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 90%; BORDER-BOTTOM: #000000 1px solid; BORDER-LEFT: #000000 1px solid; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL2324.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 49%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA2288 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Director / Officer / &gt; 5% Holder</B></FONT></P></TD>
<TD id=TBL2324.finRow.1.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><B>&nbsp;</B></TD>
<TD id=TBL2324.finRow.1.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2289 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Aggregate</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Principal</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Amount of</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Notes</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Converted</B></FONT></P></TD>
<TD id=TBL2324.finRow.1.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2324.finRow.1.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><B>&nbsp;</B></TD>
<TD id=TBL2324.finRow.1.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2290 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Aggregate Number</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>of Units Received</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Upon Conversion</B></FONT></P></TD>
<TD id=TBL2324.finRow.1.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2324.finRow.1.lead.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><B>&nbsp;</B></TD>
<TD id=TBL2324.finRow.1.amt.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2291 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Aggregate</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Number of</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Shares of</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Common</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Stock Received</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>for Such Units</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>in the Merger</B></FONT></P></TD>
<TD id=TBL2324.finRow.1.trail.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL2324.finRow.2 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2292 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David G. Kalergis</FONT></P></TD>
<TD id=TBL2324.finRow.2.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.2.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</TD>
<TD id=TBL2324.finRow.2.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">100,000</TD>
<TD id=TBL2324.finRow.2.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.2.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.2.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.2.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">104,723</TD>
<TD id=TBL2324.finRow.2.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.2.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.2.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.2.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">382,517</TD>
<TD id=TBL2324.finRow.2.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2324.finRow.3 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
<P id=PARA2296 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Robert Adams</FONT></P></TD>
<TD id=TBL2324.finRow.3.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.3.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.3.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">211,000</TD>
<TD id=TBL2324.finRow.3.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.3.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.3.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.3.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">168,749</TD>
<TD id=TBL2324.finRow.3.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.3.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.3.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.3.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">616,382</TD>
<TD id=TBL2324.finRow.3.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2324.finRow.4 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2300 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark T. Giles</FONT></P></TD>
<TD id=TBL2324.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,450,003</TD>
<TD id=TBL2324.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.4.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.4.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.4.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,569,269</TD>
<TD id=TBL2324.finRow.4.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.4.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.4.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.4.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5,732,002</TD>
<TD id=TBL2324.finRow.4.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2324.finRow.5 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
<P id=PARA2304 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Alan Levin</FONT></P></TD>
<TD id=TBL2324.finRow.5.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.5.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.5.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">35,000</TD>
<TD id=TBL2324.finRow.5.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.5.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.5.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.5.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">17,505</TD>
<TD id=TBL2324.finRow.5.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.5.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.5.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.5.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">63,939</TD>
<TD id=TBL2324.finRow.5.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2324.finRow.6 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2308 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Thomas Byrne</FONT></P></TD>
<TD id=TBL2324.finRow.6.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.6.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.6.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">191,000</TD>
<TD id=TBL2324.finRow.6.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.6.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.6.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.6.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">161,056</TD>
<TD id=TBL2324.finRow.6.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.6.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.6.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.6.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">588,282</TD>
<TD id=TBL2324.finRow.6.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2324.finRow.7 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
<P id=PARA2312 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David R. Jones</FONT></P></TD>
<TD id=TBL2324.finRow.7.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.7.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.7.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</TD>
<TD id=TBL2324.finRow.7.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.7.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.7.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.7.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">104,734</TD>
<TD id=TBL2324.finRow.7.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.7.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.7.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.7.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">382,557</TD>
<TD id=TBL2324.finRow.7.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2324.finRow.8 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2316 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Richard Baxter Gilliam</FONT></P></TD>
<TD id=TBL2324.finRow.8.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.8.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.8.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,300,003</TD>
<TD id=TBL2324.finRow.8.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.8.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.8.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.8.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3,746,315</TD>
<TD id=TBL2324.finRow.8.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.8.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.8.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2324.finRow.8.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">13,684,007</TD>
<TD id=TBL2324.finRow.8.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2324.finRow.9 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA2320 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Michael S. &amp; Ellen A. Geismar</FONT></P></TD>
<TD id=TBL2324.finRow.9.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.9.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.9.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,857,233</TD>
<TD id=TBL2324.finRow.9.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.9.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.9.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.9.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,475,327</TD>
<TD id=TBL2324.finRow.9.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2324.finRow.9.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.9.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2324.finRow.9.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5,388,864</TD>
<TD id=TBL2324.finRow.9.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR></TABLE>
<P id=PARA2325 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK2326  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2326  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2326  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">54</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2326  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2326.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA2327 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Merger with Diffusion LLC</B></FONT></P>
<P id=PARA2328 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2329 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On January 8, 2016, in connection with the Merger, the Diffusion Units (and any securities convertible or exchangeable for Diffusion Units) held by each of our directors, executive officers and five-percent stockholders were converted into shares of Common Stock as set forth below pursuant to the terms of the Merger Agreement. The amounts shown include all Diffusion Units and Common Stock beneficially owned by each individual as described under the heading, &#8220;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters&#8221; and certain of our directors, executive officers and five-percent stockholders disclaim beneficial ownership of certain of the shares listed below as set forth in the footnotes to the table under such heading.</FONT></P>
<P id=PARA2330 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL2386  style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 100%; BORDER-BOTTOM: #000000 1px solid; BORDER-LEFT: #000000 1px solid; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR id=TBL2386.finRow.1>
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA2331 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Director / Officer / &gt; 5% Holder</B></FONT></P></TD>
<TD id=TBL2386.finRow.1.lead.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><B>&nbsp;</B></TD>
<TD id=TBL2386.finRow.1.amt.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2332 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Diffusion Units</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Tendered</B></FONT></P></TD>
<TD id=TBL2386.finRow.1.trail.D2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2386.finRow.1.lead.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><B>&nbsp;</B></TD>
<TD id=TBL2386.finRow.1.amt.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2333 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Options to</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>purchase</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Diffusion Units</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Tendered</B></FONT></P></TD>
<TD id=TBL2386.finRow.1.trail.D3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2386.finRow.1.lead.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><B>&nbsp;</B></TD>
<TD id=TBL2386.finRow.1.amt.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2334 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Shares of</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Common</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Stock Received</B></FONT></P></TD>
<TD id=TBL2386.finRow.1.trail.D4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD>
<TD id=TBL2386.finRow.1.lead.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><B>&nbsp;</B></TD>
<TD id=TBL2386.finRow.1.amt.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colSpan=2>
<P id=PARA2335 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Options to</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>purchase</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Common</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Stock</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Received</B></FONT></P></TD>
<TD id=TBL2386.finRow.1.trail.D5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"><B>&nbsp;</B></TD></TR>
<TR id=TBL2386.finRow.2 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2336 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David G. Kalergis</FONT></P></TD>
<TD id=TBL2386.finRow.2.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.2.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.2.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">351,722</TD>
<TD id=TBL2386.finRow.2.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.2.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.2.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.2.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">541,782</TD>
<TD id=TBL2386.finRow.2.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.2.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.2.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.2.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,284,722</TD>
<TD id=TBL2386.finRow.2.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.2.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.2.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.2.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,978,940</TD>
<TD id=TBL2386.finRow.2.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.3 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
<P id=PARA2341 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">John L. Gainer</FONT></P></TD>
<TD id=TBL2386.finRow.3.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.3.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.3.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,020,000</TD>
<TD id=TBL2386.finRow.3.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.3.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.3.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.3.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">452,006</TD>
<TD id=TBL2386.finRow.3.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.3.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.3.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.3.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3,725,711</TD>
<TD id=TBL2386.finRow.3.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.3.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.3.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.3.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,651,017</TD>
<TD id=TBL2386.finRow.3.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.4 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2346 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Robert Adams</FONT></P></TD>
<TD id=TBL2386.finRow.4.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.4.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.4.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">147,694</TD>
<TD id=TBL2386.finRow.4.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.4.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.4.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.4.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">276,000</TD>
<TD id=TBL2386.finRow.4.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.4.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.4.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.4.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">539,477</TD>
<TD id=TBL2386.finRow.4.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.4.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.4.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.4.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,008,130</TD>
<TD id=TBL2386.finRow.4.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.5 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
<P id=PARA2351 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mark T. Giles</FONT></P></TD>
<TD id=TBL2386.finRow.5.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.5.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.5.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,735,836</TD>
<TD id=TBL2386.finRow.5.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.5.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.5.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.5.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">252,000</TD>
<TD id=TBL2386.finRow.5.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.5.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.5.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.5.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">6,340,415</TD>
<TD id=TBL2386.finRow.5.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.5.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.5.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.5.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">920,466</TD>
<TD id=TBL2386.finRow.5.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.6 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2356 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Alan Levin</FONT></P></TD>
<TD id=TBL2386.finRow.6.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.6.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.6.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">67,905</TD>
<TD id=TBL2386.finRow.6.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.6.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.6.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.6.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">175,600</TD>
<TD id=TBL2386.finRow.6.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.6.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.6.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.6.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">248,032</TD>
<TD id=TBL2386.finRow.6.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.6.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.6.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.6.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">641,405</TD>
<TD id=TBL2386.finRow.6.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.7 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
<P id=PARA2361 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Thomas Byrne</FONT></P></TD>
<TD id=TBL2386.finRow.7.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.7.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.7.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">381,056</TD>
<TD id=TBL2386.finRow.7.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.7.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.7.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.7.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">439,000</TD>
<TD id=TBL2386.finRow.7.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.7.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.7.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.7.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,391,867</TD>
<TD id=TBL2386.finRow.7.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.7.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.7.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.7.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,603,510</TD>
<TD id=TBL2386.finRow.7.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.8 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2366 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David R. Jones</FONT></P></TD>
<TD id=TBL2386.finRow.8.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.8.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.8.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">104,734</TD>
<TD id=TBL2386.finRow.8.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.8.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.8.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.8.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">370,000</TD>
<TD id=TBL2386.finRow.8.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.8.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.8.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.8.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">382,557</TD>
<TD id=TBL2386.finRow.8.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.8.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.8.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.8.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,351,482</TD>
<TD id=TBL2386.finRow.8.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.9 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">
<P id=PARA2371 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Ben L. Shealy</FONT></P></TD>
<TD id=TBL2386.finRow.9.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.9.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.9.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</TD>
<TD id=TBL2386.finRow.9.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.9.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.9.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.9.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">290,000</TD>
<TD id=TBL2386.finRow.9.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.9.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.9.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.9.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</TD>
<TD id=TBL2386.finRow.9.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.9.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.9.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.9.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,059,268</TD>
<TD id=TBL2386.finRow.9.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.10 style="BACKGROUND-COLOR: #cceeff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">
<P id=PARA2376 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Richard Baxter Gilliam</FONT></P></TD>
<TD id=TBL2386.finRow.10.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.10.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.10.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3,900,817</TD>
<TD id=TBL2386.finRow.10.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.10.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.10.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.10.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL2386.finRow.10.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.10.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.10.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.10.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">14,248,350</TD>
<TD id=TBL2386.finRow.10.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.10.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.10.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</TD>
<TD id=TBL2386.finRow.10.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0</TD>
<TD id=TBL2386.finRow.10.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" noWrap>&nbsp;</TD></TR>
<TR id=TBL2386.finRow.11 style="BACKGROUND-COLOR: #ffffff">
<TD style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 32%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<P id=PARA2381 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Michael S. &amp; Ellen A. Geismar</FONT></P></TD>
<TD id=TBL2386.finRow.11.lead.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.11.symb.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.11.amt.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,512,361</TD>
<TD id=TBL2386.finRow.11.trail.2 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.11.lead.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.11.symb.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.11.amt.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</TD>
<TD id=TBL2386.finRow.11.trail.3 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.11.lead.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.11.symb.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.11.amt.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5,524,137</TD>
<TD id=TBL2386.finRow.11.trail.4 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-RIGHT: #000000 1px solid; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD>
<TD id=TBL2386.finRow.11.lead.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.11.symb.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</TD>
<TD id=TBL2386.finRow.11.amt.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</TD>
<TD id=TBL2386.finRow.11.trail.5 style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" noWrap>&nbsp;</TD></TR></TABLE>
<P id=PARA2387 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2388 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Jones Consulting Agreement</B></FONT></P>
<P id=PARA2389 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2390 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During 2015, Diffusion LLC was party to a consulting agreement with David R. Jones pursuant to which Dr. Jones served as Diffusion LLC&#8217;s Chief Medical Officer on a consulting basis. The agreement provided for bi-weekly payments to Dr. Jones of $4,000 and was subsequently modified to bi-weekly payments of $3,000, as well as a grant of an option to purchase 370,000 Diffusion Units, which upon exercise will convert into 1,351,483 shares of Common Stock in connection with the Merger. Pursuant to the agreement, Dr. Jones also agreed to customary invention assignment and confidentiality restrictive covenants. The consulting agreement expired pursuant to its terms on September 14, 2015, and Dr. Jones currently serves as the Company&#8217;s Chief Medical Officer on an at-will basis.</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2393.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK2393  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2393  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2393  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">55</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2393  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2393.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA2394 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>OTHER MATTERS</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2396 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA2397 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2398 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Stockholder Proposals for 2016 Annual Meeting</B></FONT></P>
<P id=PARA2399 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2400 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to our Amended and Restated Bylaws, stockholder proposals intended to be presented in our proxy materials relating to our next annual meeting of stockholders must be received by us on or before March __, 2017 but not earlier than February __, 2017, unless the date of the meeting is changed by more than 30 calendar days from the date of the annual meeting of stockholders for 2016, and must satisfy the requirements of the proxy rules&nbsp;promulgated by the SEC.</FONT></P>
<P id=PARA2401 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2402 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Any other stockholder proposals to be presented at our next annual meeting of stockholders must be given in writing to our Corporate Secretary and received at our principal executive offices on or before February __, 2017, which is the date that is 120 calendar days before the date this proxy statement is being released to our shareholders in connection with the Annual Meeting; provided, however, that in the event that the annual meeting of stockholders is called for a date that is not within 30 days before or after the anniversary date of the immediately preceding annual meeting of stockholders, notice by the stockholder in order to be timely must be so received not later than the close of business on the 10th day following the day on which such notice of the date of the annual meeting of stockholders was mailed or such public disclosure of the date of the annual meeting of stockholders was made, whichever first occurs. The proposal must contain specific information required by our Amended and Restated Bylaws, a copy of which may be obtained by writing to our Corporate Secretary or accessing the SEC&#8217;s EDGAR filing database at <U><I>www.sec.gov</I></U>. If a proposal is not timely and properly made in accordance with the procedures set forth in our Amended and Restated Bylaws, it will be defective and may not be brought before the meeting. If the proposal nonetheless is brought before the meeting and the Chair of the meeting does not exercise the power and duty to declare the proposal defective, the persons named in the proxy may use their discretionary voting with respect to the proposal.</FONT></P>
<P id=PARA2403 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2404 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Director Nominations for 2017 Annual Meeting</B></FONT></P>
<P id=PARA2405 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2406 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In accordance with procedures set forth in our Amended and Restated Bylaws, our stockholders may propose nominees for election to the Board of Directors only after providing timely written notice to our Corporate Secretary. To be timely, a stockholder&#8217;s notice to our Corporate Secretary must be delivered to or mailed and received at our principal executive offices on or before March __, 2017 but not earlier than February __, 2017; provided, however, that in the event that the annual meeting of stockholders is called for a date that is not within 30 days before or after the anniversary date of the immediately preceding annual meeting of stockholders, notice by the stockholder in order to be timely must be so received not later than the close of business on the 10</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">th</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;day following the day on which such notice of the date of the annual meeting of stockholders was mailed or such public disclosure of the date of the annual meeting of stockholders was made, whichever first occurs.</FONT></P>
<P id=PARA2407 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2408 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The notice must set forth, among other things:</FONT></P>
<P id=PARA2409 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB2411  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA2412 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2413 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the nominee&#8217;s name, age, business address and residence address;</FONT></P></TD></TR></TABLE>
<P id=PARA2414 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB2416  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA2417 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2418 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the nominee&#8217;s principal occupation or employment;</FONT></P></TD></TR></TABLE>
<P id=PARA2419 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB2421  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA2422 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2423 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the class and number of shares of our capital stock which are beneficially owned by the nominee; and</FONT></P></TD></TR></TABLE>
<P id=PARA2424 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB2426  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 36pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA2427 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA2428 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">any other information concerning the nominee required under the rules&nbsp;of the SEC in a proxy statement soliciting proxies for the election of directors.</FONT></P></TD></TR></TABLE>
<P id=PARA2429 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2430 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Submissions must be made by mail, courier or personal delivery.&nbsp; E-mailed submissions will not be considered.&nbsp; The Nominating and Corporate Governance Committee will consider only those stockholder recommendations whose submissions comply with these procedural requirements.&nbsp; The Nominating and Corporate Governance Committee will evaluate candidates recommended by stockholders in the same manner as those recommended by others.</FONT></P>
<P id=PARA3514.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3514  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3514  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3514  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">56</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3514  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3514.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2432 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Annual Report</B></FONT></P>
<P id=PARA2433 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2434 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>We have sent or made available electronically to each of our stockholders a copy of our annual report on Form&nbsp;10-K (without exhibits) for the year ended December&nbsp;31, 2015. The exhibits to our Form&nbsp;10-K are available by accessing the SEC&#8217;s EDGAR filing database at </B><U><B>www.sec.gov</B></U><B>. We will furnish a copy of any exhibit to our Form&nbsp;10-K upon receipt from any such person of a written request for such exhibits upon the payment of our reasonable expenses in furnishing the exhibits. This request should be sent to: Diffusion Pharmaceuticals Inc., 2020 Avon Court, Suite 4, Charlottesville,&nbsp;Virginia 22902, Attn:&nbsp; Stockholder Information.</B></FONT></P>
<P id=PARA2435 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2436 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Householding of Annual Meeting Materials</B></FONT></P>
<P id=PARA2437 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2438 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Some banks, brokers and other nominee record holders may be participating in the practice of &#8220;householding&#8221; proxy statements and annual reports. This means that only one copy of our proxy statement or annual report to stockholders may have been sent to multiple stockholders in each household. We will deliver promptly a separate copy of either document to any stockholder upon written or oral request to our Investor Relations Department, Diffusion Pharmaceuticals Inc., 2020 Avon Court, Suite 4, Charlottesville, Virginia 22902, telephone:&nbsp;(434) 220-0718. Any stockholder who wants to receive separate copies of our proxy statement or annual report to stockholders in the future, or any stockholder who is receiving multiple copies and would like to receive only one copy per household, should contact the stockholder&#8217;s bank, broker, or other nominee record holder, or the stockholder may contact us at the above address and phone number.</FONT></P>
<P id=PARA2439 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2440 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Cost and Method of Solicitation</B></FONT></P>
<P id=PARA2441 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2442 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition to solicitation by mail, our directors, officers, employees and agents may solicit proxies from our stockholders by personal interview, telephone, telegram or other electronic means. Arrangements also will be made with brokerage firms and other custodians, nominees and fiduciaries who are record holders of our common stock for the forwarding of solicitation materials to the beneficial owners of our common stock. We will reimburse these brokers, custodians, nominees and fiduciaries for the reasonable out-of-pocket expenses they incur in connection with the forwarding of solicitation materials.</FONT></P>
<P id=PARA2443 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2444 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">_________________________</FONT></P>
<P id=PARA2445 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2446 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Your vote is important. Whether or not you plan to attend the Annual Meeting, please exercise your right to vote as soon as possible by completing, signing, dating and returning your proxy card or by using Internet or telephone voting as described on the proxy card or Notice Regarding the Availability of Proxy Materials.</FONT></P>
<P id=PARA2447 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL2459  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2448 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">By Order of the Board of Directors,</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2451 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2452 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2453 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David G. Kalergis</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2454 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Chief Executive Officer</I></FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2455 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2456 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2457 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">June __, 2016</FONT></P></TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD></TR>
<TR>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">
<P id=PARA2458 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Charlottesville,&nbsp;Virginia</FONT></P></TD>
<TD style="WIDTH: 50%; VERTICAL-ALIGN: top">&nbsp; </TD></TR></TABLE>
<P id=PARA2464.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3342  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3342  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3342  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">57</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3342  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3342.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><B>Appendix A</B></P>
<P id=PARA3344 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA3343 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>CERTIFICATE OF AMENDMENT<BR>OF THE<BR>CERTIFICATE OF INCORPORATION</B><B> (AS AMENDED)</B><B><BR>OF<BR></B><B>DIFFUSION PHARMACEUTICALS INC.</B><B>&nbsp;</B></FONT></P>
<P id=PARA3345 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA3346 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>DIFFUSION PHARMACEUTICALS INC.</B>, a corporation incorporated and existing under and by virtue of the General Corporation Law of the State of Delaware (the "Corporation") does hereby certify:</FONT></P>
<P id=PARA3347 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA3348 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">FIRST: That, at a meeting of the Board of Directors of the Corporation (the &#8220;Board of Directors&#8221;) on May&nbsp;11, 2016, a resolution was duly adopted setting forth a proposed amendment to the Certificate of Incorporation (as amended) of the Corporation in the form set forth below (the "Amendment"), declaring said Amendment to be advisable and calling for consideration of said proposed Amendment by the stockholders of the Corporation.</FONT></P>
<P id=PARA3349 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA3350 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">"RESOLVED, that the Certificate of Incorporation (as amended) of the Corporation shall be amended by adding at the end of subsection A of Article IV thereof the following: &#8220;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective upon the effective time of this Certificate of Amendment of the Certificate of Incorporation with the Secretary of State of the State of Delaware (the &#8220;<U>Effective Time</U>&#8221;), each ___ shares of Common Stock issued and outstanding immediately prior to the Effective Time shall, automatically and without the necessity of any further action, be changed, reclassified and combined into one (1)&nbsp;share of Common Stock (the &#8220;<U>Reverse Stock Split</U>&#8221;). No fractional shares shall be issued in connection with the Reverse Stock Split. Stockholders who otherwise would be entitled to receive fractional shares of Common Stock shall have that rounded up to one additional whole share. Each certificate that immediately prior to the Effective Time represented shares of Common Stock (&#8220;<U>Old Certificates</U>&#8221;), shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the elimination of fractional shares as described above."</FONT></P>
<P id=PARA3351 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA3352 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SECOND: Thereafter, pursuant to the resolution of the Board of Directors, the proposed Amendment was approved by the stockholders of the Corporation at the annual meeting of stockholders on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016.</FONT></P>
<P id=PARA3353 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA3354 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">THIRD: That the Amendment was duly adopted in accordance with the provisions of Sections&nbsp;242 of the General Corporation Law of the State of Delaware.</FONT></P>
<P id=PARA3355 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA3356 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the Corporation has caused this Amendment to the Certificate of Incorporation of the Corporation (as amended) to be executed by David G. Kalergis, its President and Chief Executive Officer, on this&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;day of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016.</FONT></P>
<P id=PARA3357 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL3377  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 49%; VERTICAL-ALIGN: middle">&nbsp; </TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: middle">&nbsp; </TD>
<TD style="WIDTH: 3.8%; VERTICAL-ALIGN: middle">&nbsp; </TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: middle">&nbsp; </TD>
<TD style="WIDTH: 7.1%; VERTICAL-ALIGN: middle">&nbsp; </TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: middle">&nbsp; </TD>
<TD style="WIDTH: 38%; VERTICAL-ALIGN: middle">&nbsp; </TD></TR>
<TR>
<TD style="WIDTH: 49%; VERTICAL-ALIGN: bottom">&nbsp; </TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3358 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 50.3%; VERTICAL-ALIGN: bottom" colSpan=5>
<P id=PARA3359 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">DIFFUSION PHARMACEUTICALS INC.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 49%; VERTICAL-ALIGN: bottom">&nbsp; </TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3360 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 3.8%; VERTICAL-ALIGN: bottom">
<P id=PARA3361 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">By:</FONT></P></TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3362 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 45.8%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid" colSpan=3>
<P id=PARA3363 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</FONT></P>
<P id=PARA3364 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P></TD></TR>
<TR>
<TD style="WIDTH: 49%; VERTICAL-ALIGN: bottom">&nbsp; </TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3365 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 3.8%; VERTICAL-ALIGN: bottom">
<P id=PARA3366 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3367 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 7.1%; VERTICAL-ALIGN: bottom">
<P id=PARA3368 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Name:</FONT></P></TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3369 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 38%; VERTICAL-ALIGN: bottom">
<P id=PARA3370 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David G. Kalergis</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 49%; VERTICAL-ALIGN: bottom">&nbsp; </TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3371 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 3.8%; VERTICAL-ALIGN: bottom">
<P id=PARA3372 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3373 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 7.1%; VERTICAL-ALIGN: bottom">
<P id=PARA3374 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Title:</FONT></P></TD>
<TD style="WIDTH: 0.7%; VERTICAL-ALIGN: bottom">
<P id=PARA3375 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 38%; VERTICAL-ALIGN: bottom">
<P id=PARA3376 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>President and Chief Executive Officer</I></FONT></P></TD></TR></TABLE>
<P id=PARA3378 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<DIV id=PGBK2464  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2464  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2464  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center"></DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2464  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2464.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><B>Appendix B</B></P>
<P style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;</P>
<P id=PARA2465 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>AMENDMENT No. 1 </B></FONT></P>
<P id=PARA2466 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>TO THE Diffusion Pharmaceuticals Inc. </B></FONT></P>
<P id=PARA2467 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-TRANSFORM: uppercase"><B>2015 EQUITY incentive Plan </B></FONT></P>
<P id=PARA2468 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2469 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">This AMENDMENT NO. 1 TO THE DIFFUSION PHARMACEUTICALS INC. 2015 EQUITY INCENTIVE PLAN (this &#8220;<U>Amendment</U>&#8221;) is made as of May __, 2016.</FONT></P>
<P id=PARA2470 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2471 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to Section 19.1 of the Diffusion Pharmaceuticals Inc. 2015 Equity Incentive Plan (the &#8220;<U>Plan</U>&#8221;), the Plan is hereby amended as follows: </FONT></P>
<P id=PARA2472 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2473 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective upon the approval of the holders of at least a majority of the outstanding shares of stock of Diffusion Pharmaceuticals Inc. (the &#8220;<U>Company</U>&#8221;) entitled to vote at the Company&#8217;s Annual Meeting of Stockholders on June 28, 2016, Section 4.1 of the Plan is hereby deleted and replaced in its entirety by the following: </FONT></P>
<P id=PARA2474 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2475 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;4.1. <U>Maximum Number of Shares Available; Certain Restrictions on Awards</U>.&nbsp; Subject to adjustment as provided in Section 4.3 of the Plan, the maximum number of shares of Common Stock that will be available for issuance under the Plan will be the sum of:</FONT></P>
<P id=PARA2476 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2477 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a) 5,000,000 (the &#8220;<U>Base Amount</U>), provided, however, that on January 1, 2017 and each January 1 thereafter prior to the termination of the Plan, the Base Amount shall be increased by (x) 4.0% of the number of shares of Common Stock outstanding as of the December 31 immediately preceding such January 1 or (y) such lesser number of shares as the Committee may determine in its sole discretion;</FONT></P>
<P id=PARA2478 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2479 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)&nbsp;&nbsp;the number of shares issued or Incentive Awards granted under the Plan in connection with the settlement, assumption or substitution of outstanding awards or obligations to grant future awards as a condition of the Company and/or any Subsidiary(ies) acquiring, merging or consolidating with another entity; and</FONT></P>
<P id=PARA2480 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2481 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(c)&nbsp;&nbsp;the number of shares that are unallocated and available for grant under a stock plan assumed by the Company or any Subsidiary(ies) in connection with the merger, consolidation, or acquisition of another entity by the Company and/or any of its Subsidiaries, based on the applicable exchange ratio and other transaction terms, but only to the extent that such shares may be utilized by the Company or its Subsidiaries following the transaction pursuant to the rules or regulations of any applicable exchange or market on which the Company&#8217;s Common Stock may be traded or quoted.</FONT></P>
<P id=PARA2482 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2483 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The shares available for issuance under the Plan may, at the election of the Committee, be either treasury shares or shares authorized but unissued, and, if treasury shares are used, all references in the Plan to the issuance of shares will, for corporate law purposes, be deemed to mean the transfer of shares from treasury.</FONT></P>
<P id=PARA2484 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2485 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Notwithstanding any other provisions of the Plan to the contrary, (i)&nbsp;no more than 2,500,000 shares of Common Stock may be issued pursuant to the exercise of Incentive Stock Options granted under the Plan; and (ii)&nbsp; no Participant may be granted Incentive Awards covering more than 2,500,000 shares of Common Stock during any one calendar year. &nbsp; All of the foregoing share limits are subject, in each case, to adjustment as provided in Section&nbsp;4.3 of the Plan.&nbsp; Incentive Stock Options issued as a result of the Company&#8217;s assumption or substitution of like awards issued by any acquired, merged or consolidated entity pursuant to applicable provisions of the Code will not count towards the limit in clause (i). Incentive Awards issued as a result of the Company&#8217;s assumption or substitution of like awards issued by any acquired, merged or consolidated entity will not count towards the limit in clause (ii).</FONT></P>
<P id=PARA3515.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3515  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3515  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3515  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3515  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3515.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA2486 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2487 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The maximum aggregate number of shares of Common Stock subject to Incentive Awards that may be granted to any one Director who is not an Employee in any one calendar year may not exceed 275,000; provided, that such limit shall not apply to any election of a Director to receive shares of Common Stock in lieu of all or a portion of any annual Board, chair and other retainers and any meeting fees otherwise payable in cash.&#8221;</FONT></P>
<P id=PARA2488 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2489 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------</FONT></P>
<P id=PARA2490 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2491 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Except as specifically provided in and modified by this Amendment, all of the terms and conditions of the Plan are hereby ratified and confirmed, and all references to the Plan shall be deemed to refer to the Plan as modified by this Amendment.</FONT></P>
<P id=PARA2492 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2493 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">IN WITNESS WHEREOF, the Company has caused this Amendment to the Plan to be executed by its duly authorized officers this __<SUP style="vertical-align: baseline; position: relative; bottom:.33em;">th</SUP> day of May, 2016. </FONT></P>
<P id=PARA2494 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL3516  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD vAlign=top width="50%">
<P id=PARA3516.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="38%" colSpan=2>
<P id=PARA3516.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DIFFUSION PHARMACEUTICALS INC. </FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA3516.3 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA3516.4 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA3516.5 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA3516.6 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA3516.7 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA3516.8 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA3516.9 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=bottom width="35%" noWrap align=left>
<P id=PARA3516.10 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA3516.11 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="TEXT-ALIGN: left" vAlign=top width="50%" align=left>
<P id=PARA3516.12 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD style="TEXT-ALIGN: left" vAlign=top width="3%">
<P id=PARA3516.13 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By: </FONT></P></TD>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=top width="35%" noWrap align=left>
<P id=PARA3516.14 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P></TD>
<TD vAlign=top width="12%">
<P id=PARA3516.15 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA3516.16 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA3516.17 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA3516.18 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name:</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA3516.19 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA3516.20 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA3516.21 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA3516.22 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title:</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA3516.23 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR></TABLE>
<P id=PARA2495 style="TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 216pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -180pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2463  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2463  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2463  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">2</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2463  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2463.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<P style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><B>Appendix C</B></P>
<P style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;</P>
<P id=PARA2501 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>DIFFUSION PHARMACEUTICALS INC.</B></FONT></P>
<P id=PARA2502 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>2015 EQUITY INCENTIVE PLAN</B></FONT></P>
<P id=PARA2503 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2504 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">1.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Purpose of Plan</U>.</FONT></P>
<P id=PARA2505 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2506 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The purpose of the Diffusion Pharmaceuticals Inc. 2015 Equity Incentive Plan (the &#8220;Plan&#8221;) is to advance the interests of Diffusion Pharmaceuticals Inc. (the&nbsp;&#8220;Company&#8221;) and its stockholders by enabling the Company and its Subsidiaries to attract and retain qualified individuals to perform services for the Company and its Subsidiaries, providing incentive compensation for such individuals that is linked to the growth and profitability of the Company and increases in stockholder value, and aligning the interests of such individuals with the interests of its stockholders through opportunities for equity participation in the Company.</FONT></P>
<P id=PARA2507 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2508 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Definitions.</U></FONT></P>
<P id=PARA2509 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2510 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following terms will have the meanings set forth below, unless the context clearly otherwise requires.&nbsp; Terms defined elsewhere in the Plan will have the same meaning throughout the Plan.</FONT></P>
<P id=PARA2511 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2512 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Adverse Action</U>&#8221; means any action by a Participant that the Committee, in its sole discretion, determines to be injurious, detrimental, prejudicial or adverse to the interests of the Company or any Subsidiary, including:&nbsp; (a)&nbsp;disclosing confidential information of the Company or any Subsidiary to any person not authorized by the Company or Subsidiary to receive it, (b) engaging, directly or indirectly, in any commercial activity that in the judgment of the Committee competes with the business of the Company or any Subsidiary or (c)&nbsp;interfering with the relationships of the Company or any Subsidiary and their respective employees, independent contractors, customers, prospective customers and vendors.</FONT></P>
<P id=PARA2513 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2514 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Board</U>&#8221; means the Board of Directors of the Company.</FONT></P>
<P id=PARA2515 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2516 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Broker Exercise Notice</U>&#8221; means a written notice pursuant to which a Participant, upon exercise of an Option, irrevocably instructs a broker or dealer to sell a sufficient number of shares of Common Stock or loan a sufficient amount of money to pay all or a portion of the exercise price of the Option and/or any related withholding tax obligations and remit such sums to the Company and directs the Company to deliver shares of Common Stock to be issued upon such exercise directly to such broker or dealer or their nominee.</FONT></P>
<P id=PARA2517 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2518 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Cause</U>&#8221; means &#8220;cause&#8221; as defined in any employment or other agreement or policy applicable to the Participant, or if no such agreement or policy exists, will mean (a)&nbsp;dishonesty, fraud, misrepresentation, embezzlement or deliberate injury or attempted injury, in each case related to the Company or any Subsidiary, (b)&nbsp;any unlawful or criminal activity of a serious nature, (c) any intentional and deliberate breach of a duty or duties that, individually or in the aggregate, are material in relation to the Participant&#8217;s overall duties, or (d)&nbsp;any material breach by a Participant of any employment, service, consulting, confidentiality, assignment of inventions, non-compete or non-solicitation agreement entered into with the Company or any Subsidiary.</FONT></P>
<P id=PARA2519 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2520 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Change in Control</U>&#8221; means an event described in Section&nbsp;15.1 of the Plan; provided, however, if payment under an Incentive Award that is subject to Section&nbsp;409A of the Code is triggered by a Change in Control, the term Change in Control will mean a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the assets of the Company, as such term is defined in Section&nbsp;409A of the Code.</FONT></P>
<P id=PARA2521 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2523  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2523  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2523  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center"></DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2523  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2523.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><B><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Appendix C</FONT></B></P>
<P id=PARA2524 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2525 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.6</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Code</U>&#8221; means the Internal Revenue Code of 1986, as amended.&nbsp; Any reference to a section of the Code in the Plan will be deemed to include a reference to any applicable rules&nbsp;and regulations thereunder and any successor or amended section of the Code.</FONT></P>
<P id=PARA2526 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2527 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.7</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Committee</U>&#8221; means the group of individuals administering the Plan, as provided in Section&nbsp;3 of the Plan.</FONT></P>
<P id=PARA2528 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2529 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.8</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Common Stock</U>&#8221; means the common stock of the Company, par value $0.001 per share, or the number and kind of shares of stock or other securities into which such Common Stock may be changed in accordance with Section&nbsp;4.3 of the Plan.</FONT></P>
<P id=PARA2530 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2531 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.9</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Company</U>&#8221; means Diffusion Pharmaceuticals Inc., a Nevada corporation, and any successor thereto as provided in Section 21.7 of the Plan.</FONT></P>
<P id=PARA2532 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2533 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.10</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Consultant</U>&#8221; means a person engaged to provide consulting or advisory services (other than as an Employee or a Director) to the Company or any Subsidiary that: (a)&nbsp;are not in connection with the offer and sale of the Company&#8217;s securities in a capital raising transaction and (b)&nbsp;do not directly or indirectly promote or maintain a market for the Company&#8217;s securities.</FONT></P>
<P id=PARA2534 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2535 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.11</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Director</U>&#8221; means a member of the Board.</FONT></P>
<P id=PARA2536 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2537 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.12</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Disability</U>&#8221; means the disability of the Participant such as would entitle the Participant to receive disability income benefits pursuant to the long-term disability plan of the Company or Subsidiary then covering the Participant or, if no such plan exists or is applicable to the Participant, the permanent and total disability of the Participant within the meaning of Section&nbsp;22(e)(3) of the Code; provided, however, that if distribution of an Incentive Award subject to Section&nbsp;409A of the Code is triggered by an Eligible Recipient&#8217;s Disability, such term will mean that the Eligible Recipient is disabled as defined by Section&nbsp;409A of the Code and the regulations and rulings issued thereunder.</FONT></P>
<P id=PARA2538 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2539 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.13</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Effective Date</U>&#8221; means June&nbsp;17, 2015 or such later date as the Plan is initially approved by the Company&#8217;s stockholders.</FONT></P>
<P id=PARA2540 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2541 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.14</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Eligible Recipients</U>&#8221; means (a)&nbsp;for the purposes of granting Incentive Stock Options, all Employees and (b) for the purposes of granting Non-Statutory Stock Options and other Incentive Awards, means all Employees, Directors and Consultants.</FONT></P>
<P id=PARA2542 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2543 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.15</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Employee</U>&#8221; means any individual performing services for the Company or a Subsidiary and designated as an employee of the Company or a Subsidiary on the payroll records thereof.&nbsp; An Employee will not include any individual during any period he or she is classified or treated by the Company or Subsidiary as an independent contractor, a consultant, or any employee of an employment, consulting or temporary agency or any other entity other than the Company or Subsidiary, without regard to whether such individual is subsequently determined to have been, or is subsequently retroactively reclassified as a common-law employee of the Company or Subsidiary during such period.&nbsp; An individual will not cease to be an Employee in the case of:&nbsp; (a)&nbsp;any leave of absence approved by the Company, or (b)&nbsp;transfers between locations of the Company or between the Company or any Subsidiaries.&nbsp; For purposes of Incentive Stock Options, no such leave may exceed ninety (90) days, unless reemployment upon expiration of such leave is guaranteed by statute or contract.&nbsp; If reemployment upon expiration of a leave of absence approved by the Company or a Subsidiary, as applicable, is not so guaranteed, then three (3)&nbsp;months following the ninety-first (91st) day of such leave, any Incentive Stock Option held by a Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Non-Statutory</FONT></P>
<P id=PARA2544 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2547  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2547  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2547  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">2</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2547  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2547.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA3517 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT></P>
<P id=PARA3518 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P>
<P id=PARA2549 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock Option.&nbsp; Neither service as a Director nor payment of a Director&#8217;s fee by the Company will be sufficient to constitute &#8220;employment&#8221; by the Company.</FONT></P>
<P id=PARA2550 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2551 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.16</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Exchange Act</U>&#8221; means the Securities Exchange Act of 1934, as amended.&nbsp; Any reference to a section of the Exchange Act in the Plan will be deemed to include a reference to any applicable rules&nbsp;and regulations thereunder and any successor or amended section of the Exchange Act.</FONT></P>
<P id=PARA2552 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2553 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.17</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Fair Market Value</U>&#8221; means, with respect to the Common Stock, as of any date: (a)&nbsp;the closing sale price of the Common Stock as of such date at the end of the regular trading session, as reported by The NASDAQ Stock Market, The New York Stock Exchange, NYSE MKT LLC or any national securities exchange on which the Common Stock is then listed (or, if no shares were traded on such date, as of the next preceding date on which there was such a trade); or (b)&nbsp;if the Common Stock is not so listed, admitted to unlisted trading privileges, or reported on any national securities exchange, the closing sale price as of such date at the end of the regular trading session, as reported by OTC Bulletin Board or the OTC Markets Group Inc. or other comparable service (or, if no shares were traded or quoted on such date, as of the next preceding date on which there was such a trade or quote); or (c) if the Common Stock is not so listed or reported, such price as the Committee determines in good faith, in the exercise of its reasonable discretion, and consistent with the definition of &#8220;fair market value&#8221; under Section&nbsp;409A of the Code and in conformity with generally accepted accounting principles in the United States.&nbsp; If determined by the Committee, such determination will be final, conclusive and binding for all purposes and on all persons, including the Company, the stockholders of the Company, the Participants and their respective heirs and other successors-in-interest.&nbsp; No member of the Committee will be liable for any determination regarding the fair market value of the Common Stock that is made in good faith.</FONT></P>
<P id=PARA2554 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2555 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.18</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Full Value Award</U>&#8221; means an Incentive Award other than in the form of an Option or Stock Appreciation Right, and which is settled by the issuance of shares of Common Stock.</FONT></P>
<P id=PARA2556 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2557 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.19</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Grant Date</U>&#8221; means the date an Incentive Award is granted to a Participant pursuant to the Plan and as determined pursuant to Section&nbsp;5 of the Plan.</FONT></P>
<P id=PARA2558 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2559 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.20</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Incentive Award</U>&#8221; means an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit, Performance Award, Stock Bonus or Other Stock-Based Award granted to an Eligible Recipient pursuant to the Plan.</FONT></P>
<P id=PARA2560 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2561 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.21</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Incentive Award Agreement</U>&#8221; means either:&nbsp; (a)&nbsp;a written or electronic (as provided in Section&nbsp;21.9) agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Incentive Award granted under the Plan, including any amendment or modification thereof, or (b)&nbsp;a written or electronic (as provided in Section&nbsp;21.9) statement issued by the Company to a Participant describing the terms and provisions of such an Incentive Award, including any amendment or modification thereof.&nbsp; The Committee may provide for the use of electronic, internet or other non-paper Incentive Award Agreements, and the use of electronic, internet or other non-paper means for the acceptance thereof and actions thereunder by a Participant.</FONT></P>
<P id=PARA2562 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2563 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.22</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Incentive Stock Option</U>&#8221; means a right to purchase shares of Common Stock granted to an Employee pursuant to Section 6 of the Plan that is designated as and intended to meet the requirements of an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</FONT></P>
<P id=PARA2564 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2565 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.23</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Non-Statutory Stock Option</U>&#8221; means a right to purchase shares of Common Stock granted to an Eligible Recipient pursuant to Section&nbsp;6 of the Plan that is not intended to meet the requirements of or does not qualify as an Incentive Stock Option.</FONT></P>
<P id=PARA2566 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2569  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2569  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2569  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">3</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2569  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2569.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3519 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2570 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2571 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.24</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Option</U>&#8221; means an Incentive Stock Option or a Non-Statutory Stock Option.</FONT></P>
<P id=PARA2572 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2573 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.25</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Other Stock-Based Award</U>&#8221; means an equity-based or equity-related Incentive Award not otherwise described by the terms of the Plan, granted pursuant to Section&nbsp;11 of the Plan.</FONT></P>
<P id=PARA2574 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2575 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.26</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Participant</U>&#8221; means an Eligible Recipient who receives one or more Incentive Awards under the Plan.</FONT></P>
<P id=PARA2576 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2577 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.27</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Performance Award</U>&#8221; means a right granted to an Eligible Recipient pursuant to Section&nbsp;9 of the Plan to receive an amount of cash, a number of shares of Common Stock, or a combination of both, contingent upon and the value of which at the time it is payable is determined as a function of the extent of the achievement of specified performance objectives during a specified period.&nbsp; A Performance Award is also commonly referred to as a &#8220;performance unit&#8221; or &#8220;performance share.&#8221;</FONT></P>
<P id=PARA2578 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2579 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.28</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Previously Acquired Shares</U>&#8221; means shares of Common Stock that are already owned by the Participant or, with respect to any Incentive Award, that are to be issued to the Participant upon the grant, exercise, vesting or settlement of such Incentive Award.</FONT></P>
<P id=PARA2580 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2581 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.29</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Restricted Stock Award</U>&#8221; means an award of shares of Common Stock granted to an Eligible Recipient pursuant to Section 8 of the Plan that is subject to restrictions on transferability and a risk of forfeiture.</FONT></P>
<P id=PARA2582 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2583 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.30</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Restricted Stock Unit</U>&#8221; means an award denominated in shares of Common Stock granted to an Eligible Recipient pursuant to Section&nbsp;8 of the Plan to receive an amount of cash, a number of shares of Common Stock, or a combination of both, contingent upon the achievement of specified performance objectives or that the Participant remain in the continuous employment or service with the Company for a certain period or other conditions.</FONT></P>
<P id=PARA2584 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2585 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.31</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Retirement</U>&#8221; means unless otherwise defined in the Incentive Award Agreement or in a written employment, services or other agreement between the Participant and the Company or a Subsidiary, means &#8220;Retirement&#8221; as defined from time to time for purposes of the Plan by the Committee or by the Company&#8217;s chief human resources officer or other person performing that function or, if not so defined, means voluntary termination of employment or service by the Participant on or after the date the Participant reaches age fifty-five (55) with the present intention to leave the Company&#8217;s industry or to leave the general workforce and completion of at least ten (10)&nbsp;years of continuous service with the Company or a Subsidiary.</FONT></P>
<P id=PARA2586 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2587 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.32</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Securities Act</U>&#8221; means the Securities Act of 1933, as amended.&nbsp; Any reference to a section of the Securities Act in the Plan will be deemed to include a reference to any applicable rules&nbsp;and regulations thereunder and any successor or amended section of the Securities Act.</FONT></P>
<P id=PARA2588 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2589 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.33</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Stock Appreciation Right</U>&#8221; means a right granted to an Eligible Recipient pursuant to Section&nbsp;7 of the Plan to receive a payment from the Company, in the form of shares of Common Stock, cash or a combination of both, equal to the difference between the Fair Market Value of one or more shares of Common Stock and a specified exercise price of such shares.</FONT></P>
<P id=PARA2590 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2591 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.34</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Stock Bonus</U>&#8221; means an award of shares of Common Stock granted to an Eligible Recipient pursuant to Section 10 of the Plan.</FONT></P>
<P id=PARA2592 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2593 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.35</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Subsidiary</U>&#8221; means any entity that is directly or indirectly controlled by the Company or any entity in which the Company has a significant equity interest, as determined by the Committee,</FONT> <FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">provided the Company has a &#8220;controlling interest&#8221; in the Subsidiary as defined in Treas. Reg. Sec. 1.409A-1(b)(5)(iii)(E)(1).</FONT></P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&nbsp;</P>
<DIV id=PGBK2597  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2597  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2597  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">4</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2597  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2597.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3521 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2600 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2601 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.36</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;<U>Tax Date</U>&#8221; means the date any withholding tax obligation arises under the Code for a Participant with respect to an Incentive Award.</FONT></P>
<P id=PARA2602 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2603 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Plan Administration.</U></FONT></P>
<P id=PARA2604 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2605 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>The Committee</U>.&nbsp; The Plan will be administered by the Board or by a committee of the Board.&nbsp; So long as the Company has a class of its equity securities registered under Section&nbsp;12 of the Exchange Act, any committee administering the Plan will consist solely of two or more members of the Board who are &#8220;non-employee directors&#8221; within the meaning of Rule&nbsp;16b-3 under the Exchange Act and who are &#8220;independent directors&#8221; as required by the Listing Rules&nbsp;of The NASDAQ Stock Market (or other applicable exchange or market on which the Company&#8217;s Common Stock may be traded or quoted).&nbsp; Such a committee, if established, will act by majority approval of the members (but may also take action by the written consent of all of the members of such committee), and a majority of the members of such a committee will constitute a quorum.&nbsp; As used in the Plan, &#8220;Committee&#8221; will refer to the Board or to such a committee, if established.</FONT></P>
<P id=PARA2606 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2607 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Authority of the Committee</U>.&nbsp; In accordance with and subject to the provisions of the Plan, the Committee will have the authority to determine all provisions of Incentive Awards as the Committee may deem necessary or desirable and as consistent with the terms of the Plan, including the following:&nbsp; (a)&nbsp;the Eligible Recipients to be selected as Participants; (b)&nbsp;the nature and extent of the Incentive Awards to be made to each Participant (including the number of shares of Common Stock to be subject to each Incentive Award, any exercise price, the manner in which Incentive Awards will vest or become exercisable and whether Incentive Awards will be granted in tandem with other Incentive Awards) and the form of Incentive Award Agreement; (c)&nbsp;the time or times when Incentive Awards will be granted; (d)&nbsp;the duration of each Incentive Award; and (e)&nbsp;the restrictions and other conditions to which the payment or vesting of Incentive Awards may be subject.&nbsp; In addition, the Committee will have the authority to:&nbsp; (i) interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in the Plan and any instrument or agreement relating to, or Incentive Award granted under, the Plan; (ii)&nbsp;establish, amend, suspend or waive any rules&nbsp;and regulations and appoint such agents as the Committee may deem appropriate for the proper administration of the Plan; and (iii)&nbsp;make any other determination and take any other action that the Committee may deem necessary or desirable for the administration of the Plan.&nbsp; In addition, the Committee will have the authority under the Plan in its sole discretion to pay the economic value of any Incentive Award in the form of cash, Common Stock or any combination of both.&nbsp; The Committee may exercise its duties, power and authority under the Plan in its sole discretion without the consent of any Participant or other party, unless the Plan specifically provides otherwise.&nbsp; The Committee will not be obligated to treat Participants or Eligible Recipients uniformly, and determinations made under the Plan may be made by the Committee selectively among Participants or Eligible Recipients, whether or not such Participants and Eligible Recipients are similarly situated.&nbsp; Each determination, interpretation or other action made or taken by the Committee pursuant to the provisions of the Plan will be final, conclusive and binding for all purposes and on all persons, and no member of the Committee will be liable for any action or determination made in good faith with respect to the Plan or any Incentive Award granted under the Plan.</FONT></P>
<P id=PARA3526.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3526  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3526  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3526  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">5</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3526  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3526.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3527 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2608 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&nbsp;</P>
<P id=PARA2609 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Delegation</U>.&nbsp; Except to the extent prohibited by applicable law or the applicable rules&nbsp;and regulations of any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or traded, the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and</FONT> <FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">powers to any person or persons selected by it. Any such allocation or delegation may be revoked by the Committee at any time. Without limiting the generality of the foregoing and to the extent consistent with the applicable corporate law of the Company&#8217;s jurisdiction of incorporation, the Committee may, by resolution, authorize one or more Directors or one or more officers of the Company to do one or both of the following on the same basis as can the Committee:&nbsp; (a)&nbsp;designate Eligible Recipients to be recipients of Incentive Awards pursuant to the Plan; and (b)&nbsp;determine the size of any such Incentive Awards; provided, however, that (x) the Committee will not delegate such responsibilities to any such Director(s)&nbsp;or officer(s)&nbsp;for any Incentive Awards granted to an Eligible Recipient who is subject to the reporting and liability provisions of Section&nbsp;16 under the Exchange Act; (y)&nbsp;the resolution providing such authorization will set forth the type of Incentive Awards and total number of each type of Incentive Awards such Director(s) or officer(s) may grant; and (z)&nbsp;such Director(s)&nbsp;or officer(s)&nbsp;will report periodically to the Committee regarding the nature and scope of the Incentive Awards granted pursuant to the authority delegated.</FONT></P>
<P id=PARA2616 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2617 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>No Re-Pricing</U>.&nbsp; Notwithstanding any other provision of the Plan other than Section&nbsp;4.3, the Committee may not, without prior approval of the Company&#8217;s stockholders, seek to effect any re-pricing of any previously granted, &#8220;underwater&#8221; Option or Stock Appreciation Right by:&nbsp; (a)&nbsp;amending or modifying the terms of the Option or Stock Appreciation Right to lower the exercise price; (b) canceling the underwater Option or Stock Appreciation Right in exchange for (i)&nbsp;cash; (ii)&nbsp;replacement Options or Stock Appreciation Rights having a lower exercise price; or (iii)&nbsp;other Incentive Awards; or (c)&nbsp;repurchasing the underwater Options or Stock Appreciation Rights and granting new Incentive Awards under the Plan.&nbsp; For purposes of this Section&nbsp;3.4, Options and Stock Appreciation Rights will be deemed to be &#8220;underwater&#8221; at any time when the Fair Market Value of the Common Stock is less than the exercise price of the Option or Stock Appreciation Right.</FONT></P>
<P id=PARA2618 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2619 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Participants Based Outside the United States</U>.&nbsp; In addition to the authority of the Committee under Section&nbsp;3.2 of the Plan and notwithstanding any other provision of the Plan, the Committee may, in its sole discretion, amend the terms of the Plan or Incentive Awards with respect to Participants resident outside of the United States or employed by a non-U.S. Subsidiary in order to comply with local legal requirements, to otherwise protect the Company&#8217;s or Subsidiary&#8217;s interests, or to meet objectives of the Plan, and may, where appropriate, establish one or more sub-plans (including the adoption of any required rules&nbsp;and regulations) for the purposes of qualifying for preferred tax treatment under foreign tax laws.&nbsp; The Committee will have no authority, however, to take action pursuant to this Section&nbsp;3.5 of the Plan: (a)&nbsp;to reserve shares or grant Incentive Awards in excess of the limitations provided in Section 4.1 of the Plan; (b)&nbsp;to effect any re-pricing in violation of Section&nbsp;3.4 of the Plan; (c)&nbsp;to grant Options or Stock Appreciation Rights having an exercise price less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date in violation of Section 6.3 or 7.3 of the Plan, as the case may be; or (d)&nbsp;for which stockholder approval would then be required pursuant to Section 422 of the Code or the Listing Rules&nbsp;of The NASDAQ Stock Market (or other applicable exchange or market on which the Company&#8217;s Common Stock may be traded or quoted).</FONT></P>
<P id=PARA2620 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2621 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">4.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Shares Available for Issuance</U>.</FONT></P>
<P id=PARA2622 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2623 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">4.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Maximum Number of Shares Available; Certain Restrictions on Awards</U>.&nbsp; Subject to adjustment as provided in Section 4.3 of the Plan, the maximum number of shares of Common Stock that will be available for issuance under the Plan will be the sum of:</FONT></P>
<P id=PARA2624 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2625 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2,500,000;</FONT></P>
<P id=PARA2626 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2627 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the number of shares issued or Incentive Awards granted under the Plan in connection with the settlement, assumption or substitution of outstanding awards or obligations to</FONT> <FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">grant future awards as a condition of the Company and/or any Subsidiary(ies) acquiring, merging or consolidating with another entity; and</FONT></P>
<P id=PARA3525.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3525  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3525  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3525  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">6&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3525  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3525.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3529 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2634 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2635 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(c)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the number of shares that are unallocated and available for grant under a stock plan assumed by the Company or any Subsidiary(ies) in connection with the merger, consolidation, or acquisition of another entity by the Company and/or any of its Subsidiaries, based on the applicable exchange ratio and other transaction terms, but only to the extent that such shares may be utilized by the Company or its Subsidiaries following the transaction pursuant to the rules and regulations of The NASDAQ Stock Market (or other applicable exchange or market on which the Company&#8217;s Common Stock may be traded or quoted).</FONT></P>
<P id=PARA2636 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2637 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The shares available for issuance under the Plan may, at the election of the Committee, be either treasury shares or shares authorized but unissued, and, if treasury shares are used, all references in the Plan to the issuance of shares will, for corporate law purposes, be deemed to mean the transfer of shares from treasury.</FONT></P>
<P id=PARA2638 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2639 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Notwithstanding any other provisions of the Plan to the contrary, (i)&nbsp;no more than 2,500,000 shares of Common Stock may be issued pursuant to the exercise of Incentive Stock Options granted under the Plan; and (ii)&nbsp;no more than 1,000,000 shares of Common Stock may be issued or issuable under the Plan in connection with the grant of Full Value Awards.&nbsp; All of the foregoing share limits are subject, in each case, to adjustment as provided in Section&nbsp;4.3 of the Plan.&nbsp; Incentive Stock Options issued as a result of the Company&#8217;s assumption or substitution of like awards issued by any acquired, merged or consolidated entity pursuant to applicable provisions of the Code will not count towards the limit in clause (i).</FONT></P>
<P id=PARA2640 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2641 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The maximum aggregate number of shares of Common Stock subject to Incentive Awards to any one Director who is not an Employee in any one calendar year may not exceed 275,000; provided, that such limit shall not apply to any election of a Director to receive shares of Common Stock in lieu of all or a portion of any annual Board, chair and other retainers and any meeting fees otherwise payable in cash.</FONT></P>
<P id=PARA2642 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2643 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">4.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Accounting for Incentive Awards</U>.&nbsp; Shares of Common Stock that are issued under the Plan or that are subject to outstanding Incentive Awards will be applied to reduce the maximum number of shares of Common Stock remaining available for issuance under the Plan.&nbsp; All shares so subtracted from the amount available under the Plan with respect to an Incentive Award that lapses, expires, is forfeited (including issued shares forfeited under a Restricted Stock Award) or for any reason is terminated unexercised or unvested or is settled or paid in cash or any form other than shares of Common Stock will automatically again become available for issuance under the Plan; provided, however, that the full number of shares of Common Stock subject to a Stock Appreciation Right granted that is settled by the issuance of shares of Common Stock will be counted against the shares of Common Stock authorized for issuance under the Plan, regardless of the number of shares actually issued upon settlement of such Stock Appreciation Right.&nbsp; Furthermore, any shares of Common Stock withheld to satisfy tax withholding obligations on Incentive Awards issued under the Plan, any shares of Common Stock withheld to pay the exercise price of Incentive Awards under the Plan and any shares of Common Stock not issued or delivered as a result of the &#8220;net exercise&#8221; of an outstanding Option pursuant to Section 6.5 of the Plan or settlement of a Stock Appreciation Right in shares of Common Stock pursuant to Section&nbsp;7.7 of the Plan will be counted against the shares of Common Stock authorized for issuance under the Plan and will not be available again for grant under the Plan.&nbsp; Any shares of Common Stock repurchased by the Company on the open market using the proceeds from the exercise of an Incentive Award will not increase the number of shares available for future grant of Incentive Awards.&nbsp; Any shares of Common Stock related to Incentive Awards under the Plan that terminate by expiration, forfeiture, cancellation or otherwise without the</FONT> <FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">issuance of shares of Common Stock, or are settled in cash in lieu of shares, or are exchanged with the Committee&#8217;s permission, prior to the issuance of shares, for Incentive Awards not involving shares, will be available again for grant under the Plan.&nbsp;</FONT></P>
<P id=PARA2645 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2647  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2647  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2647  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">7</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2647  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2647.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3531 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT></P>
<P id=PARA3532 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P>
<P id=PARA2651 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">4.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Adjustments to Shares and Incentive Awards</U>.</FONT></P>
<P id=PARA2652 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2653 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, divestiture or extraordinary dividend (including a spin-off) or any other similar change in the corporate structure or shares of the Company, the Committee (or, if the Company is not the surviving corporation in any such transaction, the board of directors of the surviving corporation) will make appropriate adjustment (which determination will be conclusive) as to the number and kind of securities or other property (including cash) available for issuance or payment under the Plan, including the sub-limits set forth in Section&nbsp;4.1 of the Plan and, in order to prevent dilution or enlargement of the rights of Participants, (a)&nbsp;the number and kind of securities or other property (including cash) subject to outstanding Incentive Awards, and (b)&nbsp;the exercise price of outstanding Incentive Awards.&nbsp; The determination of the Committee as to the foregoing adjustments, if any, will be final, conclusive and binding on Participants under the Plan.</FONT></P>
<P id=PARA2654 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2655 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Notwithstanding anything else in the Plan to the contrary, without affecting the number of shares of Common Stock reserved or available under the Plan, including the sub-limits in Section&nbsp;4.1 of the Plan, the Committee may authorize the issuance or assumption of benefits under the Plan in connection with any merger, consolidation, acquisition of property or stock or reorganization upon such terms and conditions as it may deem appropriate, subject to compliance with the rules under Sections 422 and 424 of the Code, as and where applicable.</FONT></P>
<P id=PARA2656 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2657 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">5.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Participation</U>.</FONT></P>
<P id=PARA2658 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2659 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Participants in the Plan will be those Eligible Recipients who, in the judgment of the Committee, have contributed, are contributing or are expected to contribute to the achievement of objectives of the Company or its Subsidiaries.&nbsp; Eligible Recipients may be granted from time to time one or more Incentive Awards, singly or in combination or in tandem with other Incentive Awards, as may be determined by the Committee in its sole discretion.&nbsp; Incentive Awards will be deemed to be granted as of the date specified in the grant resolution of the Committee, which date will be the Grant Date of any related Incentive Award Agreement with the Participant.</FONT></P>
<P id=PARA2660 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2661 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Options</U>.</FONT></P>
<P id=PARA2662 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2663 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Grant</U>.&nbsp; An Eligible Recipient may be granted one or more Options under the Plan, and such Options will be subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion.&nbsp; The Committee may designate whether an Option is to be considered an Incentive Stock Option or a Non-Statutory Stock Option.&nbsp; An Option will be an Incentive Stock Option only if the Eligible Recipient receiving the Option is an Employee.&nbsp; To the extent that any Incentive Stock Option (or portion thereof) granted under the Plan ceases for any reason to qualify as an &#8220;incentive stock option&#8221; for purposes of Section&nbsp;422 of the Code, such Incentive Stock Option (or portion thereof) will continue to be outstanding for purposes of the Plan but will thereafter be deemed to be a Non-Statutory Stock Option.&nbsp; Options may be granted to an Eligible Recipient for services provided to a Subsidiary only if, with respect to such Eligible Recipient, the underlying shares of Common Stock constitute &#8220;service recipient stock&#8221; within the meaning of Treas. Reg. Section&nbsp;1.409A-1(b)(5)(iii).</FONT></P>
<P id=PARA2664 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2667  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2667  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2667  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">8</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2667  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2667.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3533 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2668 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2669 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Incentive Award Agreement</U>.&nbsp; Each Option grant will be evidenced by an Incentive Award Agreement that will specify the exercise price of the Option, the maximum duration of the Option, the number of shares of Common Stock to which the Option pertains, the conditions upon which an Option will become vested and exercisable, and such other provisions as the Committee will determine which are not inconsistent with the terms of the Plan.&nbsp; The Incentive Award Agreement also will specify whether the Option is intended to be an Incentive Stock Option or a Non-Statutory Stock Option.</FONT></P>
<P id=PARA2670 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2671 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Exercise Price</U>.&nbsp; The per share price to be paid by a Participant upon exercise of an Option granted pursuant to this Section 6 will be determined by the Committee in its sole discretion at the time of the Option grant; provided, however, that such price will not be less than 100% of the Fair Market Value of one share of Common Stock on the date of grant (or 110% of the Fair Market Value of one share of Common Stock on the date of grant of an Incentive Stock Option if, at the time the Incentive Stock Option is granted, the Participant owns, directly or indirectly, more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary corporation of the Company).&nbsp; Notwithstanding the foregoing, to the extent that Options are granted under the Plan as a result of the Company&#8217;s assumption or substitution of options issued by any acquired, merged or consolidated entity, the exercise price for such Options will be the price determined by the Committee pursuant to the conversion terms applicable to the transaction.</FONT></P>
<P id=PARA2672 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2673 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Exercisability and Duration</U>.&nbsp; An Option will become exercisable at such times and in such installments and upon such terms and conditions as may be determined by the Committee in its sole discretion at the time of grant, including (a) the achievement of one or more specified performance objectives; and/or that (b)&nbsp;the Participant remain in the continuous employment or service with the Company or a Subsidiary for a certain period; provided, however, that no Option may be exercisable after ten (10) years from the Grant Date (five years from the Grant Date in the case of an Incentive Stock Option if, at the time the Incentive Stock Option is granted, the Participant owns, directly or indirectly, more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary corporation of the Company).&nbsp; Notwithstanding the foregoing, if the Option (other than in the case of an Incentive Stock Option) would expire at a time when trading in the shares of Common Stock is prohibited by the Company&#8217;s insider trading policy (or Company-imposed &#8220;blackout period&#8221;), then the term of the Option will be automatically extended until the thirtieth (30</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">th</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">) day following the expiration of such prohibition or if the exercise of an Option that is exercisable in accordance with its terms is otherwise prevented by the provisions of Section&nbsp;17 of the Plan, then the Option will remain exercisable until thirty (30) days after the date such exercise first would no longer be prevented by such provisions, but in any event no later than the expiration date of such Option.</FONT></P>
<P id=PARA2674 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2675 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Payment of Exercise Price</U>.</FONT></P>
<P id=PARA2676 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2677 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The total purchase price of the shares of Common Stock to be purchased upon exercise of an Option must be paid entirely in cash (including check, bank draft or money order); provided, however, that the Committee, in its sole discretion and upon terms and conditions established by the Committee, may allow such payments to be made, in whole or in part, by (i) tender of a Broker Exercise Notice; (ii)&nbsp;tender, either by actual delivery or attestation as to ownership, of Previously Acquired Shares that are acceptable to the Committee; (iii)&nbsp;a &#8220;net exercise&#8221; of the Option (as further described in paragraph (b), below);&nbsp; (iv)&nbsp;a combination of such methods; or (v)&nbsp;any other method approved or accepted by the Committee in its sole discretion.</FONT></P>
<P id=PARA2678 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2679 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In the case of a &#8220;net exercise&#8221; of an Option, the Company will not require a payment of the exercise price of the Option from the Participant but will reduce the number of shares of Common Stock issued upon the exercise by the largest number of whole shares that has a</FONT> <FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair Market Value on the exercise date that does not exceed the aggregate exercise price for the shares exercised under this method. Shares of Common Stock will no longer be outstanding under an Option (and will therefore not thereafter be exercisable) following the exercise of such Option to the extent of (i)&nbsp;shares used to pay the exercise price of an Option under the &#8220;net exercise,&#8221; (ii)&nbsp;shares actually delivered to the Participant as a result of such exercise and (iii)&nbsp;any shares withheld for purposes of tax withholding pursuant to Section&nbsp;14.1 of the Plan.&nbsp;</FONT></P>
<P id=PARA2681 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2683  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2683  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2683  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">9</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2683  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2683.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3535 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2686 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2687 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(c)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For purposes of such payment, Previously Acquired Shares tendered or covered by an attestation will be valued at their Fair Market Value on the exercise date of the Option.</FONT></P>
<P id=PARA2688 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2689 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.6</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Manner of Exercise</U>.&nbsp; An Option may be exercised by a Participant in whole or in part from time to time, subject to the conditions contained in the Plan and in the Incentive Award Agreement evidencing such Option, by delivery in person, by facsimile or electronic transmission or through the mail of written notice of exercise to the Company at its principal executive office in Buffalo Grove,&nbsp;Illinois (or to the Company&#8217;s designee as may be established from time to time by the Company and communicated to Participants)&nbsp; and by paying in full the total exercise price for the shares of Common Stock to be purchased in accordance with Section 6.5 of the Plan.</FONT></P>
<P id=PARA2690 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2691 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Stock Appreciation Rights</U>.</FONT></P>
<P id=PARA2692 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2693 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Grant</U>.&nbsp; An Eligible Recipient may be granted one or more Stock Appreciation Rights under the Plan, and such Stock Appreciation Rights will be subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion.&nbsp; The Committee will have the sole discretion to determine the form in which payment of the economic value of Stock Appreciation Rights will be made to a Participant (i.e., cash, shares of Common Stock or any combination thereof) or to consent to or disapprove the election by a Participant of the form of such payment.&nbsp; Stock Appreciation Rights may be granted to an Eligible Recipient for services provided to a Subsidiary only if, with respect to such Eligible Recipient, the underlying shares of Common Stock constitute &#8220;service recipient stock&#8221; within the meaning of Treas. Reg. Section&nbsp;1.409A-1(b)(5)(iii).</FONT></P>
<P id=PARA2694 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2695 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Incentive Award Agreement</U>.&nbsp; Each Stock Appreciation Right will be evidenced by an Incentive Award Agreement that will specify the exercise price of the Stock Appreciation Right, the term of the Stock Appreciation Right, and such other provisions as the Committee will determine which are not inconsistent with the terms of the Plan.</FONT></P>
<P id=PARA2696 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2697 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Exercise Price</U>.&nbsp; The exercise price of a Stock Appreciation Right will be determined by the Committee, in its sole discretion, at the Grant Date; provided, however, that such price may not be less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date.&nbsp; Notwithstanding the foregoing, to the extent that Stock Appreciation Rights are granted under the Plan as a result of the Company&#8217;s assumption or substitution of stock appreciation rights issued by any acquired, merged or consolidated entity, the exercise price for such Stock Appreciation Rights will be the price determined by the Committee pursuant to the conversion terms applicable to the transaction.</FONT></P>
<P id=PARA2698 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2699 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Exercisability and Duration</U>.&nbsp; A Stock Appreciation Right will become exercisable at such times and in such installments as may be determined by the Committee in its sole discretion at the time of grant; provided, however, that no Stock Appreciation Right may be exercisable after ten (10)&nbsp;years from its Grant Date. Notwithstanding the foregoing, if the Stock Appreciation Right would expire at a time when trading in the shares of Common Stock is prohibited by the Company&#8217;s insider trading policy (or Company-imposed &#8220;blackout period&#8221;), then the term of the Stock Appreciation Right will be automatically extended until the thirtieth (30th) day following the expiration of such prohibition or if the exercise of a </FONT>Stock Appreciation Right that is exercisable in accordance with its terms is otherwise prevented by the provisions of Section 17 of the Plan, the Stock Appreciation Right will remain exercisable until thirty (30) days after the date such exercise first would no longer be prevented by such provisions, but in any event no later than the expiration date of such Stock Appreciation Right.</P>
<P id=PARA2700 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2703  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2703  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2703  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">10</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2703  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2703.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3537 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2706 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2707 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Manner of Exercise</U>.&nbsp; A Stock Appreciation Right will be exercised by giving notice in the same manner as for Options, as set forth in Section&nbsp;6.6 of the Plan, subject to any other terms and conditions consistent with the other provisions of the Plan as may be determined by the Committee in its sole discretion.</FONT></P>
<P id=PARA2708 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2709 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.6</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Settlement</U>.&nbsp; Upon the exercise of a Stock Appreciation Right, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying:</FONT></P>
<P id=PARA2710 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2711 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The excess of the Fair Market Value of a share of Common Stock on the date of exercise over the per share exercise price; by</FONT></P>
<P id=PARA2712 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2713 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The number of shares of Common Stock with respect to which the Stock Appreciation Right is exercised.</FONT></P>
<P id=PARA2714 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2715 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.7</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Form&nbsp;of Payment</U>.&nbsp; Payment, if any, with respect to a Stock Appreciation Right settled in accordance with Section 7.6 of the Plan will be made in accordance with the terms of the applicable Incentive Award Agreement, in cash, shares of Common Stock or a combination thereof, as the Committee determines in its sole discretion.</FONT></P>
<P id=PARA2716 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2717 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Restricted Stock Awards and Restricted Stock Units.</U></FONT></P>
<P id=PARA2718 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2719 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Grant</U>.&nbsp; An Eligible Recipient may be granted one or more Restricted Stock Awards or Restricted Stock Units under the Plan, and such awards will be subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion.&nbsp; Restricted Stock Units will be similar to Restricted Stock Awards except that no shares of Common Stock are actually awarded to the Participant on the Grant Date of the Restricted Stock Units.&nbsp; Restricted Stock Units will be denominated in shares of Common Stock but paid in cash, shares of Common Stock or a combination of cash and shares of Common Stock as the Committee, in its sole discretion, will determine, and as provided in the Incentive Award Agreement.</FONT></P>
<P id=PARA2720 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2721 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Incentive Award Agreement</U>. Each Restricted Stock Award or Restricted Stock Unit will be evidenced by an Incentive Award Agreement that will specify the type of Incentive Award, the period(s)&nbsp;of restriction, the number of shares of restricted Common Stock, or the number of Restricted Stock Units granted, and such other provisions as the Committee will determine which are not inconsistent with the terms of the Plan.</FONT></P>
<P id=PARA2722 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2723 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Vesting Requirements and Restrictions</U>.&nbsp; The Committee will impose such restrictions or conditions, not inconsistent with the provisions of the Plan, to the vesting of such Restricted Stock Awards or Restricted Stock Units as it deems appropriate, including (a)&nbsp;the achievement of one or more specified performance objectives; or that (b)&nbsp;the Participant remain in the continuous employment or service with the Company or a Subsidiary for a certain period.&nbsp; If any vesting requirements of a Restricted Stock Award or Restricted Stock Unit are not satisfied, the Restricted Stock Award or Restricted Stock Unit will be forfeited and the shares of Common Stock subject to the Restricted Stock Award will be returned to the Company and no shares of Common Stock or other consideration will be issued with respect to the forfeited Restricted Stock Unit.&nbsp; If the Participant paid any purchase price with respect to such forfeited </FONT>shares, unless otherwise provided by the Committee in the Incentive Award Agreement evidencing the Restricted Stock Award, the Company will refund to the Participant the lesser of (x)&nbsp;such purchase price and (y)&nbsp;the Fair Market Value of such shares on the date of forfeiture.&nbsp; Notwithstanding the foregoing, Restricted Stock Awards may in the sole discretion of the Committee be granted without any restrictions or conditions.</P>
<P id=PARA2724 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2727  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2727  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2727  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">11</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2727  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2727.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3539 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2730 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2731 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Rights as a Shareholder</U>.&nbsp; Except as provided in Sections 8.1, 8.5 and 8.6 of the Plan, upon a Participant becoming the holder of record of shares of Common Stock issued under a Restricted Stock Award pursuant to this Section&nbsp;8, the Participant will have all voting, dividend, liquidation and other rights with respect to such shares (other than the right to sell or transfer such shares) as if such Participant were a holder of record of shares of unrestricted Common Stock.&nbsp; A Participant will have no voting, dividend, liquidation and other rights with respect to any shares of Common Stock underlying any Restricted Stock Units granted hereunder unless and until the shares of Common Stock are issued under the terms thereof and the Participant becomes the holder of record of such shares.</FONT></P>
<P id=PARA2732 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2733 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Dividends and Distributions</U>.</FONT></P>
<P id=PARA2734 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2735 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unless the Committee determines otherwise in its sole discretion (either in the Incentive Award Agreement evidencing the Restricted Stock Award at the time of grant or at any time after the grant of the Restricted Stock Award), any dividends or distributions paid with respect to shares of Common Stock subject to the unvested portion of a Restricted Stock Award will be subject to the same restrictions as the shares to which such dividends or distributions relate.&nbsp; The Committee will determine in its sole discretion whether any interest will be paid on such dividends or distributions.</FONT></P>
<P id=PARA2736 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2737 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unless the Committee determines otherwise in its sole discretion (either in the Incentive Award Agreement evidencing the Restricted Stock Unit at the time of grant or at any time after the grant of the Restricted Sock Unit), any Restricted Stock Unit shall carry with it a right to &#8220;dividend equivalents&#8221; (as defined in Section&nbsp;12 of the Plan).</FONT></P>
<P id=PARA2738 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2739 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.6</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Enforcement of Restrictions</U>.&nbsp; To enforce the restrictions referred to in this Section&nbsp;8, the Committee may place a legend on the stock certificates or book-entry notation representing Restricted Stock Awards referring to such restrictions and may require the Participant, until the restrictions have lapsed, to keep any stock certificates, together with duly endorsed stock powers, in the custody of the Company or its transfer agent, or to maintain evidence of stock ownership, together with duly endorsed stock powers, in a certificateless book-entry stock account with the Company&#8217;s transfer agent.&nbsp; Alternatively, Restricted Stock Awards may be held in non-certificated form pursuant to such terms and conditions as the Company may establish with its registrar and transfer agent or any third-party administrator designated by the Company to hold Restricted Stock Awards on behalf of Participants.</FONT></P>
<P id=PARA2740 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2741 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.7</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Lapse of Restrictions; Settlement</U>. Except as otherwise provided in this Section&nbsp;8, shares of Common Stock underlying a Restricted Stock Award will become freely transferable by the Participant after all conditions and restrictions applicable to such shares have been satisfied or lapse (including satisfaction of any applicable tax withholding obligations).&nbsp; Upon the vesting of a Restricted Stock Unit, the Restricted Stock Unit will be settled, subject to the terms and conditions of the applicable Incentive Award Agreement, (a)&nbsp;in cash, based upon the Fair Market Value of the vested underlying shares of Common Stock, (b)&nbsp;in shares of Common Stock or (c)&nbsp;a combination thereof, as provided in the Incentive Award Agreement, except to the extent that a Participant has properly elected to defer income that may be attributable to a Restricted Stock Unit under a Company deferred compensation plan or arrangement.</FONT></P>
<P id=PARA2742 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2745  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2745  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2745  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">12</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2745  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2745.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3541 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2746 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2747 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8.8</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Section&nbsp;83(b)&nbsp;Election for Restricted Stock Award</U>.&nbsp; If a Participant makes an election pursuant to Section 83(b) of the Code with respect to a Restricted Stock Award, the Participant must file, within thirty (30) days following the Grant Date of the Restricted Stock Award, a copy of such election with the Company and with the Internal Revenue Service, in accordance with the regulations under Section&nbsp;83 of the Code.&nbsp; The Committee may provide in the Incentive Award Agreement that the Restricted Stock Award is conditioned upon the Participant&#8217;s making or refraining from making an election with respect to the award under Section 83(b) of the Code.</FONT></P>
<P id=PARA2748 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2749 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">9.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Performance Awards</U>.</FONT></P>
<P id=PARA2750 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2751 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">9.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Grant</U>.&nbsp; An Eligible Recipient may be granted one or more Performance Awards under the Plan, and such awards will be subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion, including the achievement of one or more specified performance objectives.</FONT></P>
<P id=PARA2752 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2753 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">9.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Incentive Award Agreement</U>. Each Performance Award will be evidenced by an Incentive Award Agreement that will specify the amount of cash, shares of Common Stock or combination of both to be received by the Participant upon payout of the Performance Award, any performance objectives upon which the Performance Award is subject, any performance period during which any such performance objectives must be achieved and such other provisions as the Committee will determine which are not inconsistent with the terms of the Plan.</FONT></P>
<P id=PARA2754 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2755 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">9.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Vesting</U>.&nbsp; The Committee may impose such restrictions or conditions, not inconsistent with the provisions of the Plan, to the vesting of such Performance Awards as it deems appropriate, including the achievement of one or more specified performance objectives.</FONT></P>
<P id=PARA2756 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2757 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">9.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Form&nbsp;and Timing of Performance Award Payment</U>.&nbsp; Subject to the terms of the Plan, after the applicable performance period has ended, the holder of Performance Awards will be entitled to receive payment on the value and number of Performance Awards earned by the Participant over the performance period, to be determined as a function of the extent to which the corresponding performance objectives have been achieved. Payment of earned Performance Awards will be as determined by the Committee and as evidenced in the Incentive Award Agreement.&nbsp; Subject to the terms of the Plan, the Committee, in its sole discretion, may pay earned Performance Awards in the form of cash or in shares of Common Stock (or in a combination thereof) equal to the value of the earned Performance Awards at the close of the applicable performance period. Payment of any Performance Award will be made as soon as practicable after the Committee has determined the extent to which the applicable performance objectives have been achieved and not later than the March&nbsp;15th immediately following the end of the performance period, or earlier than the January 1st preceding such March&nbsp;15, except to the extent that a Participant has properly elected to defer payment that may be attributable to a Performance Award under a Company deferred compensation plan or arrangement.&nbsp; The determination of the Committee with respect to the form of payment of Performance Awards will be set forth in the Incentive Award Agreement pertaining to the grant of the award.&nbsp; Any shares of Common Stock issued in payment of earned Performance Awards may be granted subject to any restrictions deemed appropriate by the Committee, including that the Participant remain in the continuous employment or service with the Company or a Subsidiary for a certain period.</FONT></P>
<P id=PARA2758 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2759 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">10.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Stock Bonuses</U>.</FONT></P>
<P id=PARA2760 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2761 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">An Eligible Recipient may be granted one or more Stock Bonuses under the Plan, and such Stock Bonuses will be subject to such terms and conditions, if any, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion, including the achievement of one or more specified performance objectives.</FONT></P>
<P id=PARA2762 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2765  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2765  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2765  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">13</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2765  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2765.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3543 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2768 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2769 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">11.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Other Stock-Based Awards</U>.</FONT></P>
<P id=PARA2770 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2771 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">11.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Other Stock-Based Awards</U>.&nbsp; Subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion, the Committee may grant Other Stock-Based Awards not otherwise described by the terms of the Plan (including the grant or offer for sale of unrestricted shares of Common Stock) in such amounts and subject to such terms and conditions as the Committee will determine.&nbsp; Such Incentive Awards may involve the transfer of actual shares of Common Stock to Participants or payment in cash or otherwise of amounts based on the value of shares of Common Stock, and may include Incentive Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.</FONT></P>
<P id=PARA2772 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2773 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">11.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Value of Other Stock-Based Awards</U>.&nbsp; Each Other Stock-Based Award will be expressed in terms of shares of Common Stock or units based on shares of Common Stock, as determined by the Committee.&nbsp; The Committee may establish performance objectives in its sole discretion for any Other Stock-Based Award.&nbsp; If the Committee exercises its discretion to establish performance objectives for any such Incentive Awards, the number or value of Other Stock-Based Awards that will be paid out to the Participant will depend on the extent to which the specified performance objectives are met.</FONT></P>
<P id=PARA2774 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2775 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">11.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Payment of Other Stock-Based Awards</U>.&nbsp; Payment, if any, with respect to an Other Stock-Based Award will be made in accordance with the terms of the Incentive Award and in cash or shares of Common Stock, as the Committee determines, except to the extent that a Participant has properly elected to defer payment that may be attributable to an Other Stock-Based Award under a Company deferred compensation plan or arrangement.</FONT></P>
<P id=PARA2776 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2777 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">12.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Dividend Equivalents</U>.</FONT></P>
<P id=PARA2778 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2779 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Any Participant selected by the Committee may be granted dividend equivalents based on the dividends declared on shares of Common Stock that are subject to any Incentive Award, to be credited as of dividend payment dates, during the period between the Grant Date of the Incentive Award and the date the Incentive Award is exercised, vests, is settled or expires, as determined by the Committee.&nbsp; Such dividend equivalents will be converted to cash or additional shares of Common Stock by such formula and at such time and subject to such limitations as may be determined by the Committee.&nbsp; Notwithstanding the foregoing, the Committee may not grant dividend equivalents based on the dividends declared on shares of Common Stock that are subject to an Option or Stock Appreciation Right and further, no dividend or dividend equivalents will be paid out with respect to any unvested Incentive Awards, the vesting of which is based on the achievement of performance objectives.</FONT></P>
<P id=PARA2780 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2781 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">13.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Effect of Termination of Employment or Other Service</U>.</FONT></P>
<P id=PARA2782 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2783 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">13.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Termination Due to Death, Disability or Retirement</U>.&nbsp; Unless otherwise expressly provided by the Committee in its sole discretion in an Incentive Award Agreement, and subject to Sections 13.3, 13.4, 13.5 and 13.6 of the Plan, in the event a Participant&#8217;s employment or other service with the Company and all Subsidiaries is terminated by reason of death, Disability or Retirement:</FONT></P>
<P id=PARA2784 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2785 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All outstanding Options and Stock Appreciation Rights then held by the Participant will, to the extent exercisable as of such termination, remain exercisable in full for a period of one year after such termination (but in no event after the expiration date of any such </FONT>Option or Stock Appreciation Right).&nbsp; Options and Stock Appreciation Rights not exercisable as of such termination will be forfeited and terminate.</P>
<P id=PARA2786 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2789  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2789  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2789  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">14</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2789  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2789.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3545 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2792 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2793 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All Restricted Stock Awards then held by the Participant that have not vested as of such termination will be terminated and forfeited; and</FONT></P>
<P id=PARA2794 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2795 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(c)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All outstanding but unpaid Restricted Stock Units, Performance Awards, Stock Bonuses and Other Stock-Based Awards then held by the Participant will be terminated and forfeited; provided, however, that with respect to any such Incentive Awards the vesting of which is based on the achievement of specified performance objectives, if a Participant&#8217;s employment or other service with the Company or any Subsidiary, as the case may be, is terminated by reason of death or Disability prior to the end of the performance period of such Incentive Award, but after the conclusion of a portion of the performance period (but in no event less than one year), the Committee may, in its sole discretion, cause shares of Common Stock to be delivered or payment made with respect to the Participant&#8217;s Incentive Award, but only if otherwise earned for the entire performance period and only with respect to the portion of the applicable performance period completed at the date of such event, with proration based on full fiscal years only and no shares to be delivered for partial fiscal years.&nbsp; The Committee will consider the provisions of Sections 13.6 and 13.7 of the Plan and will have the discretion to consider any other fact or circumstance in making its decision as to whether to deliver such shares of Common Stock or other payment, including whether the Participant again becomes employed.</FONT></P>
<P id=PARA2796 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2797 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">13.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Termination for Reasons Other than Death, Disability or Retirement</U>.&nbsp; Unless otherwise expressly provided by the Committee in its sole discretion in an Incentive Award Agreement, and subject to Sections 13.3, 13.4, 13.5 and 13.6 of the Plan, in the event a Participant&#8217;s employment or other service with the Company and all Subsidiaries is terminated for any reason other than death, Disability or Retirement, or a Participant is in the employment or service with a Subsidiary and the Subsidiary ceases to be a Subsidiary of the Company (unless the Participant continues in the employment or service with the Company or another Subsidiary):</FONT></P>
<P id=PARA2798 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2799 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All outstanding Options and Stock Appreciation Rights then held by the Participant will, to the extent exercisable as of such termination, remain exercisable in full for a period of three months after such termination (but in no event after the expiration date of any such Option or Stock Appreciation Right).&nbsp; Options and Stock Appreciation Rights not exercisable as of such termination will be forfeited and terminate;</FONT></P>
<P id=PARA2800 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2801 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All Restricted Stock Awards then held by the Participant that have not vested as of such termination will be terminated and forfeited; and</FONT></P>
<P id=PARA2802 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2803 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(c)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">All outstanding but unpaid Restricted Stock Unit, Performance Awards, Stock Bonuses and Other Stock-Based Awards then held by the Participant will be terminated and forfeited.</FONT></P>
<P id=PARA2804 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2805 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">13.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Modification of Rights Upon Termination</U>.&nbsp; Notwithstanding the other provisions of this Section&nbsp;13, upon a Participant&#8217;s termination of employment or other service with the Company and all Subsidiaries, the Committee may, in its sole discretion (which may be exercised at any time on or after the Grant Date, including following such termination), except as provided below, cause Options or Stock Appreciation Rights (or any part thereof) then held by such Participant to terminate, become or continue to become exercisable and/or remain exercisable following such termination of employment or service, and Restricted Stock Awards, Restricted Stock Units, Performance Awards, Stock Bonuses or Other Stock-</FONT>Based Awards then held by such Participant to terminate, vest, settle or become free of restrictions and conditions to payment, as the case may be, following such termination of employment or service, in each case in the manner determined by the Committee; provided, however, that no Option or Stock Appreciation Right may remain exercisable beyond its expiration date and any such action adversely affecting any outstanding Incentive Award will not be effective without the consent of the affected Participant (subject to the right of the Committee to take whatever action it deems appropriate under Sections 4.3, 13.5, 13.6 and 15 of the Plan).</P>
<P id=PARA2806 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2809  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2809  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2809  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">15</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2809  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2809.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3547 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2812 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2813 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">13.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Determination of Termination of Employment or Other Service</U>.</FONT></P>
<P id=PARA2814 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2815 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The change in a Participant&#8217;s status from that of an Employee to that of a Consultant will, for purposes of the Plan, be deemed to result in a termination of such Participant&#8217;s employment with the Company and its Subsidiaries, unless the Committee otherwise determines in its sole discretion.</FONT></P>
<P id=PARA2816 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2817 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The change in a Participant&#8217;s status from that of a Consultant to that of an Employee will not, for purposes of the Plan, be deemed to result in a termination of such Participant&#8217;s service as a Consultant, and such Participant will thereafter be deemed to be an Employee, in which event such Participant will be governed by the provisions of the Plan relating to termination of employment or service (subject to paragraph (a)&nbsp;above).</FONT></P>
<P id=PARA2818 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2819 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(c)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unless the Committee otherwise determines in its sole discretion, a Participant&#8217;s employment or other service will, for purposes of the Plan, be deemed to have terminated on the date recorded on the personnel or other records of the Company or the Subsidiary for which the Participant provides employment or other service, as determined by the Committee in its sole discretion based upon such records.</FONT></P>
<P id=PARA2820 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2821 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(d)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Notwithstanding the foregoing, if payment of an Incentive Award that is subject to Section&nbsp;409A of the Code is triggered by a termination of a Participant&#8217;s employment or other service, such termination must also constitute a &#8220;separation from service&#8221; within the meaning of Section&nbsp;409A of the Code, and any change in employment status that constitutes a &#8220;separation from service&#8221; under Section&nbsp;409A of the Code will be treated as a termination of employment or service, as the case may be.</FONT></P>
<P id=PARA2822 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2823 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">13.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Effect of Actions Constituting Cause or Adverse Action</U>.&nbsp; Notwithstanding anything in the Plan to the contrary and in addition to the other rights of the Committee under this Section&nbsp;13, if a Participant is determined by the Committee, acting in its sole discretion, to have taken any action that would constitute Cause or an Adverse Action during or after the termination of employment or other service with the Company or a Subsidiary, irrespective of whether such action or the Committee&#8217;s determination occurs before or after termination of such Participant&#8217;s employment or other service with the Company or any Subsidiary and irrespective of whether or not the Participant was terminated as a result of such Cause or Adverse Action, (a)&nbsp;all rights of the Participant under the Plan and any Incentive Award Agreements evidencing an Incentive Award then held by the Participant will terminate and be forfeited without notice of any kind, and (b)&nbsp;the Committee in its sole discretion will have the authority to rescind the exercise, vesting, settlement or issuance of, or payment in respect of, any Incentive Awards of the Participant that were exercised, vested, settled or issued, or as to which such payment was made, and to require the Participant to pay to the Company, within ten (10) days of receipt from the Company of notice of such rescission, any amount received or the amount of any gain realized as a result of such rescinded exercise, vesting, settlement, issuance or payment (including any dividends paid or other distributions made with respect to any shares of Common Stock subject to any Incentive Award).&nbsp; The Company may </FONT>defer the exercise of any Option or Stock Appreciation Right for a period of up to six (6)&nbsp;months after receipt of the Participant&#8217;s written notice of exercise or the issuance of share certificates upon the vesting of any Incentive Award for a period of up to six (6) months after the date of such vesting in order for the Committee to make any determination as to the existence of Cause or an Adverse Action.&nbsp; The Company will be entitled to withhold and deduct from future wages of the Participant (or from other amounts that may be due and owing to the Participant from the Company or a Subsidiary) or make other arrangements for the collection of all amounts necessary to satisfy such payment obligations.&nbsp; Unless otherwise provided by the Committee in an applicable Incentive Award Agreement, this Section&nbsp;13.5 will not apply to any Participant following a Change in Control.</P>
<P id=PARA2824 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2827  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2827  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2827  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">16</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2827  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2827.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3549 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2830 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2831 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">13.6</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Clawback/Forfeiture of Incentive Awards</U>.&nbsp; If the Company is required to prepare an accounting restatement due to the material noncompliance of the Company, as a result of misconduct, with any financial reporting requirement under the securities laws, then any Participant who is one of the individuals subject to automatic forfeiture under Section&nbsp;304 of the Sarbanes-Oxley Act of 2002 will reimburse the Company for the amount of any Incentive Award received by such individual under the Plan during the 12-month period following the first public issuance or filing with the Securities and Exchange Commission, as the case may be, of the financial document embodying such financial reporting requirement.&nbsp; All Incentive Awards under the Plan will be subject to forfeiture or other penalties pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act or any other clawback, forfeiture or recoupment provision required by applicable law or under the requirements of any stock exchange or market upon which the Common Stock is then listed or traded.&nbsp; In addition, all Incentive Awards under the Plan will be subject to any compensation &#8220;clawback,&#8221; forfeiture or recoupment policy that the Committee may adopt from time to time that is applicable by its terms to the Participant and such forfeiture and/or penalty conditions or provisions as determined by the Committee and set forth in the applicable Incentive Award Agreement.</FONT></P>
<P id=PARA2832 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2833 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">14.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Payment of Withholding Taxes.</U></FONT></P>
<P id=PARA2834 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2835 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">14.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>General Rules</U>.&nbsp; The Company is entitled to (a)&nbsp;withhold and deduct from future wages of the Participant (or from other amounts that may be due and owing to the Participant from the Company or a Subsidiary), or make other arrangements for the collection of, an amount the Company reasonably determines to be the minimum statutory amount necessary to satisfy any and all federal, foreign, state and local withholding and employment-related tax requirements attributable to an Incentive Award, including, the grant, exercise, vesting or settlement of, or payment of dividends with respect to, an Incentive Award or a disqualifying disposition of stock received upon exercise of an Incentive Stock Option; (b)&nbsp;withhold cash paid or payable or shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with an Incentive Award; or (c) require the Participant promptly to remit the amount of such withholding to the Company before taking any action, including issuing any shares of Common Stock or paying any cash amounts, with respect to an Incentive Award.&nbsp; Shares of Common Stock issued or otherwise issuable to the Participant in connection with an Incentive Award that gives rise to the tax withholding obligation that are withheld for purposes of satisfying the Participant&#8217;s withholding or employment-related tax obligation, will be valued at their Fair Market Value on the Tax Date.&nbsp; When withholding for taxes is effected under the Plan, it will be withheld only up to the minimum required tax withholding rates or such other rate that will not trigger a negative accounting impact on the Company.</FONT></P>
<P id=PARA2836 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2837 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">14.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Special Rules</U>.&nbsp; The Committee may, in its sole discretion and upon terms and conditions established by the Committee, permit or require a Participant to satisfy, in whole or in part, any withholding or employment-related tax obligation described in Section&nbsp;14.1 of the Plan by withholding shares of Common Stock underlying an Incentive Award, by electing to tender, or by attestation as to </FONT>ownership of, Previously Acquired Shares, by delivery of a Broker Exercise Notice or a combination of such methods.&nbsp; For purposes of satisfying a Participant&#8217;s withholding or employment-related tax obligation, shares of Common Stock withheld by the Company or Previously Acquired Shares tendered or covered by an attestation will be valued at their Fair Market Value on the Tax Date.</P>
<P id=PARA2838 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2841  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2841  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2841  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">17</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2841  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2841.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3551 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2845 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">15.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Change in Control.</U></FONT></P>
<P id=PARA2846 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2847 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">15.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A &#8220;<U>Change in Control</U>&#8221; will mean the occurrence of any one or more of the following: (i)&nbsp;the accumulation (if over time, in any consecutive twelve (12) month period), whether directly, indirectly, beneficially or of record, by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3)&nbsp;or 14(d)(2)&nbsp;of the Exchange Act) of 50.1% or more of the shares of the outstanding Common Stock of the Company, whether by merger, consolidation, sale or other transfer of shares of Common Stock (other than a merger or consolidation where the stockholders of the Company prior to the merger or consolidation are the holders of a majority of the voting securities of the entity that survives such merger or consolidation), (ii)&nbsp;a sale of all or substantially all of the assets of the Company or (iii) during any period of twelve (12) consecutive months, the individuals who, at the beginning of such period, constitute the Board, and any new director whose election by the Board or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the 12-month period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board; provided, however, that the following acquisitions shall not constitute a Change in Control for the purposes of this Plan: (A) any acquisitions of Common Stock or securities convertible, exercisable or exchangeable into Common Stock directly from the Company or (B)&nbsp;any acquisition of Common Stock or securities convertible, exercisable or exchangeable into Common Stock by any employee benefit plan (or related trust) sponsored by or maintained by the Company.&nbsp; Notwithstanding the foregoing, a Change in Control will only occur if such event constitutes a &#8220;Change in Control Event&#8221; as defined under Treasury Regulations issued under Code Section 409A.</FONT></P>
<P id=PARA2848 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2849 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">15.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Acceleration of Vesting</U>.&nbsp; Without limiting the authority of the Committee under Sections 3.2 and 4.3 of the Plan, if a Change in Control of the Company occurs, then, unless otherwise provided by the Committee in its sole discretion either in the Incentive Award Agreement at the time of grant or at any time after the grant of an Incentive Award:</FONT></P>
<P id=PARA2850 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2851 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">all Options and Stock Appreciation Rights will become immediately exercisable in full and will remain exercisable in accordance with their terms;</FONT></P>
<P id=PARA2852 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2853 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">all restrictions and vesting requirements applicable to any Incentive Award based solely on the continued service of the Participant will terminate; and</FONT></P>
<P id=PARA2854 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2855 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(c)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">all Incentive Awards the vesting or payment of which are based on specified performance objectives will vest as though such performance objectives were fully achieved at target and will become immediately payable; provided, however, that no Incentive Award that provides for a deferral of compensation within the meaning of Section 409A of the Code will be cashed out upon the occurrence of a Change in Control unless the event or circumstances constituting the Change in Control also constitute a &#8220;change in the ownership&#8221; of the Company, a &#8220;change in the effective control&#8221; of the Company or a &#8220;change in the ownership of a substantial portion of the assets&#8221; of the Company, in each case as determined under Section 409A of the Code.</FONT></P>
<P id=PARA2856 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2859  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2859  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2859  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">18</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2859  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2859.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3553 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2860 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2861 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The treatment of any other Incentive Awards in the event of a Change in Control will be as determined by the Committee in connection with the grant thereof, as reflected in the applicable Incentive Award Agreement.</FONT></P>
<P id=PARA2862 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2863 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">15.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Alternative Treatment of Incentive Awards</U>.&nbsp; In connection with a Change in Control, the Committee in its sole discretion, either in an Incentive Award Agreement at the time of grant of an Incentive Award or at any time after the grant of such an Incentive Award, may determine that any or all outstanding Incentive Awards granted under the Plan, whether or not exercisable or vested, as the case may be, will be canceled and terminated and that in connection with such cancellation and termination the holder of such Incentive Award will receive for each share of Common Stock subject to such Incentive Award a cash payment (or the delivery of shares of stock, other securities or a combination of cash, stock and securities with a fair market value (as determined by the Committee in good faith) equivalent to such cash payment) equal to the difference, if any, between the consideration received by stockholders of the Company in respect of a share of Common Stock in connection with such Change in Control and the purchase price per share, if any, under the Incentive Award, multiplied by the number of shares of Common Stock subject to such Incentive Award (or in which such Incentive Award is denominated); provided that if such product is zero ($0) or less or to the extent that the Incentive Award is not then exercisable, the Incentive Award may be canceled and terminated without payment therefor; provided, however, that no Incentive Award that provides for a deferral of compensation within the meaning of Section&nbsp;409A of the Code will be cashed out upon the occurrence of a Change in Control unless payment was specified in the Incentive Award Agreement at the time of grant and the event or circumstances constituting the Change in Control also constitute a &#8220;change in the ownership&#8221; of the Company, a &#8220;change in the effective control&#8221; of the Company or a &#8220;change in the ownership of a substantial portion of the assets&#8221; of the Company, in each case as determined under Section&nbsp;409A of the Code. &nbsp;If any portion of the consideration pursuant to a Change in Control may be received by holders of shares of Common Stock on a contingent or delayed basis, the Committee may, in its sole discretion, determine the fair market value per share of such consideration as of the time of the Change in Control on the basis of the Committee&#8217;s good faith estimate of the present value of the probable future payment of such consideration.&nbsp; Notwithstanding the foregoing, any shares of Common Stock issued pursuant to an Incentive Award that immediately prior to the effectiveness of the Change in Control are subject to no further restrictions pursuant to the Plan or an Incentive Award Agreement (other than pursuant to the securities laws) will be deemed to be outstanding shares of Common Stock and receive the same consideration as other outstanding shares of Common Stock in connection with the Change in Control</FONT></P>
<P id=PARA2864 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2865 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">15.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Limitation on Change in Control Payments</U>.&nbsp; Notwithstanding anything in Section&nbsp;15.2 or 15.3 of the Plan to the contrary, if, with respect to a Participant, the acceleration of the vesting of an Incentive Award as provided in Section&nbsp;15.2 of the Plan or the payment of cash in exchange for all or part of an Incentive Award as provided in Section&nbsp;15.3 of the Plan (which acceleration or payment could be deemed a &#8220;payment&#8221; within the meaning of Section&nbsp;280G(b)(2)&nbsp;of the Code), together with any other &#8220;payments&#8221; that such Participant has the right to receive from the Company or any corporation that is a member of an &#8220;affiliated group&#8221; (as defined in Section 1504(a) of the Code without regard to Section&nbsp;1504(b)&nbsp;of the Code) of which the Company is a member, would constitute a &#8220;parachute payment&#8221; (as defined in Section&nbsp;280G(b)(2)&nbsp;of the Code), then the &#8220;payments&#8221; to such Participant pursuant to Section 15.2 or 15.3 of the Plan will be reduced (or acceleration of vesting eliminated) to the largest amount as will result in no portion of such &#8220;payments&#8221; being subject to the excise tax imposed by Section&nbsp;4999 of the Code; provided, that such reduction will be made only if the aggregate amount of the payments after such reduction exceeds the difference between (a)&nbsp;the amount of such payments absent such reduction minus (b)&nbsp;the aggregate amount of the excise tax imposed under Section&nbsp;4999 of the Code attributable to any such excess parachute payments; and provided further that such payments will be reduced (or acceleration of vesting eliminated) in the following order:&nbsp; (i)&nbsp;options with an exercise price above fair market value that </FONT>have a positive value for purposes of Section&nbsp;280G of the Code, (ii)&nbsp;pro rata among Incentive Awards that constitute deferred compensation under Section&nbsp;409A of the Code, and (iii)&nbsp;finally, among the Incentive Awards that are not subject to Section 409A of the Code.&nbsp; Notwithstanding the foregoing sentence, if a Participant is subject to a separate agreement with the Company or an Affiliate or Subsidiary that expressly addresses the potential application of Section&nbsp;280G or 4999 of the Code, then this Section&nbsp;15.4 will not apply and any &#8220;payments&#8221; to a Participant pursuant to Section&nbsp;15.2 or 15.3 of the Plan will be treated as &#8220;payments&#8221; arising under such separate agreement.</P>
<P id=PARA2866 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT></P>
<DIV id=PGBK2869  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2869  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2869  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">19</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2869  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2869.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3555 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2872 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2873 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">16.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Rights of Eligible Recipients and Participants; Transferability.</U></FONT></P>
<P id=PARA2874 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2875 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">16.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Employment or Service</U>.&nbsp; Nothing in the Plan or an Incentive Award Agreement will interfere with or limit in any way the right of the Company or any Subsidiary to terminate the employment or service of any Eligible Recipient or Participant at any time, nor confer upon any Eligible Recipient or Participant any right to continue in the employment or other service with the Company or any Subsidiary.</FONT></P>
<P id=PARA2876 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2877 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">16.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>No Rights to Awards</U>. No Participant or Eligible Individual will have any claim to be granted any Incentive Award under the Plan.</FONT></P>
<P id=PARA2878 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2879 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">16.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Rights as a Stockholder</U>.&nbsp; As a holder of Incentive Awards (other than Restricted Stock Awards), a Participant will have no rights as a stockholder unless and until such Incentive Awards are exercised for, settled or paid in the form of, shares of Common Stock and the Participant becomes the holder of record of such shares.</FONT></P>
<P id=PARA2880 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2881 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">16.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Restrictions on Transfer</U>.</FONT></P>
<P id=PARA2882 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2883 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Except pursuant to testamentary will or the laws of descent and distribution or as otherwise expressly permitted by subsections (b)&nbsp;and (c)&nbsp;below, no right or interest of any Participant in an Incentive Award prior to the exercise (in the case of Options or Stock Appreciation Rights) or vesting, settlement or issuance (in the case of other Incentive Awards) of such Incentive Award will be assignable or transferable, or subjected to any lien, during the lifetime of the Participant, either voluntarily or involuntarily, directly or indirectly, by operation of law or otherwise.</FONT></P>
<P id=PARA2884 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2885 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(b)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A Participant will be entitled to designate a beneficiary to receive an Incentive Award upon such Participant&#8217;s death, and in the event of such Participant&#8217;s death, payment of any amounts due under the Plan will be made to, and exercise of any Options or Stock Appreciation Rights (to the extent permitted pursuant to Section&nbsp;13 of the Plan) may be made by, such beneficiary.&nbsp; If a deceased Participant has failed to designate a beneficiary, or if a beneficiary designated by the Participant fails to survive the Participant, payment of any amounts due under the Plan will be made to, and exercise of any Options or Stock Appreciation Rights (to the extent permitted pursuant to Section&nbsp;13 of the Plan) may be made by, the Participant&#8217;s legal representatives, heirs and legatees.&nbsp; If a deceased Participant has designated a beneficiary and such beneficiary survives the Participant but dies before complete payment of all amounts due under the Plan or exercise of all exercisable Options or Stock Appreciation Rights, then such payments will be made to, and the exercise of such Options or Stock Appreciation Rights may be made by, the legal representatives, heirs and legatees of the beneficiary.</FONT></P>
<P id=PARA2886 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2887 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(c)</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Upon a Participant&#8217;s request, the Committee may, in its sole discretion, permit a transfer of all or a portion of a Non-Statutory Stock Option, other than for value, to such Participant&#8217;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, </FONT>sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, any person sharing such Participant&#8217;s household (other than a tenant or employee), a trust in which any of the foregoing have more than fifty percent of the beneficial interests, a foundation in which any of the foregoing (or the Participant) control the management of assets, and any other entity in which these persons (or the Participant) own more than 50% of the voting interests.&nbsp; Any permitted transferee will remain subject to all the terms and conditions applicable to the Participant prior to the transfer.&nbsp; A permitted transfer may be conditioned upon such requirements as the Committee may, in its sole discretion, determine, including, execution and/or delivery of appropriate acknowledgements, opinion of counsel, or other documents by the transferee.</P>
<P id=PARA2888 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2891  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2891  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2891  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">20</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2891  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2891.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3557 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA2894 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2895 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">16.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Non-Exclusivity of the Plan</U>.&nbsp; Nothing contained in the Plan is intended to modify or rescind any previously approved compensation plans or programs of the Company or create any limitations on the power or authority of the Board to adopt such additional or other compensation arrangements as the Board may deem necessary or desirable.</FONT></P>
<P id=PARA2896 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2897 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">17.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Securities Law and Other Restrictions.</U></FONT></P>
<P id=PARA2898 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2899 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Notwithstanding any other provision of the Plan or any Incentive Award Agreement entered into pursuant to the Plan, the obligation of the Company to issue any shares of Common Stock under the Plan or settle Incentive Awards in shares of Common Stock or other consideration will be subject to all applicable law, rules&nbsp;and regulations, and to such approvals by governmental agencies as may be required. Notwithstanding the generality of the foregoing and notwithstanding any other provision of the Plan or any Incentive Award Agreement entered into pursuant to the Plan, the Company will not be required to issue any shares of Common Stock under the Plan, and a Participant may not sell, assign, transfer or otherwise dispose of shares of Common Stock issued pursuant to Incentive Awards granted under the Plan, unless (a)&nbsp;there is in effect with respect to such shares a registration statement under the Securities Act and any applicable securities laws of a state or foreign jurisdiction or an exemption from such registration under the Securities Act and applicable state or foreign securities laws, and (b)&nbsp;there has been obtained any other consent, approval or permit from any other U.S. or foreign regulatory body which the Committee, in its sole discretion, deems necessary or advisable.&nbsp; The Company will be under no obligation to register for sale under the Securities Act any of the shares of Common Stock to be offered or sold under the Plan. The Company may condition such issuance, sale or transfer upon the receipt of any representations or agreements from the parties involved, and the placement of any legends on certificates representing shares of Common Stock, as may be deemed necessary or advisable by the Company in order to comply with such securities law or other restrictions.</FONT></P>
<P id=PARA2900 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2901 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">18.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Deferred Compensation; Compliance with Section&nbsp;409A</U>.</FONT></P>
<P id=PARA2902 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2903 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">It is intended that all Incentive Awards issued under the Plan be administered in a manner that will comply with the requirements of Section&nbsp;409A of the Code, or the requirements of an exception to Section&nbsp;409A of the Code and the Incentive Award Agreements and the Plan will be construed and administered in a manner that is consistent with and give effect to such intent.&nbsp; The Committee is authorized to adopt rules&nbsp;or regulations deemed necessary or appropriate to qualify for an exception from or to comply with the requirements of Section&nbsp;409A of the Code (including any transition or grandfather rules&nbsp;relating thereto).&nbsp; Notwithstanding anything in this Section&nbsp;18 or Section&nbsp;19 to the contrary, with respect to any Incentive Award subject to Section&nbsp;409A of the Code, no amendment to or payment under such Incentive Award will be made except and only to the extent permitted under Section 409A of the Code.&nbsp; If any amount is payable with respect to an Incentive Award that is subject to Section&nbsp;409A of the Code as a result of the Participant&#8217;s &#8220;separation from service&#8221; at such time the Participant is a &#8220;specified employee&#8221; within the meaning of Section&nbsp;409A of the Code, then no payment will be made, except as permitted under Section&nbsp;409A of the Code, prior to the first business day after the earlier of (i)&nbsp;the date that is six months after the Participant&#8217;s separation from service or (ii) the Participant&#8217;s death.</FONT></P>
<P id=PARA2904 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2907  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2907  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2907  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">21</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2907  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2907.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3559 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2911 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">19.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Amendment, Modification and Termination.</U></FONT></P>
<P id=PARA2912 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2913 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">19.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Generally</U>.&nbsp; Subject to other subsections of this Section&nbsp;19 and Section&nbsp;3.4 of the Plan, the Board at any time may suspend or terminate the Plan (or any portion thereof) or terminate any outstanding Incentive Award and the Committee, at any time and from time to time, may amend the Plan or amend or modify the terms of an outstanding Incentive Award and Incentive Award Agreement.&nbsp; The Committee&#8217;s power and authority to amend or modify the terms of an outstanding Incentive Award and Incentive Award Agreement includes the authority to modify the number of shares of Common Stock or other terms and conditions of an Incentive Award, extend the term of an Incentive Award, accelerate the exercisability or vesting or otherwise terminate any restrictions relating to an Incentive Award, accept the surrender of any outstanding Incentive Award or, to the extent not previously exercised, settled or vested, authorize the grant of new Incentive Awards in substitution for surrendered Incentive Awards; provided, however that the amended or modified terms are permitted by the Plan as then in effect and that any Participant adversely affected by such amended or modified terms has consented to such amendment or modification.</FONT></P>
<P id=PARA2914 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2915 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">19.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Adjustment of Performance-Based Awards</U>.&nbsp; The Committee may amend or modify the vesting criteria (including any performance objectives or performance periods) of any outstanding Incentive Awards based in whole or in part on the financial performance of the Company (or any Subsidiary or division, business unit or other sub-unit thereof) in recognition of unusual or nonrecurring events (including the events described in Section&nbsp;4.3(a)&nbsp;of the Plan) affecting the Company or the financial statements of the Company or of changes in applicable law, regulations or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent unintended dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan.&nbsp; The determination of the Committee as to the foregoing adjustments, if any, will be final, conclusive and binding on Participants under the Plan.</FONT></P>
<P id=PARA2916 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2917 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">19.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Stockholder Approval</U>.&nbsp; No amendments to the Plan will be effective without approval of the Company&#8217;s stockholders if: (a)&nbsp;stockholder approval of the amendment is then required pursuant to Section&nbsp;422 of the Code, the rules of the primary stock exchange or stock market on which the Common Stock is then traded, applicable U.S. state corporate laws or regulations, applicable U.S. federal laws or regulations, and the applicable laws of any foreign country or jurisdiction where Incentive Awards are, or will be, granted under the Plan; or (b)&nbsp;such amendment would: (i)&nbsp;modify Section&nbsp;3.4 of the Plan; (ii) materially increase benefits accruing to Participants; (iii)&nbsp;increase the aggregate number of shares of Common Stock issued or issuable under the Plan; (iv) increase any limitation set forth in the Plan on the number of shares of Common Stock which may be issued or the aggregate value of Incentive Awards which may be made, in respect of any type of Incentive Award; (v)&nbsp;modify the eligibility requirements for Participants in the Plan; or (vi)&nbsp;reduce the minimum exercise price as set forth in Sections 6.3 and 7.3 of the Plan.</FONT></P>
<P id=PARA2918 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2919 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">19.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Incentive Awards Previously Granted</U>.&nbsp; Notwithstanding any other provision of the Plan to the contrary, no termination, suspension or amendment of the Plan may adversely affect any outstanding Incentive Award without the consent of the affected Participant; provided, however, that this sentence will not impair the right of the Committee to take whatever action it deems appropriate under Sections 3.2, 4.3, 13, 15, 18 or 19.5 of the Plan.</FONT></P>
<P id=PARA2920 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2923  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2923  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2923  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">22</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2923  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2923.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3561 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2924 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2925 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">19.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Amendments to Conform to Law</U>.&nbsp; Notwithstanding any other provision of the Plan to the contrary, the Committee may amend the Plan or an Incentive Award Agreement, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of conforming the Plan or an Incentive Award Agreement to any present or future law relating to plans of this or similar nature, and to the administrative regulations and rulings promulgated thereunder.&nbsp; By accepting an Incentive Award under the Plan, a Participant agrees to any amendment made pursuant to this Section&nbsp;19.5 to any Incentive Award granted under the Plan without further consideration or action.</FONT></P>
<P id=PARA2926 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2927 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">20.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Effective Date and Duration of the Plan.</U></FONT></P>
<P id=PARA2928 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2929 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Plan will be effective as of the Effective Date and will terminate at midnight on the day before the tenth (10th) anniversary of the Effective Date, and may be terminated prior to such time by Board action.&nbsp; No Incentive Award will be granted after termination of the Plan but Incentive Awards outstanding upon termination of the Plan will remain outstanding in accordance with their applicable terms and conditions and the terms and conditions of the Plan.</FONT></P>
<P id=PARA2930 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2931 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Miscellaneous.</U></FONT></P>
<P id=PARA2932 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2933 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.1</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Usage</U>.&nbsp; In the Plan, except where otherwise indicated by clear contrary intention, (a)&nbsp;any masculine term used in the Plan also will include the feminine, (b)&nbsp;the plural will include the singular, and the singular will include the plural, (c) &#8220;including&#8221; (and with correlative meaning &#8220;include&#8221;) means including without limiting the generality of any description preceding such term, and (d) &#8220;or&#8221; is used in the inclusive sense of &#8220;and/or&#8221;.</FONT></P>
<P id=PARA2934 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2935 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.2</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Unfunded Plan</U>.&nbsp; Participants will have no right, title or interest whatsoever in or to any investments that the Company or its Subsidiaries may make to aid it in meeting its obligations under the Plan.&nbsp; Nothing contained in the Plan, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative, or any other individual.&nbsp; To the extent that any individual acquires a right to receive payments from the Company or any Subsidiary under the Plan, such right will be no greater than the right of an unsecured general creditor of the Company or the Subsidiary, as the case may be.&nbsp; All payments to be made hereunder will be paid from the general funds of the Company or the Subsidiary, as the case may be, and no special or separate fund will be established and no segregation of assets will be made to assure payment of such amounts except as expressly set forth in the Plan.</FONT></P>
<P id=PARA2936 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2937 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.3</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Relationship to Other Benefits</U>. No payment under the Plan will be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare, or benefit plan of the Company or any Subsidiary unless provided otherwise in such plan.</FONT></P>
<P id=PARA2938 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2939 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.4</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Fractional Shares</U>.&nbsp; No fractional shares of Common Stock will be issued or delivered under the Plan or any Incentive Award. The Committee will determine whether cash, other Incentive Awards or other property will be issued or paid in lieu of fractional shares of Common Stock or whether such fractional shares of Common Stock or any rights thereto will be forfeited or otherwise eliminated by rounding up or down.</FONT></P>
<P id=PARA2940 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2941 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.5</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>No Representations or Warranties Regarding Tax Effect</U>.&nbsp; Notwithstanding any provision of the Plan to the contrary, the Company, its Subsidiaries, the Board and the Committee neither represent nor warrant the tax treatment under any federal, state, provincial, local, foreign or other laws of any Incentive Award granted or amounts paid to any Participant under this Plan, including when and to what extent such Incentive Award or amounts may be subject to tax, penalties and interest.</FONT></P>
<P id=PARA2942 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<DIV id=PGBK2945  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR2945  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM2945  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">23</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR2945  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA2945.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA3563 style="TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Appendix C</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2946 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA2947 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.6</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Governing Law; Venue</U>.&nbsp; Except to the extent expressly provided in the Plan or in connection with other matters of corporate governance and authority (all of which will be governed by the laws of the Company&#8217;s jurisdiction of incorporation), the validity, construction, interpretation, administration and effect of the Plan and any rules, regulations and actions relating to the Plan will be governed by and construed exclusively in accordance with the laws of the State of Illinois, notwithstanding the conflicts of laws principles of any jurisdictions.&nbsp; Unless otherwise provided in an Incentive Award Agreement, recipients of an Incentive Award under the Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts of the State of Illinois to resolve any and all issues that may arise out of or relate to the Plan or any related Incentive Award Agreement.</FONT></P>
<P id=PARA2948 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2949 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.7</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Successors</U>.&nbsp; All obligations of the Company under the Plan with respect to Incentive Awards granted hereunder will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation or otherwise, of all or substantially all of the business or assets of the Company.</FONT></P>
<P id=PARA2950 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2951 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.8</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Construction</U>.&nbsp; Wherever possible, each provision of the Plan and any Incentive Award Agreement evidencing an Incentive Award granted under the Plan will be interpreted so that it is valid under the applicable law.&nbsp; If any provision of the Plan or any Incentive Award Agreement evidencing an Incentive Award granted under the Plan is to any extent invalid under the applicable law, that provision will still be effective to the extent it remains valid.&nbsp; The remainder of the Plan and the Incentive Award Agreement also will continue to be valid, and the entire Plan and Incentive Award Agreement will continue to be valid in other jurisdictions.</FONT></P>
<P id=PARA2952 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA2953 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">21.9</FONT><FONT style="FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Delivery and Execution of Electronic Documents</U>.&nbsp; To the extent permitted by applicable law, the Company may:&nbsp; (a) deliver by email or other electronic means (including posting on a Web site maintained by the Company or by a third party under contract with the Company) all documents relating to the Plan or any Incentive Award hereunder (including prospectuses required by the Securities and Exchange Commission) and all other documents that the Company is required to deliver to its security holders (including annual reports and proxy statements), and (b)&nbsp;permit Participants to use electronic, internet or other non-paper means to execute applicable Plan documents (including Incentive Award Agreements) and take other actions under the Plan in a manner prescribed by the Committee.</FONT></P>
<P id=PARA2954 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<DIV id=PGBK3566  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3566  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3566  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">24&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3566  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3566.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 100%; TEXT-ALIGN: center"><IMG src="proxypage1.jpg"></TD></TR></TABLE>
<P id=PARA3567.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK3567  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR3567  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM3567  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR3567  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA3567.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 100%; TEXT-ALIGN: center"><IMG src="proxypage2.jpg" width=850 height=1100></TD></TR></TABLE>
<P style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;</P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxypage2.jpg
<TEXT>
begin 644 proxypage2.jpg
M_]C_X  02D9)1@ ! @$ R #(  #_[0C<4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  R     $  0#(     0 !.$))300-       $    >#A"24T#\P
M    "           .$))300*       !   X0DE-)Q        H  0
M   ".$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M       ! #(    ! %H    &       ! #4    ! "T    &       !.$))
M30/X      !P  #_____________________________ ^@     ________
M_____________________P/H     /____________________________\#
MZ     #_____________________________ ^@  #A"24T$"       $
M  $   )    "0      X0DE-!!0       0    !.$))300,      =+
M 0   %<   !P   !"   <X    <O !@  ?_8_^  $$I&248  0(! $@ 2
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-
M#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,_\  $0@ < !7 P$B  (1 0,1 ?_=  0 !O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B$P4R@9$4
MH;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B
M\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>W
MQ__:  P# 0 "$0,1 #\ ].=D.%CF!@(:0)+HY =X?RE6IJ:ZL.=2 YQ<XRR3
MJYSOI;45W\];_6'_ %+%8J_FF?U1^1)35]&O_1#_ +;_ /,$O1K_ -$/^V__
M #!74DE-+T:_]$/^V_\ S!'QFAK' -V#<2!&W_HZ(R22E))))*4DDDDI2222
M2G__T/2G?SUO]8?]2Q6*OYIG]4?D5=W\];_6'_4L5BK^:9_5'Y$E,TDDDE*2
M2224I))))2DDDDE*22224__1]-=59ZKW 2'$$:^36_\ ?4:L%K&M/( !4DDE
M*22224I))))2DDDDE*22224I))))3__2]+OR[:KO3;2YX@$/ >1_5]E=B&<[
M(#2X8Q/@T>I)^^A!>;LC-RF U,;0YC&S4'N.Y@M)<]SV_OI_0O/-M7_; _\
M2B2DWVZ[<0:"(,2!89^$4)ZLS(L>6BC;I,N+VC3S?0U"JQK7.+397$2-M+1_
MWYR+]@=^^S_MIB.GBIGZV9VI9YS9Y_\ %I_5R_\ 0L_[<_\ 4:R\ZV_&N=6S
M[/:&L#W;@&N$[O=8W:[V?2^CO_PG_7*YZAE-<068S0.3I.@<XN^CL_P?[Z"G
M<;=E[H=2P-GD628_J^FU/ZN3'\TR?#?_ .8+-Z>;,ISFN-%9#0X-8UKB1);N
M^CMV>U73@./+V'_K3$E)C9D1(K;/AO\ _,$XLNW %C0TDR0^2!V,;4#["_\
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M_]7T;I_]/ZGI_AZ__;?'5]4:678^9F6>BY[,BQEC',+=8KKI=NWO9[OT2/\
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M #$  &%C<W!-4T94     $E%0R!S4D="                  #VU@ !
M -,M2% @(
M            $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P
M%&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)865H   )
M    %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG9I97<
M  /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P    #')4
M4D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P
M>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C
M         !)S4D="($E%0S8Q.38V+3(N,0              $G-21T(@245#
M-C$Y-C8M,BXQ
M                  !865H@        \U$  0    $6S%A96B
M            6%E:(        &^B   X]0   Y!865H@        8ID  +>%
M   8VEA96B         DH   #X0  +;/9&5S8P         6245#(&AT=' Z
M+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M
M &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L
M="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M  !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@
M245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N
M9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(
M    3 E6 %    !7'^=M96%S          $                        "
MCP    )S:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@ C
M "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )
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M2_[<_VW____N "%!9&]B90!D0     $# ! # @,&                _]L
MA  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0$! 0$" @$" @,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P@ 1
M" 1, U(# 1$  A$! Q$!_\0!&P !  (" @,! 0            @)!@<%"@$#
M! (+ 0$  @(# 0               00#!@(%!P@0  $# @,' P,# P0" P$
M  <&" D !0$#!" 1 A49.1I@. H0,QA 4#$P%!8A,A,7P!)P@* C$0  !@(
M @0%#P0-!P8)!1$" P0%!@<!"  )$1(3%!76.'B8("$QTY34-1:6MA>7M]<Y
M8")WN!!0\$%1<;(C<Y4V&)E 89&Q,R38,(&A,K09T9(T)=4G5WD*P4,F2(AP
M@*#Q0E)B4Z-D154W1V<H6!(  0,"! ('!04&!P       1$"! ,% "$2!C$4
M0:'1(C+4!U%A$Q468,!2))00P2-4=#;PL4(TA"4F_]H # ,! 0(1 Q$   #O
M\     CT4>DR0                  ".IV"
M        ".Q <GR                   0;+;
M          ".Q <GR                   0;+;
M            ".Q <GR                   0;+;
M              ".Q <GR                   0;+;
M            "+Q" S$  \GX,/)\@                  $&RVP
M                    KM,A-T  'L*X#(R?(                  !!LML
M                            *[3(3=( !["N C(39
M    (Q'8"                            *[3(3=( ![",Y82>
M            #V'(                            %=ID)ND  ]A&@L;
M                                               !7:9";I  /81H
M+&P                                                5VF0FZ0 #
MV$:"QL                                                %=ID)N
MD  ]A&@L;                                                !7:
M9";I  /81H+&P
M 5VF0FZ0 #V$:"QL
M    %=ID)ND  ]A&@L;
M       !7:9";I  /81H+&P
M           5VF0FZ0 #V$:"QL
M              %=ID)ND  ]A&@L;
M                 !7:9";I  /81H+&P
M                     5VF0FZ0 #V$:"QL
M                        %=ID)ND  ]A&@L;
M                           !7:9";I  /81H+&P
M                               5VF0FZ0 #V$:"QL
M                                  %=ID)ND  ]A&@L;
M                                     !7:9";I  /81H+&P
M                                         5VF0FZ0 #V$:"QL
M                                            %=ID)ND  ]A&@L;
M                                               !7:9";I  /81H
M+&P                                                5VF0FZ0 #
MV$:"QL                                                %=ID)N
MD  ]A&@L;                                                !7:
M9";I  /81H+&P
M 5VF0FZ0 #V$:"QL
M    %=ID)ND  ]A&@L;
M       !7:9";I  /81H+&P
M           5VF0FZ0 #V$:"QL
M              %=ID)ND  ]A&@L;
M                 !7:9";I  /81H+&P
M                     5VF0FZ0 #V$:"QL
M                        %=ID)ND  ]A&@L;
M                           !7:9";I  /81H+&P
M                               5VF0FZ0 #V$:"QL
M                                  %=ID)ND  ]A&@L;
M                                     !7:9";I  /81H+&P
M                                         5VG)FZ0 #V$="QT
M                                            &+D+SR  "69L0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M)4F?$:B*P-CFS2%Q8"3T*S2U0H&-REXY3@<:>HV(:2+$"HHVL:])@F)%MAO
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M*%HOR;W43O9:.8UYW?KF2\#Y-V
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M21-.'$&^R-I:&;0
M
M    !HTC@                                                #,R
M9P  !_.4+V0         94;K            !X/(  / /(!X/(
M        *?3LL%DX  .A&=MT         $6BZ,\@       ZTA%\W*;$-4G
M$TRJLL1(7'+G%$[2-1*HB<3M*R2Y T^0/+)RY<                  %/H+
M@@  =%H[CH         (6%K1Y       !6F;B-F$33U&/$ICTF"GH/A,3./,
M<-Q&5&HCD#"21QCAJ(M*/V                  4^@N"  !T6CN.@
M   A86M'D        CJ=.@E<>DT.2=(=G.&PS."6Q'PBN;',N-=&1FAB91=L
M6.                   %/H+@@  =%H[CH         (6%K1Y       !$0
MQ(V\0^+%"LLVN;7,-/!$LEH<":.)9G"'(&<&(FLSDC?IN@R(
M      I]!<$  #HM'<=         !"PM:/(      !^#K%&NRQ4U 6CE)A)
MR\B(2C-5F[B'ABQ*XB:9>?.;#+12H@Y4NY)-@                 %/H+@@
M  =%H[CH         (6%K1Y       !X/(!X/)X/)X/( /!Y
M          !3Z"X(  '1:.XZ         "%A:T>0     #Y3]GO !ZSV ]1Y
M/(!^SUGL/G/H!^#]GRGZ/H/!Y                  *?07!   Z+1W'0
M      0L+6CR      =><I9+M2"IB)NXYDD:17-1F5$73U$]#9Y"LRXAH6MD
M#"0IG)J,B06!&@#81LL[3(                !3Z"X(  '1:.XZ
M "%A:T>0      #P809P84<J9    :R-F@                       I]!
M<$  #^?Z=L@         'VEEH
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MDT0823J(2DB2*9MHB490;;/V<F<V<Z>3@C<YHLSPP0XPD(1H/R2#-.&VS C
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MT"35(X$M35!*(C2<V9P1P/J,E/T8P:F)"'Q&?%M8  /!Y     !X/(
M       *?07!   Z/IW@@ #ARHTY4X4W>8$;L-'GY/2<@1\)6&L"39'<R(Y<
M^0^XT8;4(Y$IS:YK(Q,Q8V8:@-E&3$B2(!Z#GS'3##]&<GJ(V$J#CC%BS$VH
M                       4^@N"  !T?3O!
M                         I]!<$  #H^G>"
M                          !3Z"X(  '1].\$
M                            "GT%P0  .CZ=X(
M                              %/H+@@  ='T[P0
M                                *?07!   Z/IW@@
M                                  4^@N"  !T?3O!
M                                    I]!<$  #H^G>"
M                                     !3Z"X(  '1].\$
M                                       "GT%P0  .CZ=X(
M                                         %/H+@@  ='T[P0
M                                           *?07!   Z/IW@@
M                                             4^@N"  !T?3O!
M                                               I]!<$  #H^G>"
M                                                !3Z"X(  '1].
M\$                                                "GT%P0  .C
MZ=X(                                                %/H+@@ <
M":K.G>=X(                                                %/H
M+@@ :C*\CKS'>"
M  !3Z"X( &.$)#J]G>"
M       !3Z"X( &'D&SK('>#
M            !3Z"X( &.%:)USCO!
M                  I]!<$ #7Q $ZWAW@@
M                       4^@N"  /!T?CO!
M                          I]!<$ ##2)AU8CO!
M                               I]!<$ #'""AUC3O
M                                    I]!<$ #5Y4&4DG>"
M                                        !3Z"X( &M2OTZY)W@@
M                                              4^@N" !KDJA*(3
MO!                                                 I]!<$ #79
M5P4#G>#                                                !3Z"X
M( &I"L H6.\&
M"GT%P0 ,#**2H\[P0
M     *?07!  Q(BP=5$[P0                 /!Y/!Y!X/(/!Y    !X/(
M/!Y/!Y/ /(                *?07!   Z/IW@@              #JTGO.
M((0&[R0!M4@$2H-TD4S."1Y7N7SG6I)-EI17H>#$C@"/9V.2I@LC(5&A3.",
MQ*X^8LK*1SGC6QVP21H              *?07!   Z/IW@@
M "KL^,]I[3#S<YI$Y,R _1^#$2;) PL(*Z3;!)(CH42EZIZC5!/TB02U,!,5
M,(,!) FM"8)7V<J<F69F;@              I]!<$  #H^G>"
M                                     !3Z"X(  '0^.]B
M                                       "ADD&6Y@  HW*7
M                                          2!.V@<T
M
M
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M?Z75Y)VW\PO<78! 6I2F/Q3Q!>#6V%T8?>6=CTE6O.%)04:YJWS$$>LPA/<
M72YKP6V2Y:04)M^3T+O)FR%])Z);M.*39R%RXB$2RZ L]J[@"X(6-\#H7_M7
ML47#A;JN)$'O)VW)LRN.=B]ALUFB4<VO5FT%ACA"^CGYY3I'BV!WJ(D%/RR2
MMS<EJ F2R Y=?%($MB=:9B">!\H")?8T[$[9R+;1?,2:RBUYKZH69+=]>)N
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M$TO2OCD-D[+FF%69QNQ>PDVB<'6I%-(M[J46[9.M2*::J_5'NU42@F2%:>4
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M]75@B^KJP1?5U8(OJZL$7U=6"+ZNK!%]75@B^KJP1?5U8(OJ'DBS"# M,/\
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M<Y:4ZSIH:E;P45;$@2E Z-5QF.*NMD;DVZ]AYQ5FB?/6<$TK&8N[ ^YV#:'
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M.^WZ+=3R=W9!7]S+JU"""6AIY@^1T+A)RN> I!R<@-FE-*R<86) 0H26*T$
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M9X/G17E;1,M465NO$8S4%1;T3&*$1HL2*W5*%]N?'$VV2YV(X@(:.)$8DCK
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M+RPC*6S!Q]SU+VF<:,7*ARX3L T14@H5619$!T"QWLRD?8*TT'B,\MK0OO2
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M4_79O@%[-^U\>WOQ^HI^NS? +V;]KX]O?C]13]=F^ 7LW[7Q[>_'ZBGZ[-\
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M24L*&2+.# Y#^P>N6GIDB)*F4*U:U8H+2HT:9*#M3U*M2;T%)TI)6!",-'G
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MU=4CA%P<MWF\7(V$6U:M%.EK1^T]68)\9ZGG[;KA542/2Z8F1-_-6-C0RK9
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M!L[3<=58^.*N.UK5.Q^K%%46 AD4QIF&Y(877U<+I:%O,1Y[\:H'D_M<FF%
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M:VZGD4GRE[9M1 36-456YA7GQ"^7Z9LL6)8Y?'7:'L$$>)62:ID921L*<W4
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M_P"/]D5>6[&0R^'F.;<\G- WB1LF1N328,YN4]_BSTPNP<IC!YSU.W[(>,]
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MHI2\5VTN22-NYYN<C)2J<A--)QV@<9#QY"7-U_PSME_%?B*;2K*%VZ?H[+O
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M .QH?"&Q>[P;J$J@IQX6@!D"W R/]H 6,>0ES=>C^'_NSME^C^/^R_L<6=L
MT45MK!V.K,RO+I7-N:W6+6=XRH$1B:&7*LUS4,E;TTPG>7I(O"D:NXD"PXN0
M#$A.1'%B#QY"7-U_PSME_%?A-5L>U;W_ *I<5+(\/H9=L9IA<M%UH42RE%&G
M-ZJ?3IE;V%.\+L'="1,(?:*!!S@./6XFD 6Z8\T24KH1*Y#$EDCK[E[[ S>#
M/RF..RMG4/$/F##'U3-*8NXG(Q&H'%*8-,M3" <5G(!XSPPQTO27FMM!\@>V
MMC(<I%RXMCF1B;S75:2B X/3PMC($;4SH1'=JJ4FBP @@(AB_-#GB+1R2Z\[
MH7.?+&A:\I'35O5>T]B&!G(0K<(!HI2\5VTN22-NYYN<C)2J<A--)QV@<9#Q
MY"7-U_PSME_%?B*;2K*%VZ?H[+O &4M10_6JQY/LHS?&!2L2D?&FAFUN,G4=
M\&B1"&MRH(QW4H8!#Z,#QQY"7-U_PSME_%?BUY$P:\;HU634;,WOCFU[$:K6
MG1K]-"'!'(5N$%5M$Y:F]78CTD+CA@#TC=@PTHY2E+%T"4E=/D)<W7_#.V7\
M5^(K43-J?S%JR<Y;X9PDFE\:-WC3M6- F9B<G\W$FL28,2*/,'?B&L:=)VY@
M>\K32B =)AH,9E51/.I_,6LUSB7@;"N:4/HW>-Q58[B>6)M?RL1FQ(>Q+8\_
M]Q(= )U?8&"[LM*-('T&%#Q@!?\ <4YN0.N,(.L9RT-E@ #ULXQUACS%^@(,
M=/KY_>QQ #)-0^WMT?2&"1&(0ZMZR6;L,.-8C>&+)X9T"O&MRS#QNGA\'@_"
MSJ96Y3J>SZ>P,Z/(2YNO^&=LOXK\2#;$&O6Z+?&X\]X83J<=]5K2;]G7-1F0
ML\<"O8=?SFO$]>6;*AZ I[T21DON))ZC_9DCSCR$N;K_ (9VR_BOQ*8Y&M>=
MT*8/B;0B>5;IM)JO:>N[ \$+EN4 $46>+$:6U))'<@W&!G)4V1&E$Y[06,!X
M?HZ9I+S6W<^/O;HQGN4=Y<6QSVQ.!K4M.1#<&5X11D:-U9UPB>U2J2A9 >0(
M(P_FBQQ":L:M/>9A!G&<O9+&DEUMZ$7Q6=:Q\XXLTP+A,IY)V%&Q1=F#V60C
M5*3 E %G&,^SCA35L@U;W_M=Q3,C.^YEVNFF%S7G6IQ#T4::2WII[!65>Q*'
MA"$GH5I@C[1,(6,"QTYX\A+FZ_X9VR_BOQ3MR/6OVY<\:;I0-;DSPJF]6K2M
M2UH.0[1Q%)22+<KB*M*R1UHX)2%P4BA.Y%EF$N !IA8[0 L8\A+FZ]'\/_=G
M;+]'\?\ 9?V.+.V :**VU@['5F97ETKFW-;K%K.\94"(Q-#+E6:YJ&2MZ:83
MO+TD7A2-7<2!8<7(!B0G(CBQ!X\A+FZ_X9VR_BOP[5[&M:]Y:>7L\46R\Z1;
M.ZBVYK[!UR-"[,S0:T,\OL%G;FASE!QKV XEN*'E0:F)/-QCJ$CSB:0!;ICS
M1)2MA$KD,262.ON7OL#-H,_*8X[*V<]YA\O8H^J9I1%W$Y&(U XI3!IEJ80#
MBLY /&>&&.EZ2\UMH/D#VUL9#E(N7%L<R,3>:ZK240'!Z>%L9 C:F="([M52
MDT6 $$!$,7YH<\-5>276S>6X5[O%4<N)D>L6HMN;!0=$B7.SRT%-#O+Z_9W!
MI;)04:R#..;C184%)CB#<XZAP,Y\A+FZ_P"&=LOXK\0VT6N(V+!&V;,:=]1Q
M&VX2]5M93 2H-/*"WS* R,E._19X+R1G(DRH 3,!R'.<>OC_ .ZZQO6PMZ4]
M1K/)5JALCSI;UEPZN$+ZY)2,*E"!F42YX:@.BLA/G S"T_:# '(<BQC&<9X_
M$2TD]*&E_'+C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\
M<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*
M&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$]
M)/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C
M\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?
MQSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23T
MH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3
MTD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^
M/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E
M_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/
M2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1
M/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QS
MX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:
M7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD
M]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q
M$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'
M/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2A
MI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/2
M3TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_
M$3TD]*&E_'/C\1/23TH:7\<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\
M<^/Q$])/2AI?QSX_$3TD]*&E_'/C\1/23TH:7\<^&"MZBW3U3M"PY4J-11N#
M0/8&K)3+'Y40E/7'IV:/LDG7.CHI*1I3#<E$E#'D !9Z.C&>/W>MZK^#^+CF
M'8YHM^ 9Z,TOG<]K:H:BD=LM=911_C$#MIWK>.09JDCH\L;E'V$LAD4/;P2R
M9(<'%Q7"&8K+QULF_P!CM;?3TLS_ (BN/[':V^GI9G_$5Q_8[6WT]+,_XBN/
M[':V^GI9G_$5Q_8[6WT]+,_XBN/[':V^GI9G_$5Q_8[6WT]+,_XBN/[':V^G
MI9G_ !%<?V.UM]/2S/\ B*X_L=K;Z>EF?\17']CM;?3TLS_B*X_L=K;Z>EF?
M\17']CM;?3TLS_B*X_L=K;Z>EF?\17']CM;?3TLS_B*X_L=K;Z>EF?\ $5Q_
M8[6WT]+,_P"(KC^QVMOIZ69_Q%<?V.UM]/2S/^(KC^QVMOIZ69_Q%< C5=4O
M34_D TBA;AAA6Z5RRI]$D2X!E0J SL5^+UPTB8(NL:;U, *#Z^<\>15CZ_\
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MQFLWQLD+G,!6U.ER)4N4. $+4A:\FX"O,-"#@G66IZVI)"I8:*T^G5AKZZU
MVVWQA[%8FQ3$_*)4!;;>NEC1".P^KV)RCAHVAX>D ?"*#!Q@##L(CS,TN!QC
M-0!.L'GE;!\L"0G-[))\)T]+U0'8,$=E[+UYF;W>RUYU2-^5*HS)S<< \[LT
M176*R7NR5:KGR\I6P:2[!:5:_24N!4]L(P.\V>=Q)9KOX*D3$?(KO>4;:W0^
M(72>0J(4%"--<D>#BQ9(Q@LV*7Z&/:=1?E\S:\]F*2;XT\2>P8OMQ%V77:;7
M!7Z>TW-^7N)]52]SD,AIU2I6Q-K;@FM;.J[<+@<%,I&'F>W%&T.L3K--<Z=1
M[1ZD1Z-KETJ2N%"/-TSNI6EDV/:V2RESRUVTPIXRT.CNW]I&%A2>3-X^XE!'
MCIUV,UF@\-=7RW+07Q*PYW,:MMK8)+4<5:X"^RPV0D:WT$[-=Z66G6NC86E7
M*V'"O$<19,6*TYI?1T:!;-(F[7QZG.TF[6JVKEF?1S()58]/(H_<.R!M'V&]
M5NYK3H?*&N3H&Y&8>4W/I&5T<>,FM[FF.-2FEYHVK;CJRM8JXSF\=\%ST1%V
M"3"63O3S5RJMEGF#V34ICO-#4R2>$W-K4^1.3D+A+$P,EI30%I0N1.2:3NO8
M*.Z8-6M&V6MS9L-3\9IN1V2CO^J2W]+ Y3&(=-$4Y5J66X2E,3G1?A=Y8T3.
MF:'%-@K)1A9Y COVFY@_F_O'S@CO'+X\W]G^<$B]7S__ -*-S_K?2G_)>6;_
M $N\/V&PCC'\6/\ 5_D*_;Q?3#DYWBYVJFO)>X.ML7*Z5\LN%O2H4K/9"JEU
MU@GT\HEK#X*2&MZL;'DQ$I2$'D]0XDL87*^ZNK847MEY^GG#I+ RZ<.O>\;,
MVLRW==.,,KU)7!A3_&^SXXA<\=FF#W#L.P1]@G&,H5Y*Z[C"1!G8VU)#<=V$
M*G-UD;?-K*DT5B\)?WE<@>7)P1-I+A%H<VI#6]&!,AR CK=CUS#!#N)DK;66
M)H66^H"YU)9K/)I#/[":U]0NZT]U6U+&$$^E\D35[6HW94-6!E8 MJ E5U3B
MRPFEEC#%UU;T<K0/,,N6#7U'Y+(;4N*?RY-8=8PB:US7)JN76#/Y3)76)PF'
M6._I&R/*E1K C$[*32D83A]IBX1PS6B/QH%ZUI9%)S!&FFEEF-#+5=RDN26S
MX!4S(XS=6STFRSTMY59<"X@0S#/-/$/IP+HSP^7Q6M?-<4N64T[7%%265(7F
M1*%<@JFHR (:\9W9H<7Q:U+W*.(TQ*4#N8GRYG)4Y1!QYA90 AO_ %Y;81TT
MWM'(+WDUYQ0$KEB@N;ONRJQU6W<KP^>'Q/[!F9*7U8+LVU6D WY/SW,*? 0X
MQ(BK J7XQ))=0U0ZPRA&?-K 1(GV@Z*L$5HUS6KFE;)4B(5LC=,S##EXQAR>
M\HSC4+B-4B-&GR*T2*,B+!+@RN@)>H-KQ8]5U'E4UU2L&0670TG=8= '>.Q)
MRE5<2V4N BEJA$8J4HU'<E8CT8 )PJ'$%+I\8.LV^[C)91S&?'Q)LL7:*MY#
M4M_OC)#SY2..,:.S8/*W!.M;4B<EK*5*AK$Z<E9_/\5S:[/K;%ULRJ6I832-
M?#E3S+IO%V.O:XA:RO(2C.@,QD3[ WF1L,-<E:$#\M;3WTT"U2,U6,U0:8-G
MJ:242B)@L'GMPS^%I879%J5VYUP]WK)#)A<C!"9) )['9!"J\G3^;D]PB2!4
MFC.<8 $*  0 P%CF:NG)9%W)@KNNJE9,4[L3L;2; FKFI&T]DKB*BC]/VU#&
M!P11-O4G%)S%!!R@0CC1&&#&8/.56Z$?HEE;]B5<C?9N.68DLZ51Q/8,I9L1
MR4V:VU:KE1]6M5G2)CQE(LD29F*=SR1CZRC(A9%QL&5,ZX$\G;16)2%NWJ7\
M<IHA-FT[UU%!<4W(1A;)&C%'\1$59LO00UX1)5V47^]EG]J=UY]?:J@DI=G6
M6GM8,G?6&RK;8F4E_NUA>HM;4^B4,8Y^BA%?VI.&>0+R5\I8V]O?S#%9QW>\
M'F",RWPMQUL@3"P$4-*-8 M\ 4/U7&OU%RTR!+GN 2M773W%UTX2A7UBRK4B
MIT&L7-JQ()0E.)-./&8X4@NJZ>R&&&6,QVZWG2?97924V'"[!8F59'FF3U]:
M;[;KA9M;J,L2Y2D.*9'1 E6)S1!/+-]G%(ZZL54H6>H-=;2KR[*BB;:_RQ-\
M7;6JV=G6?$9TX/?A\<BED@Q8:HYZ<CW=6N$]."@XUP[SDXS&=>99%*9;6R3Z
MJ2>^Y;0K^*1S5:[05UV?<I4\WJ2)4NDJC,D99\ZS1R/,;G3"Q"B,4=*,I/U
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M>3,#,%GH#C/%_05!=5>)1ZTP*M+1M26NDWAZ*"-M=6O%0S6+SA#)\OQB11$
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M=.0!R+#G+9D_,<4BK$@4NLAE$F=T#!'(^U(B^V6.CX]NIZ5N:FY,5C.1GGF
M*#T>OGISC&89:SELYKTAJ^Q'H$:@EB*[D@:>%3*1YR;VC%&).<\@9GIX3X)%
M@U*0:,\D0<X,"'ULY?8K++0@ ;/9ZVFUKH*533J(AN66PZ!1IVECRNAU=K'E
M(^/N!LS$J,)&  2!A)$/M,%!&8%)8U$V3![!9>XQ\R1(8G,XK+'J!/L@C[?)
MBX7/4D5>'I/&9@VMCH3WI$:=D8#,BZN1!Q@61R@%T5,9'B8))[3/>R['B1C6
M75\&< -$[LG*P+IV>(%"78S"5V=L]"% H_FCC &?F\6A&G]<X&SJJM?-B-G'
M6",$AK.42"05;K98<YKF:&Q4<>GKDT.4H<'*NW160UF*2%+>D($!VPVK"E"0
ME7-Z6M.N+6B+>YJF)RD=;3F-SEE:Y WD$*7-@='*-.+BB0/+80K*$>G,,P:
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M0;'.LTJB)+Y8IJ2MI#<UJ\O)U8XXQ.JN"H5\_2/<"TP=W:9OA[,R#=IK)##
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MF.N:L2W37V$ V4OZ4X&MLB#5F@1+'9URU1BLK!>G*PFY>W,KLO%A8UB-.[R
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M49/,4D=<PP/;8Z+DF$2HEXEDXJF8ZFQI!7==W'4E@-<R2[GW GI2H.Y6VQO
M:O;I:US$"T$F:O""DABRDR4-<:HR842QQ*OM1K)E&S!LIV0C$[H,5CU.R%0
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MM?;)+)R $B>J4M:+S=(CA&TM;$1<K*@T#<[N+M&WDDEL)R$IP4I-=Y,9$Y[
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M8KHA:FN;6,%3.;[J]0( LS<4UKI3*MIG==7ZD#083*#XM 35G7*5N??0\O\
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MD\&>GJC#UK)EMCV%#Z38*NOB=ZX.#W=4SA%>H9#8T$*:SW9##5SU(0$O"1S
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M76-\P>3(8A3$H;&5K-:8@^O$=;W- DM,U8\HU<3[Q('9+&S,)BEYA,@4 2&
MQG.18VNUB@;/+/CKJ&*JD=FRY>TM2>!2!WM=LE#JF9H&^I7A6XR)7#3HHI1/
MV3D:0M$Z8$E"(TPH[LZ7@+%0EO; V3?:Z>)(A#Z<'4S>ZE(ZTCB.3REV?7BX
M+-JF,(V](V*R@E!PX&'G'9P !>?9X@RO8]M;=-YG:,I<89 JFV8LFBF*?3)R
M3K$91((Z3!+/L"+R$+LI<B<E$(W-0I",X.#RBC!A"*Z%5B7-69,TH.I))==E
M50S3>'+;E;H''&8AY5+$]>GO*%_.4N24:0",!P2"U!BE-CKXP8 7%3QU9=M+
M)W_8..,<JIJ-.=DP8I]MR/OJ<E4R.<!9C'@2V:(' L\.$IR$M04I'C."1#SC
MHX,2.^W^I:;N#Z.+=U<KYJ8DM+(4PFQ,>Q=19)2PD.S<>\)"E*7H">FR>7@8
M ]8/2[2*(5!*KK<4?@X:"KZU45RVR:3=\<T*8\;.HLZ95W 08;$QXEQV5SND
MZR=,/L>U/R64."V6\Z^6_0];65)GF/P>9WK+]9F)MD&(=$K;F4V?43;$[]FD
MA&WP5-33B%P*PBRX@*- N*3&-R9P6(H\@B>V&K\K73F9"K6,I&"]JQ=SI9/P
MHVY8&#L8$4A4#?),8WO2,P"$G!B@PM81U09P<#K3"HH':M3RJSJQP/$\K:(S
MJ)O<W@>3%A:,XN2Q)H<%#W'A 6&X+.PH3E=F<, !]!@L!XKZL;3MBHH18MN*
MRVVKZ_G,ZB;!,[&< +DS<!#"8R^+DKK*5/A1T*3%!1E&Y&J4 *#_ #@\!S)Z
M9@%R4I.[)K_+F*75?%;#A,CFL/%'W\<4?1R"&-CFJ>6'XO28(VY;VZ<L:19C
M)1F CSC&6*;2QL?79LD%JTK4*1)&R$2MS#)KWMR%4O#E0R%RUN($THI5.T9R
M\P)N324(#1E%G&!"4-7<)DI9+"9@M)LI9&>M7^*2:3S&/MUC0NH)+)8:B\-)
M$D@:(;,Y^U(7=44H[-"8K*)&+MC2BAQ)6USN"O#;9SV\Q6 *T4I8%:.Q)*Q(
M)&M?8W$S2EAI,G>6IIACN<J3)<G&D$-:G)@0A),ZJMDEVN>R+S5L(!6AEF;%
M16!Q7%)567:DC#$(N(];)IM&)M/<,ZI408__ !+8Y'\7D2H UO9BR(L-_P"N
MT -?7N4ZY-,&4V2^G,2I)!CG*>26UX@**QM\<0I<REXB;U4+FF>QI"#6Y(I&
M!,%2:I+5DIG^PRZWL6U5+,-H(:ZZIZ)AE]BRU^>G=KC3"TQUE&J;&TD9K@YD
MX4N+BL;VAH0@-6+U:5$G./+=F$G5S9I3?L?G-D0JP=5&N'U8ZW9#4%:P&M;4
ML.>.AK=:BBJY% R:[MZ'KDJIGDKFH>E4C0-J,A0Y",2%:ZT7!'9_F$SV6J13
M=T,4L;$I-C4;K\4%;;%CZJ>R!0),V,+[,8PY!.;&HDQ6XF +&::22FQ@\0X5
M#Z)O,-=OOTED0390Z'QAPH&REM5R<R*3I*V/\;ECY,HLE5/Z58%B72AC8FV6
ME(%!S0H6EX*&; E#RA+//L"Q(Q5C4=E[AK":G<Y7E<8C'VDND4>&\EE";ABR
MWM>5[LHSZZ9&?U1]229H:\Z>N@$/&U%2@54V5#K"Q'C'Q,<M9O#7Q3=W7P6!
MV1D#&FR?V?;X+,ZG6Z@NB459+K$B\475ELB@UHL=]D<D@,9AM7SQXUSE.R[3
M)I@ZO4H098(.[1J*N#&F<1DA.4RI.>WEDB[$XT%;@D%YT?&S;N[DOJ,#M:,&
M9OI:(>$Z)0W.-?#6O"8$W+="%R?L#V_*DI1DTO #!=<..(1(5M53VWW6R;0A
M-'0>NJN)@892_P OGF7$+$W%'6/,:^A;>SE%-)XU!RQU3%E !ZV!9S@/#['K
MM/+U!M"(SF/0%VJ39F75)#ID.0SMD;))"PQ)SBEAS:"3H$R9G@ TP61X7*,'
ME'ISBRSR1@Q9:>+7=2+\JIDUR6W 0P6;!G4VK<-Y*PYX7V)X.=C\0[*$I"?A
M2<XY3EE"*,P88'(!8XI:F:VN>M+"ENP\*M^P:P=(!-(9)(K)FZF7:*-<\;4L
M@:'M0%=*0G242@E$G+/--2,[D>;DHM$/.7&S"=L=8?HYC\M,K1PG2>\*T%$&
MB<%LBV2_$A5(BW_P2CD8HTS*7$#=VN%)J)(8:6 0"\BP.05:...%>2Q>[6XR
M+8FYI7^).2J?GJ)L\2R'JTJYP:LMDO='@]U"-","4Y2M..+Q_.B$*CP-VH6R
MVOD&WM=GNQZ4MFU?H2=HK<,\EM9O%Z)RWDZL[TM.>QF12^I(BO<VT3\UMZ0I
MN9<( C(,*2I1VQ)V/8JA'QBH,U6ENY_:;<@;@T4^)*<N(6EV4Z)WDQ+".R4,
MZH L. T^!&(S0=/7+$'%:KL[1ZS(6VX2"@5,L%=5:)D5EE*9(JB11=?'"?BR
M9:0.8)CFP7<LFX YA$F%C!_YG"^54E8E86G&F)\7Q-PD%72^,39G:I(SYZ[I
M'%KC&%B]*W/#;APP,Q*8,!P J,"R'&#,9%LO82NZZRE0=2(9(9??\6@4YATI
ML&!(XLG<S\L#[&$;V6M:Y&X."(U"B1K1)L&.)F".L$P6<<0[9.P)ZP):8GDD
MI:.1F>H'^/*8PXXOB51F+0>1$2%0[(V(V(E9E)3DO<0*1$IV=,H5A[0LK\Z=
MQ. V+!DU@U-+;@B4VJEVF<(+LV(MU+6Q)Z;D<U=X4TO[H[,,"=WV+"5-K@J
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M"Y'0ZH2U9)D<57DL\@(0$KU);25A3JWMC=44TYJPO7!+7U<K*=UP(ECE"93
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MPM'"XY%:FU6V&IJ005E7N1G@Z8W%-=6I,PI(9@$:;F]7#(^FI-S2'*#"T)P
M#1Y DZHS D6#;VY=9:ZF3>7LSLSL%EU7?UA64IA$,(E+:MB-(5S5LPUVK=O@
MD \&@$X2-X ^KG>22!,6H6A$G"@3M6/XO4\P?S?WCYP1WCE\>;^S_."1>KY^
M_P"EZX/ULYUZK;2\:Z5MZ*>T]K==EF0M0[-0'QJ(E4)KM_D3 H<689A.'9&0
MYMQ8C$V1AP>#&0=..G&<7^O!==M;!U?35.1IYM*;3/09?J+8-$W;)[7I9BJR
MMFB/6R7#FVQ 7%65D/KRK*.:S0,:%C2* +NLX%E#K^7)Z8D\6T_BVP>U=9VU
M?:]Q@,H<; 2ZCZ^;9RNU8;!ZL;WPVP(\XE6G0 BFAU/)ZCF6T*2AEI25:4\V
M3QR_M/K,IVSR@T(;6\%>;(KF2IIVGV#1[#O,<4O,FA!\B3UZ"'QO6I_.?RUJ
M8]0F58 G2%K<9"<.^]XJ.9GNMY1&-;-A)_"&JU8H,Q3'+ JF/3=$0>^,"C"<
MJ21=/+(KE0D4$#RC?&D12@D79G@SCEZMSCF$1J2CESRU<S0\$3.=D<"Q6TQE
M-'2YEA;4G7N"B,JI_9=<RF0L^"\N:L,?C^,%",+/(-4:X2-)KC--=V*W]K-4
M(@PO5E.%>3]GMG7?8MHF[P4NCB^"2AU!#++;$L8)P]M*L(CV+*I*(H]:4JP8
M&P; K'4Z2P>9.]72BUM9W.PY[64ABUK1:K]HJHUIN-8\I(\^&.%?N["KMIJ<
MV1*ZE]B\(U@1F")-3*$>'.O%],SB?+"+,VY46&_G2.L(HQT!4.HB_75':SJK
MRC6'/%F(XV5?90FHMM2*'IY&A-"842$99@9DR16I;$K]0PP^,69'7"0%8=8]
M(Z^F*M:C9BU\D0(4[)'+/;!(RS'>-9/5B2$+$YJ98M+R>)/;T"KZY)5);)9]
MZ7C7BB-1$^B<N>JKM^#0U[A"J5-3CN&D0MT/CTA8ZL<WN0.JTQ]+.8"&H9YZ
M,TDD9)TC>G35R\%FM2*U;5UZANQC,L@:M/85_P!0ERM%(H2UU:MD;9.&2(N\
MXKZ011KE+D%,UGR-KZA^$S>H3N)D[?XY4JV1VU&+JJC7Z+5C7%K5S8\.LNR+
MT:A/=7EQ"_6E6BK!5&3VI$N4/3GVHB&H#:> G"TX2<D_8%^NV)IJ_E]>;975
M3J* DJ&-S50J-P(<<):8\Z2.-+W!CEJ]*-R.,PZD#+[ZG-*$,HDS B@;%R76
MBW:>I^,ZW7--:(A58VC3:RP4=XV!6\9C:^6OEPSQ#,6V05W G>2O8FMI+C"3
MPBD0$9=%1JPQ4!M23*E[KIES^(THW.OC6&F+RBCW"CXR5+ZTJQ3<S56#S#B7
M4N=+4Y<&BK^$,M,2$IUCFD G&F)+-)4#MM%&=?)/*)U E5#CB-?Q&W:=DSE+
M&[8+8^(:Q1EHE\F;) 9!*FM"+6!-D69%&7)T4'LY6#@G*.U)&#$KK]5K$_W9
MLR^[(;1Q:%T9!99 86SUW3.MK;48IFKGER2A>DA#@KBTNMYECR144'O,@='I
M,(L@E&4K5)DV:&HIK?J,E>P7+]KB%N,T=XW#K!3L>Q4/F\AN"/2N.KUZXV/3
MR-RN+J6;!G6/1(QM9V4^5/;%J!7JBBU%7C+(S5<(N2;0V20R.+I6KL5+1LAQ
M&96D=8ZVM.5-:9D2G!KE'S7 \\M<Q(U2E3W)23A"93$[ET6C\.K^X%=YL)5I
M0>\*EORJ&"6TK7.;H''E4UJA[=\9.D]0L$I=, 6I&U>VK(DN1*T@,G(CE-@6
M%5S*MK7+96NYDT;(3:\6A<@=XPIJ[EFT1N31I %L><,]];U#E;"5Q=TZX>%F
M#5JAK'G!:4HS*G5*.UE89Q@9O:%4MEH$HAK&%58E*%R NQ<21C2MXUD'@HG6
M(N:!H?%B@13BX)P$#)394I1'1F^X;W19!:HM6OG_ &/8#8X4_.;EK8[O(8=:
MK]'U(W1K%'7.JV^2DS,];@1F,ML<5$9+%V_K3\U.H<5>M%33UVU[RQ,$3B:Q
MWM*\JYTOV.W1O%P/GCF\F.35$(7$H=%(TG*;D8%8):%> \1I #\$/%F%Z%VT
M[+('J\U[H7!$4EP4L2KK#7*:IYPKJUY7R!8^DQZ1V+-D-;OBLZ-MIYYC8C;3
M1C5&G#3D'V?%X[KW9FQSK$IWO"].Q31)*?K0$%J'2TZ@<3@U(9('M 5+3E::
M]4V&(L8@N+@J(&6K$E*SA0"T[!3Q)TGT9!?$ KFO_C[-*KHF,-3'--,:*VI:
M$.)9)W$]V>I!)6:T# M#'A"X25T><*D:=/A,E ;Q5UTZI69%:+275#ZRMYLL
MZYH*&4F06EI4V-4UD;J9"#'YL8@SY/$#QDI\.BT3,@4#$H49. 4$LPJW)#MI
M5-"PB"SR\1%[*.FKWQKDNSU6(WQJ8]6YE Z75S ACCQ-L*'=5@21"4J=Y6H(
M:<L"<@MVZ!5L9LPUHJ:E@W/2&'R/3UKU^FDB36$W[2HJ0@=CW0EV;$ZNL6@K
M=4%_V@^,"=J.4&@)Q$>YK1J%#NB.!4Q"6Q:, ][Z:1V)N!K>E>JH=R6+5]\C
M4FH=&SPR7',,Q3/-UL"&$;#-AYQIN4"A:^M"G';DH51!9=]0F_I,GD=E4G=C
MG"42A]K,FD[97UJOC4>?H5*[4J5M>Y)&8N=*5ZIU%'EC.N-0O492H5AQ2-R&
MX(4U9:R3*OE)OTB2&G(F&5%V'!$TJ$]WS,C*^KURAU+C7'6/-Z^13(:=#()-
MV#>T,Z@T9(352DK) K#6VMKO9M:TW%BMYOB?<0917\R36&KY?,JEK!>B1/!H
M^]9ET6[^V0Q<O8#' H(5_=C23NZB[ :C8FK+HI)5K^P5WK_J[8\*@;W*Z\L&
M1K5ENSK:-J?92NF=<O#HU=V<&BL&A+EH-P$;8O1*Q%&J4Z@HX6RD9,HJ5.LI
MH:#32P&>'1>SZKE$OE3975WU]0DMC$\0,[VH9J,LK$OM%D/11]_<<KC$"D1R
MSN'4#@Q+";UI:3ZZOS1:EMT99;C*IQ!)5!Z[MJOJ1@VST/CRB<1EP-:'9IMC
M7>6+7YN<>A*!&N85C6J+ JR1DR [G.M3.C.V60R5F_-$*G%@P*M$42:[=6HP
MPAUMBRYRXLT+KAE$U.R$U><I&><C6+"T("3U(@A$"P]5]>IE9%J.>N^QUW/;
M ME$ CS+3[#K]-Y=2DDDZMUF;DRHK/Z;AB*XMC;4)1'AMJ;SE*DQN[1,4="(
M_$:+GNTFRU@2FTBT<#C:JLZ<BS9#:0KZD7VU)JHFS^XIXRRQ%+,KL86AC(7Y
M&^N;D_D%F%@2)U*Q.\S.'5E8?Q<;;!T8KTKXR>"8Z_"=MWK*C-5H"G1A//4F
ML[C3TL?SD[^FR8=WDQ ;W$P\ RC!QZ6L.@=JOK'+ZXV<NV,Y3W;2*)S<*4U&
MEL*AMM3E2WNCVB"VKG%VFA6(XT&F]]<\8!E3W (S!$.[=7^J5IVM5S$5J8D<
MK39YQ5L6SF4[PMK25KE&$,&F4A9W]6<]3.3,[4^*Q#*2L1+H6M$)040J 0PL
M<LUQM0FYF]\NEKN"FVY\C;V[U\10LN:X;+@1&2L0'1@MB0RU>\D&Q1O1"0A=
M2@G!6*&PX "C76NF76*QG*M2;CKO79EO-;+X0PM#E=ER:T0G92JHVY5N[K$M
MEQQA>FN>(6-R<EB$'@9W-#@X@1(5)B6A=V-@JM=U5HVM5]'NA-2U,8PO[I8U
MJ7T]Q>%5)%X$/"U&QL^;;F4V9RTA+HO+(CY3AT.2S&$J@_B#ZY&:6V,W[1O-
MG/T GM3.%J5@3'*_C[7737<+3:J6UP*S(M.H')ZY7FC3!;2\NQ+VC.;E"(G(
M,J.+4A)&M,]LVN]>Z!@FS>PUOQJ=5RR-U;U)-7ZY&<Y<U0Z4O#7)Y[(X^AI-
MU<SVYO#C)R''02:-5DI,=-B_[M%V2K6VLKH9]:+ V8B?Q:=D;7L&_A:4#5#&
M"G .0;7F$6-G,K8HB.0(D64_QI>2DQ1)J0E2N)U+4TC2D-$R6GMH?3MK->;_
M *<F<NBE;BUNO&WE!4D86-U,E-0W#%G"KQ+'J,2%I3K0)FP:!(:H5+\&(T%S
M7GK';5&1*<:LJMO:52 DM<VS);=JUN=JEC*QG;62OW]49&+#4RR](FC0-CF,
ME.K"]%&95%"(6%)6#6=SY?MKI-O7]N<I>31A]STN2PCJTB"OTU:+(;KH,=PP
M!V;75=#'^-FH2A8<4,D:!EFE>#CR',=%P^+57;<L8[<K/6ZU7Y[2M @R2!QW
M:UM;WFK$Q$ :DC\[3=V9&-S)=)64@/ !F:Q]JF&XJ F)2U,%@VA]I399*+(V
MLJNC78BYZ/8V6UY1IE9DB@5VF.)[M(BU=;,V4$56KF%0Y$&B=5!>$IA:3 P*
M1516L(JJVWR-V6@U_"LF/@GJNT.D.RE<0:TH"UND$;$SRXKF2.Q>R&<4I=B%
M7=F(:H0^JH3$*%!5@VE7FITGJZV5FL]$[7:_,-FSBM)3'[%INZK:B-8'O3FY
MQ)]5I(?*HR.094>!W'_RDA4D-P8,6%20C6R-US7T7 BM2IMP)C:+H_N[<Y**
MS>Z,U^#8L;RB*%@DJ6H6:5'#-7EI"\Y<2$'9%Y $W/$VM'::A)S7%CU51NH-
MLN,>:7R RU-;S-N"Y+:[IZ2Q-3#GIR:X:MEUNQUT;W%E<!!RP$%E']LJ),"+
MBO4L5UCL@U0Y(M@)+<+JXRF.,D2J*N-:#J#5V99;,^/J-K<[FC!D=V ;U+4&
M-MQZQ8M0*T!Q*4\HS)=L6&@H&[$ZN&,52/\ 6D/:$".1.=SG[!6&U5+2E=LS
MZ(#-$(O<DCL>1M*!T9%[AE RIW8A<)S4(RUAR75;5**T>YZS2,NX)@DV^02M
M]J^SG!NA<6K%);</;:W?$RXR.2B%VA!W'!ZA\;@ >6Q8D5-^$Q*A,,1WL?Y_
M8_?_ /#ZGV/8]CCV,?Z/V/8Q[.<^QCV<^SG^//'L>S[/^?C_ *>/6QC'\7J/
M8Q_HQ^S[&./8_=^[/'L8_P!''L>S[/'L8]GI]C]_^'^/_D>8/YO[Q\X([QR^
M/-_9_G!(O5\_?]+UP?K9SKU5GT?8 7$R!V_7\NK.:$,Z\QJ=SXK-V-;'7XIK
M=B0C.;%YC8O-P4> .1E#S@6/7QQ*YQ-&N2))#/:?C=&3Q7%)*OC9<W@4)LJ.
MVO <2M,BZ4SS)(%*V$X+.YF![RC;WAS2ASV2P>,3"2H'FPNU>'._YU'*<GEA
MV%-M46BW=E*^MF!6[.G>A$\MCA;HFL %U2!:ZH$CPV@"K<E!S<8WGG&&BM&0
M[2W++Y994A,H)%5,DJZW[F73'75-K:9;IE=/E7W+9CPOL!K?5:"[GQM7HPD%
MM2AE4G(5Y3GE8O/4S?4]X6SEYJVQJ_G=<3->_3J326QW]GLU,]$3IW=+'DS@
M\R9PE<@/D*Q28X'FF&%J#NDO "PEE@M&T%L5>54CN2Z:DOJPD9[UDR-OTXIB
M%/<&BR-0P#2B1YB#NW2AV5O;4+K)W=S=EJL_I.4G9$PE(Y!>LL##[1INSH/]
M(]W3N?!@Q>O2&2MU+UU$R)$XJTS164&23%SP! $&5;B-5D:]6J,+*$".5&K3
M6(1%(C3ERT?&E#?/WA%(6B(7E:];W=+7 A[)Q@\R4M=E5,QN#0N'C/<<)A$Y
M :2:8 2V?)6Z2R5^>$FPB*2!FTA.E#3*2-HE5,*[GQ(V=<GPW.OQH.H9AQ@(
MR\ (+RK $/55#QAU3UQ)KC?FY0SM<.B[1:MNS>T&BL*SCJI<JBE5U<WRMT6)
MHC!8QEP&4F* $U>8F*2IU"L\A$C+(EL/<FZ3 3RS:)'N27($,F7HIC#-A6Z2
ML$I03JNY.3C"^'#3K(\!*),GZ2%#4L6H#\&I%J@H<\?IFV60]Q"Q'NQYP[T6
M=9\M+U]:+;MR+.L.L2[8E4Y:W#'&K7D3/(70[+B0+L4[LZK7,A.6Y*CU0YVU
M/<XV,FDGL"35//W"V9A>,K<K=CUFT64\(JDL>#S1'EM-A\AA3.[80%)49(&5
M6C3A K0*!'KAJT9=;VA;SG%UKQ<\WL%GLF;NMANUH6G=#S73PYV-+Y*]FX7&
MO$='!% &THD)9*4MZ6%%!+(R64"8S1]EU\0]LM5N;FR]:RJJZIM6M4W\0VLA
M,6+46S$(PN1B='==#TB9D<'!N5-B]T94:5"L./3I2 %QV1-2&1IU<6V6L+;!
MF1X?U 6E+;%FU5+Z8E  MQ90"/B6*!3EP3I6C'0G2FB+-!GK%AX9A)'V]I(F
MBS;4$9AC7,[A?Y"RPF T#=M?; TQ6\/9CB"6Z/0NO[&K="8G(3EA4K4)IR5>
MH5%83X3N+RWO]U5A8*RW[=NE!;E/6W)J[M2/2.^FUB:;?CK!+68?:I:]G2.+
MM@E3(<4H2%K&Q&L)[-8C2J"6_P"(B.QZK;F/^[FIC3'6UC/[ S1B0:LKW,VJ
MIFS)%9CJ;\<QL;RK:'Q<I,4>'F]2=E668J,$JXL%=")'>T39)LDGJ>.P&.7S
M9[#7='K;3>2I-8[]K[$V:0H$E4R&52TGPIA4C$/P6J.4EMH421:M3*)O04W9
MYM:D9M.Z&[8.UYC94\?WZU+)MMJ'&$B252:=HCVA8 9D2AK=&E"9$4C2*XR4
M8W'%&$J5/:VF]2U%-.^7"9<IDQ T2]<U),AOG6BO=2;!(9DQ!60-"<=,5@TI
MFX)7K-[@68L+Z331</UP0AXM5D4ODDE$_+JPBU9J"@V*TITUJFJ>6A'J;(=2
M8@VS6; 7JE#B?DHQ-EQ7K7 A.0X+E:HY-1-IR5VM]K<JMS5EB2.7_G/=E-CA
M&11:3N4C,3G!#X2E" \[*HTO.#,F&Y'@?6]?BK*&3AL=SB%1R6XIBQODAL)\
MD%@R.5WS5UR5!9DBG\Y=A*WJ8/#S#KV?RRCE(NLE-[H(KJA2% Q%893UH1^F
MJK<M98SI]9\C2R"Z6&W7>D8V-]1H(T]BA,X;:_NEK3MLC/RV('Y V#:UIRTT
MY8XHG%2W!L"5!33'#Q9C-M.Q2DWXUK!)SD.XYE1FW9E"CR5W5"<N'23#EKR$
M&<-G9GX+QG!XL8:@L,@N^OWUDF\?F[7-ZYMI]ATZ0FLFM=9ZFKHVCE+62!P0
M1>6TU4+"E=24^25)RY)WPH\@\76Q#](P26W8?2$&CM?PUAQ"+#6L<V%"JP-0
M"B$+?)<8C7*I/%R$K2E2KDCB6I \)",%K\J<&'Y.IICE>S^["MUHN836=PF=
MD[!*29P=)YJUD,8G&2N'Q8&TR$Z(,V%2:/&'(NV90.:W*<81J,B#"K5DD]V&
MG2Z&KJ_E1\&G-XS615+-[7K"&HH)#;NGU9'*RHJ_6HWLC4C/,5%DIFY0\(4S
MH8B$XIB50+28D0;5/9K*@CQ5C.@46].R\T=6+Y(,3!= =<G)N=F]ZIB.8F)"
M5T) UJ<'D*&Y"6 W"9$E(*976"VQ<;E(U]HI[*N>?65-E]AV/?B=HJ^35A%H
M+8<K<NZ9^),01/"%8VH$2=,F2JVDLX)?>%"L\Y5=TBD]TQV0.KO2<ID\5@%I
MO<0KF;3C7*9)9U24XG$,0EF()6_5\^-Z7NI2T1K6<2C("I2'"*"/#?')+'I#
M(8TC=]PG17'7.5O.6E[(WN<Y:Z;(,CP%$>C7',LD'.'$IN+*/).:"C0A3F8Z
M@>+'L>.3V]K*G%HQ:NX-(Y->EOR>V75/#:H=+"=8#&F(^1C%X';6(ZSW8.>S
MQVJOM0FJ1G*.N<.2)U#Y?:^//;#8$-982X71)54&KJ 6;;4$O*60.M(H8#P3
M$8^LL^M61R":46-SP% 6F$K$DZ2.+8I6.+8>T5YM]L)6UQ[?.\Y!*)!,\LU;
MLE-14U)KX!J4(FR$2^106E4#+WQ68,A %8I6 +..&,H;'5TE5RF&M<1E4'G%
M?R2KGL4)FM;2VNEQ:V)/\$?$R=64R+6PD TF B3FDY1J#BNI^?C(2(<BF.RT
M8,,:+BBDCF\7V&L%KLN?0#8&?/MK7%7=AS@:]2[S*,36S9.X/HCEHC'AO7+3
MPH5R5.:,@1T?LV?RV&V?'+SNNQ*RM#5>PI]4\RK" VRS16$JZJ:YX>L4/TD9
M'^!P!B,D 5Y&4ZI[1)UA!12A A5 K9^A"6U*K8JS,UR4I*PK.V9G&:JFKCJ;
M-&^?4*\V?#!."Y-/GR%R%O"(U6M,R<[@SC+CE6:40:5$X@U)9F6RPNC-CM=6
M$!TN7J5)5:;4RV*36VTJM0< 7?7I4^PQ$)N6C#VC<5@98,9"//#PSD$S7*1]
M>M07YP[26J\FC<-&W*(NU!" 9@C @E-ZR$-^7</KX=\ &$WH"/..'B:)GB[H
M!-Y-/[6FTMFU3W1-:QELL9KP4,*ZU*FD#[$%S:N6U%*'6+-RXMJ"(![4X)N]
M-RI(H&88-SD@D$C)6NNR-8;6'D)I&N)0$VW4-4P^F(6:F3?G=G%DL&@S>4>V
M9$(M2H",X0^N//#;I"ZESB74.Q1I!$HRFE<Z?W"=1-DC3\FD5;_%:Q$:ANE3
M&\T^O:VWXIN9"@+DR^"41A9XCR,&YB-LMCE:DVN*,2R?S=SMNTK)?9Y8-AR.
MPH"TU:N4V,].>0 ?D$:KMA1M#"WD%(V]E3$=*<@)IIYAME7Q:-@3T-93B@*+
MI!WI*$SR5Q**66U5G.MA)3+F"]V!N/ QV+7LM2VVB2EMPL%'=@F7ISC1HUQI
M U=VNA=DE9>+'9+LDU--EFRUIUYEE\QEI*8X[?$AJ)N<$S(KMAC1(4!Z=Q+,
M)*\+M+>ZC)&Z(DZL!-J8FVPDGNQ#9]>6B@NJ=W7*I=98153#;-KV#UNX2%RR
M9AYJ9'"KHEK:K:59)Y[@1(E@U"HP_)1Q4;I*]G>7;(.8M9(]K-,%-C3R92Z'
ML$&&R1',]B=#-SZO [5)"9;+X<VNP2DAV7%,<T-82U186Q$ B-W<!_NJS+NC
MOQC3BN*Z;9D=F6(_LD@@@:W3Q.1/[WG!BV(16,"49:&XD*=,D<5ZUP$$U<M5
M*#JA<(>X7-#DM35M3U2+F&'W+.(M'+J@NO:5*GHYJV"9V)Q0$6F=6F4XL(SU
M&2#5B0\Y ORL;3!(\UU*F@B4X>*LL+:2SHD8KDRU2F)E6XDFDDNNP;@ER$('
M!M<'J5K!MB<>< ; "  KI" .,5^YUVXW5$VF"P^HHFY01DNB<-5<VFJH:+M$
M,J2;7+"FUP1LUCSR(Q>/MZ'+@L!C#HG;4 '$I8%O0X3ME4JDU@EQ=DU-A>F3
M*<CGCLC?FFH*[DK/,84N0OB?!:X%@QZ4Q]$N)>!B&(1J8.#"A@$, JK!8SO8
MI[E4;7/&%CD#)-%[(^2&.VA6RVK+#89RH3E#22ANF,<6!.6X-( 9W].2>4,K
M(1!',(B_LLH<V6:T%K]KBY=,P>VUS:H1JZ_S.6T?(XD],BAK=XE:,#ETX4NJ
M*1MYY#@0XIDB@H0#$Q8L,4L<G6T+8EC9!+EKI[DMWV,_6L[3N-7THJ,RQDLW
M%*!J4;J2M14A'T*-(02E;6UO).3IDQ8%!O6L*D')7=<ZK:<L,9A[*Q6+>=DS
M RFX1 '\4KJV*4,YN+[X3J<BII2!,Y1QR;30OR!6V-V<KS"VY$60T6 V2.ZI
M!<#>\V9)'6\9K:K[*K<F$DM"MVVHUKY+I4Y%C XGPRNV9&V1A*2F3-S"6FP-
M.GP:8>,UK9O";H\>"VUO;?"KVJ[\\N?@](2D\)/*[J%]_=U_8]JI/ZH.U.$(
M75QT]'^7\P?S?WCYP1WCE\>;^S_."1>KY^_Z7K@_6SG7^7^O_D_[OW?O_L^M
MZW[5<P?S?WCYP1WCE\>;^S_."1>KY^_Z7K@_6SG7Y1\P?S?WCYP1WCE\>;^S
M_."1>KY^_P"EZX/ULYUZJ96BZ1&Q9XW0ED4/JN(U'"7JRK+?R4YI!.6Z&0&.
M$J'Z4O)@C\9"F2@$9D.!9QCUL\0>'!@NWE:I)Y;[[03?8MTZOV#5%1,ERQ5+
M(%DLK>76=+2T43C$PB9,5<1.C>I4!6-^$)_;E P2;D%)UBT+%TN<;_B%FS>O
M)="$P)96*ACJ<J,&R8QWL%H./86LY9F6)@-H1"%A>84H"7G^9'PM>:XG4+L!
MG;UYC4L=X-*F.7-:1S())/4-BMQCZYP1IG).6H ,9 AX-" P LAQ@6.D<#16
M+7JF<E9= GP@B<QLZ9$&,I*,]W+.BY2\;R4)I*7%C5X$4$28 P9,P'KAZ7V7
MXN*ILQ",&M1,BE@;*A@HRP&OI28UD)?7T+UEK9CWDM84)(!2:5E4$P.2NM@6
M.EP/<;"@;>F:8RAFSJI73..HR&N%NAZE(US)S-4KRBD42<UB,XE,Y#%A(><6
M( #,Y"+JHCBIQ"S2G"6J8$A-)E;&:4LG*(:PM9"40P+,A63-*-M4X-:R^LM+
MRG,P(O&0"Z%\ADSRRQUB:DIBQT?)"[(F)D;$I>0A$I<G9Q,)1($N!CP')A@@
M@P(0<9SZ^.+)F<NE\;0L=1PL<_L+LY TG.<:C'@YT=$2]R:^] 4) OR5G4>#
M.UZ@7 98@DY%G&>B)VU3,Y89)');!(+8P6P#NU_&^*1ZQHTFED5)L&+$+5#I
M"'Q6S*>N8B7A+-+&68'/3DL70W3 -NU7F)O1;Z8QRK-BQ ,7>0Q<A8IDW@R0
M>%LM3A\74S>>8O[ TS"(LD8CNH$ LX32M"\LBV+K&@I_2R=&\(54;4,AR,MP
M*>B'Q.8:VG,YB(SML*@&"(['H'UNKGIXD<E9+5J]WCL0PES*7YNL2)+F2,]_
M2IUK?F2NR%T5-["!P1JBC2,J3"^U+-+%C'0/&>(L0CM2KU)T[=75E@99-B1(
MT4Y<F!8)ND#?#PEN@C)(Y,+@480L3HPGF)CBA%F=4S&0X% 4-B5ZKG98G,!L
M&33B-GS,DUF*1G.Q1D7)7F/)8VHM<4)7@101)@& R9@/7#TS%4.PH 6FKQ04
MBGR@Z;1PI/!EYQ19Q:&:']_$"+*C"S@9"!;V(A8&'.,= L<6[142L-E7S*ED
ME,*)8YC<FDN$.2N_%D^;:WCT/F0' UFE4K<'.MG5(>W)1B4DK".PZHC.D.'Q
M,Q/C*\GQIV&PR EH=43F>Q/A:1*O-9'LA&<::T/1*!>G.&E/P X)1Y8\AZHP
MYS,TZ^R*\0JJY(;U-A)G"<1M"= 2'@K!S.=."E#@$Z)$NI0L93C7A("=TXZF
M18SC/$H62BQ(#&4T'6M;?-5#_-(ZT)X<L?RD9\=1RQ0XKTI$<6R%,X$&H25@
MB1JRC@"*Z^!ASF,MC]+(NRN4S6&-L0;GB1,[4OE;F6FRL\'1E&O6)U#\O[J'
M)G9)0FCP7C(LXZ/7X M53^"D(Q2-VB&51TQCY*8,L84[@K?(KWDY<6F%)V5(
MTJS5C=U^^)BDIHAEX"6/(:^OFK[>A+K5-KO1T;K>4.K\WQH$ND('5P:$L>;$
M$@/;E^9$Z'-AAR9M$6%P&G&6/) <CZN*\8+/F"0B56A:M1U!%(2P*&Y\G Y)
M=L\35O!7=TB9*\I[;(6?*UI1"IW&3E(FZ<]86<XZO!ZY<<F1HDJ8]6L6K% $
MJ-$G3 [4]0K4&?S:=*25@0C#!9P$ 0YSGUN&\Q'.84K+=(L?.6T:26,BD#A!
MTPD8%$V;Q%*Q!6PY.-Q3X,="^E$7D\O&3>D8>EWGTA/MAN8F77>[-I%(#:T<
ML.)U.T'L(S:SS9_0I>^=1:>NL>0)#F@HLS(7-E/ O*'V0P8$LOFWU#VDKMND
ME;15:K86@UZ="G6V+ BU90_&&PHPD8DQTJF*(*DW(P@3)\C-%^:#/&;-^E*M
M_HT[;*?Z1_CU&,0#*C#GX$[KB9Y<\1SO?AG_ '7LN\];O'\U_M/S>%LB>W9J
M:&!L;E;NYOKNY)&QD;&I"D,6JW1Q=EAI2%$W)4I>3#3S!A*++QD0A8#C.>'#
M*Z=0E%AIBQ,Y<\K9:QI<-L'/$I"1-G')RL&$,./&B.P6Z&="(S)0L8,Z0YZ*
M$IL^W84OL'9QMG#W1[6R/J!\0SUCKI"B6RIX:'QK/5,QB(@QR3I$N.WR<O6F
MY*3@,[(X1<K(;IE#EYT#.$DG):.5,:L<)6@287&))@!*L.'&CBT6>V$%9@G(
M2OS\XZOK\7Y7-/R@,P=M<)!7T:L%[:L)5\+6.-FUPQVG%S(;+&U8N:I6@'%9
M"G[P>F'D!"KKDYZ1 SQ,WY1)R:X10:SK>JIV#;RALK,]<]4;)BHG8,@CY4I<
M4.7R"H7921DAW)Z4QQ"DDS\W!H.F:WG9,K9XS4U>09XLF73H]2-8Q-L*86@Y
M]<7PDYN(5GN9 VPGKI )0'&+AC 60$8S !S&:E;[-9VR0337JK=FHD\R9Q98
MY#)+6]Q2N50R$H625NCJ0UN<Z5OL,<2SF8D1BDK"<6?7SC(<?1]F517$ZPR?
M&7,(^,C1\<\1WPAX,\/9BO>_#G@3"S^:[WV'=^U_,Z_6];A&;8MAP" DN"9:
MJ0G3J:1V'DJR6]0VI5AR8;^O0]X3I%#NF <,OK!*&H*"+H$:#&9<\H+&KQ<T
MP )IDZ=D,XC:MHA9135X;$9+G(EP$FC(<-&<*\Y79(QA-GM>GJ?G<-<NS<%4
M_%-\0/3JRRG-CPT,;=VJ,JR&^2N;6^C>@-3D@CC@J*(<#DYQI:,XT #<A&+&
M,I$\@LZM6$Y<F8%R(A\GL99U2YOE2LYOC#@@(<7!-E8ADB].80WG SDM:: 0
M"<C$'..!0 4KB@9P%BS)Q0H4E9\3(,<PX9;<OXHME7A[PR!5X[/*OL.[]K^9
MU^MZW#H9 IQ#)L0SF(2W(^'2MAE)2 ;FB XMX%XF)>N[B8N0F!.)";U,G$BP
M,'2'.,\1J"6%*'20SZ4(K86I(%5[838,U;!4]2<MO^1M\CC+,O\ "T>=7BO(
M6M,9DZHHL;JKP DGIZ^!8CZ%KFL53221QANEJ."N\E8VRPTC0Y1IFEX/"\'/
M79D+4J;X[($:M:6<2#NI"@ Q9Z@PBS])_P!*5;_1IVO88L?X]1CX@94>$\LG
M=?CIX3^+?>_#..Z]GWGK=X_FO]I^;PJU0(L%@-OQ%4:6\UM?86@+<$=9+WY7
M'&]]/5G8+;QG."YN4FEI2C3% 4*?*HT)9 R3#%%G([(KQ56R4A6H46(3.(V9
M 4Y2!8-N7&*)D4O-CQ1:)P*$0<+O&<%'8Z@N@73C%B3FHG-P=HS65Q6O1DB<
ME:#*5.IG-,215%9H;'SP&GIWV,B<TN1-[B0/)*].()@,8#G'$0MVB9VT/S%,
MH>CG:2-N;DU-=B,49<3CB$#E,H-W]4]Q).L$1D18UH"P"+$ 6,YP/'#=/QVU
M5@(&[JUJ%IG)MB1(J&.:UK*<SW5"WRD3KX#7+FU.RK!GDE'C&2!*<(>,8*,R
M&6J4\I8)$X0B"J+)D$7BC^RR&8D0TIK/>$CTFB[<N-=U*1]0IA9;3,%A*7"$
M#!8OSO6K&:HIO'XF&W(K6LJAT/L)^8H98N2K<80R. ,+S!GAS*?&F5O[>$W!
M+<, E!IJ8X)>!Y*'T<:QPV'N5@R:;[;SBYH34T):X;TRL@% 6BX5!:,SG+0I
M=$QT.@S-,6M2%,M4=8YS2ICSD9!^$YX2QD3NPZ^A!H&P+R,J83:.1@T#2)S0
ML@77);XX(!^"A/;FF1A4XQV.52@LKK=H,(11:-2*:PU@DLX5'(X9'I!*F1D>
MI<I2X*$L31=K<%A#A(%20H\ S"TA9H@A%CIZ.G'2Y2>6OS%%XXSI#%SO(),\
MH(^PM*0L18!*G1Y=#4Z!O28,,"')IHP@P(0<9S^=CAO4LEAP)X2.\:6S-I5-
M4TCKD0ZPUM4E(G*8MAR%>H*71-M6G (4N(!92$'9Z@QXSG'3"4!4_@AB^RD9
MKC7*(J8QXQ38#>G;T[JI7P=.%?D^6(D[:I H&<@"H*"0,)F18!G N$\JI>=-
M;F,YRL1M.A;TN:V:RV_%7VA)*AE+HZ0 ;@HD3>Q8F,55 2K#20D*2!$F %T&
MAQESG]GRMCBL>;$;JKP-W>&QL7/)S2S.#\<RQE$XJTALADJMO:SA)6]-UU*@
M0.@ <^OG 'N+O3W$XPHIS6Z\D$QM-J+KN(.L,VKBKQ,JH1-4D?EI36OEQK(Q
MG^$VH!G>F\_J%BP+(\9X:6"/SZ"OKX_11)/&-D9YC'G1Y>X,X'$$MTT9VM"X
M*%SE$UXSPX)<20#1F9$' 3,]..)[:]LVY"F&&5E(HG#IPI1O[:^.<=F4Z?&F
M-1.(NC,SJ%C@W2)Z>7U* M.I 3V9 Q*3<EIRC3078^$.BB'QJ@K'<*QG4PL@
MLF"PP]X;8Q$I:9(8U*7L\IG?X"J:YHB"F>BC,)#S^T '_J9SPWO+U;56,S0[
M,":5-;L[6+$FUK<XNN7-S6ADK8X+G5.F<(ZM<W=(F*7%"&F,4*2BPCR,P 13
MV\9VWREUAE<1XZ3/Z.#1Y9+I6J;R5*1+DI@C3=_OKTM&-8'."BL];(,"S^]P
M56P9Y!<6*<S D *\',F ,_\  YA&%6',4,RL\/A;0IL]H)1V/98+_.Z>CA&;
M8MAP" DN"9:J0GSJ:1V'DJR&]0VI5AR8;^O0X4ITBAW3 .&7U@E#4%!%T9-!
MC,N>4%C5XN:8 $TR=.R&<1M6T0LHIJ\-B,ESD2X"31D.&C.%><KLD8PFSVO3
MU/SN$5D?2C6XJ]=%(4+1/ 3R+"ACPY#7&M934U2GPKX!<G,YT3F)@D$J!CRH
M!DKHZ^,XQ1U]0&6IFB#[&M G>H4E@*&Z$2V7!">O(RVMT8>%X5ZMZ#X,-,$E
M3]L: G&!YQC&>,B%G&,!QD6<BSC&,8QCISG.<^MC&,?O\5$SQ>[HTXM=VKMF
M&V$SH]P;6JO25FI<PCT'MP$HECNN0(8L 3W*F\3'E9@L3ZC5DJDN!)CB#391
M3:H]S0.4/I".[#OD\<4Q*&I":QDT@D<<0N!%D*5)<=/<TJB,*%:M/V@0)FT1
M2H9G9F!Z4DJ@DHCDUB[AV_@V31!\;)-'G'*12>B5A0/;,I6M:P:1:F,*-P4:
M/LS 9 +H%C.,/#?';*KI_<HZ@4.TA;F.=Q1W6L#0E5K$"AU>DS>[GG-;:G6-
MYY1AYV %EF$F %G @"QA+(1713P6!9)D4,3/OTH0O+*KEKDWI7=NBJ1U\,80
MJ).N:%I*HIO"/*HQ.: P(,EC (3\2^3B$,PHIF-?&S#K,&%N'%0S%28AB0Y*
M!6K*RQAE:XOL6O*GL\.)N>H1UQ?F\14+3-(4ZBG+<YNL,"URYC<,S!O90IAO
M"^)82J3,R1M9P*R\K%"3M"DV!AR/..MCIDP'J:0IG'"VIO>Y>!VE[&VCB;2[
M94A:W64A5JBA1YI=!(S,)52KLR5&0"ZF<]&>BR4ELJIED-2:_OFRD_6P^+'2
MQ#'Z\8YQ#( 8A6GH%01)YLYO$Z1*$+2:$L]8W%J%)><@('CC8REH8:^BG>K4
MFKV)6PF<V<YO;$CS9];,=KQ0IB<S#!%/9)D/D24Q086$(2% Q%9Z<ASGBQ&&
MKY@D/E576I;M0RN%/ZAO8YN"1TE/%-;SIX;(F<O->W*%D2M$:G2NX"<)%.<8
MZ!8SGHXD31'93&7UUB"\EJE;6R2!I=W*,.QQ&%(&N1H6]6H5,;B).,(\$J0E
M&" + L8Z/5<P?S?WCYP1WCE\>;^S_."1>KY^_P"EZX/ULYUZNI(M8,-JR5QB
M,\_?8CF%3J-R&1,[^PNFL=E+=A7*)*E;0Y-BIO>9>!?8C.<8R&%B$48 0LCZ
MQ?3Q'6F10.L@44S2WGQ,Q,&CEIJ:^0,]/<PA]K$>N<,B2V#L"MYK)M7,<?<D
MZ_P$B,.B77P>G)--$$L5\,=WQ6#Q* /(Z@9J4;5)=%2384EH@\.<6F2H;CM[
M7>K*=@UK1AI6+$J>*+')GQ*"B@+\N!N2SDI9>W;A"*&@4 2P'GI1C9=PW+DC
MPCC5L-M:4_5E'NDBJ2O(]F%%S64QZUDJE2U$+4K\3'C2W=W JQ@9 B5O*@B2
M77O7RT[ TIGDIL+:75M0]Q".0+8R0S*J;;K5FE9\W=HF[P:8V+4[I8"5[;E$
M@0" 9@*H*=:E4 +[71)B1U]K])SM.8[,I_:D+4V8^I8KMDPS_<HV^6#EO/"U
M*7&6\.O.NT/2E+6-UDS2\1XY_*1DI61(B$X .V]L&($+'[4W4!QG&^3' UD<
MDT6A7_>*;":_M])S:%(9@ZQ8!#Z9'H76CQ*%2QB _H6QRFH#,  L%DKAO8=@
M*H=:HSM#K60TW%2SXO$ZO==&W+6V$LUKMQ<5#2SA6O$1&_')!*#4!&1'$X&)
M.7G.0!BS==%CQ67238%M4U?OXTD3U")CF%2:@L-;!T$;H^=B+$"=C7V04@6&
M28R,LU%B9*3#/73FYXAE9UFUTU0DQDG(9?="KEF4-<T4=(?]NU,SH^3DJ9MF
M"M21WF,2=D,9E*!7)1!7J2D[VJSV!^51A1^KMD7/4M:BK)BW/MJ^+<I66RZE
M;"9(K&'/1;&M\+>TD&J77VB:"^-,HLMJ0+%3?'(U@)*%"@<UBL]S$IP1:6MM
MD,;0CF,4AF^9C/%X2X8DS*V0VP+%OB<51&(MA"E(3A2(*]E+2C2MB<H $/4P
MD #'98QPF5P;7FG]<5]A\D&I=08_$"9HV,S[LC;DAF--W$@NVX&QK@T7)@;C
M$62+N2414C$XOI;O(W$@0@E%F*5>RC-KS2.N:R!;1:Z:K4C3ED.3VPUJZ<NB
M3T+9,[F<YF=:0E+!G%Q4-\S530J1(10U6T+%$E;<86 *"(MQ#MNX0FAX#7B.
M \].)[+.6YTF=T<;M=KK2G:LHQSDE4U]'<0DJ;2N/VJE4*FTA8D?28^<6[NX
M%.,#($4MW.JITS!7ZR9SH_.]4X=+1VS7Q$>O^:RO9=KNY+9TA98I0%?2%K(0
MLB T>'6PY),)8F>'IS2)U/@X05!W-SN$;)#J8IB9ZUZ".VHQ]4QQ6O7Q'9?3
M:0VM.(5ANJZM8HYO;,8JNN2QU(F,;VY9WTAQ5"R 0,G!%%W2Y&\Q'L9L=+)S
MMYLWWE$2WN*6]ME9$MLR6Q%P2)QB(+.J]M=D$4*P6$LK"9D+P LL.,!QLK+)
MQ6M9[&E'U9S XQ'4TNMFN(_$]P%.YEO$6##XK;+.R4)';9*8(BA"0HD:N?SF
M8',STV%EQ8 $QN#"*HJE>ZPK8R:Z];@3"[9I9KI,X4GF6^<7LO6U[JUBE4](
MVCKW9Z ,]B:RNTD!%6A',&=\2GPYHPJ:3VYP[$.=4V]=2.L^Y<?@G+_H_31P
M8-B+BE F/6BR:QOY?<;S;\(DAE;E3>9,1T<<D;4WJ6!-&) :HB+, 9:=&/(D
M%=UZZU+5$AH.!<ZZ[^90NN[-P-2A5+*DOB/W:9F!G4V[18MZ+EL7<;?R@<<'
MN)B98!"$Q/DX"@7=],Z@5U_5I;O3&JFR6GEDUVSVY4+1$P2VW)]"I$S[9LDK
MG>N=VIT*&1,D:$E?5,>9V"TVX"-!X/<Q=8\L!9B2IZ;N5 \\T#1C=XK=>9V4
MTI;RBE%T/'*,@T]H\^/R&&N$[=GIB+K-U6-Y:9_"S.2![.%_NZP9B0U)85F4
M^JIE\=I9;$:' 7-Z/DP%L4AEH36!1";HG)=&XFK61VU8='4DC08.;B!!0NI8
M/YT(<&F3!GB%K1]F;V6PY'HM31)<Q;0 9.3?<SO<+S:[0M+%%Q9S9[(IN@@*
M1L%G S4\-**"/(32>'^B8C$:L:AI^6]S!M28<UEV.UE-3?,+_P":#%]GZ69\
MJ^YBR%B*HQB"-:N%C/=7#_=AXR+\_B=Z\TY'(?+;&D,UUM?4<6GTA(B\'D+1
M5^P]2V5-&22/Q[0^EIFQTB,.7IQ![DIR?VG9]D9U^IF77+$JKJ>JV.1;VYV5
M0<O^%SNF%D-:(4#2DG5(Y\2/EF4+:&K([1D,Z 9+5Z-9!G!*!M5&F$..'L)1
M@*DT>O0MNL9D8-<$="V@SN#\YSV//K"\1-9&Y-#4\F?6:,N<EB[:TNAK4B5C
M;FP9J DO'=D^.@DNQ0W/+ZZV'V&B-W:00RNXI,GY,BAUY\O7EQV0Q2> 4)/)
M,>QR%JC2[8P>':2/B-Q;7- -^/18=<GX+R<GU[VM?:6I2/P7^\;S K)>J.BL
MYBJS.HT)VIA>MC)6/Q&6"B35&I4Y1Z54Y(I$\(X\6WEHG:4F91F*LF*E)E[U
MX_OL#.F8Z"8:91R!;:L4!"]ME;%NC$-H7\-@L==:\0V8M<6L6#Q5:PKG:Q'N
M>21&OECLFQWAJ_/5<PFV[$H.L=9XGM';E)SVL*;JV9167-,3:X30L5KJ4X=,
MPN.1:-MCR\2ID4."@"5+V9IZLP?:GYZ5!M66!?E74E8-.1':/G?6_(&&6*HU
M/4IL;WSL&HGO7Q47%'MF7(5CPN88PZE.Q(P=#6 > C$+M.C@_ES3LN'#V,7:
M&VCKH#+G)A/T#;+$D4/ES+!^VE6$*LS+.TK'%NZJHA,;W$)&,DA_F<<78XRS
M7:A&Q]D/(GB.BU,Q!]=H%*R:SVYC4DNMX&?%W4$<*:HVS'+)(Q.A<E0 2F$J
M\].,!.39%BO-A9^XM+K#V*\*\V5<K=0697Y,H9D<=TTB^NT@U_4M@J(=M@)F
M+$L:U:7"?Z1T5=*XNH O\%@> Y)'JS9K? *RGU?T]J]S$Z[=T]BB85N6BT=B
M:XJB-4RY,S$_-SB4=D+O%%X%3@6' FTH6!Y]8>>%*&EJYUDC\Q,Y.VANL#XQ
MR%' )!!I?MQ0]U2&<W@_O42=(F^P2331;$'H[,;F,F:W9OQ)3$BAP3J$9)Y(
MX-8&RM)U+(M?H]:W,'LTF&V)-ZXNDUH:MMJ'T]A4#9%$<;JXAT(-E"&5U%)R
MG\MJ86UA1=[#W(2I.9@X4OA%Q5C1TZLM/R&46@E8N,ID,9FQD8VL9K>V1F[&
M*.O3VT+#HO'FENFT7-3/R8PG*10D#V. Y2A%B"[!3Y:SO<19KF@VR+A;"*S*
M^)DK4E8M+8WKD^Z^+&P=$.U_33&9<W*DF4^;'15RKBR@"_+6!X#D@>NNOTV@
MM=0NX(? 4B.XS:Y2LQJ&1S?+N]K37=SDS2WH#)>XB0KR\"6G]H/(LB#@6<8X
M;ZHC5'Z]O$BASOS?75_W%,M-A061LF7OO2&S4?I(B;LBV"_'I&LBTFMIE9I
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M-)1C:FVHY&I-!Z4??"$T06L0^K$LS:$2MP!%C&9N=W(A"H5EGY$$$7%'-/\
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M*L>K!+$[J;961&M'-1"R:\K17>DW^D2T5+"*-PJ.SV8'/$G$;X-S+GV1_%U
MI/1-/<TIQA0MH+%5[C[Q5'%MS,Q<C92CZ5LFL(E4=HM4:K&/4Z:SO2%VIV2S
M$I#):^CA2!SP0\E94EG'!QD(!X %+8;1,;ACM:$[ U5M@IU;8Y!$4VOSCLI2
MD1B<*KBV%*!3!U=F$K&5H@C(>8T)Y,2P*W%I3*C40C 9ZTQ8%=O[*M45E2':
M1G0QE!(JI.2Q1EW&DK9.+R);7YQJ%9-I.^O<T8F]8D>I,ZOSPB2-Z9N"IRWD
MEI@S:6NEMWM3$DM761ZTZN-RI=]@K?\ 2SKL\+GIX! Y<DG]?6"D3'-+W(W
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M-X*QD,S5&V1%%54P@">(M2=N&8I61AV>R25W@_K'B2G&BXY^WZ7;@]G&<?\
MULIS^]GU\?E'S!_-_>/G!'>.7QYO[/\ ."1>I?I,K0.[HECS([/RIN8&Y0\/
MJ]*S(3G!0C9&=&$:UW>%))&0)4I(1&J3LA+!^<+&.*^4U)I+M30:2PTPY(3:
M3[J9&:9@C_&%T6<I WHK#EQ9QS^G9GL8R%"0C)292:[A1@-ZN,C +G[]/L_2
M]<'^;_ZV<Z_>_*/F#^;^\?.".\<OCS?V?YP2+U,S^CT: N?9ALKQ!3'3L?!P
M)MX%5?%(:_O01).XA?<DY.[;&2NSZ>MCHX!F^)-=:VM&=^)4P-.XN>IR0"A
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M8TC1 -<E<B5-1YQ:(E,')QR@80 QD6<8S5SNQ5?S*C4<]DR2]%]F;+4!"H9
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MR3X0[YG N.4[MD[-U*U#IK>7.MH2(T_&:LE-I-^Q*%@K^T;/KHIKNMS*DIL
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(C&,?_>B__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxypage1.jpg
<TEXT>
begin 644 proxypage1.jpg
M_]C_X  02D9)1@ ! @$ TP#3  #_[0R"4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  TP    $  0#3     0 !.$))300-       $    >#A"24T#\P
M    "           .$))300*       !   X0DE-)Q        H  0
M   ".$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M       ! #(    ! %H    &       ! #4    ! "T    &       !.$))
M30/X      !P  #_____________________________ ^@     ________
M_____________________P/H     /____________________________\#
MZ     #_____________________________ ^@  #A"24T$"       $
M  $   )    "0      X0DE-!!0       0    !.$))300,      KR
M 0   %<   !P   !"   <X    K6 !@  ?_8_^  $$I&248  0(! $@ 2
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-
M#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,_\  $0@ < !7 P$B  (1 0,1 ?_=  0 !O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MU"P@ND#=C[03K^>^IM?^K$885-3VV-N8ZQKVR RL$ZMEGM]W9)3>9>YTRP"
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M#+IN(@6.9+B-P,_1L_._-4*W8U@VOLR08+=6[B[][=^B^FW<I.&(^0;<GW2
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M&Z=9/S224__9.$))300&       '  @! 0 ! 0#_X@Q824-#7U!23T9)3$4
M 0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&
M5     !)14,@<U)'0@                  ]M8  0    #3+4A0("
M                                                         !%C
M<')T   !4    #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!
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M0B!)14,V,3DV-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M
M    6%E:(        /-1  $    !%LQ865H@                     %A9
M6B        !OH@  ./4   .06%E:(        &*9  "WA0  &-I865H@
M    )*    ^$  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC
M:               %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                              !D97-C
M "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-2
M1T(              "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U
M<B!S<&%C92 M('-21T(                             9&5S8P
M   L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N
M,0              +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)
M14,V,3DV-BTR+C$                                  '9I97<
M !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A96B       $P)5@!0
M5Q_G;65A<P         !                         H\    "<VEG(
M  !#4E0@8W5R=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L
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M.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9
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M 0,1 ?_$ 1H  0 " 04! 0$            '" 8! P0%"0(*"P$!  ,! 0
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M,5!@41(B,D$P87&1P,%PD- #_]H # ,! 0(1 Q$   #]_
M            /'HE(                   '>'HN
M             >5!><    U-  :&H !H:@ &AJ:@T    ! 1>T
M                      \J"\X   /HB0ED VR!R?  :$0DO@ $0DOD2'V2
MN    " B]H                               !Y4%YP   ?1!!.H!ME7
MBTH ! 1/H ! A/I YN$Y     @(O:
M >5!><   'T003J ;95XM*  0$3Z  0(3Z0.;A.0    ("+V@         K,
M<P&4E=R32S92,R$P\JL3"=0>IP !YX$Y%G0   0P8R   "*"[!S   >5!><
M  &IA1F@!\$<DD@ T,),W  ,(,W,+-3,P    48,],B  -PG L(     #SO+
M0 \/C\AA;XMT>YIF9^'\_7L?CF/WC'I69$#HC!#QB+R'I0103T?1U)'Q#A;8
MC0QX   'G>>MYV(  /*@O.                   #RN+^DJ  ',*ZE[@
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M0 5Z)Z*TDZ&3F>D(&<G!)4*=FZ2 ?)?D\0CTI*_GH\>$Y^B,E,  YA74O<
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MRJ1=4^S"2*"2"(C&2>S>(A)3(K,G.E)N,G,>,4(,/0TQ QX   'G>>MYV(
M/. \R"?3T3/)8OV5E(+)S(N,R+6$%ETSR?,>+T$@E5#T[/-4W#G&IE1A)GY/
M) Q!YAYZI'G:7./.@SHSPP4]&BFY7P@0]Y#X.B!G1G1S"NI>X     'G>6@!
M(QE0           (P,>   !YWGK>=B  "N)@1AAEI')80JH3V61,M-#Y-30W
M#Y!'A(AJ?!]&T;YH?)N&A\'R?1]GR;9]F@/HU/@U/+4L62J  <PKJ7N
M!YWEH =4<<PDRDX)VQFI'AVIU9R#K3<-XYIV9W!@YW)FH  .K.(   #SO/6\
M[$  %=B&3H#NS"2QQ!I+1-))0               *4'9DJ  ',*ZE[@
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M9BA$I$I.) )F)EQY['J*?)T0,Z,Z.85U+W      \\"T(
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M'R     >=YZ"',-30KT8H1 >EQ')N'(-#J3'"<38(N.\/LX!O'>D\@
M      I0=F2T?0-LVSF%=2]P     /.\M "'B*CI#HC0G$B4FXFDI$;YB!,A
M@YUY84Z Q8EXI:>B!4$N@:     'G>3X6.(#)U,/,%*SGK^
M       4H.S/@Z$&=&=G,*ZE[@     >=Y: $ %3#:.C-DD0P(G$O >4QH1P
M6%.H,++C'0&'&:%0CUL/.H])30     \[ST#.:  >>!)AXW%N"*RB)['%2B'
MB(2Y!^@ \A3R6/1LAHA N"5D+''Z5           4H.S-3H09R9P<PKJ7N
M   !YWEH 1<5N,G(>,F) .@.87)* ':F$&1'9&X6*.E,#.S(&/0@\_ST3
M  !YWGH&<T  \\"_95PR\ATF$V#JC #.#J21RO!VAA!,QAY9<W2L1F!UYU!<
M8KB2N8.0*9>348*8:9@8L<@L:0Z6**0E@#'CFGE6>Q))QM WS>.85U+W
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MT    *HF,F5$5F*GH\<H  \\#T]*Q'V=D8:6*,2/DG<RH
M%*#LR5  #F%=2]P     /.\M                "K9!9VQBI#![$G*  //
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M                            'GJ4Y/.$]+R,3&ST;*IEY3"SX)%+G@
M           %*#LR5  #F%=2]P                            -#8.0#
MX-3Z                !2@[,E0  YA74O<    >:QA0
M       !B!EX                  (+.U,Q  -TG@]#P   #SE+5
M                 %1"W8      -0      :        &P5!/34    \Y2U
M0                       !40MV?)\'T?)\GV#4^3=!L& $!&<G:').O-#
MF&IQSY.2;ATIQBR(       !L%03TU    /.4M4
M   5$.050(\*W%XR!C*CI3V4/'(]MRGYQ#S;+$'F 50)=(3)M,4(Z)S,-)?*
MBGI$71/8P        V"H)Z:@   'G*6J                        *B%N
M#"C@G..W-PQLT/D[4R\&P8N5X)*!MGV:  U/@^SZ.@+%        &P5!/34
M   \Y2U0!\FAJ?)J?8                   !40MV
M    ;!4$]-0   #SE+5 '@,?)()$1=4]0@                   "HA;L
M                    V"H)Z:@   'G*6J ,..6="<HZ0E4
M        J(6[                      -@J">FH   !YREJ@:E(#+B/-YM
M;2( S8\=H1]US*G+';D'=4YGR1G1WY@A".B4[K.X*:[,RA-62<R-B,"&CMNM
MCO*D.&!DH$L$M@      %1"R1"A+!TQ$YS3MBQ9H    #&2M!OF:&'G1'?DU
M%3CM28"(#+SIRRY7 X!G1&9/9-   !L%03TU    /.4M4 5Q(G(SNNE"OU6'
MG,,>T2=FQT@#1?G-UA58[8P*R1)7(HI+=TL+-U308<8.0&=/HL'FB,Z@RXLT
M3:       5$,P/,,E<QLP\R(RT]9#L0    "D(.E.J.Q.O)^,',*.08N6.*_
M%ZBF)QSE'6$SEG   #8*@GIJ    ><I:H&IYL]##JH_Q>BY!1B'5,#\\=SV3
MEG%'>=LU#A<_BB6;YU]ZL>DIUQGE':7>G7.\G=^><ZWN)EK/I$Y"YW!4GNGF
M&7\,7'LI9TSZC<D       "HA;L&AH?1N&R?0    !BQ1D[(R\@K9PY<C!?@
M\ZC?+ %:R>3&R]91TX9H806?+<   &P5!/34    \Y2U0!&-G60PJ$V$"G-N
MYM'(NR^C#KL%)PHW)B.;1PXMQX<F4[50I:NQ$]C$RP<\KP=X8M=RSM*,B.LN
ML+0       *B%NP        :E>S9.G.YEM2Y%7..>=.<<XY(!%Y8$@HXQDYT
M!(Q)X  !L%03TU    /.4M4 >6G2PNB)L7J:4;(Z[)^^6(O[IL7P1P.Y36O#
MZ&<7=E.B$NN8SS07E$Y7>M_,\2.CFD.M[Z8[6L(2*X&=%!.^>XA(?#%P[**]
M4^X?'        J(6[        !CYY?G/,W*_;-OIGDX/0WGCSQZ)XM(L)DJH
M6O(9/40\S#KCN"-RXA>L   V"H)Z:@   'G*6J *7RD>$'%JRNQP)2-".Y9_
M#*Y0TB0(GLS>EM$0PX4K50K+,2G$XR6K-HIR9@;LHF,FA:4JC*\,       !
M40MV        #AE1@=D9P13+*H<\PR6[#NSKS,2'RWY5@Z0L&1:2.3J   ;!
M4$]-0   #SE+5 %1RMI'W7/H;E$+8HB,<,6]"9SX(PPJ[W3Z#<$9%HK)T3B?
M'$>[)/O/IES1Y)],YK6+\X)/(H.F(I*F^A,E\$9G"RYCI<8       %1"W8
M       .A**'9G3$2F;'4EW2K1@9(A"Q9<C(O:4B-\P\Z(MJ6I   -@J">FH
M   !YREJ@"BI\F!%R2%S#CE$?DD&4$ V2U5F9Q3H"$#*"ZA024Q$T0G\CDA4
MRXB(C@R,M&5V+S@       J(6[        !CQ58WC*C$3 C)BQQ4@YI,!#Y(
M9CY:TJZ=49>1P3J6%   -@J">FH   !YREJ@"OAA)%Y;XK8=&=J8R2R8;*#N
MV;J\,;! IT!T)FI<\I)TN+5.>"83I2'SIR$"03+B4B+"[P       *B%NP
M      ?12DWSH3BG>' )4,>,7-#&R?B!"ZY3\VSM#KR8BPP  !L%03TU
M/.4M4 >;I@Y'YZ+$'D1G0D=$R'<E4"WAG!&ACI7HE,],CR$)S+O$U$+&$&^5
M'.(9:6P*U'ID       "HA;L        &*E&#M#+R"CB&\7Y/.\U+!E:">3&
MB]Y1HXYJ1^6D+;@  &P5!/34    \Y2U0!!!R2)+K%U0+#;,T,:T2'FZXC31
M,N;;E'MG=488;!8P@VSEBJ>S>*TFANG .Y)9(J+2@       J(6[
M *S'P=,9@8T=T;AVIT1PCZ)#(=+,E?#JR23$20"80  #8*@GIJ    ><I:H
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MKTH/A>#F6+L\]]738.RT=ELLOBA?-U&R5:+44:E!^ATN"R\('ZESN5,@
M    *B%NP        =>4<.(="=1H^9<+);4A0CPRPC(L^0B7V*6'1G-,9+'E
MK@  #8*@GIJ    ><Y:L T -0 #4^34&A]&AH#4T-#Z-30T /HT
M*@ENP        #Y-0  :FAJ:'V?(- #4T-0  #8*@GIJ    >?1&X
M                -#$#T-!H5\,J.R-@D\  C,DDW2LIFY,( ,>.K,U
M     !L%03TU                         (D*&'IF=V #0\Z"U8/DK41R
M2*"S  !%A*!NE.R6B:  82#-@          ;!3X]-0  4U.*;978F(OZ>=!Q
MCE'8$BD/FP6?*"EVB$"Z91<G,C ZXL\4N+C%.2V164NR5).H+#F$'"(Y+NE.
M3Y+PF<   I@>(!^DHD0  \^B,@                      7L)F  !"A#QW
MI70F LV5/(P,A.W,..[..3:4M)U,++;D-GT0J;9=4J$77//HD8YA; J<=(2"
M;A.12(F(C@Q\]-#.   ;9]&IJ              0L4*.R+"$"G8&<D*GV=N;
MYQ2;BNY:$K@90=H1H9J<(BLE8].0  :'GL8N6/*OEGBL)8@@DR@S\@8L\5A+
M-E8B8SI".RS!64L.5Y+%$#';$G$$EARO!9TK"2>:$7ECBNA8HKJ3P1:=43,0
M06,*YEFBLYFYE!#A9@K26>*P$UF'&,D\%="SA6,LZ5T,H,H(>+-E8RV)4LF8
MQ<Q4GDKJ6<*R$DGE(2T7E*B$B$!%L"@Q?@IH?)?4\WSTJ**$^D'&4G2F%$HD
M1'OT9^  :'R:GR?1LF\?!] ^C0VC=-  #Y/LVS< /DT.G,*.S-TS8P@U-TZH
MR\[DP0VS>,W,6.N,Z.L.A.U,1,K.[,#.X.6<DT,6.*=R9@8:?!UYLG+,].@.
MK-PRTQL^#$3<)..2;9N'CT9V0R6L.*58)I,#,2)]*<GI(><1=HDH\YP6Y(<)
M<,'.M)S/0\^P               8@?D1.Y+!'Z6CQ:/*$L.=\7I/1,_->=00
MV?K//,$H<?J(/( \N#T8/+X]<#UH/QI$[%QC] )YM'YR"^) A^Q<_,*="0&0
MV3X?J_/"H\G2S!^MH_,*=65C+.'JJ>G1N J>=F?!VAE1@1R#MB.C+3F&8D='
M2DLF.&/F:$/$SF(&%DO$X   '5G0@           &AH:GR?1\'T#0^S0'R?0
M-3Y!J?)] &@!J:GR ?)N'R:@T-0?)]&A]'R#0^CX/H^@           <HR<U
M  /DIZ20                 "+C;)2.M*DF>$JF)F3$6EBR%"/RV0*]E@#Y
M(S.>9B8.=V928B<\[HPHR$[\PDS0T,+,Q.L,.)!/L^3</+0Z\&X<D   XI\
M   '!/;$S@  T*T%F                  4D/(,]ARXY^>(Q [4B,]D3&3S
ML++&A[7@H^985X)7(,/DE,GHJR8Z9:<4G JR>GYYXER"O16LL.2 0B3D860L
M348N6G!1(P0  ').&>E8   !64M\28  :%:"S                  (J/RP
MGZ-"WX/,L\8C]:(/&0K.=,6'/<4%,"I9>,PXJV86>II\%&CKS-".#*R3S+2W
MIY!F4%@"W! !7 L,8R2*2 4P+3@J"6^  !SCS'/2H&)@ '?'.*REOB3  #0K
M068-@\1RT1AA\DG$8'V9F1X7&*NG&(B.Y+FD*DVE6"=SS8/T#'*
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M,4O\9Z"'RGIZ1 %/3[+?@  'R?!N&H        !YT%IP5!+?   YQYCGI4
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M!ES   <0X!W164IB>MI-8 -"M!9@'1&\:FP:FZ<XZP^#=.0=D
M                    #S-)L!H:@  &AJ    0.0\>H)+P -"M!9@ K2<([
M8D$S4[<                                            $6GFL>F))
M0 -"M!9@ IT>0A:LR$]&26P
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MMGT?1O@    &R:&IM&^;!]G(     !%AODF  &A6@LP
M                               "+#?),  -"M!9@
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M/S1'1&9EW#TA/SLF^<8]5"[)ODF  &A6@LP #0&H !H:@T-0   #0&H
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M!#I;<@X[DJN9T=^;)8XQDZ$QTJT>QQW8   -LH$80>G *0$*'J4 4/(E/4H
M^3RC/HS4XY.Y')DI(I6,[PE<K 6I(,+'%,R=#N#O3<*\$;EYB$B=2S
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M>/1>DM""K91L]B #ST.E/24 ^2)#DG/,>-PZLEL[L
MBPWR3  #0K068.&0N9@140H2,=P8J84=N923*8^"("Q1&1T)WAG!$!LG8'=G
M>GT3Z<H   &V>'!> O6"EQYYGNZ >7IA1Z[@
MBPWR3  #0K068 *1$%G0E^3$""S9)R.A(#),,A(S)<(T)B-TJ>6",(,U.486
M3 4X,O/3@Y                                  (L-\DP  T*T%F "J
MA&I,Q5$MB4W)D(?.K)[),*?DWDDD<$H$0G='),1,U."8Z=F90;AEI90
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M8;Y)@ !H5H+,
M BPWR3  #0K068                        !44JN>A9$1(I$9,!%YRC(3
MMSX.*=$8X9(9H1R<\Q@SDZ@WSKSDF3G-.Z)<         !%AODF  &A6@LP
M                       "OY2\N.022<0R61*[$^GR=L<0ZHY)@1*YSR/#
MOSF'9G1G6'=&&$GG!.W)A         !%AODF  &A6@LP
M        "OQ7,R<B0M<1R=02^6//H                   BPWR3  #0K06
M8                                                !%AODF  ZDB
M,QDLP                                                "+#?),
M!'YYDEWBS                  *GGFZ7Z+L \>2 C] 8
M           !%AODF  XQ6 [ LP                 #CF*G:'? Z@QPSH
M                          BPWR3  = >;!:XLP<0A@D4W3#C(3M#$C+3
M4Q@[0R(P [8XIV)S#'3)S)0      #Y/)<OD3P"NI2<]8@
M            "+#?), !QBEY()9@Z\IV8D6-*V&5DP'<%4C/R-BT!B!CIA!,
M9VI5$L60\>AX      !MGA$7./1,%$CSR/?H
M   BPWR3  8R4/)^+,                  '&.2 #CG(
M            (L-\DP  T*T%F
M              18;Y)@ .,00=*6:
M                 !%AODF  ^"HYVQ:4
M                     $6&^28 #&3R]+H%F#8(S,O.<8^9(<$Q8S$^3AG-
M.*=89"<8Z\YQQS=.P,#,S.M-H[,Y!UQUQVQVQTYL').V,0-PXIV1W1L&ATAL
MF^=@?1DI]                        $6&^28 # 3SG+?%F#JRAYTA.Y3(
MM61"<LEXY970G4K"3.=P069Z3^0\8:6/*ODGG+,0.W,H-TP$CLOH4.,J)/,U
M*O$DG'-@G,PLR0A4L$00=L8&>@IE8                       !%AODF
MQD\/CU/+,'1GE>9:9R1>308F3"1Z=P<@K8>BA0HD4ALR$L:5@,4+7D&$R&!'
M0&?&#G++%F"D9&,$PD4$U$6&0F2$F$.$:FV9L=T63)T- :@
M          $6&^28 #'SR1+YEE#ISS+.X.\,++8%7SB%E2HA.!WQ@I(! QE1
MFAW1@!A1DIQC*"$2;#F$0DB&($G&$G>%A2QAH?)J?1\@T/L^3Z/LU
M                  !%QS"3  8.>/Y<\E@VCCG(/HZPXQD!MGV8\=Z?9\GT
M=:=B#4ZTYIN&R;)S#Y."=B#:/L&H/H
MU- 8>3J28 #ICPI/18FD%8S.@           182H:  XQ(1E(      !!AV(
M           !UAV8 !NDN@  %;"ANB5]YQ'DB"S/S*CUI,$)=), !T!2(R,F
MD%0RW@           *@%PCX !U1@Q)P      !44MT            8:9D
M0^3    1B4A,].NLT.DAF$+SF%DNDF   I,32"H9;P           %0"X1\
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MGP[TGDG,    HB5B+(%^P        # B8230 #0K:<<    T-0     #0U
M           !H:@ &AJ                   ;!9@Y0
M
M
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M_P#MH0_*)U1_XW]6OS/6?^<=/#\M>('HH@>+7] RD^Z#Z"S_ ,X[?\"Z=_\
M;0A^43JC_P ;^K7YGK/_ #CIX?EKQ ]%$#Q:_"/>15K4,7QG(.OC.0=;9G;S
M?9*IR?\ '0C9(MFS#XWJMN[9==.7D)C5QZCN%<WP!/@23<Y'HH<?[9A/SB0^
MGN<IT<ML,>/E8X^>7&,G)*Z>K//D^BCQSIT0I<!>;P1] [B0\FRN?&<@Z^,Y
M!U\9R#KXSD'7QG(.OC.0=?&<@Z^,Y!T=)G[\= _@[U^1L=:4GW0?04KV583,
MQF&A].Y;6_;#HUP0X+>I7M[$-D8:$\NK5D8=2+2M::8;+Q6$ANAFX[H6_1-,
MO^7QHL^0TZGDS_C'/;7QCGMKXQSVU\8Y[:^,<]M;1>GQO;L5#:H2, 'I'/\
M<8Z/]CG9VMSB?XLN,5P<GI)FY_KKS&AX..!;FB,2$:.<B  QG:)^'.'80XZ8
MJ\RL@%227(_QL0>XK8&Y\O7ZHSFY0>.R$G'+ I$9$@0.35I^%08BO!813&A4
MP"J>0D"D463*B2<53G2XT17.+)X>(AL6%,,G4\VBQ4EJ2IC.^EFVZE]NEU=1
M6NC,@[A(G9B3/Z#2Z\K-RV^KH_S'H.6W[9B5_C^M*3[H/Y09_E'!'@/U4_\
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M$21+MEI,S(+S5FG+5LN9T2CE&X[%&7TWG$:PG,J5:F=)T2WD\$I*72VFVU\
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M2$8.+N6I6(K%X^CX@%;C"'A:0#Z1>+66[D6GEQ92WSVL%$0ELUC)_'*<&NG
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M/G\B382!MR#9QF9 OY'*Y,KVOR)KTP5X73HVC.'QS*/&?OX;DH^W>"/ =RG
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MVR'8R1024",4,3@Z-B$,8K'9'N#D-QCM+?'W#US+ZS&B&!C(DH[8M8;> 4:
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MZ^7^SX:/M=^A&7SH]%/U)3>*&],@K2@(0K6WB:BKOKC'<^<UXW Q -CF;?\
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M7-GCTS<AS+L3BEMK0]274D,D>PB4&NF,+C^PV:(62-))X.2I#_W\&+O"#-=
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MI]%:V[3-(%)DT2CU@7*#L70^T9#@>+<?6Q(T8A 61B*"I&L8QR)Z)$V(X^)
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M2&GPP(V,^%!;"&4YLX0]2OZ#+QOTO^U_Q$>\=X;[MEI7'M%VV89/VJ*DLO\
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M<P'9KIU]K^)LK>?,E)B6:E]-[:VRM2CS"_Q-+V>_Z&M*8FROY\Q=C]#),?\
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M>_\ BX7&"6@(_P!7;C_\8#W\L"$F+H4_7/-+#KBB!/,\KP XEZPZN */B B
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MG:3./@C0ZI#.K;HEK28+HI2#Z'JT> +EAV!U (N^=J-613F @+"H($X1[?\
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MI_LNZ0'6FBF0_+X=YAX=12@;I\1\/1QVPBL@BL).Y)R)?-3(ITB;+KD B7K
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M44IZ\=!5L^I+,RCQ27D2-VZXG=H0B R$J_\ *5<KG*8I.29$DRQ&RP^D):K
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M^434E2Q\D"3LZ(@")!3Y*'\!$H (\/%Z!78&FNI A&3^:H7=#$4]1\T14%5
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M P<YN=[?MORO:H6OR186P2.7WJO7)O"22R8K(,992"D'IHYRZ0 3I J!/-(
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MRE=(KZ><T3?:K2W(WGMMK>FA69FGIWJU+WU?,K&LZ*Y%1%63D$&_DL&4=(J
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M\@$X@)N0F$ Y?\H_/'@O2!B] B)>E0X<N?+P\#?4\B@'+T<O#T< )$P*(<P
M2B8! !'F)0$! 0*/SO1QRYJ"'YJJH\_<\>9QZOS>?IX$P&5YB(B/-=8P<Q
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M>DR@]($ 3F^J,($*!0$?<  ]S@3B"G4(=(B"RQ1$!$H\AY*!X>]#@0-Y@@8
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M4!8AE%1/5[Q6&<TA-T\.X$L*5Y.KN6B*7<QJ4-LNHHG; 4J*Y'%Y@&IHXI@
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M5%%(ZI<('T<L1R(HAS >0DSNMD$!Y>'/F7YIE^VD/UTO&&_M6^_TI7?\M/\
M[BJ__$*T_)Y_^?NA_<'CT!_Y_P#T?R?0' <@ .7HY!Z/H?.X] ?^?A_<X^@
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M^93!_P#(5>#[XI@\"VFK&,/B >!2^(CZ #AES 0_P)GZ0Y>ALD _G#\T4!$
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M=6AW.O3^ABRR6WZ^XI(QC,&D?-1YTEE$6C-N"AB:!<DS]T;W8KC;L1URZ0]
MV+!(V&T^S_[']#SF9A4W4S9(<*8%-W&E/C6+U=-2/>QRL29%I,I)."(ZG>U(
MFQ9W?*=F&QM%R22L2ZD8ZZYU"6>&=V&*?5\/8\M"N;#!B^BW;9)N5RV,D<6[
M<QC-T\NO$U?NY2KT8W;_ &:Z));;IN+VQC>NY*;IF/.*A)V%',&,G+G[>IF5
MDYAW'0Y21[ML=@\%PW:(N4&9XXZDGMT=048C//NM0VT:CA%MU6UV%H\B#=Q"
MN S=#37AJ@PMS$$BT0TD]C0CC(2X*-XWUR.%OW#04OJ9](PSMLF)O'J)9XV4
M1E5M&O=XF6^D6UII"J+!-DI>.VF&]G48I6KI<JHJ.7#D$'BR[=OW0.X-/N*E
M8R7D!3RISF>K]O=?R]')5YW,R0D1G-,MI(71HO?8*(1LRLJ]>R]?C7W4)"2:
MWK#'U [^W:!M)--JG;=@],<UJNZ)C\8O?[TS[@M4;]S,Y 2CR/EX FTR?;0V
M@&]1FG[AG#)S#U%TKTO$E7#;8G;2#WY2J.L:[VY>^T21U7M\)5*W Z)L7<7H
M=MT/<I"+?&3OUUL6+WR.<F;PT3+MU7[,Z;1:$= 9=;"2D'F0N)9$!!Z0+S(&
M=5OI'I#P 1+\[P^:9?MI#]=+QAO[5OO]*5W_ "VNPEET??,X;UCLLDY=N]P+
M9[=BTS+*/=X9LE&-BE:@L@YG(I(I042;K]2:2O,Q0 QA'C\:3Y2'X^>V?O[C
M\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y
M2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^
M>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O
M[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:
M3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'
MX^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V
M_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C
M\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y2'X^>V_O[C\:3Y
M2'X^>V_O[CNJT&*[A^^RSR%0RU:9;5W1N\?7+U1II5*PP+9-G9ZA+O\ V58(
MTIG7F>KN"G2%0A3"7F!1!H).Z[Y2=/S&;54Q4^_C<@(!E4@/T$)[2$"))%$"
M$*'H*4 X_&R^4J^/SN/\8\?C9?*5?'YW'^,>/QLOE*OC\[C_ !CQ^-E\I5\?
MG<?XQX_&R^4J^/SN/\8\=J^E9IW2]]LK,2_?;V@YE-PNF=X&MZ+39VEZ'K$=
M#VR#FJI.2?LJ492L8F**A%B'(8AA 0Y"(#7;'*T>:T:2LK:^OXVIUIXJA/NH
MW.*>\O%I?MDDH:711CXN"8J*NGSXS&*8AT"Z=H@HGU71]*Y#:PIM2S^^W@L\
MRM%87F98V=]I.5]X<_"IUE95F,>8]!UAG&MWBKX$3RJ"@F*1J)5Q[I*A<(NI
MP43E)<'&I5^K6&(NA(XNB9>-UE_:%NAVL:G++.73E(Q$SMTA1('4F95%5)4V
MI9RCDELOSC+62*<M-P,D$5##:7E8I%NC:8\EIV$:5MC8'T'>FRXM4I)X^:(%
M*N\;-D7+4ZSN(E,.FU7U=L^VUW0Q87ZOG85EKB&G]OV83DO!O'4<P=VP)J2[
MC8=9FW!NP5*1HY*J9,02,H>4+G5@66^YA$Z0C7TIV)D)==>?[FS]K]6IA(^!
M:S,BM8;3=R K')IM%0>@/JJ9#+E.4KV<CH)6H9Q-=KG;WL54IDNE%.+56[+H
M&G]T-#N3"8GH9VZCY5H1''(XK8B(^2B!#F >:@E)W)A,9399^O\ ;B;M]B)*
M;A9AJY?VRX]R%D@Z[3(&$JK",E9XK"%-/)+23P$UUQ( $9-'BPF2)*HM,.N$
M7&5B_P"#9I:_;\\TK5Y967?KY+9U77<%E5PAZM=IFN0DW&>M/57B,2_&*%5P
MDS.=JX03R7*ZGAT@%HVK*X?<:@[6U&D2,%%9;9JG>+5 /[B[@"2KR%NXI45P
M@]@4T' M%5T!!TJ053)=LE3U&A0-*O7<%A^>Z7%3L5:C*TNT6*TYT^T&9KM#
M2?1QDUI2$BXPZ[F#>2Q+ W;*"NBV>L&Z\@&2Q#K.;EI5AV69ND+6X>HL)V14
M0&CTU[<I=1VUJE:NEI75=,VQ46Y6D4X2(8YEG2K9LDHL6P-I[)-+O+"Y6GX2
M9E6*O3'B%MI62PG;!VD:_:XZXQL!&V5=Q=(Z>[@G E%T#"*(B@9)Q(-O+1\V
MAZ[1LOKB%,L^N0<$=O:=&K;^YR68HR^OPMKDE*97'BDE1;@+S*5 8$?G>,.I
MP9%54'2"Z"4IH=GP^4!E3>W'&^YS185MI50)-0U&W:YV*GT2$IR,@V8MM"M[
M=2M++2B"*C)HU460;-W+M=9(IQMMOS^V4IO1W,1:;O7:[.4NXDM-&LO9GMW=
M1#QPS,DG!HQ,BUB\M,@OY!B<I$B12N5&*KDY<_9VC(7$[,VI2/<3\'F>DUO2
M$J177FM5O'VMID[35XQ[4T8@;#9FXD"1>Q#E1=-1HDFJY(*?&G:YW-19;=%0
M6ZW[&ZQ.T&(B8! ML@LDI%ZS;,G,6=X;URS[39I20A8%\*A&QII1DR6!,7*1
MQMVH)T>5M\E2Z-,75]GE:<)N++-G@8=2:DJ[6G"Z2+5_-'1;*I-2*$1*Z7 A
M.I/KYE>7VJTVSW^DV"RHTS'&<(=%RGLKAD.I+2U^H00,)9IYU!OU\PF$$S.&
MY&#=E%J23IPS:"X53R??XZ(DX6)U'+*9J,+$2AVB\Y#0EVK,;;&D.^>-%UF[
MATW;/4RK&14]764('+F4 Y1JB.,[M3HVTUVE6>D3"V4:E:8B887F9L,.Q),R
ML+GJ<;7V\,>%24DIA):0JK--X3JE^HABC#W>8P)]5:V^R+MOW24>OM6J#TT!
MG?='9K34,X</"-X\C=><82U0>.)A$JQ8]G& 19-\LL86Q;18\YH]KR^QUFT.
M82.5M4/%R\1;FUB[.-I[E<_L3EA;(ZK6V)K"[7/4E2@,>W>.3B@8G4Q<'6'4
M-LFX][+U[),[MFCS<7%'8IR<E$4Z#?6"38QAY%W'QJ3]TV8G(B*ZR2)5!#J,
M4O,0MW;8SR \);,TK[BPZ19FNF5*WTN+169T63@F=4DX!N9S<'DFPT%D+CJ1
MCR,%$G!%!.)$?6(C[E<)27#VSXIW@WIQ-VI4 >0D]A6&.](IBD0P6.G'3R"T
MXD<7;-R)"KH$$A%4!$5>)#/+5V\7Z7TZ ?Z"SF*Q1)![?V9FN;X_A>P2:\6_
MI=-FI1T\D8K?X=DGYT8TB6KQNZ%U((-RH++WS9*JD9I)0^*VO2J>>>C3)JL7
M)*"]M$.29B5U0 BS=5-(CMN93QZ3IF'D)N)&Y5[):VO>XN/) M+1;+<T9T^T
MWFF(8.MHTD]K4&V)(5NMOFVP*#&']<4< NS$%D"HBF<]LS>$[>])E)>!U.\8
MI$RPFDHVG36E4'8JKBLI%N;]*U)G0F45)6*P.7;)=E*2KT&$>/KC-DX630"X
MV.VXC9(Z$KT#W/2\&K"6V)M<G9U^U;N(HO;3=6H0L9$I2$:A/WB_M7$2)"NW
MJ[!!<5&B:P(HK:]3%\S'-J'F^<4.9(%Q"R5[0BW29TS:Z3,"XKMJK];DEJ5,
MQF=,W48X<L(IXW4%5-=%118$VMAC<\T+[EMN50;.(B]EJ<+>?8OJ+QN^>!\%
M["LVAY4)./;JM.2RB?E@OYA# H0H\99=MG24W&\SW9DCWTZ78(\*+C3"!S-\
MI6B/J31*MY[\;I:X)[-+),TCF9 \(1$JSDCET@D:Y:E%4J6T5Y7:Z-@;4.+D
MX&"FK2KS;%0AXQ]:Y&,@V,BOZP $*NJ J&#RB%45.0AJR%5K"$[-:)K%9P^"
MJCJVQ58A*A?#U;;KO:F5QL5AKT/;ZQ*P4)CKUL[@Y2!1F6\D+5J1H4%Q5"DU
MJ/Q>>I</?;+H5(AK.]O-7L3=2TYME]*U>Q($9P*9A6@E:[=VZ32237,FX<$$
M2)BD(*<!8IB,,ZC!AM%G5>F3CXI)(F?9S;M.D07=RBJ30BTJSJZS<JIS !7"
MY3J#T ;E7J^GDDHUKT[K>)XP>91O56>VAA:=U[=JGW%5B25STA$IA:I0T#;4
MV$D]*N54BS5RY1;K-&ZZB5"G,B>Q<18;7M^>469G'T;&R[N*I;UK8K/:S0,9
M-",(\L,E&58S%J+P!00%T*O+K(0Q>\7MW2QPR5_E^V'N(93+QAJE3GJ= UIS
MV=3.XEL"=ACF .99ZC694&IHXC-$YG?EG36.S6*\#"?S,1R$ Y#SYE#.JT!1
MY\@^J+R'YIE^VD/UTO&&_M6^_P!*5W_+3_[BJ_\ Q"M/[2]Z_P#(JZ_[5U;A
MC_FYA^YB_-=I'_RROL*_IJ9\52=[Q&&3R%7CK2#JD)ZC3H^]BWM;6+?.G$A6
M8!>$L,D9['02#E=XX;-A(U8IJ*N#$1*8P2E/G4,FSN>K]^89U5WS^MUD[*UJ
MW/#L-4+;*K)0:$THTH$AEN@5"K+S4D+"/%-LWCA4,W3;=;'MMQYSCV=WN]ZF
MQRR9HN-9V2.:)7]"MV.60:6Y6CUM*)2"+95YU'K.5%521L@=-HY% PG!.I6X
MLMVN733=_23@ZM;'U0K+RV:6QJAD&$4R^$K^O%D9.)]=2(QBC.' -Y)ZW%FS
M,NNW,BFYLL;;.WRT5>5E9P;A:W<?66,*R;W2H3.WSMGFY"S,HL)N+N3?MZ!\
MY<M1>B]D:RD*G4M'&\C2=PIV<]M$OD&BQ%KE]DNK7-:8RA;6PKD\YLMR^Z@D
MYKS-X[?0=JB5)!ZVE40=-I)OYQB%7*!N+5:J).9GE%;C+RCAS*SMJFTJB%S&
M J$%N,FWA8J#C2S["C9Z?<'1Y-6491C2!E7KP[@J17!5E[1&RM=IC/[M<.C&
MW&NZ9 TTSK3XV%K5KDTX^X1HN)UM(LX.D5*0>MDY4X)C$I'5;^8DFKY6A;M6
M;7A(3= SJAW:/EG%0@6=?P3-J97HJFMI;)YKX%L#5**%EHD>6>2CWJIV+N42
M!RFV,N)30,UV]P.)M;%?7.M:C#.:'08BKV66DHFP16<;'=7*3>NQ,RREU9Y^
MUBI1R[*BX=B8$_LA"FY9HPML-VW8CJR%?DR9:Y"AU>M6&O5"V6YTPGG4--Q5
M>(-/ITG=+4NG(NSKM(\CR5/YZA1=?9*_F_<*TRZ5-*Z3JL-5LVWBNU:>35L6
M#7[0,SF;F5E))V& KT=(2M#F#P;]ZNS5D&I54TP\XJR!#WZ:>]O%HJE4V>LE
M)+2N>,I8\/M*%$8)U&>81[VJ+RB4LWRZGMS,9AN@+5.N1!3D< Q9B9/7LCI-
M9[<[;I%CF$K]L]?A*!5)!>\V.JO(M4]LLDNG7C1=]L=+E;0T%VY3=/7D.\D"
M@X%!5<0/.YCLM.R:.LW:A.5G,JC==1S:HNFU;LLM4H>UK53*B+Q\G<6%:J58
M>,EI2609,Z_&&Z .Z(()F/HSZZ5&J9DEEDO%0\I:[I1:HDC,V&&O'<CVDUB'
MI",$>P6"SR[>'QBVL&;5NS.L%2D!*!0;JNT$:@X;0?:.YI685#7)#/$4*+03
MQ-.I6?PU>N6SN:''IP @RAJY$W2,DI<8U/H)[126-S.H!N,TIEX<367PC>85
M[OW&3XS1:O7J9L1L4M69Q\3.Z?.&K2;-).AV>0A+"B4LM#*N0@R Y6511(U6
MHTNIO]'39WZ>F:W53F7E$'+B9K4_%5*QHRK!6-3D:PQAK%.LF3MW*HLFB"KY
M #*E\Y,3,J=O5&P> S&GUBIV=)"^T^CN*/6(]CH;"F4%&.K;N,=^HG2OM\!!
M@9NS*BFZD3D X'6$IHIG2M;H4=7$,NN.FUBFT^,?HJ-:%GXW%*?1B:FUBFOL
M%\SD*#.,VD*LDS>.'L2[;-VYE&RI"6:6PB8QJB3F@P"6KZ&SJN?$S^R2,;,T
M*4V%&6T5JWJ\4[).'H'KLV+=Z8SDS4JZY2G 3G,WJLO9\08/T<XQ9U'U"%I[
M:;>ES1G,L)'#HUI78* >J*1%5->4YF'ADDC.HV,>GDD6I&YC+# 4V3@>V+)#
M66T:!!1%2/3:'$LEY"AW/0,-F9>52K<4M!5YO*S,I.0;1:4.T4=#).HT %8[
MAJ$E;'&[T2<S_P"%45FKXQ$9F8&7L=FK3ZUP]<;5M"'=35C;6&GQSN01,V:.
M&;J,:N%BG,B@L8E?TJ*B,8Q/.G<2G"5&;HU/AHEG*0UG5<WH\756-*A59&88
MRYD5YMPDR16*=-!5ZJ'0DHJ53.=-L6$WYS4XJ0T2J-=-9569@W%2>Y;&6Z5T
M&GSD^B[KY(QSD]]]8<B1RB_"%5<+K(@RYJC:;"[==N>N0E1MU-T&VDM%(AYN
M0A[Q8BP68T*X24!9ZV,Z6Q6%DRBH6,=^K"L]9>I((F.W.W VFY31;I5-#?TI
M)U7=%JC=LXD(A)F[<2M9DHL3/6)8&QQ)9"+>1KT&*CML@Y24;+"10!3X:5)\
M\PJ&AKSIVOX.SI%\H,=6T+/;X*P1>3:=&.*_8J\W9.*U9Y-G%18R2Y"QTJ"K
M!J94S@4VY;(;[G.'5G6G<7CKJT/$,]K;&\2,/-WEE4,85?R2$&$O)LOA_3F;
M6.$%% :/8YJ)_+%- P%CFMEQVW1LWI$MV^2Z-=IK>QL"37<K9;!*7!.9!.#%
MBXS'6+A19!Q.SR8N*_)R+ 5'#A15/J+[9[?ZE@,]%9*PBJ<V>TO/8**-38%K
M.1FJUIC%>77HUVA5G5FBVMDB7+8#,'C]N5^T5453\T'CZY[!6HJ/:R%&A5DR
MIS,D]=2>FU.1O5'BF,5%1CZ3F7EFI,4\E4T6R*YBQ[5==0")I',7,*;IANVI
M<^=6PM:P.$LM:H]MCZL:#EZK6(J>SCV;&3\52JNA+2$,T3==;!NS6%F"OE"9
M#GHV$5;1,^UF?J4?+Q^F9VB="PMDH8DH[ILVA-L7;16(F849UNZBUS$%PV,\
M;.&XB*B"Q"#V@9[9*]V_1?W5&-=AX:I8EG%=K5MTBK:IHF9-*BM2M1RR[4&S
ME;Z%"+KL74G#>J*R$K%*,W7M$_DIDQ+MN=42T6CMM!9C*3#..;/;@WGW\>.?
MV6TN;@,%%QL[/305'V+*NXE51LA[/)'&!NDW2:I2N.]S(9DZE:WK5OI]<SO<
M:G 6EM8[=G+IM6GMPJ<&Z;6-HM%J2MF)&,G3@K9RH\=E:@0JKE%-6G=U,'8Z
M&QO_ '.1#;4LLL-WH249H%!H,7F-*P\]9KIAJ*5ERN@EB\S)'IMG[A)H]E3/
M4&2JY#@D&71$QLN56Q6]N:K=LI;SK5=_'OSS4]9J51[O".96'-&Q3*;LL')1
MT3+J*(-W;K[$W6.*Z0*=PT%A#?'8%O=\I[ILFS N1Y.,4QB]:T7M@N]H<O0+
M7JBP-!1VF4FN)((SX%]FS+4J!$W*C9)0Z6$A\[$,@*/T2YS6BC]'Q#YIE^VD
M/UTO&&_M6^_TI7?\M/\ [BJ__$*T_)GKA:9 (BLU>)>SM@EC-)!\G%0T:@9S
M(R2[6*:/I!5LQ;$,JJ*2*@D2*8X@!2F$(2Z5V9;/ZM8XEK/0<RLFZB4)*%?-
M ?LY-)";;QKY)FZ8""Y#*I)]2!@4^H$#<( 99+_"41<(#UE$JR($(IYB9N?2
MH44U"B EY\P$.!.=5--(/+ZEE#E(@453 5,#+&$$BF.)@Y (\_$. 3<&! QC
M@D05^2)5%QZN3=,ZO051P(D$.@!$W,/1Q6:O+V.'C+)<PFAJ4$^?(MI2QA7&
M"<G8!B&BIBJO/8D>L19STA]B(8.?IY<%1,NB18X*"1%14A%C@E^F^6B8P**>
M6'(3=(#T@("/@(<%3]8;@H<0*1(7"(*G.)2'Z"I"<%#*>6H!^D Y]'OO1X\?
M.^CX!Q*90WM<.OID)3(;1)>BIKG&QQ]'L4Y*5J#M#AD*8![)DIZ$=M4SE,80
M50-U 4!*)H>LN'I2SD\QGI&+8)I++'6:5DL,>:.LHD0Z3,[4E@:&*18Q#K J
M/E@;H/TP&7NY<I+Q9ZM<+G"PI&KQ<'5=H,K4X2V/%I!!!2-8K14G>(M/U==5
M-PMZSU)$.5-02"5%9)<Y3)E,FW5375(*R954>M-$YS%!5,X"7GZ>?AP(HJIK
M%*8Y#G1.54A%$Q$#)'.F)BD5 P<ND1Y\^!505(ND!%#BJ@8%DNE$%!5'S4Q,
MGS3\HW,.?,!*//T<%$AB'(<A5$U$S%4253/]0HDH03$43. >!BB("'%>"T3K
M"#&VVJ'H]9!\=0HS=PL/K/L.N,0235$\G*^I*^24W24WEFYF#EQ-6^PEF5(B
M!8GD'J%<KD_<)]PB19%#R8:K56.E[)8) ZBY>ELQ:N'!B\S 00*(@7SUT6_4
M #_A*A&XE$0((E."PD$ARBH "4>0E$>0\=1C 0!420+YH@D)EU^8)($!3I$Z
MZ@E'D0.9A$!\/#@?2 @(E$!#D("4>0@(#[H"'%$P^=M1FNI:2*_P2JR$#9)#
MUE-&"LMD26EIN/B'-=K:<C#TZ459>T7;4SX6"Q4 4,00X 0] ^(?\OY9WK_R
M*NO^U=6X8_YN8?N8OS"$LM6+[;//D2L!89]4GEVED#+)*.4W+F*CCM5648BD
MB)#KF.?[,<@"!>LO.Y&?Y[?,_;UZ?1CH,E_K;NK25EA%XF/=IS[6.=KN#D3]
MI*.FRB8F R944CB'V4>7:1_\LK["OZ:F?&6+R%ODZ-:LAL5DG*I.-H9G9HE=
MM<JTXJ5GAI^MNY"&&19OHU=-5%1%ZV5;N6Q#<U$S*)'96:/OMBB(WV-7:).5
M=[4ZE-UZ4R:MYQB^<MZ<VC@]D,HN=!KC:+M*3\APT3]I+('CE$D4 +'O:CW.
MV]& RWN&L_<32,G<5/+9MIG\WM:>NJ;+7)R42C6=PFHK3H_:IX8E5\NFM!)*
MI&;^L"ES-B$:UV706=0RS,.V#,= J:,+2%6FQQ/9G;WNE8!)OYF2CWDYG[V!
MT"6=OI0D.X(C*-E :F\HI 5'*H,^V7UW!4/#L%RRK3]<1ISD99KA.>]P53HM
M^:.56\I"J/)&0[@5)I9$I%F"ZD0W1 #(+K]=LR'2-?LNBVJ\0-MBY_6CU:B5
M"9;R-J!V"$A U"LQ#6IL658!=(&3=RF]55(W*#Q=V8ZIS#>]'[BKA;M7D]"M
MMPM5TD,XH#*&G:_?LQQ7++;24*'!K1D1&LSQ6$0SIB\%PX.@J9=-RD^34$@3
MN1(ZEIZ,;)N,L5AK-#&@:]:*BTSJ%NU*EXZ >1[<6J26BY=I$[6)83)>]C)1
M<4/+5$AR:U:&=\EHF'T ]A7J-<94VL>=EY[C::C:;2PK\X9<!>UY<]1*T8L?
M5FOJ;9R)%5G0(I=/=#N<4^@*99]3O>*5RBQLF^;V]E&8KG4A!OM5EV+%)HDE
M59?;7#R5%5HCU.$7;-@[<*G6 "('L+_5$\JP6X]LRG;OIPM&U*DI;2&EWUID
M^F<P1+;F:KBJJ6N 4]0:S,>KZVDL].FDBHX%LHA7-#GM6M,$N[MER4<LW1*N
MU<2\O9]XUSN&S!E19=\J<]4MN<WC7)!%B\30D'L@T:("5-LY3,Y'3,^BNXZS
M0,W>)#,+<_U]#/:#!S]-L&0U2;I;*[P3]BZ8S$9<GE4?I.7-A5E#2X2S91=5
MVJP<*1@3_<#3]9DM1(,KH[R(9RZ=7F92O7'6UV$SJ<A*7>%<J^TE9]^HH[39
MI,HXZ /^2QW!"(@30]1I6_W?,+KJ,U>FMC.RJE'M<2XS74,E[?\ ,M"SEC%6
MELX!K(2+?MRA91A-(F(\CW)W!#)N&Y_+!QH^>[S>:%I<7?!O^>V?X)T>RQE+
MEG&@]VULD8]Y5)ULM'6J+E:WWA3\$8JJK==)-BS=I*IN 4ZE)L=&L-@>1+[M
MP"TLD6U-<KOGV-UI&.NS&;&/;MD(\_<=4"5Y.SMQ1+Y+2*:*1OJWF$.6I.GV
MG63/CQ%'OF>6&.@H2N32-LIEUN.1:%(-Q":_PB&?L;?BT(9-R@903-07;F((
M+ H25T&:TBT-E[9=M4E+M"/:Q69R$G*)K5CJUHFZ4W8.W""#%]"R58Y1\PN1
M_P DWJQ7#)?H1$E9MKNT34(O7B90DBS8,HQRU.3)NX+-NX2-,J9YR6!27F,T
M0BU1)R\EJ[45)R5(3G!3S+:-!K31"S]QTU=VE=@:1&SVBU_N'ONOZ+)Y],W5
M)E[>/1(2:V-U_P!&/32#-RO%L7B*+%Z19RM*9NAW+7MA;)ZWQ]DE=099]GGK
MAV;7M*A.S"2B"4V10D:J3VKD\-YZ3H4E#M9145BIF( I&LB.>=RF@TJI6>%R
M^1D:26A9=8(P^QX]G>7Y=2]2/+3$.K9?91:IC\&+JN(/4&;A\@=05P144;GT
M:J(;_HE6J6]C;HO?:S&5G/GYM'KDUW"ZWW)5R$@96:9NY;/GE2LVRS3!1XP.
MJK)Q*B8J$3<HD<IZ)"1VGR\++W-KV_)Q<\_HU0L(T^1P'-Y'-8:=KB#D[.6B
M9R3CI99XF_BY&'DXM^!!;.O(\]!QCV*S6NW5J.62M-D9.URT77[FOJ(5JB3=
M$DDM0K-A3-6[:6>1GE)51)VDNS+-MVSA5NY22.W4KV.7/?\ 2[9AM5I<Y7H/
M.FU6SJKO6MCF>VESVD?#16[Q\,ZG7+IIC\D_.6/$ 8FG7IG?25NF@R1@=TT;
M>+9MVOT[08=]>K''Q>?TF!O+;-8RLCEV87ZH49N$>5CD&BU"*NC,@JIO"65$
M5#]#54&H:19Z7:I&RQ%U6ET("$GH2-1EZ?"6*[S.@RL*XL[9\J>T-4)Z6*FT
M.9JQ,DU0 %@=*B"H23IYOFCQ]<L-TT1W:ZNQJ^>'"?RG1.X)KW2/,F//OXM[
M*QWLC:#2#EM8&OE29H>4.R4(91!NZ2R#:G\S8X*R9.2PL'<97WC5K#:96I@$
M9.)JU]*HBH\?Q-.O$<QL,45)1(S:2:F+U&177(I 0-B[B-*LK/.ZQEF68_YU
M3SR/4H.&9=-S;YOFTH>.C&HWN3GZ]/'B7-@>>2]3(U;N$DB+>>9>[PD+;Y:\
MO+E7:C25;%(0<-791&D9Y'3$738M^I&O'J\Q.-DK$\46?&.BU,HH(H,FO,X*
MZ96K#W#6*T6^_3&/R\+>9O*,V+]SU+$:-)9O2V-6A(GV4[BI1M69,ZY9N/DX
MZ<0E \Y)Z5N<[,UTC'6ZZE;IJ_59&LS]SLT?4WML=.ONET+47EHD7J+1FA*S
M<G-4!%)V)RD(L1TJJ("H ".HWG1_4H;)87/IG*,3JA[E6KS(M(2R;3:MC?K1
MTS7L^H<HI6X]:Q V25L!5YI90?*,0A&OKDCI#A;6;1*L+ON&:;/!1SJLUALK
M2D\Z[M;%WDA3"/V2B*EIC)S4;A)H'=/2 X;QJZ1"@95 IS:3:*7:I&Q1-V6F
M$*_"S<'&I2],A+'>)G0I6%5LS=\<]I:M9Z6*FS,=LP,DU;@"P.E1!4-$T5]I
M-L1<WS0H'1WT>G&5Y)E$.:YW)YIW,DC6CQ<%5CLUY[,F\:=93D8K5P98"@LF
MF(9&:9VNWRB^7X-7NW"4=O:145E+3F&=R=MDL=]3:LW;!G7+M0&MQ6;N9$$7
MB,R""2IVJ*X>9Q.U7[ILZ^;I9]V6X]9H^,;5M=XQ8]F^@R.P5YM(D1$WL>6T
M-I<"I2""I ]7:+-UVQ??%ZNZ6Y9[N4E,S]$P_3KI#7R*J5+<,[31\U[;.X;*
MT<VLJ*3V8;SAY*H[!86SF707;BQ?*)+LV:(I*(K85X 7GBF2&  \0Y'SVN&
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MRN3I)JI+LK/;<;S>KR$%3^X^N7ON6@-$"TWWN3L&J:M4+E0+E8X,S5E8V+F
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M3]2(+>*@R.TM%!L!RQBIQ;/69F#A(Y%8]_()F.=+DHDF</G&(4P>GG[H#[O
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MJ9!<@(\8]!GR"=RO%=6[7-?[BJ7*6FP4BSS6BUZ&N.)P^:6$4:O(N93-W#R
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M6<Q$G58V>OEZD\ZK-B@"*IPMQ@\E=6)3,(^\1I'"OE3)(GVD0RICE6*H/6
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MS^ M7MEPO\37WKOY/S.</S%S$25FIE.),VBK7+)W,PJX48,$&IG"#AH3UA,
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M]":QVLTX)3*>Z;:YL'\1K&]9?0M(C'>O0UHK5HV"+<P%C>LVDQ,@H[0!7UE
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MO5Y:]V UKN\K7X..AY*X6<S!M%#8;0_8-V[J>FO9K)%N#ET=58$4B$ W24
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M>R9Z0(=D2F+IU7K+/^> HG4$B!#MO$JIC!W4:AI^,EKF>.\]@'=KEF7=;-:
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MI#*5XZM97I]L<VR_.7,NC(TO*TJK2I8=AEJX]K\DG.)U<)8D(O'N2/Q;G14
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MZODQLYET(J\$!!NJZF4E%B* @46P91VQR%LT6*IF,U>"K-*L4)(UM&YHC5Z
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M9G+/)WY*1LTK(]K46DTS&V6;+9#![+7K1:XWV0R0(,;8ZW!NDD$SR<4^.W2
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MYSE1324'F!#F,!#"'I\0YB;GR HCU^[T@'CU#T\P$!)[[PYCR'Y_AQR$Y"F
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M4C-D[:6\8H_>J1C=[E%X</6\<HZ5.Q;O7"-B21</$&IB$54(0A#G 1 I0$
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M//@I@\!)SZ1#PY<PZ1'P\.8E\/H>'  554H% 0 H*' O(>?_ #0'D(^/I]/
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M1K=_M=9T69K]H;;O"U^L:/2)-FPB!"J.XNKO)"%48"@H5VBH#A0QQ<'Z?$!
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MKR$8S34LS-^W3*(%=&'_  KFL3DIS'^P>^_Z':#_ $*3W]A@(& O2(&YB "
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M\U*.C;57(Q]L$)+5NJ'TI3,'$BPH=@NC11U1JM.ZTK$KI5:2L#9Z)6"!G2@
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MZ? RATJU7K$UKE:ANUMWV_5=!ZE(/)J*GFUQI]RI=O6<-O)1%K"+4]L*Y"+
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M8;C;Z9):A8I;2--GX;_9ZFI!U#A-UMLZVJ\9E:H^N'7<('63KD=4RKE,*7-
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MQ>9"+-E5LL+1'=#4CT)%.OL8FJNXQ:'=H-9ERNH#/FDL?_#%3 8[I03"'48
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M 13&68Y@_+8T9B?6FK9;W-Q5T6?LMJ<M&H+O[/<5W;YP_E4V:*1.@YDP1(
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M--I^L1-=M:<@9\G'-W:;E_U&> "8) .VU?2&55U&.Q*&&]Z+GD@FZ7&)<1L
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M[[E,#1'3R6=]W,UH4-6XZRUZ)4D,P#0U)2/D(Z=>R[=I%/!KI$P;E45([;*
MF)BE. !Q?(C[DFPY>RDI6)F$U-@V>%V-]//3-WS1P$*[BYR<<0#:.;HH@LDJ
M8A5C*D,4!,4_+O<AJS432<GL.A=OLUF[4TK MB62,ID)0V=F<G,_D4"1B4<Y
MAG)!(\!%14I.HA#$, \:2PB923+@5S[?=)IU+DDGS9"0RF;TRTL).7H<:W;/
MS2IHN)7\]^R70(5L1);RA.543B.4XK8,JSV%IF:M&%=M6O*V]*PQ5XH]9B48
MFNEH5-9FCK! 7*;2\L[D),AFC3I,)14$PD+H;*TTHM6A*Y:6T92Y<MG8SI]"
MKYF!7*]@68MB$<54Q7@F:BV7ZUN9.LH]/O>)Y2^:2QOK)\X1/7V3"@Q5*/7V
MI3OA7;NGK"5DU9]99)= H*J%0Z#(";I'S.1,<U1.Q0-\BS7S7KEJ-_/5#1,U
M#1EIJJ%;A*S)I.[^^DIR,:0:)8F!1CDF[6),7UE5%;J5Y]M\!:J@WKU5[677
M<(#70"V>OSK/5&NKR#E.LA7:XV<^V85PBU?&5>ED$D$&X$Z2\Q,;GL&A(55G
M Y7/87DU(ISN,4AVL:>9K$H_=2L0R@F*R;R/;QZ#D#$4,U2;J]0^68?'A*<L
M3V<K6;Q_;T,-&6NOR<45RGJ+&W3CJOHOX59PH^?QT$E,%E2@*'JZRK8A14 .
M?$,VW&#:0VEP2KJMSKR,?1[^&MR$*IZI&7B).P=.@;MK2S*5RH@MY2Z*XG**
M1"] ?V'WW_0[0?Z%)[^PW,//Q<?-PT@5)&0BI9DWD8UZB1=)<B;MBZ35;.4D
MUTB' IRB'40!](<=V$I7\^2F=(N.]:QH605Q[+5E1G/QML>0C*LV20.XFVT<
MVCVBB2SE5LLNDY.DW,7I+UE$VJR%CQLS+>9VQ*7&7D+YIL)++[E8I-ATRLBZ
MG:@Q<,J/'1[9N:/C&(I*-VI13$ZA2F4.&UVN4R<C.->[ WGLHQ63OL*]NC")
MN\W PDDTLVB,DI=.R3DE/NU7#(CAP]?K($(CYAC'2 CK0J=.0-RF5;1CD?7*
M;,5]-%[F=1J=F;3UM/ 69S>HJ'69R,N120E2)M$W\H5-%JBND1,HC*7#,\VF
MH[1YRPY%.->XV.VU6H4J"85 K-M;64]D:DU[3?$]3;NVZ3'U1^15)Z0?7$S=
M?$SHN4Q,P$E>]#Q.ZM-6C=$5KE;S>"H[9K$:#3;!G99AF:[.K/#0R#AFX]0>
M>85SZH;R0*)E>Y6K4//A4L.6UV&3S*6):(Q?X9W2VT]Y,1D7),%P8IU!6O2(
MM 7!VX4ZT5DUQ I#AUM\(S5K$SUO4K-6<W:,G7$<W>WMX_FFUKUI)E.OE'K6
M.N5TFW+L6DDJ)TV[@P DJF8$E2=S5*5SI[%$N&BI73'<\=WVL$TF+3AY"!FX
MDMIU8$;0RD[$E.P1E8E:64DD4D6Z2*JA2J ">Z:]=:W)2-QUS9*1,DJ5RNM.
M5MAT)%U4\^=S]BLU59(4[V[)OY5S),H>.0*D1%-LT('FJ 4FOTFO5-BZH.S=
MRN*;^76!M-<;L:7'T<&I[/79:HOG*=BE9M=6-.G'*-6RR+@5BB82"!Q)VLWB
MDUB+.TJW<!(Z#JDNU4A8QV:/"AJU:.EGYE%T'EB=LTTD&28)^>NFBF4@ !0Y
M<4F-/@<A=>VS-+;7)V.C$-%HM9:7:WQLHW?,[U;FKIY(2TA6J:\=K.&D+ZJD
M=RLW%1<YCJ"DE<(6\T%@%.A+)4G5/FIA[%6%E>TD&D;95+"6 ]6,,"XJ]I2!
M)(J_F*&<-RKI&*7I -"B*YF*$_M+[8M<LU*JLC9:RE''8W*W.',%;)614E@B
MU&$=&N/7%&GG^M*& &XE(8YC%TMU+X&ZG-@MUY)8=&^$VR5XEDVEK8&1HVT6
M2&GZM'M:_392!:I@TB(M98C9-$O4FNF80'AWC-J=LLKA5-G?VJM4:1;):"LA
MCZ%B1L47FNDRE6L=?&[OIJ53%26<!)JJND2@BLHJ4YA#1,QTZA,;4_<[1/:#
M%9C6[2RSYY/U\=#C;29)E<(R<E(Z(/8EF!9"-;]4>=EY)&"C@##ZR6Y,KTTE
MZ["3&C2]@SB@6*\_=,L&?424;,2,J[.71>0?^O2!YALNL5!%=P"!5A$5%.?,
M/FWW[0??N1;CLK_D:CO^N9G\J[^.DIC<O]DST (__FHM7SN/TL_Z$WTN/TL_
MZ$WTN/TL_P"A-]+@.:1A$.8 (D$1 !Y<P >7@ \O'Y_ \TC#S-U#S3$>9O\
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MW1^B/N\&#I+R/XG#D'(P]75S,'+D8>KQ\?=\>!,)2B80Y"80 3"'AX"/I$/
M/SN.7(.7+IY<@Y=(<^0?0\>.0> <^?(/1SY@//Z/, _.XYB "/,1YB <^8^
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ME;_'/JCDV<6NB2C-FK9D'NDO'T;7H6G6>P0:J*$"WD:^S@3*J%*JZ KAZJ*
MIE'A"@3;?-G+UEZGUVG/8R7C7MR,D5T"DS>AET4U7=D2.MY1#D,H4&X  CSX
M^I'CZD>/J1X^I'CZD>-#RTLO\'C7FOF@_;8LQD CBG?L71U_4@7:^M&$C42%
M)YA $Q@YB <^$B])N9$DB#S+TB(D3*01$O4?IYB'HYCR^>/!%" (&(8IRCR
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M('/G[[I >0FY"(?0X$HB8.?+Q*82F\! ? 0\?<XY (CZ?$1$1\1$?2/C[O\
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MR#JY /,H>/IXY<SCXB/B<XCX_FB;G]+@!YG]Z/, ZS\AY\OJ@ZN1@^CQ[O\
MR&,']P0X])OT9P_](&Y\"8A1*81,)A Y^9A.;J,)A$PB/,WC]'CTF_1G^NX
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M'D81^V5E6#1L]?1Q7J9I%BP>N':+%^Z9^L>MLV3US&."H+G*1-4Z"A2&$2&
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M&22+%@W>-GB8'$R?;76-@4?K:O7<'R6$TI25=@_E#WN*H<"QM8R3XIC%>/\
MVX@OYRH"/6IS'F//GQHE;FZ$]T&WSVA9,URN-BLVF](EXVXL;U$3<Q+1R,%
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M0R@E$O33L-RBOA5LOSZN(U.FUDLI+RQ8> 0%<Z3 DG-/'\PX*D=T<"G6<*J
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MSJ_\.1O[XX$!N=6$!\! 9R-Y"'^4<>^N56'F @(#.1H@(&\! 0%QR$!Y>C@
M"XU4  #%  FXSER.("<.7K'H,(<Q^>/'/X9U;GR .83D: \@$1 /\8] <_\
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MB/+IYC-Q@CRY\^7/UCT<PX#_ ..56\#"8/\ IR-\#" @)O\ &/JA P^/YO
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M&=(B81,81#UCD(F,(B/SQX$!N56$#?5![<C??>'+WW^$>/A\_@#_  QJO4
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MJJX1(0ZJ"5E6462(H "F=1(G,Y"' >8"(  ^YP=PY&9;H)!U*+KV-PBBF7F
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M59*H5W+M0P6!PB9:UB#AV?JK9D\N%88JI(-F*D2Z)%Q%P:QT8V%-0&PM2H]
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MARD>PM3B#J[79]+7@JM*3^O3EMAV+QVRAF*%Z2KU&79,R.95FY%-0%FJ1!:
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M ..MVN_QAQ_4[7_XZW:[_&'']3M?_CK=KO\ &'']3M?_ (ZW:[_&'']3M?\
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MR**/384([,I5J#*0I#--J1-"ONFX<CE48ID  ,H4BJA>1U"$4,8A?F!^@/\
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M/0<H^D1*'H'W1 0#@>2A!Y<@'D8H\N9A('/Q]TP<OH\ 8H@8HAS P" @(?/
M0\!X]^8"A\\P](>D ](\@])@#Z(\&'S"<B  G]\'O0-SZ1'Q\ -R\/G_ )3S
M,8I0\?JA /1XCZ?S.!%10A */(1.8"@ B'5RYB(!SZ1Y_0XY<PY\N?+GX\OG
M\OG<<@4((]73X& ??!_S? ?JO'T>G@.:J?B B'OR^(!XB(>/H\..HIBB'SP$
M!#GRY\O#W>7 #YB?(0,(#UEY"!>74(>/B!>8<_G<^/>'*;D(@/28!\0Y@(>
M_/#\MY>83ZKH^J#ZOD!NGT_5"4>?+T\N#FZR=*?,#CU  $$H<Q X\_>\@]//
MCJ,8I0Y\N8B !SY]/I'_ .F'EP ^:GR$1 ! Y1 1#T@ @/(1#W0]S@! >8"
M" AX@(#X@(#Z!Y\"3K+U 43"7J#JZ0'D)NGT\@'W>.8F  Y\A$1] \NKD/SO
M>^/T..13E,/+GR*8!\!]WP'T?EA2F,4HF$ * B "81Y\@#GZ1'EP @8H@(\@
M$! 0$0Y\P 0](^''0)R@;D ](F#JY"8"@/+T\A,(!]'CD)R /, Y"8.?,P@
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MT11,K#&9E^ZL$X^I\K6IM&34K[F3)!.$+OY[Z72B%@B$9Y.O>4J<&A2'%ST
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M"B]8.DET3\^E5!0BA!$ABB)U53 1,@<S&$0 /$0  \>7,3"/( ]T1Y< < ,
M#Z.H.D1#YX!\X?<^?\P+AVNDV0*=),RRZJ:*0'75301(*BIR$ ZRRI2$ 1YF
M.(%#F(@ @/(0Y@ \A\!#G[@_FA^0)AY\B@)AY (CR .8\@#Q$>!<IB*B8!S
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M56&MT_0H":8+*K)"W4L5J@#@NV62*I#QQO77@D3*)>)WV_5Y-"FIUS/'==<
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MZ=I=G?G?2K<Z*3RNQ0P$4Z0=/54R>I KU* 0 ,8F;/&];JCLU^HE:GZQ!2,
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MOE^\]\/B/+W?R:6W?MF[QLMW8=CR:S9VFDLU72'O%P[S4G*#CFW71.3F D4
MQ3#R#D(\=HOF"4J9OE*^PA,P+<NDPFWR  I4O-#EYACB'3T^^Y\N7S!7!DD3
M/4>Q11%-;H(9TDU7[@45%T45  5DT5E$$S*%*(%,)"";F)2\MB-Z3C\FK@Y0
MZC<S$(7N5W83!TB813 PF*(^ <_ ?F#&'T%*8P^CT  B/I\.)5+MW?7"/AIW
M2-9G9YTSM]98.W,7-P6)$IZWKT\\"22192<78FS),@^:Q9I>5TE;^K%XRUGJ
MRKIU465CPR=LQH&SUSVF8\"SK[^R24P1NWBT8,:S/L9=9^I&.WCJ3=.8M9OR
M(U5(&&59XPN*>55'&ZF&@H5NW0,=97>EP5_I;PK1)U'3,5,.'98.+>'?*)K'
M;OVYE4C* "@HN&MXT*,A'^D4"S[9)4Z1@I.'FG<7"2>'VJ A%8Y^M$L'+2(M
M^F"W6:QA$%@8-5&Q%P,5 13Q^(SIRZG[HRMV3M-,FTY2"9G4K4<\BQTJ6<$F
M5&I9 KI%NY,#9!3J$3]/E+)AY)V]DV4]HD8R+P]_4HR5EIBM/XM-XZOT8\:M
MG*4:X&5<7Q^PA%'4J\\KU%=@,:4JAG)')"-Y6$;6F/BB-^[2IV]9.7?P9TKC
M:]$AE(V8A4G#M!\U>2;AF]%G)L2D3*@4OO@3%+B?B;0DBV=1S?/8QDT6!KT-
MYF)QK/(NU)JJ1Z)45FQ;8S<E Z)E$1*4?)$"  <+Y]/0RTS>2:SI=YEY8]BA
M'$1:"W*4U!*LR#)?UB$%+X-6V>AK(DBNT;%:,62(H=;Y B ;Y4VX29GDI>*W
M-T>597V/F9"4IZ\75T;E#UWUV*A(R$NB4<QDDRS#ULW<2UA>&>O53='K [1:
M- <2JEXT2%SR*7EPLRRS!1Q 8_78!\>O-V;LR5800N+B2.86Z38IW1U'*91!
M0%#0CK)7$Q%3W^SSDE!E@T>\1,H1S<J+.%0E)&7EW1KA-N[ 5G)2*B3]4'39
MVQ$B*G0)Q ,^L](>V,\O7L_V.!!6%LBD/7D[E:H*K*U>2M5<5E&D9,1:2M?>
MIL5'"+WV<_<-S%*4ISJD<F9DLTO>+1W$9-9[Q*.;C 25:+F*U:SZ/T)"KQDK
M+I,XUHV-!R"+R-CF[--5VIYJ+=T10I#PU8SUI-1-LAHZH-&$13'L!!2:;*,?
M1_K\)%R4BNG#PK<\4D=$54Q4!NCS$B2P%\A28JL,2>BX)Q,=V;UC*-[3GY7L
M<G<5Y&QX\,89$[8Z#UO99!9=HX50=E;$."1RH)%6(JU,XGY>8Q",MU7:UTD;
M8Z\G*OH)*G($GK%HQY&.9OEV39Z@X0.R;D?>U'#@5R"S<E;N$JM%-G:JN,)3
MV33,U&QD\V@'JCJLZG!3TT+A1([.2>-B0;)11RW,L9H[;D*EY2B_E@%6<X0]
M$C)BDX=VN+9R->C):72935??C%L7%@\E'UV7B&KQJT$JZ"95E1\Y0B1C&XTB
M4MEAE/ND3$'#,J<UM4M$RU8@)F.QJGL3OD&T8U=(I-G.J'E5I(YS+ [,F*A2
MBB*8#7F^6R=X8B5&B>NMI.XY\-I)'-+:]<7>/G7[0C5%Y:7A1A5$E455DA@F
M\BU.NHY6*"UJBY2R6%M>U'EK+6'B]MH"TRS3?1M1,5=>0\]=@JR+&DL#>%2$
MPBTG5V2ZI2-4_-)@IF[JT?"%I/YXXU1.M2=6C%7*(0I$+6:<?O!%DXAFDR8Z
MZZ#%NX*] OD$2*50JZ+&+KDA=TZA&URKQ[QL_M]??W1_&,)*G)SK6 F;'(2<
M@.EN5&UG7"4>.A9K1;R,2*J5=(R:,W#Z05R%F<:+I4VD*DBP?L/@]/W::FJT
M2*+%KJL&A"0T@B+LJ2;4BS\RRY6Z!5002_L6[_Z/.OUYOQ2O\RI?KJWS0_0'
M^YQL']X_=GY E.4IRCRYE, & >0@(> \PY@(<P_-X I0 I0Y\@#T>(\Q_P"4
M1'B#90M!7N:4G"6Z>5_PD6O6I6!BR(0D.42E3>S9D9,\BH@ G4/'L7 D HAY
MB43%K4RL2<>M%TN0->8Z4L#BJ2!YNBPES4=5U&/CIVQKQVBKRRD13C^KJF>2
M#)9-3SCF!$MFN==D\]K\,G@KG0H")&-D)"7>ST+LUZH]CDZ[+N)15N[C1IU>
M9)@F>/=I,I*0;+*>8BH""L!44\^3"(G=6TO/VLN,@=LX/$YQ8X2EO91$DFFW
M.O)FE920D3-RD4!6%AG"Z0&(JFOQ7,QI;J-KC!CL.81=FL!X][+&EZK,U30+
M5/5$Y5?)0AK!(.Z:V4*Z(=4/93P"])#G*L+*P7J3K=HF9#)<KNKV26:+5ZHU
MV3T[5K]!2$Y.)MDI&1C*?381JR!7H7,9-LS-U#UF,KQ>6C/.Z[6H>IYQHU]%
MU<K!*Q,@D^K,Q#0D)"RK)\R:*P)@!_[1E!D21JB47),%"II'!81[:+/7VS%P
MYV73LQ@)N1C0D585E"SK-].2K=LG,QJ,D8EF0B@CV0JI)*E%SU@<5"E,:=EF
M$128*#@B9NFL_:2$S*R#V1L>IS-3L3-(BR/LY,D?#5ARF505C'2?J""A!33$
M!H^:RU1H\*A:-DTS/DY5.=G!<O(*GP+J8@35M%Q&(-WUT6:-?-EVYE/54&)#
MJ('4,4"GD81LZJ<Y587::'6FM0:1[YG<7E%M6,EEI19V^\Z6%\^-?G?F1+A!
MHS0'U)PU645Z#$X5[@3YPZ;OXU5-S+4M19T^?HP9+06OO7K,\<S<KI.FC$_G
M&2,D=)J)5?-$Q$3"(,7&4Q+"XKVG7*G&QL[,R"+!\^S6EN9?VFDK'-')F+-:
M<23360*LX?#'F*X23$AO,)5YXU0:VZ>DI=.-E&D9(+LX5LX1K\M+JMF3Q=(K
MD'EG>Q7LV)(N7J5?O$2F*J(=!CJR-,A61(S'$[!(1+%Z\-67]JG=SA<Z-9TY
M63CX^7:4^A0@*KR"AG"9>;DY3] IIF#NST)\_89_*4*0E8RIQ+1[&.)/)F['
M/Z[*/6ML<R$2O&-KG&2KUQ(//6D731%%5 X<T!Z.(VJ36>/9AL6QJU=O=W"C
MM@\L\.@Z<A4+FK"UJ&E3A]UROKMW<"HW9)1BKIN\*=5-'WZ%5K#?.J[6&,F>
MBSJCMU*N7;Y\V=6'UJ>I"8!&R#1%Y*-FAZR! *9\WL*2QPY$Z$4WN>DSN'JM
M>B(N\2LL_GY62^$@I5BSQU/80J$6U;&;,)@CAT62=E=^3SCW[/R4^9A7-9*5
M"3P-Z$PT+MW0<+2T9$O''L:SVAO7KW5H!NUB6;RODD!GX=5"0E5WOM9,),8T
MR1F"@)S%J;WIE2T4745%)V4J,&] 9-]98^ 2AX]>><I5UG,2TNL$<FZ?B=DQ
M66%9R0R:1ND'+V8I47.%E=MK*J+&'4CHN3N%=PN>M%8+%V![%2K)G1:[:H@S
MLST[5VX<$.WZ_.2ZR'JK\)>9G7@PR/KC^SK1BU@D.AX]9!,O%85C%1,C'3+J
M-57CG[9JBU?LA371#RSAP7DF4.D>9>7/P'I OAX_^J'+@"E#D <QY<Q'TB(C
MXB(B/,1_*>1@Y@ E,'I])3 8H^'SA#BRS;K)[I _"V4EIF<@:#W$=Q>:T=>1
ML+IQ(6%9GGM"U2O4>)3GY%XNX>I-(]!)TX<*JJ%,=0XFK&?4.NP]1I=-A(^N
M5:KU]BA&PL!!13<C2-BHUBW*5)NU9M4RD* <Q'ES,(F$1'\BP9/K=1BKSGMK
M1:HS]<EQ=IH.#1[]I+13YF[CW+*1BYB&F&"#QD]:K).FCI BJ*A%"E.%.U"K
MYC;IBX4*4"=J#O2]XW?88FO6$C99DVLT=5M8T:YUA*RQC9VKZD_]4]<9'4,=
MNHDH/5\Q6)S:J"_F[%36C^,K=OJ.A:/E-U80<LJ@ZE:XK;<MM-/L3^M/G[)!
MP>/7=*-#.$B*^6!R@(V][A] >5^9OJD>>W6RTWB^:A>)MM#)JHPL(ZO.GV>X
M6X*Y$>L+*M8XCPC%NLNJH1(%%3F^8, "(")3<A#ES#P'Q#GS#F'%QIM3K->K
M5G9P^MNZO-V=&6GT8IQFT);'X,IZ"1"%]=FP"J(R#YH1V0J$3/QJI3 )A\RP
MUL)+,4(2COH9:1=(FGI&0L4"\S>QVOU.-,S65:PLW-3$2W&+*0T@Y,R(;FS=
M@JBMP^G*_ U&O$E<H0M,39C2;IRK$3Y]0D\_=BFFXBY*%>1BL3'@ZBP4%91=
M\J1$_4D(*&!"2B*?90+-=T:<G+2;Z;@4(I/*K+8&M'2;E9QD@1*ODC(WIDE5
MCKNB)E*=,ZIN?+#[PM"Q3MYL$QDD22*+).48UHOHZ<.Z?$C'Y&0@K[.3D3>I
MBN9,5>@.0**""0P^P-6-<=R<HXBV3E9F]F"4>*%W;3U5_9I*1<LO:I:G$II"
M[<+$(9/R2<TG"J(IN#Z)J\Q..*O;I2K7J[0YW;6/826:1ZZKP\)!OTIQF[B"
M3%,8H'3=+.D3-_66YSG2 G,A8JL2U;:2L?[2/'L] 65>IJ7A@$R>,K23&&K\
M/)+_  ^T:N*MK+&)D:(1ZT<#T1*D@B+E/-ZJWHM:J[.9CF=V?.I:<?+*3[!>
M*T=PIG2!$(F1]4LLH\KZ$0U*4[=P%I:F0, (F]7XLM?6H[.GURMGM)7II61>
M*6L[J,F4H.*B7,>#<[:-DR$1,_>)..@WLZ48'2*7D<5;!GB#\BV:H/J4Y<C)
MM8]R9,KFH7-Q886#;1T*PD()!>:4@'39[+N7A9LA93U$4O9ZR96L-"Y[&65H
M8^?@JK)R$M'K+M+78I)G+S#52/AY%%&(KK.#%B=8_7_TW-QJ9P!,Y@/!K%IP
MV**6@KC/2\J9XNW30;U-*/$6+,&35X[=RB;624E'2*2+A<D5'NS)I"?DH3*)
M>'KT/#1TQH%4CK36EEI5Y(&JMRJDTR32?31:VK&LY9>7,UG(8&;@%'L29%1P
M0B2Q3+:JS68TZ1C,XK5/L2:;J7F1D46,Y)03"3F+&+:,]F1$*@I.BDU$5?-,
M+0Z@&7*9P5A8VLY5(*SK5]EN$FR+$O94]HNBU,G+1)P\' P[.$&-;DJ,/!MH
M674<<TU'YN0.$G!"-WK2E36?5>,;/;M1J8S<%EY!TZFE[>O7^F;A%$!>L7<7
M9HM\]DH,G,XK,VH]1E/+4.*=:CZ=3<]39&PNR+V"T+2%C:#7;YKL-3[G&OV+
M5[$)13Z(B9TK(CD[WK83$>\\]OT"FFC6%HQ5<WLZ'NMMM4:XB9#V(^K+"H6%
MG$KR-B1C5D8UDQO2L65P=!PDJ@+A %S(H./-XKL8YSN$;UNS67+FJ;X):T+2
M,;"WO,'5^DO7TD8E=,LM'OV9FS8$BJ)JH_5)G6$$N)*]4;.*;/I,ZOG$@W@C
MS4N$C)S5YUFZ9JX]05:LU&2L PBJ>#Y$QG'FJ&<B514J*?FFP>$CI:*3IEIG
M+[$7"/-'>LR\N\89W/6"MB@^5#R8Z):.81958"%%PLOY1?,\L%"GFN;NGST!
M7.Y<E&7JC*.>PLF7+I'(8F<9EFWQU9Q5:?"WS1G;-TDE'MG2#4Z1P.!1 4;#
M9L_KK5T3,J;=YMT27G1A8DEACZ5-NY=RZ5BVJR%(5^'!XYB[4Z3FE(9^F<3@
MGS3:U1Y$P$939TUXJ1HMJZ?&FZI8Z/,:@NC)2:JT4D<965AZ21*18F5!)'S&
MZS<1YK=3:G?] 3=%4T-I5$X!M'O&-A+7Y^G87ZO)JR)O: RDI&7:]R!T3$*T
M:G9@JW4ZUD2G(%RFZZ-8>*R2S((TL@WD4@3(S8O3$$Z!CBVD(AP_4BWZ)Q Z
M<E'..9$_ A?[#N_^CSK]>;\4K_,J7ZZM\T/T!_N<;!_>/W9\P)E$$3F,)1,8
MZ1#&,)"F*41$2B(])3F /S!$/='@B2;9N1),J1$TR(ID3(1 1%$I"%*!2E1$
M?>@'U/N<%.9L@8Y 5 AS(IF,0%A(*P$,)1$H*BF43<OJA*'/T<>**7I$?TLG
MI$# (^CTB!Q#Z C\_@.220=)@,7D0H=)BD*F4P>'@8I" 4!](  !Z..DK= I
M?+\GI*BF!?*Y'#RN0% /+Y'-[WT>(_/X,46Z(E/U]8"D00/Y@%*IU@)??>8!
M0 W/T@ <^ *9L@8H 0"E%),0*"91*GTAT^'EE'D7EZ ]' \FZ(<^7/DDF'/D
M;J#GR+[A@Y_1XKMQE(2-=V6H'DC5>64*N5>(&82(C)"1-)0B#HSE-,.0K%.*
M0^*?0;F<064:MC+@0A/-,BF90"IBH8A 4,3KZ"'6.)0]P3B/NCPC'S#!L_8)
M/HN2]3<E,+91Y"2#66B5EDB"4C@L?),DEB)J 9,3D#F' %.@B8 Y^],D02AS
M^JY (" <_=XZC)D,;D =1B%$>11ZBAS$.?(IO$/G#QU%:-BFZ!3$002 13$3
M&%,1 OBF)CB/+T<Q$>%TQ9-!(Z$PN2"V1$K@3I B85RB3DL)D0 @]7/F4.7H
MX#I12+TE(0.E,H<B)@()D#D <B$ 1Y!Z Y\%6,W0,J7ZE4R*8J%]_P"9[TXE
MZB_9/?> _5>/IX$Y$DRG$.0G*0I3" @0!#J  'D()E_0A\X./?))&]^FI[Y,
M@^_2-UI'\0^K3/XE'T@/B'!X\(R/]04.LHHR]3;^J*'<.5'JYSMQ3\DYEGBQ
MU3B(<S*&$P^(B/!.3= /* "I\DB!Y90*4H%)[WW@ 4@  !Z   ]S@ (0I  I
M2@!2@4 *4.12@    4H> ![G]E#S]'(?[G!DKQGEO93,SJVBY;1J_#+U*R2-
MU<T>ZLJ(UEF/_3L:UB&MD>/0Y%?*(%9%2Z'2A.MN*VP9N\K]B@I;#:BE>[<]
MDH.+4BO83."BIEZI%'B)*3>K2$&A+E1.B9!,XJ)G\@5"=)C'IT+0EXJGL,]-
M8)^8F1A$YR/N2&BV.CJ4M6'92KXJ/L1[3'RRKM$CQJX,JGY2Z8I_9HF*TW+9
M2OTN_0'<%'2I%9RNRWEDRZWOZNB:1=L9>.081>@0L?(+HJE4*NP62!-P*1.:
MPY)98FOSBE,O[%D%;&)@6"#:HU:,I$E;?;<_#OY*,<LX"MUJ#,!T68.GG,I$
MT4E.?4$.ZN-2L+BXLLNH%[LT)2HV.<Q39O;YF%K;IM"NK!/18&2A'4ND[517
M5*H6.]\F9=0O0+=PBDBM'R;))<A%$2^6NT>I><4JJ)RB E537$3%,'CU#S](
M\"!$4B (\Q J9"@(]'E\^0 'CY?O?_9\/1P!Q;-Q.40,4XHI]13 <5 $INGF
M @H83>'_ #A$?3QX(I!S$1'DF3Q$W3S'T>D>@O/Z ?.XYD12(/,!YE3(4>9>
MKD/, Y\PZS?GC\\>!*LDFJ4P=)BJ$*<HEZBFZ1 P" AU% >7SP#@3>4GU"/,
M3=!>8B)1*(B/+GS$HB'T./\ %D!\2CXHICXD @$'ZGTD!,H!\X"AR] <"8R"
M(B)2D,(ID$3$(8YB$-X>^*0RIA !\ $PB'I'A,X-T .D"@)&!),#)@LH154$
MS=/,@*JIE,;E]48H"/B <2]A1BF*<S-MH9G)2!$O\(=M*_[3"%05ZO> 2-+,
M.02Z0*)2K&+XARY&\QHV/U@)3]:"1NLHJ"J)3=11ZBBJ/5R'PZO'T\<E"$.'
MB'(Y2F#Q#D/@8!](<&-ZJWZCB F-Y*?480Z>D3#T\Q$O07E\[I#YP<(MGC)L
MHP2=1[T6A"F;D5=1;LC^/.N#<4O/2:O$RG!(_-,1#Q 0$P"0_E)]28B9,W07
MJ(82"F(D'ES*(D,)?#W!Y<**G:MC**@0%5#()&.J"8"5,%#B43'!,#"!>?/D
M ^' %\A+I "E OEDY 4HB)2\N7+I*)AY!Z Y\2#:NPL=$LY*:F;$Y:LT3 B:
M:L+UQ(34B4JIU?)7DW;I118$^A,3&$0*'4/,#'01,8  H&%,@F I1,8H 80Y
M@!3&$0^<(\<DR$( \Q$"% H"(F,81'D <Q$QA'Z(C_8EW_T>=?KS?BE?YE2_
M75OFA^@/]SC8/[Q^[/R.KH,?WQ2]).74/4/+PZA /_3Q(6JF&?+P;"[:%0RO
M7C<&Q7\MF=SFZ%8WC @J'.O#JV&O.@9N.0%=M@(N0/+5((T6+D*Y,2,9<I*Q
MQ[RR,7<(E&U).L5F2MS]_--'\FTFGS56%AW0I%C6SY8RR8)B0#'+S@K/*6F$
M85RSOH&.KTVXD$2QTP[M*B*%=19.0$4U%)9=8")\Q .?I$.&QW.G5I$7D;7Y
M9JB95]ZTX9VN;=UNN BT%B5T=]+3D>X;)M.@'8'04$Z12IG,4S)W>ZXT=INI
M5BJW=2*:*J;R$,V+*MS%,7F L2O$E#F^H%N<%RB9$!4"%MS^TPC&MV-]%QD%
M,O)!)JQDI&:<BRBV"1UP(=-Z\??801.4JA%0,10"&(< '6V%S@W6;>HKR7PQ
M*\*G#E8-G!FB[A95<$56X(N2])BG(4X!X\N7%ED&VI5!5M3'=C9VHPR?DJPJ
MU01?.+,"K9=%)VZ"*0C5U!%!-4%DTC'2%0I1$$J)\/(GVJZ8T1PP> Y1-$2$
MCI+.QRM/KS=Z"G,DW*0=7<ONA4B:*;82"=0IS= /8]G>XR8EH]M#O7,-!(R4
M[+E8SMH9TZ.D"1L.P?/%6!YQ\F!U2D,";8P.A_P4Q%C5NH6=X[BY6UQ%TG8I
M8T5+.89*,SYE$/[2ZF9UHP7B8%)FWG&XI"[62!R(B5+J. %&'M$U:X*.KE@4
MCDX.;6DVPQDJ$JAZTR59.DSF36;F:$46.J'V-)!(ZIS%(41!K&4BYQ-E>/ZR
MQN3)&,%TH+FK24Q*U]A-E45:HH%:NYN">MB%$X*B=HJ/3TD,(34_:9@:3 1D
MS;HMC-6DS9FQL3*CF4;V2P0WJKAZY]C1THW68G,X3;K^NI@B"8G51!1!%HYE
MI!1Q<Z)14E$(";;L3S.BQ;"<K:I)21CV4:I''AY%-198JH@FX'U/D+PR;<Z=
M]3<R=;K2\$SL[9Y;(QY!K*0,S99ZL5QV9FZ0*Y!S8'L <R#4A5'($61 Y"G4
M*7A:';6AF]=LPM'M99D1R[BH!6FQM?F;$A8)U!N>%A5F<5:&2R0.%R>M%5'R
M/,$A^FMS V2)3BK@_8Q59?+O$FZ4S*R1EB,XUFFMTKB_.HW4(=$Y"*I*D,F<
MH*%$H0NOUFMVIQ!659J%>B9-BWK]ADF4A; JL8_/'3KJ/"/2?F43=D3<'36]
M64#WOF>\%\5OH=94&.F[177I/7_+4:S-*244MC)RDJDF= 8+RA*LH8/)%0Q$
MR'.H<A!]E_=+JYG8ST560%-XJHS]N3=7^&L='^T2M_9X&6JH>T#*>;Y"33DH
MH<@"'$RI]TBK G7ZJC=IIP$AYC&,JCB6D(%O-O)%%%5@FT<3$2Y;I\E#'4,@
M<2@) ZN(]N1])-DGMPU.EJR$I%/(6+826-H2ZMY>.I*739,S130\,H5JLD=3
MUU,?.1 [=-95*9+1K3$V<:](,8J="*<@L,1)2,6VFVS"0(<$U&SX8IZBL9$P
M HF"G2<"G Q2N4+99HZ(69QK"7=-U3J+O$H^4F4:]&N?46B;AZ=-]-N"-DN2
M8]:H^',"G$I5TA R9_%,X" @<@@!B'*("/,IRB A\\!Y_E(E*/2)A*7GR >0
M&,!>?(? ?3Z/=X4W/')?L4H.4V.>NYZ!G>H43<[;HPU"G7:Q56*^&5^I^F0]
M;0GK>RKI7BYV4.HE%"]\KH<F0$RF$=QZM5&CNM=S^*M;^H^TQF4Z_)K&792D
M<VE3MF2D@R1D6:OD*G124.B)1.0IN8!^1*W7+Z]6K5I,G;\LS+/X6YR,A%4\
M]SV74Z7D]<E+8\B3%E2UFOR=R3?OR->ETJU;'(D<AS 8,-L?<[(=F^KY+JO<
M%C_;M,QN$TG9\QT.M3.W6E"FU>\1TC=[WH]?FXVNS[A$7T8J@U,NS64.1RF=
M(H'_ ":CVY]I!,%KE@4QZ<VV]Z)W"Q-[M]=;PC>Z1-#K],JM,SVS4^4<34F^
M7>/7<BY?@@T0:I)%2.=<1)IG:'W8,,1F] IF(T/N#K.F=O["]5>F3%/O5WN^
M?J56;I.AS=HF8NS0<O2SK [:R;IF[:KE$Q$5 Z?F#% 1 3%$ $/2 B'+F'YH
M<*O'=3A':RMC=6X?64GBJ"5G>O(61>3S1F=V=FQDGTG -72QT$TP.[*HN("J
MNX,K:M 9TZNM[I>HWV3<K"1B)WEEC!;,6QXZ73<'7:/&:B<:@0Y3)\CI)%*(
M<@X(-8K\1"')#HU\%634P+GA6TI+S3>/66,KYC@B<M..W0J*"94Z[E4QC#UC
MPFX7I\,H=L\M#]CS]I<XQS=%UW%H-%"9^<D8696<J*+%;E33!8YE4RIJ&,8<
MQ+-1K5:.RB=&Q5J%(@D6',_)6)>J,T7C+RQ*JRCXV94,FF @!U"%!3K)U$,Z
M<KYQ53+/JY%5)Z<&CH3.J[!.8UW#Q3@?6R^8@P7AV@D,/V7DU1*)Q(D0H+-(
MQ C5JL[>/A0(990 =R#E5V]6 ZZRIP]874ZA(7I(4?J0 / /[3W?_1YU^O-^
M*5_F5+]=6^:'Z _W.-@_O'[L_(<,U.0)N4S)*<R]?O#ATGY!S+R,)1'D//F
M^/".8YFK:?@:SG+#.1;&VV^RW=_%&L4BI(K1+*<MDK,3!8*,$_DLVQUSE01*
M <S&$QC0"SZ4F(EU6EK$YBW4.HQ(HFYLE/GZ8X74!\Q?)G.S86%5=    !PF
MF)P.0#)FS?.U7UA90>66*I6:L)LU8MXNZE*4N5W"C-C-1,LU5)ZX0%#N$4F[
MMNH(G;+-S\C UTN;TM[-P%,D*3=$91.3A&\274\HF]*=Z'?K%)$C2LRHR2]I
MDH]9FBHU9,FH*E\E%=--8CV<MCN8D&[IUI4](/'DRW)&J,M,S_X 3R#E$$4H
MD\7$51LV&/643,NU5;>:98X*+ ?/,S7>34;5\[ML%=848M&NH+2,S!22TVFY
M?M58-Q")D?S+M9R)F;1HJV44$6AFYN1@M7;K9[U)1-07BEK589%[*5Q.790[
MBPE=&>RHR\%(5Y6(4DD@1*F[9*IJB'2 &.',+/?UI&VN)>9-;9(\W-R<,8:V
MG:4)(LTM%K'A&R<<T;%D5E 5.!E0 @"=0R?40T'/+VR_JLH.8I5@BX$'M>+%
M$E*?#S,&H\65)7QD7/PG:3 G>?X1R341(+7U<.L#*/J-)V:#7/%DBR$3"M*,
MT2-I"$=1[LC(*ZFW6D&+"N,6(++ JHNW;E,L*JPF5&+5FY.59)L(&XU=RA%"
MS13E8&\L8UM,LW1W+5TNV60=0;!RU7;G1525:@0PJ(J*IFJ>:R"DXE6Z>Q<0
M[ 6LB"<B^@96O251LT+*/%$%2JM;36)IVT=*)$1<)@OYC91!0A#%2BZ_.3[^
M/&"K50*\M;^*46]5A[';I*%*HY8Q<.T4E'DC?UFXCTE\X$T0 OF=0J.9NZST
M^UC8>1N%@9/Y28B$XJD,K:\B)N9;0RDS'NV<&Q+;H5O+E6+Y;@7QE147.BH=
M$7#R1GIKRG%US^^ R;A&I(MIK/7<6]8HMUA8'>>S99:'0]:2454$"E$$C)]0
MCPCGBUV?1BV>TN@/4I09>&8SU4CZ=8IJ:IUX6]8BUXU-0DW&N"];ENHR6*V4
M(9/F!N>B0+2>L\U7-1DKN-W92TA#RSB3"U5Z I\S&NYPD6E-.WL>2JMSF=O5
MW,J=X0Y73A9, 1+1LJ(Y,Y4Q64@[@RC(IU&1L@G(/GLI*(.)V.@V+..:M['*
M"X<G;HMFI5!#["5-,1 T5D57M:Z:%3AJ:9I)M'T%.3K6,8R2<C7I%TDY9NX]
M5&9- '*FJ=L*2Q"J^4/43J+<+%,6NW1T=-GLC^V.7%D80\:K$3;F,F',5(/0
M8M_58&/G(!B]3+YJ?69N*+@RS599 ]3I\;-3K:AM;C8[#=H59VDM(V>!L.-.
M<BDJ?[6*P%5M%3+,R*S]</+>_IIFZZ!Q2 FAYB27M[6O:=%5Z)L*@O8>2=@U
MKLS8IQJ9)*7A)")>'=+615)=-XV<ME$4DOL0&*)C0M+LMBD@0L5PTN=A8IP_
MC6K^8F=%JUE97-HS\N.%R\*Q8STA(H"4/,;'Z 4.=$H$&?2H%TL#1Y<=)C-%
MN$C8&D-.KS3H\BC(79DDFDQBV\::\*G=G662+_@2SPXMB)ID32):K:XM-K@)
MFW9_"9N_7ACP"@LH"#M#BUI'ASS$%*+QSMZ]=&(XZ3BD8H$5(0CE))<B;;S#
MK%1*5,BBHF,L<A"@4IEU3&,99<P!S.<?$P^/Y3U"(  &((B(\@ H'+U#S\?0
M7QXBNWG4NSWOZ>Z/F*^D1$P;.NTO1](I$TH^O-PG(5]4]$J3>2ID[%SL1*M5
MD%DW@ GYP)K@DJ10A.U3(]7@!JNC4G)82.M]:.]:2"T!,.5WDHM$.7;!5=DJ
M\CR/RI+^4<Y"JE,4##RYC^0,G2Z);],EZ+L_;1K#RCT"/:R]XGJKD/<9EFEW
M9"IPCM]&DGK WJ57>+-6!%BKO5DP12 RARE'M6QW&.UGO0K<Y7.]#MEW"SVG
M<NV;0\.SJL9QB>@-- N\Q,7/0643'^N%AXL4&+!N"[U^^72123'F<Q/R:UN<
MYA?<5JV8V7MDD<F">[>LBG]KD("^L-6:7-.(L]5I@O+5#,Y2O.3+-9 S,\><
MZ"B)UB*^613:^[.,Q3<\DQL.TO(^W>)>=PF:36-7"SZ-6-7T_2)\:[0;85O:
MG55BZ_<V*9I59N@U5>F411%04SB7^V5W_P!'G7Z\WXI7^94OUU;YH?H#_<XV
M#^\?NSYBN1V;VYI5(^.@==8S(KV:8KSE[,7/-K-4:<X6"+AI$[^-BYN:2<]*
M:[%9L=$%RG<'3*@:@O9+;%)H*B6A+GCU+5/-6Z#JO5R B90&BS:%)*3#B-?0
MKU9JO(NE4E_;;@/(;B!S*1U:C;Y$(E;Y].P,MG(W&7;U":G)>\7N<?L)2T%J
MCRR+0UAB[BU6?+D33*1["H%4:.A-YJ&B9S9(AA!NK!4M"S5D1\Z2EHF0BG\5
M+56#L[HC1(3)LIR-73>&:=(JH)K"D8!.7BS.G#YC7X"0HE!K$%48*7DY=A79
M* KZ[-U*,E#LXF/1-%F518MC(M^;ANQ25-Y1C$3);:GI,Y":?;[9/Y&M(3]A
M77<)N:YFNF0%RDH=91"OQA$&<F>,<RR34C8>B7DUP574,8[HVPH3^J,K54-*
M@]>K!*S:QFI)E#Q.B,)PL#(MX:-:Q3%:0BFTRWA7)7BDH08J,(8BAU%$$FO;
MY!49>&HS;/K]FDM>(=M.2:#<U(J,8>/G*=6GS*)2;RS4Z@$0%%R@V1=MNH!,
M@(E*.G2=,OCJ@S]HKF.P=6GVLE+I2,2A3+58+#=&IB"A)1##X3QT@@EYZ#5P
ML(HB90OV-(2W%M [:^0B)NT:(LP@UK#,L$4:58$JS)U6&>/EXN9FD'3"11G8
MQX=HZ:G693RBY52E%1H-EF:;>6N?UV5N=%FSN(RQ3:]EG8>$J<Q59!H_5D8>
M98U\*XH^92,>U0(L=:08^<FZ9*+F$+$H$)2Y6J2U0I+%6.M=@GP+-3=(U>N:
M*UK?LHL.^BH%B_0A%R*2*8+B=99N91L(M@.IHL/]U)&4;WP=-C8OU^?M3=W1
MHF\'ABL)VM"T9N6R5M8L&+Q@V$Z!F,6+X'0)O1(JU6RJL1$?5F]CH-FBY>2*
MA+6./A 0C&DJW?2D4Q; HM.RLF@\470:.UD?5Y!V50KLIT0\R7I]N]FM+9:\
MSJ;2'@7]@G95+/[-%1,0JFS4L#QDE("NTLS,\NNLBD51&2=+$*0X)@LKNU/K
M:\539[2KWK=W@[A!O52N3.M+E',\C+RJ#=BW=Q<G&NW_ *BN)%'/45N#@B@"
MH"*>D3EA]AN9G0;'7YYZYAG,D]61BXFJQE?85AW*R;1FYE8^E(IC&QZYDRF5
MCFJ0G(D)C)IQ43G=V@<A/$YE6<X.\I4S*(&D%*K>E9]1]Y!:Z$>V1LS)5VY+
MUH.G$:N]53 5.0J\,X*I'K?V7.-.I3^3MU@LK8B9[E4!@V+E"+BF+A!RY<OD
MT3*2(F(NT1(J3H7*N*9(:Y7/0&TY3H*N9TU9Q9+79W"H66E91=*O)6!2-6BX
M]-](.[Q9&\B+A9^X.\*B0ZB;51$I%*N^NEG97Q)GG,E5K-;96:G'%BF9Y>WN
MY^/;LH%6+8P4-'I,WBAUU4??K&$B:B8J-P<J0ND7BSQMV"O6/;)&ONI!25?3
M%>B]'2SU"&90YWB!46!T6-6=(.D4S@B0ITP1 _ONF8L58T=%&%D+K299C6Y2
M>N$*WBJW'M%V5A30]GM))B$F@=QU-&P))HO1,<53H'#BDYO /V 3]8CL]//>
MN3%B2A[:M6UX5_<860GT 7L*,7=%6KQ)=8453F(X-YJ!P,<G",JRUF+Z"5C3
M(%^L-IT*$3ECW>!O# )@6 )2PL/7W<_"LUF!G+L[9C5V:@.%U3 0F(/[GJB5
MA9YO8)66LC=.ZW9\%B8/X9>,A84S=ZQ;-Y(M!\HX,".?L:J<XY,=-([9(%T2
MFY 8"=(!Z!$I/>@(!S'F AR'G^;_ .0MW_T>=?KS?BE?YE2_75OFA^@/]SC8
M/[Q^[/F*XTHS>_N869@=$:6/X(QT1Y,8Y0@SO86<<2[UJZEBR*#MN#=BQ:II
M>NJN0.583-Q;N%R0$/:WV8&4D@!*+AJBRG7327J=9)FI&:LZ@W5:G3O!)@+;
MZP0IF+7U7FF1,1'C/Z3H+*S(:6M2)-_/GF8\#ME5:C/1U8?/"2D:S91*+>24
ME4'4:V,7ULT:<OF&4406.(ES>%MJ]?>WC78]I-$@*HYD6<% U1^QAP3;J%*+
M-%?245O93UTDX%RQ13()#@KYX9PECZKMZ^/I%0AKTZ72@UW1,]E5EV5IL1R/
M8TS91_$=22Y00(E[\XJ& 4TS%&]:4[I-P8ZJO4(>)91<=!0ZDHZBX'>MA59Q
MK.#<.S5V2GF6=2<>H"HF3,]37*L(DZO+)W)LM>@YE8SB#M$13XFAO(^&MDXU
M-'VE,[JMS:S%LU8O)>MN89)LF=-=-O((N"^:H<YTDJ/\**Y;:RU6P>MUR,;2
M#V=5B&Z32GYQ'96JWB;#-S,M658AO6+ Y<,'!C/(-293;.5ESG*8C%6PQNEQ
ML,UF*&[:J+6D'HDK,'6V1-0A'R1Y.141&Y;FFC-^2;K7?Q95%T5D$>:(5ZF8
M0W?O+'+9S;+*Q8.V$$M4CO("]YVTDE+2\D&KEY&":HS,BG&@V P'?J$ R*A@
M('%K=;"X?GM1IR-;1C4C&$:1;=HCGE0676@&[5'RUP/='<DF91VY4 ZS?ES(
MB4I0G[94*KI3RS3F&UY &4W%TYTY^'L!9I0(^1D*[$'1@FLTI%32R[EA&KH$
M41%!(ZAE6YE2XZX>-U@@'D_I+[7EY>-B1EHN.C='37JS5O'149Y)HY_EC-ZF
MT/ZRW5(Z.U4,+IR)4#XY9,7@9F0);M%RI>R*C!-5'<3EUA?,9"S.)J#F10DH
MI3V"Y%-8Y!!>/4$3G(IY?E' ]'B;K8-\A*TG$IMYU!G+61>SMI4[&4=ND9$K
M1K9(Y 4CF14243]H-03527Z3^;P1Y5HNP/&;;"]!EC1D>W@4DI+5R2%0)5F#
MA>2:G5(^*S<RAD$2&(V. 'ZRG,"/#66TMO<FMPE0R:T/&$FP:HU6+>N\#5@+
M6A'QA2.&D#Y>ELG)I&/2=**HJJIK"(I+%.K.OFL4\2ULU@ADH)I)QU52D31A
M65/;W)19L7_H0B2MS":/'F4$HGA004 0'I'CN,E*RULWW9YRT;39*6HHE$R4
M@[E!EI&/STT"A(I'8.(PD'',21Z#HJA"-2)$,'24"!EKBV-+<RJ\19*#,7,M
M<8Q4>FX1FLZAXL[15M'-7+^4BD;^_FQL#8X%(Q2*P7#RTD@.#:_8Y73R=B+E
MZD!)O%#"1!\S0UO-I-W#@4C:3*,XE3%IY:.,1BX5(<% ()1.(CDK"\DOKU1S
M.7^*T=PI4J3 5_RXYFW<Q<](+1*LJE'P(/TE&T2V:.1/(H*E<'= JF=F8)^F
MM+Z^:,MJI<]"(LEX]Q M:*[QUA4;3'(-9(OJ#:(=SAY,SA!0!51D12=]1 ,F
M8UI6WJ%FH6'-!KEKT9(0L)$H!(HZ1>T$A56B@,Z>OQI*43YAO-%!=,I%R))&
M.8H=T$'7TK =]:[7K,C2969L;Q&S@I,9154J@K1W1V:D7'1K>ZD=-6H*JLDF
M*;<IB H/,QG#:782!\_+7X]5BK:VB,)/&CG4'1CQCF,%E&#-.+T@\1LGM5F_
M(V337,R*)T@$O,)&4CKQ7SS5@GYE*H7Z/GF<[3F\BND9"O*KV41DI(Z/D"Z=
MO"G5;/)5X[5;"1N9),G]B=2ARD 1 .9A H<Q\ #F/AXC^1X" _0$!_N?0^9Y
MF,!0$0 !$0#Q$>0!X^Z(\"4#%$Q>744! 1#GZ.8>D.?+YCIZB]7+GT\PY\OG
M\O3QT]1>KP][S#GX^CP]/C^1S,( 'YH\N.8>(#X@(>[Q[XP!S^>(!_=X\! ?
M=\! ? ?0/A\_YKJ,(%*'+F(CR#Q$ #Q_-$>!Z3%-TCR-R$!Y#Z>0\O0/ E P
M"8O(3% 0YAS]',/2'/\ *0 1 !,/(H<_$P\N?( ](CR#CJ.8I"AZ3&$"@'T1
M'D ?,"4# )B@4QB\PZ@ PF HB'I #"4>7S^0\ 7J#J'T!S\1\.?@'N\@^8Y@
M/,/'Q#Q#P'D/HY^@># FH0XD'I.!3 82CX^!N0CR'P_(N_\ H\Z_7F_%*_S*
ME^NK?-#] ?[G&P?WC]V?,4BLP\- S<W>F>BKLBRTHNR1C0IE$G;.U?O4D2@L
MXC5I2,2;K @)W(E4-T)@0BBR>C1KMC6XNMU[+<DML+$-';I].C,7B <VB:=3
M3@S1!-&(.@]:M(SRQ,*Q6BRIRE,;D:GKP=:H$7:)U"HHO'<LK/SL&RDYC4K%
M2YB7;0S"0KTDM4H^)H[XAUU7R*C:2E6!5/,3(JDM2HJK0%1FE[;#:%+*GMTW
M(Q8+/:O5W<M&,8!K&-G*SXQI%(BTD!0ZF\:59<@&.7D*M"G*;#N)5MHV$9ZI
M)MW<M&Q#Y_JSP[&=/"JRS1 LF2OD;'=D4(IT>4H5N('=$%,^3P#NI468ONC5
MC/9=[/,6UKK^<PDE==0BZ8M'J&<N[)(*+LHJ7 I6Z3MPN#]J8ROEH+$Z)*1J
MIJFT7;9MI=@*C-QTF_=&M=:1KAJN=HZ0?MFR4 DYDEC2!5&BJZR/0*)DS%-U
M9EG#6B5A0MMLV-5VROB69YU1+C4ZK=IA^2) S(57[^%DX!H8$UDDTU&JJ@>:
M941%%O7W:;=_27>/3MK:1,%!2,M;7-GB;W3Z^[>&*DHJH>+08V<H)(() /Z:
MHN<"D3$$8.R0M5FDI+7=7J3(:LA,LIIO4JEJ$)G,)&H0[R3FU;#>6Y9]*:D?
M5_5D58MLL9!L0QB"$BRITC7)&NLV*RDNWE(!1"6K5O0H4E?JQFBJ9I?VD_G+
MA'1@)R95$6ZS3VI&HLB [46'B2V>JTHNFFB+!4X)>NLW:Q'3I*ZRR%2AW[$S
M)-8SE!E9YF/4>B4!\J,!RL'Z5Q6IF--GL+-V#.-YN3E&8KUB.YCINE)TY6C0
M,>"DV4C(D:>T'2F@>-7*KD&IS))H&$2\8-<JZTIT.OJ%JAF=N0F6\Q.LV4$_
MH5VM$DG5WC>0@0&<7EJPB@S7=D<-^A;D=$YC%Y5C/[;346\^IEPW&QW"',_"
MKN9:/L1JPN6+%ZT;-@!_ZL991J505F:H\C%\HR9AL42I6Z74Z_4W6R!(!=):
M?C+1/)9A&SY46=2BTXP0EW(R4*F]?N4BK-$XET HF5524XH3QI%42JIV%[2S
MS-?DI"2E[8:%EL\;6N<D8YM'N&\1'L7DW8&#2*=JNGB:OJKL@)KB8%$-:E%J
M[4I6IYG4,?D6[5U.2D/9Y^UZK=)JMMXE$YHUY#MF16T1R;=1O-5=J@!^D@<Q
M4FIA*A2$%'ZOW+U52!A8>;83,A 916;K*T5!V_D+%+(I2"QJJ96762;ID<$5
M3,@FW3*<JN/Z:%98'?ZM9:# -ZZ\EE41:A;W:2#Q9DZ.T;>NIQR!A5*H<J/4
MD(&*10XD2/C%;F(RE5^*N';TXU*S1\0\E9.3<6N2E(I&,1KRSU@V,6I0S1%T
MFY74 %U'2Z9!)TEYA9']+AZ[2XG/F_=B>1972ORLN]NSK#*A !4U&:A9.$4A
MZ^K:K1Y\B9),YW2;--)LZ(0YCG/F-@@HA:7K$AGM?LNEV)1_4ZG8)"5S-W?K
M"_C&3&,D2M7DV6-%O%-&8.TRNG*::AC*\TN*_MEPCZ'8?_D;1UQL,%4HJS0Y
M4GJN@0M?E"-"N9JV/@2:1<\W333,)A1=)KJKF.D8A$.XJP-:.TK=IQV%NIX(
ME@93/L>2L-8CKB@DSE8Q5Q$RCIFG,T\'*RC-R""S"3;IH.15364" )-1N?VZ
M.G;'VU0)D(5.;@0*UUJ(O#2S/XA1>0FU',E\)8$B\>18ZB(QY0;"4RYC.A2N
MKRL.*N5>07;(-')'J"CEJ:,AYANX]4DV[.29J-2S(L%R+I$$[MDLHGS0.D(_
MV)V\P5:L$)7HV]7Q5C822;>*=R5L:MY6H0Z5(K+.579B_F)-"TN)$Z3%="22
M91*[I(QDFSA%4P"(@'0("(#R'ETCX@(>@>7$M2IV:+=XJQ;A;:#")N64+#R=
M+AXC-JG>8XC<D)&ME)U@T<3+E)VN]$5RH&;F!03=8J;16H"KU*=4QR#J<R[)
M(V!XR>3ZUE@[BY5@X]NV;+N F(E_$L7*X DHB$?ZR!3G5*84-(GW=9S@\-F-
M9KSA^[C;!.*M[387=POT'(/ZR_.R,T/3)F*H9S1"Y^MPHZ>$*<#D3'S,SB9;
M,2LE;U?[I0GQX\9I9O%OLXG:AG]Y,F[<L4VY @]"FY4"'<^0F]CH)46PJ*K)
MB6T4B!J]1?L:;N%!R^7?O+#(I.741:X:SFEG4<@WCU#%GX6Q5WU?H6(1JH!E
MDR'.9 JJ^ST&HQ52&S4+(8FYP\]899ZC#1MBL%BA*VB6T((,UCH1L>UL[=Z8
M"E43*4$O,5_P@R:$L68KM?G7C.5T]+UA-TO# LUA;;J4;6/4(L>L3,JY#YC_
M /&!=10 *K*-3D.0IA V.2@53/G-;U6=29E5:6"7,_:1+AAEC%!Q'K)MG4;(
MN%K)I)5R'*<4#QJ(  @L;J&J3YLHJX/Y*6D6<^X2EI].LLV=<AI&QRXL)<S%
MPD:7FF#,6S!H8ZAFJZ0K.S%15(!=2N=B;TQX_JVR7'/:\G&H3,)#1=?9Z>AG
M=<EKPZ?2<VX \2U=%E9ETW!NW%DF<R:2(<A#7KD]&N,H"'KV=N,^J9(=V#N#
MD)G)X?09=[;)P9(J\]Z]*6@B*2;<K!--BV3 "^:HHJ>"F;=5:O=2S&"9#?G#
M*C,YV/!E>[A)-6]A29LE5+,])3%&DXV!)1P[769+M%#J&\D5#<8]&,J+&VJ)
MT>%MLC)-U'L@A862\,>N(QJ,.UCT7_M(X'FSF<)%1445\KH1$##SXK,;$4:#
MHC60U&E52P?#5A8I!0L!,0&INY=E#N$GE::KS[V2SUJYC'Q!<L082B:2J!G)
M3@72&KRN9G(RE'S2BV6,G9&:GJ_ .K#+-,I5LJEG2]6D5H.MI*::469DU5ER
M%:\E1.*@&!_,P*T2WG?@S(2# TFW<OHQA.I0ZCIL$DR9/63]9JQ?\O6$4UDU
MQ(4Q0,4_(P3=SMTA!OT%Z5F5BA8R(BACSL7$QE%>MUD"2D#.5BR2DA8YA<4/
M+(@DV9E23 G4!CGI<)+9U5H>6L$ :7G;DYL4XAE]=49R-H.\%::-!+OEFCB-
MJBS1(J1%7:<HY;E.B8BJ93W.*BZ;1X,D I>&L4>[VB2@I67?5B<6@$48B =Q
MS%:QIH$BG$BJNFNS:/$7C)FV7]=.)3#E%!J=&GGY*W4K 647L<RG&R2EGQ[1
M-'3CH@YXEE)*&-)5>/206<LVR2C)RH81!<ITD*1I"C9K"_="BG5LKD*HHLD_
M5ICF45+6Y=9H^*W?IFDX%9DZ5 Z*?D*.RI'*4P<AS6-M$33):0O5]T* =+UA
M*;B$&L+ ;2WR* :Q3&0DK"O(V5DC)I3,L)UT41CF+M1--( #HO<8X@*=)J5O
M1EJU'M(>RO59%.OLZU:["D246*Q7C1N=Q"FN&4.S2/U)2ZYF3I$IV8J.WB$N
M_JE@0#-L,>QDI+HC7VS2PZ)H-MHM@MMTD8X5F;:N(+Q2+L2LF[=)NB4Y>7,0
M,$36W;S/E*A-TV^W!,D;&6#V^NG&N\M5J:4._=S3=N:/3AKZ8T@9>.%PZ<$!
M1(K1/[  "'H$ '\_Q_*,2RL;-;JK6=J[J,0RG1G5%L<G3K1,YQ8)62DK74F-
MN@7#*Q5UE;6\$1@_7CG+5X9@LLDFLGY@CQV"73M>F-GH$EL/>?5<*U.+FNX/
M;]1JE[RZSY!M%ED*Y.U/6[[>X+K;3U18NF;QLBW>,U4A%-4.H?F-$I.[3.K3
M.>8[VQ8'9*+G]+V34<EK+*X:OI?<=%W&XR9<HME+E9Z?<PN91;)N9ZY71:MB
MJ@FF4RIC<=]/:Q1;+H+O",JH/:5H.:4B_P"B7/4U*+8M=B=A+HA:Y:M'FK/<
MVT+9'-)8.E&"LBLU2=E551(F*IP^8C.Y+=Y7N!NNVZ;-ZG;+'>67=+W%4A1I
M(HZ1=HZO(5FM4/2ZW2ZQ'4N'CFC.);LXU-%LBS2$Q5% ,<W:9I&G6F5N]^M>
M00CRT6^>53<3EBD&;N0BR2<RZ221!]*+M&*?GN#%\UPH J*"8YC&'B[_ .CS
MK]>;\4K_ #*E^NK?-#] ?[G&P?WC]V?,1Z,Q3#7FTKL9B2J\>:/@Q3;/';^*
MJ;!JXFIQ5%.O)6^TVF.ABN4BJE3%]YSKH:)K*DSF1CLL8*V'5+35<VL8PCBI
M0KN$8-ZE:Y]!:8E'8L@L$)4$(=RW;LT#J*%3<&!HGX]!J/12U=E&SN@463D$
MZ5*PM94-%,'#ZQ>WZS),4WJSE]$.I*AS*JKELU6AUU&"?FK X7:HJ9O;-7I,
MZM:H5_IS3.HY\,(Y<+1L5,1]'EY]E7F]J%E-,)MU(M4D?L"[Y@U<'</$&C5)
MRH6O5>OTR4N,]:9>LR;8C&)ID@\:L'54GK;7K]+@I/E48F85ZJJF:$./M<I3
MMQ;(*)J@<("L1=0"J6BRU)]I$1 3<;5$9/V5&V]PD\DW[>"DI-PT5/8'YGQ'
M"_EI&>KK%$X/TG)"3$Q8<WL*%=J(:NWF[#8FE4ZXM/.@B&,C[/KRLF^GW*5R
M3FCHI%*DDH5) IG)4T5TC&H$=5L=D)>0M.HN<I?3:L#3H;X)7BA5&T6"R1?M
M)=XGZQ(YDP@UTEQ(H1%5(ZHQ"KX>:0O@L5.N$BI#U^!DG-DA(F!>H)15JMK6
MOJ,F2LG-Q,H_,Q73%\](V2,D!&OE!YCLS=!2<60RQA*/2W73&+26AG]=:.IJ
M:IF&1VCPSD7$VV@GS&PWBHN!C!64\YNR29"FNY(B9(HYW:V^1Q4A8M:NU6K5
MEF&K>FM)VOI-*M.W%"RS\JZ407LR5,2J0@FBV7<.0,!3- ,)"E&MWJFTMY<Z
MG)7.HT6.J?JL4SD4$YJY,*@LHW;33CV4L:,%P9ZB!W)0<IE /,(8W3Q<M2KC
M5M;:=FSV6<*B-<8+/32", F]6&*8R9"$:R\K'2_DB1QZFZ3%P=)R5(HFYT>"
MC\U<R$X[L>91-WH9EJ@=+*3VZH6;2(R4>H/'7JDJM32TTXF;,T3.3K="T?YY
M>1C7S0*Y3['*U/.4*"28D*I'T4S14NFSYVT+%Q+AG:4FKF2:QZR,N^0,)2-D
MG7JQQ]I).6B95;GGKZ'4<QVL6N,L#VOU:53"MT?.<^N$W.2KUM)O746^N5 O
MK< ((&'U=LHV>G0$I2#=HRCT1DW@\XI=5FBVE5M5@BWDU%R=PBQJM</!*R"+
MIGFZT2JB21;J'CA.[$\8==N/G*0](?4.9@;E:*'"VBRU6SQU<>H-8PL)$69%
M![(IO7:%B9PY+7'@@HBFL!3R)0,"*R3I)*S,5J99I>7:!:K*Y&,JU;3=3A8(
MEFIZTVBZ?2S$7+F:<Y_*0S55X=!8R;'H7\MHHB*E(E9ZB,[*PGYA]_T5.HKJ
M!!+UFB6*[(&(6-@+:R8/T2ULS<CE86S!FH<55'B92@8U)1K=+DYRXV2$484F
M,@ZU4(NSE@'6G5C.7D0U6EYV%-%PJEJE6KM=(JJ3 2I^^,9R4J/&F:/+UAS&
MUNA6+1JR^7?Q,8^?6!I5C(1-DDFK%L9=59I8'S,S<$'(I*.BMR"L0"=/+47:
M%!5A8[,)B+BB+S:U>6>2TW#5EG8I!+U*,-()Q3F@V156*14,HL3UEJHNU.9$
M4SG(_?8R\2(_<5*%- U!>H3#6=LFM.L[E"QK$DVXJ763IU>+>S"\FBT26647
M,F+@2"<VK1E#B)>XVB@0&D7.S0\,C -RR1<\3E8I^O/2Q9,K&(=SUAJB\(0D
MCY;\ID$E%TD6:C956@98.52Q;1+';(QL>QJM.?1-4?T>A,;[+MRO$)$40)G,
M?88YHFHP36$[J72)'%63*Y50AK3#UJ5J3"7))/6T'+M(IF\0\V4="Y77;P;Q
M_%H*OG1CKF*"OK **'!P4J_F@']B1BLS$1LJI"2*<Q#*2+%L]/$3***[9O,1
M9G*2IH^6;-W2I$W*/0LF14Y2F #F 3\_J0(;F(_. H\^8^GT<3D3$TB<LTW6
MKAHE,L*\.A6$)5"U5JCP%@"#C5W,@B9><OKF4BHM!)ZHT!,I/,>J(I(I=4='
MRF(!)OK35<ZE'#YI,51K)&@M:QS1))>1/,*2$7)/48QBQDZZCU&1>IG=G<H)
M%0^RA0W<QGTS%,YZCYI+F@HF$K;YI ,Y@962K5=D5C2K-FZ7K435Y:4(#<%V
MB"<:J"1S.EVR:]3856O-GS);7M5RR7E'J3!E)P%]H=5F+!-R;%*/3DFSHTN@
MS7;.S"NT>)*.#)+D\PJZ)7%,9Y58W5LD-#E*VK(C6Z0"D@2J)72/DM)4D74^
MD=W PKK.)5BD=4!F^IN3R6HI*@8=-,EBL[<7%4SWX07CX2UNF%C7E30MAZZ$
M(]EIR2<-K U3L4-.K$9) Y+_ - .3%*"B[#UFS9#5*=,2$E!SVGC:YQRTAIN
M!CK+)S 2-K9K3CF;>N'![([D 4?,D$U?9P+,D'Z+05VB0US+X3'XI\@TU,F=
M^UTS5.+CZI%$QZ/UWX31\<IR>.$?(:(QR;5H";@JC,JI@*0B74C&/\;92%2+
M*U)I(S,!&TILV:-K1%Z&_>JMJZ=9J^?*UJ)J:[E<AB)D<-GAP0.JN04%-1CV
M<0Y>1M3=S#;2)A M%)"JR;6=;9BR9VMT^L+($G=HLK%6)3&532]3;L 7?BUC
ME6JZE9UE4C]6HZ0$.:&4KT2Q&9F5YVN.I6OI.$EUF2!%EXN)!JD<[A0G+H I
MP2*!BU#*/@DTJ5\M%'8VEG59.*IJ#Z#C9'V_,LHN18UZ5E>8+(UF0=@NS]9B
MD5VP)JN".7"":D=;D,^G):=25L:%?AYZ#IX3L>^;IU@(HBLR_G',7'-;U)7J
MOLVRJ+GFBI)D,\*W20<'2ISV2SMY+K76RUMH=G%0E=D304LQC?:\?)3*KM^R
MC55:XE%)(M%$5%W N$DBM"&$J92W1^U[='MLH$C2<6F8LCZU56C6*WR.GZNY
MSQC5WCJ*E1=5]G6GU03=KJ+.3MG;=$J1 ]Z0.)ZJ16?S[B;B8V]S[ZOQ?L$T
M<FUC)VV0T6O+2KN:39L@T&3J;X&AA,=%IX ^,V%0@FI6:Q<+.!9+?&4,\I'0
M\; K1=.-=Z]27==;SX*2[)VV:'-=HZ/2(FU5$"FZRD!NF<Y:3L=QS->I0%R"
M+$E0;,JA..X-X_&4EJT@^?1[DM=$9B;AFX,A(8#%E7K0@D*N81);3RM!!S7X
M9&T$N]BFV-'CXXY5;!'YJP06+8)EJ21C[]<HUU#"Z>&1;HA$ K("@S.V7-:)
M2HT>;ZPK%<>1]O5B(*M2EIB[74U):-;P$VF_;SC06T._%FV=J^KM0,=3U9<Y
M"*&)F57B,]FJI9G&!0EHK3Q8L2YB8*ESCMB=YGQ91K,NW9Y..<UYDLY-ZJ=N
MH)$S)NEC"?E7[7=\K=4^9ME]W9O5*_74ZM9YR76RA"XEL=L0/&/&9U;':*Y3
MW:Q@0*LY31/Y3L_E^_XK$!6:):I25TB>AW[%1&!J#9NLHE!6%ZI=Y9Z[FVAG
M1:<XSUXP54 5)(CEFD+-)9N*:_%MJ4-G"M]MD.PJ\(:NB%=@8*P+35ESZ+4J
MYYV9Z&J;>O,M:B9-9-9$6*J+TR:)C."KD(SDG$2P-*M2NE$'QVR*CYBM)HHH
MR8LWIRJ.6XO4D2)JB0X>8F0I1YE    YB/+W1](_FC^;^44ICFE^A,VT?,M=
MS_9J-8[33E;[4E)^@OG2Y(.UUAI8ZE)/H&>CW[ALJHTD6SIN8Y54S=1.0]N=
MM[H=TP"9S[MPUY'>:]4<%Q&[4"RVC2(>FVVD5=M8K5H.Q:4U:4U@PO4@X=H,
MF2;MRL1$H*E*!A#\F=WGMCV/%*:K><GSS++U3]OQRV:+&J(YA:M.M-8L=6FJ
M3J^;RD8_54U20;/6KHCENJF1!1,Q#D,!NX7N+WO3Z5HVP]PS#):Q+-LNH$IG
M&:U.E8I$VAA4(^'AK)<K]9Y&?DG]VDW4@\=20IF*=%))),J(B?\ )4Q[&NY+
MM/6S2%D;K\!9+2NVG2Y70HJ"MMIG[,S:6!Y6NX&#J<W*UX9X6Y'!(YND[*@5
M15$#&.4<;[<(>PR5OC,>HT536]KF&S-C(V-9F*SB0F',>PYM([UZ0<JJ$;D$
MY4$C%)UJ"43CQ=_]'G7Z\WXI7^94OUU;YH?H#_<XV#^\?NSYBLO].A'DI-HQ
MUZE*_P"I-9]PLK'U.O&N%B0%.*,"$HNT)!-WC!B<J[CVBV2=-4>MN=9.FR^B
MO B&A;+6Y:J.',@^A)%"VNT%F<6U;+,UF;HCJ0:2CADNB<025;.54E@\LY@X
MKVRP4<G4JVPJ"OLRQ3PVN'7:5J>EI2P%"4A[,JE*@Z+)6-]ZOZXU%VU(^712
MZ$EC$-2&$U0G$P:0N6V9A".'ZI#L$W\2:Q/;W&2R2,F89:K6<E:<NFI%DW2'
MF(HG,1%7RP+"2,+4TF+RNLXF/AER2DTH+)A!TAWG,6S*1:1434;MJ@^5:])P
M,!S&\XW-8"J B]JU>4;/T8][& _D)J>G7RK:1FG-@?&=.YR3D%WCMU*NC*'<
M*F.N( 4G7T% O%AZJ\X<IVQY8WED;OI^POV\R-JC6,3+M'B+V47(,;ZE&-BM
MFQ0*BR,@0S<J9B@/%?GTZ(D2:JTZUM,!)%G++ZS'VA#F9U92B,P)%Y^=6 BL
ML[5!1>77125>F7523.5G*61I)C)-EJNBX4;S<RFU?P5>MD-:W< M'%DDXY!O
M9%(1)G(.$DBNG#(11,<R?O>%G+F +ZRYFIBQ+G0D95 @S4_1@S>5>))(O4DD
M0<4TH,RIE*5)( \PA2J^_P"*W%S39V^1J<I%3,&X/*21)!M)1+1>.2<+2"3H
MCQ[Z[%O'#1X1<ZA'K5TLDL!R*G 6>;!63,*;'SD99&$7"S=@@EV<W$6%"U1\
M@VF(>5932*J,ZV(L(%< 10I?*.!DA%/BPT*%I\9#5"T%DR2\!%"ZCV!RRS0&
M3PK!)JX2]CE!N  B#,4"MS!UI 0_ON(B.@ZJJR"$<T]ZTD!G[$ZF5GM'AW%=
MA'LE,/)5Q(RSQ> >N&4@JY454E&SE4CL5@./%CHBE"1+5+86LDG8A&<LJ";Q
M*FR+N3JZ!'"4R1XT;PB[PR:":*B9"-B)H<O)23(5BZ=49L[/'0]CK[9-W*SS
MIJ,/;:A6Z'86#AHO*';.TI&J5&/:B*I#F(#?S""54ZAS6>:JM?<L'MP@X6OS
MY5YZPR;-VP@T7Z*"Q&$I*/&365D0DE#R+Y(A'DFJ!%'2BQR%,#6TTZ+-'EBL
M[;9O#)N'3V6D&L"E*MY-R62LDT\DK-8G#@L7'-D1?.5B,&D:DDW @**]2T_+
M4$JDJX=SKQPX:62VQA%QLC>20EVBS6-GFC16)64F7KE-D9,6C9^\7=HIIN55
M%30T?>HQW*,8.2=239JVF9B(0=A(PLI7)>*F4HE\R).5^;@IERU>Q[L%FCE%
M4043$0*(0-JCZ25A-5I-F2'59S]G;LT#,+0WN31PO$IS013]\C8&I%0<.$55
M_*YH=?D&,F-LI[2O)C5[M-6F?L4&Z?23V/=2%T74=63U5!V\6"*9OW2RBH-V
MODH(**&,D0@B/$U%5J'.Q8V(Z:LVFM)RTBI)."13:'5>.G4D^=NE'SUHU SI
M?K\YTY,HX6,==110U<JL37W/LJJOXR5B3/YZP2DD,G#3L-9(V0DIB0E'$I,.
MFLK7F0E,[56^PMDT/T@H)\2,FIG\2H\E5[6X>F.XE!14&\,G;&U($:>O^J(,
MIA.0<J';ID*BFY=+KIE(LLHH:(N2-847M<&T49Q]@?3MA?R)2N:L6F23E<[N
M552<OYRN(H(2#A0AEGYFC95<RBK9N=./^"B]@C(:-C+*Q) +6*3EXJ2>VJPL
M;+)6.9]L+/9&2LB;]LHFW<JKG,DW<+$\04#I_L4P\^7(IAY_.Y (\_0/%T83
M\-,U.;1/I]TD$9JT7=@#EC8)*6S2SW2MN(RP.6,2HI*TMRC$HM3-)!@\2]89
M-T7*W69+V3H-=AI.@,\Z@UW9;K-M21D55*B_=4MG*/W<CZF[B4ZE<3BY56.H
MBN5^B5V<RJB #3N4?&V-D>IU&)K$/%S$^A82TY>[1N?14O[/>2T<\ZZS-VQ1
MDJNZ )5HU=/FX>\471/1*0YCUJ[/34U9M/IR19&P2C5.5DWE0R*TRJ0R<NZ!
M-M&QM_8HA'$$Z3:.*<S5#J1#DOIS4X6J0LUPMVCQ=M=2[N0;MTK[\)%?480$
MGZT6VJ:$5<Y($4$R%;G,Z.Z5)ZT<RO$KH%)JCXL%H=>MM!E'3F9MC1S::XSM
MKN.DO:K=U+BNN56>@G+UBX4Y.D#2#M9,R9W[GK3T%C +(6I.0GY<'WMN>5;&
ME[*F[;R<J>)6DU(DTAZE(.6Z"OD=39LY522Z"'$./AC['#X1>W_A1[0]>DO_
M +.? O[GOKOJOK?J?/X(?X)Y?E^7_P#5.GS??\*KW*$=2Y%FS=NLS]NSS&.5
M]493T8V<J1\=)-&IWR4=9GR +B7S127Y"(]!.FV-@IS0K>[N'SNQ($?2Q47#
MJ1EFM@<.6*8/P)"N"V-F622.R!N9"1,=RF)5E%#FJ-3M-43DH*B/$7]39EEI
MQB>'=(0LA72'3=L)-J\=D-"RBZ!R.%%2'!3J, J%(<L?>4H!LG:XR!1K329*
MJ[!<(9KYX-&RZ0./57:K)-VN1!95,ZZ*;E8A#E*LH!F+%I2DDVT:Z>/&9#S-
M@7\M=[#P,(J*@KRJ@N4T6U6C5D"*]9&SYBB[2 CI,JP5Z#L\6YE8RLR<5+QS
M=28F$/.?0Q0*R-+J-'R"DXAU@"BJ3P5DEE2E.<ICE 0)3:W42QE:2:U!BE&%
MFK"Z(DSH5ND[S46R;A[*N7A4H:S3#AP3[)S4*<$E!.D4I :VEY6T7$ZS+-%0
M?'>R8!_T^K**OCKMBO2LW2R)YU_ZH=5,YV /W(-A2!=7K@YYE1FC67KHUPT6
M^0DYPBJ9ZD2L)P"K@ D_+?K,DZ9&%$ZY5#K U*"HGYFYQ><OJVG)TR#G(&Q0
MD))OY-^C#RE3N,=?:DI&KN'AW;-&JV>':+QR1% 3:$;)I)@"1>CB=(I4BII6
M9Q(NIM!M+SC9!XI).!D5"D30DB%8H,9TYI5DFV\E-A,*'?M@2=J'6-*V"L0R
MT?*3,5 P;M527FI!%.(K3<S:(CV#22D'C2,;(E.910K<B7K"YC*J]:IC'&$L
M%=KOL^7KE3;4>'=>U)ASZI5V@@+>,\EY(.$%O+$/TU0IUA]TX\5MQ)5 KH]3
M-?!A2&FK"1L0FF#-&NK>09I2Q&DVTF#V%X8$7I'"38ZO4@5(Q2"5&\1=3;,[
M0VDW,NUDTGLK_@CQ[%S,2]*T9F?&8-F;Q&QOUE6Y$BMU'SQ9V8@N5#*C(6B6
MK"+F=E0AO7WY7\JW%=6!F:_.Q[OU=L^2:IO_ %ZIQ15G!2 NY;1K9LL<[=!-
M(O\ 8UW_ -'G7Z\WXI7^94OUU;YH?H#_ '.-@_O'[L^8JSE:5>19ZR^LKQ,&
MJ2*Q78V:D6*DN 7%8P'2]3:V$SA(4Q ?.2* ^]$W%,A9.PRT$RJ.BU'03HQK
M=@Z1F5ZE(DDF<:_2?IG!-$7*95$UDQ\Q!4A3E*8P!REL2FK@^C$)J!8UYW9H
MF*8^<9BP51%%-6!DG$C'KI+LVJ:#D@J]#@W480 IA)Q6'S2Q21W-7T73-':B
MJUCS>?(Z5&V^/=,%BB3H%K#_  L,HB("!E3(E!0>1C<,F\H_&3D$6K9%Y(BV
M29B_=)-TDG3WU- ZB#0'K@AE02((D2 _2 \@_M8/_P WT?\ +Q,0D$Y/%OYN
M>L-K?6%C'Q:$F[MDEJ;+6H"Q2GV$"3*M7L$6W02;KB*:[0AB"8GF''BS,IRY
MR!:[[:\BF1\>SK[Q=K45JYE:,PWFEI2"50=REDN&7,GJZ:J+IH@V(=L4ATW)
MP2I]EE])L\Q)U'.X[/VQGD;#&3%M'ZM5-2,XCS'\UY$LUW-2;1I&?FK@G'I(
M]2JBJ)3#2;;,3#^%F\^<,I&J/(Y))4\9,,K3 V8'RACK(F>-7J4",>Y9F_P=
M=J[.)P,HFD8C&D(2SJ7KL'&1$- (.F[)L[91T?$,X]R5P\: D+UT_?H*O#*=
M"7E"OY)  A -PQHT39YJ<J,0G-^R6MC.>4FD'<Y<K+;';EU8WKU[*R"1$;"D
MQ126,;RTF)3B83JF O\ :B[_ .CSK]>;\4K_ #*E^NK?-#] ?[G&P?WC]V?^
M4=W_ -'G7Z\WXI7^94OUU;YH?H#_ '.-@_O'[L_\H[O_ */.OUYOQ2O\RI?K
MJWS0_0'^YQL']X_=G_E'=_\ 1YU^O-^*5_F5+]=6^:'Z _W.-@_O'[L_MGAM
M:L-7>S#3;[-,5&/G$'X,FD'.QJE<48L7A3,715E[ SEG)&13*( L^;I-@-UN
M""6 =6#!<RI<;*SV95Q\\LNZ6MZ:.D=<L$J^I9D$*5@UN-(-GN6MFCY8X&)Z
MM8G0QBO0S1/+\76RQ=6>2KVIN4VR3&2]:B6,@W4/$"ZLI7S)G./35&!9RBCE
M\Y0:+N 28.0204.0I3VYXTB9B8L=0J9K*^AX1JYG81P=6H2%O8%86N#;R321
MK[IFQ#_I5!%1$J"R;@4P2,;H8[&H64951TU47=(N8MVG,Q:K647AIAM(Q9@!
MPW4KC]@[![Z1*1J<Q /[T!IY)>AW*M15T8[*M$OGZ#207]=R"Y#5A05)!N)*
M+097=HU<O(E=9XB97RP2.F0>HY9:WT)"8?5R,E9F(;34E%O(F-L#B"4.V?KU
MUPY3 \I&MWZ"K91P4@%*NB8H ;P$9!0C*Y!,PK&+&?KJ-5?KS$3/R#RC12]6
M%KUI>NS;&6T*.0,FF/2H)CBF8_(O7*0=K0FJN[CBZ=("Y<PTHYB"0F8V2ZP3
MY21E$VJ:4=.2S.@23]LQ$JAA:H<^L3&*7BO1<(PNCU>R6-S5F2Q*=+&8MI2,
M8HN+"5^_3!1FFE5I);V;)@F=55B\34.HF#-)1V5I1IX)QS:G\?#RS.'KT$_G
MGCB.F9]6N).DD&)3*J TD$#^84 ZU>D$FY5W*A$!J-?OKZ58O[O#7J=@3,8-
M[*M%F.=1L=*V8';IH(DCCH,Y5$R9U^A 0$PJ*)D*<Y;B]AW,FZ;42B-M(L1S
M0SY+RZ@_K;:V1<FP*H4BS\9:$<&.U2(GUJJ-UB#T"4O5+N%V]QB6==A8&6L;
MR9ILRQ;UYY/V.6JK>J2PD(Z61N;66A7/GQY4S&210%43B4Q.;>YKR5C3C74<
MI*-XPU5E0LBK!=C"/J\\)"& JQFUT+:(E&',!A%XXE6Q!!/J.)+9&7V%<07L
MW0ZU1*JK&)2<FO/+VVB5NZPJ4LS?Q\-\')M4\^+,[8ZJR15DP^S>)@)88>22
MG'3ZKFK[.5+#P$K*('G[0M'I0-18O&Z M%K9)HS#-PBS4.D)VSI-0#" *@DA
M7Z/./WL@]FI2#C?7(9^P0?N(\LVJQ=-UER]!HZTM:S(K1*HB4723)43E1$"
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M9"@B9^T<R2AB+"/640((<A* \,&M/B7M7:1[F]'39PKI)FU5C]"AX^$GH19
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M:7G#&PS4FPS[+]/:7;0;I+J##(,8FLU.L1"[MX[<*D2(4H% 14.0IO[;W?\
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M>>6<Z)52)J"74"/3'.\)'Q";LRAB'.+E,K8CD3&3^QF-ZR!^8E\!](<P\?\
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M2=74 AP2,3F(PTDJJ[02C_7FP/E%V"*#A\@1F*OK)EF3=TDHL3IZDDU2&,
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M0*#SX11S"+,WF9ME#-HY\=^DO6&<DLWK,BZ.HFF9"3D88B2KE$.94%C&( B
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M[:YV0/DN-'M#F2-6G4PVE7-J4<ZXA6GQ4FH/M(+!NEB^6X01]31;(@U\X5#
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M0H)AU@GX^^-U'.(B8XF.8QA$#5BNF 3BH(&AVA@%0Q3%,H("40%0Q#B CZ1
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M?Q]KF$_Z]Z9^"_C[7,)_U[TS\%_'VN83_KWIGX+^/M<PG_7O3/P7\?:YA/\
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MK;(-IIVY2(V3<>H((&0Y 8XE*'/I(4I" (\^@A"E(0A>?H*0A0  XMW^:/\
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M59+0_P ":T]F6#":]LRL>@@Y=OE$&S=607='\H"F 33AW5LJ:32S4OY0:F6
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M_P!41^OX^^%;_P!41^OX^^%;_P!41^OXY&T&W&#YQCHB'YPF$.?AP'/0[?X
M !]D2]  !0#ZOW"E /H<??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M
M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M
M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M
M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M
M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M
M_P"J(_7\??"M_P"J(_7\??"M_P"J(_7\??"M_P"J)?7\!RT*WAT@(% %4@
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6F $3(FDF!2)$*0 Y% .0>Y_^*+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>a1.jpg
<TEXT>
begin 644 a1.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M# P,# P,# P,#/_  !$( ),!P@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M[U_2O^S-XXU3XF?L[> ?$FN")=:\0>&M.U/4!%'Y<8N)K6.27:N3M&]FP,G
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M./Y^GXT 345'%<>8^W:P;&3Z?GW_  J2@ HHHH _)C_@[N_Y,7^&?_91(O\
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M&<88]\$?M^@PN[^\,GFOYK/^#7[_ )2RZ9_V*.L?^T*_I0DF\FV5NNU,X]:
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MTG]]'0$?SKH(VP^WVS7W5-MK4_C6I3E";IR6J)**,XHS6A(V5%DC96 96!#
M]Q7Y%_\ !QK_ ,%)_CE^P5\;_A?I_P +O&"^&=)\2Z)>W%]%_9EK=?:;B.=
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MKC_TEMZ /U8Q\OX5_*E_P7=.?^"NWQT_[#%K_P"FVTK^J[^#\*_E0_X+N?\
M*7?XZ?\ 88M?_3;:4&D#Y)E/'^?6OZ[/^"6AS_P39^ O_9/]$_\ 2**OY$Y?
MN_Y]:_KL_P""6?\ RC9^ O\ V3_1/_2**@F>Y[U7Y)_\'='_ "9W\+_^QT;_
M -(YZ_6ROR4_X.Z/^3._A?\ ]CHW_I'/02?@&_WV^AK]J_\ @SQ/^E?M&_\
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M\"_M'^#X_$7@/Q=X?\7:-(/^/S2[Q+A$/H^TY4CN& (KMXL,#WYK^-S]F/\
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M?\&B)_XPH^)G_8[/_P"D<%4.I\1^L$2R*@^95/H3G'XU_/E_P=A? 32_AO\
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MH;'7&XUWNJ_\%//VCM:M&AN?CE\3FC;LFNS1X^A4@T$G]4/[2W[7WPU_8_\
M \FO_$SQKX;\&Z: 3%_:=ZL,U[CJD$6?,F<] J G-?SI_P#!9[_@M#K7_!3C
MQ3I^@>&;34?#?PC\/W+7FF6UWC[1KUPN4^U7"CC:BL1'&3E"Y)R>GQ%XE\0Z
MCXUUZ;5=<U+4-<U6X;=)>ZG<O>7#'_KI(2WZU2F.?.F9MTC*-TC-A@H(Z$@C
M@=L<^W4 #8PMO"W_ "SCC'+$\;B<#Z#H/;&:_4[_ (-@/^">=Y\:?VF'^.7B
M+39E\)_#65TT-Y ##J>LO$T1=3T>.VC=VW#I(R]"E>&_\$K/^"'OQ(_X*.^(
M]/U_5-/NO!'PC5R]WXBO;=XY=9MR<&*QB;YF<XYD?,2@\;C@G^E#]GW]G_PG
M^S?\'M \#>"M'M=%\+^&[8VME9P8*@$DNS'^)W<LS$]68F@#N(8]L>2VXD<D
M#@U^&O\ P>%?\CS^SO\ ]>'B#_T/3:_<X#"XK\,?^#PP[?'?[.__ %X>(?\
MT/3: /QI'^L'T-?T%?\ !I'_ ,F#^.O^QVN/_26WK^?1&!<8]#7]!?\ P:1_
M\F#^.O\ L=KC_P!);>@#]6?X/PK^5#_@NY_REW^.G_88M?\ TVVE?U7_ ,'X
M5_*A_P %W/\ E+O\=/\ L,6O_IMM*"HRL?),OW?\^M?UV?\ !+/_ )1L_ 7_
M +)_HG_I%%7\B<@POXC^=?UU?\$MCC_@FQ\ _P#L0-$_](HJ D[L]\K\D_\
M@[H_Y,[^%_\ V.C?^D<]?K6ARM?DI_P=TG_C#KX8?]CHW_I'/02?@(_WV^AK
M]J_^#/'_ (^?VC?^N/A;_P!"UFOQ59>&/L:_:K_@SQ_X^?VC?^N/A;_T+6:
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MS-M7NN^FUS](O^"*GC^\\:_LDM9W4TDZ>']7FT^ N.5AVQR(G_ ?,85^?_\
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M'#*N)/O #Y6[<_I5BB@#Y]_X*8?LE:I^W'^Q1XZ^%>AZM8^'=2\4PPPPW][
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M?\H5OA/_ +^I?^ETU 'X3?%;]J+]IGQ!_P %W] ^)&L?!G3;']HJWU"QFLO
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M"'W_  78\/\ _!77PMK>DWVCQ^"?BEX3@BN-2T6.Y^T6>H6[L5^UV;-B3:&
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MQSIZ:?=0:O# JP!9O-#HT8!SDD8;/^(!]UVUNJJ/Q_F:F/"TV--BXI"YYZ4
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M#@#X'ZG^T!_P1R^/'AG1HVDU!=#MM5ABA0LTHL+VVOW0*!U9+4J /45\=_\
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M&YFVKCZH_P""=W[$6C_\$Z/V3/#7PC\/ZSJWB+2O#)G:&^U)(TN)?-F:4Y"
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M?"+XF_$;X/M=2,TEA;'^U;:%3TCA8M'<(@]'EDZ#D5Z__P $ZO\ @W)\&_L
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M@9&>HK\F/CI_P9^?"+4?&DFO?!_XG?$;X/S32M)]EAE.J6]LAR/*BD9TN%4
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M-7'-+MVL,<444 .9 ^,_PG(I0N#GUHHH C=<M0JC-%% $A&X<TWRUSTZT44
M-,:H?E&._%2+]VBB@"/%+&,-110 W8,U+110!&5&ZA!\U%% #RH+!NZ]*%4+
AG'\1R:** &F)2^[:N[UQS2Q#:*** '4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
